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Abstract 
Regulation of nitrogen catabolism is of immense interest in the kingdom Fungi, as 
nitrogen source utilisation influences key aspects of fungal biology including 
development, secondary metabolite production and pathogenesis. In the 
basidiomycete pathogen Cryptococcus neoformans that causes over 625,000 deaths 
annually, relatively little is known about nitrogen regulation. In view of this lack of 
knowledge, this thesis is articulated through four major aims to investigate the 
interplay between nitrogen catabolism and virulence in C. neoformans. The first two 
aims scrutinise the wiring of the global nitrogen regulatory circuit, while the last two 
aims examine specific nitrogen catabolic pathways of medical relevance. 
In all species of fungi studied thus far, GATA transcription factors are the 
central regulators of nitrogen assimilation as they globally activate the expression of 
permease and catabolic enzyme-encoding genes required to degrade most 
complex/secondary/non-preferred nitrogenous compounds. The first aim is to 
characterise the function of the nitrogen-responsive GATA factor in C. neoformans. 
Here, the C. neoformans Gat1/Are1 factor was shown to regulate multiple key 
virulence traits, in addition to its evolutionary conserved role of controlling nitrogen 
utilisation. These virulence attributes include the formation of antiphagocytic capsule, 
deposition of antioxidant melanin in the cell wall, production of infectious 
basidiospores, and the ability to grow at high temperature. 
Given the importance of the GATA factor Gat1/Are1 in pathogenicity, gaining 
insights into the molecular mechanism governing the regulation of Gat1/Are1 activity 
in response to nitrogen availability is pivotal. In certain fungal species, GATA factor 
activity is inhibited through interaction with co-repressor Nmr proteins when readily 
assimilated (preferred) nitrogen sources such as ammonium or glutamine are present. 
This regulatory phenomenon, nitrogen metabolite/catabolite repression, enables 
preferential utilisation of metabolically favoured compounds thereby conserving the 
organisms’ energy to maximise fitness. The second aim is to characterise the function 
of a potential Nmr homolog in C. neoformans. Here, unique evidence of divergence 
between different fungal species in the evolution of Nmr-related proteins was 
demonstrated. In addition to its functionally conserved role of inhibiting GATA factor 
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activity under repressing conditions, the C. neoformans Nmr homolog Tar1 also 
positively regulates GAT1/ARE1 expression under non-repressing conditions.  
The transcriptional studies of catabolic genes from the proline degradation 
pathway were proven to be a fertile area of research for investigating the roles of 
Gat1/Are1 and Tar1 in modulating nitrogen metabolite repression. The third aim is to 
formally characterise the functions of these enzymes. Degradation of the 
multifunctional amino acid proline is associated with mitochondrial oxidative 
respiration. The two-step oxidation of proline is catalysed by proline oxidase and Δ1-
pyrroline-5-carboxylate (P5C) dehydrogenase, which produce P5C and glutamate, 
respectively. In the C. neoformans genome, there are two paralogs (PUT1 and PUT5) 
that encode proline oxidases and a single homolog (PUT2) that encodes P5C 
dehydrogenase. Here, the expression of all three putative catabolic genes was shown 
to be inducible by the presence of proline, however, only Put5 and Put2 were required 
for proline utilisation. Additionally, Put2 was required to prevent excessive 
mitochondrial superoxide production probably by limiting the P5C-proline cycling 
that delivers electrons to the electron transport chain and to O2. Intracellular 
accumulation of reactive oxygen species is known to be a critical feature of cell death; 
consistent with this fact, the put2Δ mutant exhibited a slight, general growth defect. 
Further, the put2Δ mutant was avirulent during murine infection, making this the first 
report highlighting the importance of P5C dehydrogenase in enabling pathogenesis of 
a microorganism. 
Multiple lines of evidence have also suggested that the enzymes of another 
catabolic pathway, uric acid, may be important for pathogenesis. The ecological niche 
of C. neoformans is uric acid-rich pigeon guano, and uric acid is also a well-known 
inducer of the virulence factor capsule formation. Assimilation of uric acid 
necessitates several enzymes including another bona fide virulence factor, urease, the 
only enzyme of the pathway that has been characterised. Since uric acid is the end 
product of purine metabolism in humans and it acts as an immune enhancer, uric acid 
utilisation by C. neoformans during infection may potentially serve as a method to 
modulate host immune response. The fourth aim is to characterise the functions of all 
the uric acid catabolic enzymes. Here, complete degradation of uric acid to ammonia 
was shown to require: URO1-encoded urate oxidase, URO2-encoded HIU hydrolase, 
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URO3-encoded OHCU decarboxylase, DAL1-encoded allantoinase, DAL2,3,3-
encoded allantoicase-ureidoglycolate hydrolase, and URE1-encoded urease. Further 
studies however, are required to verify the roles of the C. neoformans uric acid 
catabolic enzymes during infection, ideally using a modified animal model system 
that lacks these biological enzymes for improved mimicking of human pathogenicity. 
Overall, these studies lay an excellent foundation for future research into dissecting 
the link between nitrogen sensing and elaboration of virulence composite in C. 
neoformans. 
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Abstract
The habitats of fungal pathogens range from environmental to commensal,
and the nutrient content of these different niches varies considerably. Upon
infection of humans, nutrient availability changes significantly depending on
the site and pathophysiology of infection. Nonetheless, a common feature
enabling successful establishment in these niches is the ability to metabolise
available nutrients including sources of nitrogen, carbon and essential metals
such as iron. In particular, nitrogen source utilisation influences specific
morphological transitions, sexual and asexual sporulation and virulence factor
production. All these physiological changes confer selective advantages to
facilitate fungal survival, proliferation and colonisation. The three most well-
studied components of the nitrogen regulatory circuit that commonly impact
fungal pathogenesis are the ammonium permeases (the nitrogen availability
sensor candidate), ureases (a nitrogen-scavenging enzyme) and GATA tran-
scription factors (global regulators of nitrogen catabolism). In certain species,
the ammonium permease induces a morphological switch from yeast to inva-
sive filamentous growth forms or infectious spores, while in others, urease is
a bona fide virulence factor. In all species studied thus far, transcription of
the ammonium permease and urease-encoding genes is modulated by GATA
factors. Fungal pathogens therefore integrate the expression of different viru-
lence-associated phenotypes into the regulatory network controlling nitrogen
catabolism.
Background on fungal nitrogen
metabolism
Microorganisms are constantly challenged with stressors
such as nitrogen deprivation in their ever-changing local
environment, and various regulatory mechanisms have
evolved to ensure that genes are appropriately expressed
according to their cellular state. In eukaryotes, studies
into gene regulation in response to nitrogen availability
were first carried out in the model ascomycetes, Saccharo-
myces cerevisiae, Aspergillus nidulans and Neurospora crassa.
Unlike diazotrophic bacterial species, the free-living fungi
are unable to fix gaseous nitrogen and therefore have to
obtain reduced forms of nitrogenous compounds from
alternative sources.
Pioneering research in the model fungi led to the under-
standing of nitrogen catabolite/metabolite repression, a
transcriptional regulatory mechanism that enables prefer-
ential utilisation of easily assimilated nitrogen sources such
as ammonium and glutamine in order to conserve energy
(Wong et al., 2008). When metabolically favoured sources
are lacking or exhausted, nonpreferred/secondary/complex
nitrogenous compounds are then selectively consumed
through the expression of permease and catabolic enzyme-
encoding genes of their specific catabolic pathways. This
metabolic response to nitrogen limitation typically necessi-
tates two distinct signals: (1) the absence of preferred
nitrogen sources leading to the activation of globally
acting GATA transcription factor(s), and (2) the presence
of a particular intermediate or substrate of the secondary
nitrogen pathway leading to activation of pathway-specific
transcription factor(s). Thus, both global- and pathway-
specific factors are generally required to induce the
transcription of nonpreferred nitrogen catabolic genes.
FEMS Microbiol Lett 345 (2013) 77–84 ª 2013 Federation of European Microbiological Societies
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Over the past decade, interest in nitrogen metabolic
gene regulation has expanded to encompass a number of
pathogens including clinical S. cerevisiae isolates, Candida
albicans, Aspergillus fumigatus, Coccidioides posadasii and
Cryptococcus neoformans, a few of the several dozen fungal
species that consistently cause disease in the human pop-
ulation. A common feature enabling these pathogenic
fungi to survive in the environment and to cause disease
in a host is inextricably linked to their ability to forage
nitrogen from the surroundings. This article focuses
explicitly on our latest understanding of how nitrogen
regulation influences specific morphological changes,
sporulation, virulence factor expression and catabolism-
related pathogenesis activity of human pathogenic fungi.
Such physiological responses are critical for successful
colonisation of a host during infection as they help evade
immune defence systems, facilitate attachment or invasion
of tissues, promote dissemination or cause clinical symp-
toms of the disease.
Fungal pathogens of humans
Saccharomyces cerevisiae
The hemiascomycete S. cerevisiae is one of the most
intensively studied eukaryotic model organisms in molec-
ular and cell biology and has recently emerged as an
opportunistic pathogen. This model yeast shares a rela-
tively close phylogenetic relationship with the more clini-
cally prevalent Candida spp. Its natural habitat is on Oak
trees and fruits and can be widely found commercially in
breweries, bakeries and scientific laboratories. Infection
with S. cerevisiae presents with a variety of symptoms and
is believed to be acquired nosocomially, through sexual
contact or by oral ingestion (McCusker, 2006).
Under harsh conditions such as nitrogen starvation,
S. cerevisiae a/a yeast diploid cells can undergo a dimor-
phic transition to an invasive filamentous pseudohyphal
growth form (Gimeno et al., 1992). The high-affinity
ammonium permease Mep2, but not the two other
ammonium permeases Mep1 and Mep3, is necessary for
differentiation into a pseudohyphal growth form during
ammonium-limiting conditions (Lorenz & Heitman,
1998). The mechanism of ammonium sensing and the
signal transduction that activates filamentous growth in
S. cerevisiae, however, remains obscure. In a human host,
ammonium is present at varying concentrations in all the
major tissue locations (Supporting Information, Table
S1).
Activation of MEP2 expression requires at least one of
the GATA factors Gln3 or Gat1, depending on the nitro-
gen source present (Marini et al., 1997). Mutations to
Gln3 or its cytoplasmic interaction partner Ure2
abrogates MEP2 expression and stability and results in
pseudohyphal deficiency (Lorenz & Heitman, 1998).
Heterologous expression of MEP2 in gln3D and ure2D
mutants does not restore filamentation, indicating that
Gln3 and Ure2 have additional targets that regulate
dimorphism apart from Mep2 (Lorenz & Heitman, 1998).
Consistent with this notion, mep2D mutants of clinical
S. cerevisiae isolates display equivalent virulence to wild
type in a murine model of disseminated disease, while
gln3D mutants are slightly attenuated in vivo (Kingsbury
et al., 2006). This suggests that the ability to sense exter-
nal ammonium is not essential for the survival of S. cere-
visiae in vivo and that the mep2D mutants may still have
the ability to undergo pseudohyphal growth given the
availability of other serum nitrogen sources such as
amino acids and purines. Aside from ammonium, in the
human blood glutamine, glutamate, asparagine, arginine,
proline, uric acid, allantoin, urea and creatinine, among
others, can all potentially serve as a nitrogen source
(Table S2). Whether the attenuated virulence of the gln3D
mutants occurred through an inability to utilise a
wide range of nitrogen sources or through a defective
pseudohyphal developmental pathway remains open to
speculation.
Candida albicans
The phylogenetically related C. albicans diverged from
S. cerevisiae c. 200–800 million years ago, and two-thirds
of the C. albicans 6500 genes have clear orthologues in
the S. cerevisiae genome (Jones et al., 2004). While this
diploid commensal organism generally occupies the skin
and alimentary canal of healthy mammals, it can also
cause opportunistic infections in most tissues and organs
of an immunocompromised host. During infection,
C. albicans switches from the unicellular yeast form to
multicellular, filamentous hyphal and pseudohyphal
growth forms that serve as a means for tissue invasion
(Lo et al., 1997).
Neutral-to-alkaline extracellular pH and the presence
of CO2 are critical determinants that autoinduce hyphal
morphogenesis in C. albicans (Vylkova et al., 2011). In an
acidic, glucose-deprived environment (such as inside
phagocytic cells), C. albicans utilises amino acids as a car-
bon source and excretes the amino nitrogen as ammonia,
causing the surrounding pH to rise (Vylkova et al., 2011).
Mutations to STP2 (encodes a transcription factor that
regulates the expression of amino acid permease genes),
DUR1,2 (encodes urea amidolyase that catabolises urea to
ammonia and CO2) and ATO5 (encodes a putative
ammonia exporter), either abolish or delay pH neutralisa-
tion (Vylkova et al., 2011). Consistent with this notion,
genes for arginine metabolism are induced following
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internalisation by macrophages; CAR1-encoded arginase
converts arginine to ornithine and urea for Dur1,2 to act
upon (Lorenz et al., 2004). dur1,2D mutants are defective
in germ tube formation in the presence of urea or argi-
nine and are unable to pierce the macrophages cell mem-
brane to facilitate escape following phagocytosis (Ghosh
et al., 2009). Urea metabolism via the biotin-dependent
Dur1,2 and dimorphic switching are therefore important
for resistance against innate host immunity. In the
human blood and cerebrospinal fluid, urea is present at
very high concentrations (Table S2).
Starvation for amino acids or ammonium is also a
potent morphogenetic signal that promotes switching
from the budding yeast to filamentous hyphal form. In
support of this observation, the regulator of the general
amino acid starvation response, Gcn4, has been impli-
cated in dimorphism (Tripathi et al., 2002). In addition,
dimorphic switching is Mep2 ammonium permease-
dependent during nitrogen-limiting conditions (Biswas &
Morschhauser, 2005). So, unlike S. cerevisiae mep2D
mutants that exhibit a filamentous growth defect during
ammonium-limiting conditions, the filamentation defect
of C. albicans mep2D mutants is under general nitrogen
limitation independent of nitrogen source (Lorenz &
Heitman, 1998; Biswas & Morschhauser, 2005).
Similar to their counterparts in S. cerevisiae, both the
GATA factors Gln3 and Gat1 activate the expression of
MEP2 in C. albicans (Dabas & Morschhauser, 2007). While
Gln3 is required for nitrogen limitation–induced filamenta-
tion, Gat1 is surprisingly dispensable for filamentation under
both repressing and nonrepressing conditions (Limjindap-
orn et al., 2003; Dabas & Morschhauser, 2007). This
conundrum is explained by the observation that a func-
tional Mep2 is not required for filamentation in gat1D
mutants, suggesting that the loss of GAT1 may lead to acti-
vation of other filamentous growth-inducing signalling
pathways (Dabas & Morschhauser, 2007). gat1D mutants
are avirulent in a murine model of disseminated candidia-
sis, and this attenuated phenotype is not associated with its
impaired serum nitrogen source utilisation ability, imply-
ing that Gat1 regulates additional unidentified genes
required for pathogenesis (Limjindaporn et al., 2003).
Indeed, more recent findings have shown that both Gat1
and Gln3 regulate the expression of DUR1,2-encoded urea
amidolyase (Navarathna et al., 2011). Virulence of the
gln3D mutants is also reduced in comparison with wild
type, albeit to a lesser extent than the gat1D mutants (Liao
et al., 2008).
Additionally, while both Gln3 and Gat1 also regulate
the expression of the proteolytically activated transcrip-
tion factor-encoding gene STP1, Gat1 plays the predomi-
nant role (Dabas & Morschhauser, 2008). Stp1 mediates
the induction of the major secreted aspartic protease
isoenzyme SAP2 when proteins are the only nitrogen
source available (Dabas & Morschhauser, 2008). Secretion
of aspartic proteases is one of the earliest recognised viru-
lence attributes of C. albicans as they directly modulate
host immune response via their role in nutrient assimila-
tion and degradation of extracellular matrix proteins and
immunoglobulins (Naglik et al., 2004). Consequently,
sap2D mutants also exhibit reduced virulence in various
animal models of disseminated candidiasis (Hube et al.,
1997).
Aspergillus fumigatus
Aspergillus fumigatus is an opportunistic pathogen that
causes life-threatening invasive pulmonary infections in
neutropenic and immunocompromised patients. This
saprotrophic fungus is found ubiquitously in decaying
soils and on organic debris, where it plays an important
role in the recycling of carbon and nitrogen, which
demands metabolic diversity (Latge, 1999). Like its well-
studied sister species A. nidulans, A. fumigatus has the
ability to utilise a wide array of nitrogen sources, and this
nutritional versatility has led to its widespread distribu-
tion. Transmission of A. fumigatus occurs through the
inhalation of germinated conidiospores that can lead to
hyphal invasion of lung parenchymal tissue through the
bronchioles, often resulting in severe asthma, sinusitis
and even death.
Nitrogen starvation has been demonstrated to be
a prominent host-imposed stress during early-stage
A. fumigatus infection (McDonagh et al., 2008). Unlike
C. albicans, whereby dimorphic transition from yeast to
filamentous form is required for pathogenesis, after spore
germination A. fumigatus exists only in its monomorphic
mould state. Instead, proper regulation of pathways
involved in growth control and nutrient sensing are
the critical determinants that influence the ability of
A. fumigatus to cause disease. The cross-pathway control
system of amino acid biosynthesis is an example of a
growth control pathway that is important for pulmonary
aspergillosis. The bZIP transcription factor CpcA, an
orthologue of C. albicans Gcn4, activates the expression
of target genes encoding components of the amino acid
biosynthetic pathways during amino acid starvation and
other stresses (Rhodes & Brakhage, 2006). Although
cpcAD mutants display wild-type growth on ammonium
or nitrate as the sole nitrogen source, the mutants are
unable to derepress the expression of genes associated
with amino acid biosynthesis when starved for amino
acids (Krappmann et al., 2004). Independent neutropenic
murine models of pulmonary aspergillosis experiments
have demonstrated that CpcA regulates pathogenesis
(Krappmann et al., 2004).
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Nutrient sensing-related pathways also contribute to
A. fumigatus virulence. RhbA, a member of the family of
Ras-related proteins, is implicated in sensing nitrogen
availability (Panepinto et al., 2002). Transcription of rhbA
occurs throughout the asexual developmental cycle, sug-
gesting that RhbA functions in normal cellular processes
instead of specialised developmental programmes; rhbA
expression markedly increases in response to nitrogen
starvation, however (Panepinto et al., 2002). rhbAD
mutants exhibit wild-type growth on rich media or on
defined medium supplemented with ammonium as the
sole nitrogen source, but growth rates are impaired on
secondary nitrogen sources such as proline, histidine and
nitrate (Panepinto et al., 2003). A murine model of pul-
monary aspergillosis indicates that the nutrient acquisi-
tion role of RhbA is required for pathogenesis (Panepinto
et al., 2003).
Additionally, rhbAD mutants display enhanced sensitivity
to the antibiotic drug rapamycin, suggesting that RhbA
functions in the nutrient-sensing target of rapamycin
(TOR) signalling pathway (Panepinto et al., 2003). The
highly conserved TOR pathway acts through the GATA
factors Gln3 and Gat1 in both S. cerevisiae and
C. albicans to control growth in response to nutrient
availability (Beck & Hall, 1999; Liao et al., 2008). Multi-
ple lines of evidence suggest that mutants lacking the
GATA factor known as AreA in A. fumigatus are also less
virulent than wild type in murine models of invasive
pulmonary aspergillosis (Hensel et al., 1998). According to
Hensel et al., these observations are likely caused by the
reduced competitive fitness of the areAD mutants given its
inability to utilise a wide array of nitrogen sources.
Coccidioides posadasii
Filamentous, saprobic Coccidioides spp. are members of
the Onygenales that are found in deserts and semi-arid
soils (often several inches below the surface of the soil
where nitrogen levels are higher) and have the ability to
survive harsh environmental conditions such as alkaline
soil with high salinity (Saubolle, 1996). Two species have
been characterised based on molecular and biogeographi-
cal differences: Coccidioides immitis, which appears to
be restricted to San Joaquin Valley of California, and
C. posadasii, which is widespread throughout regions of
endemicity in south-western USA and northern Mexico
(Fisher et al., 2002). The multicellular hyphal form of this
ascomycete can septate into single-celled arthroconidia
and be inhaled, to cause potentially life-threatening pneu-
monia in both immunocompromised and immunocom-
petent individuals (Cole et al., 2006).
The host macrophages in lungs kill invading microor-
ganisms largely through nitrosative and oxidative
stresses. The production of toxic nitric oxide is mediated
by the inducible nitric oxide synthase that requires argi-
nine as a substrate. Like C. albicans, arginine metabolism
by C. posadasii also serves as a means of innate immune
evasion (Ghosh et al., 2009). One of the mechanisms
employed by this respiratory pathogen to facilitate survival
in the hostile host environment is to induce the produc-
tion of macrophage cytosolic arginase I (Hung et al.,
2007). Arginase I hydrolyses arginine to ornithine, a
substrate for ornithine decarboxylase, a key enzyme in
the polyamine biosynthetic pathway and a potential
regulator of C. posadasii parasitic cell differentiation
(Guevara-Olvera et al., 2000; Iniesta et al., 2002). Host-
derived ornithine at the sites of fungal infection may
enhance C. posadasii growth and proliferation through
the provision of a pool of monoamines that the para-
sitic cells could utilise for the biosynthesis of glutamine,
proline and polyamines (Iniesta et al., 2002). In the
macrophage, arginase I competes with nitric oxide syn-
thase for arginine, causing a reduction in the production
of nitric oxide but an increase in ornithine and urea
production, thereby promoting intracellular survival of
C. posadasii (Moali et al., 1998). Treatment of C. posad-
asii-infected mice with the arginase physiological inhibitor,
N-hydroxy-nor-L-arginine, results in augmented host sur-
vival, indicating that arginase activity facilitates disease
development (Cole et al., 2006).
In C. albicans, arginine catabolism works in concert
with DUR1,2-encoded urea amidolyase to promote
hyphal switching that plays an important role in facili-
tating escape from host defences (Lorenz et al., 2004;
Ghosh et al., 2009). Unlike hemiascomycetes that use
Dur1,2 for urea utilisation, most other higher fungi
including species of Coccidioides and Cryptococcus use
the nickel-containing enzyme urease (Navarathna et al.,
2010). Urease of C. posadasii catalyses the hydrolysis of
both fungus- and host-derived urea to produce ammo-
nia (Mirbod et al., 2002). Ammonia and urease released
by C. posadasii during the endosporulation phase of the
parasitic cycle creates an alkaline microenvironment that
likely interferes with host defence function and contrib-
utes to exacerbated lung tissue damage (Cole, 1997;
Mirbod-Donovan et al., 2006). Consistent with this
notion, the expression of URE-encoded urease is upreg-
ulated during the parasitic cycle endosporulation stage
of C. posadasii (Mirbod et al., 2002). Mice intranasally
infected with ureD mutants exhibit a better-organised
granulomatous response to infection and increase clear-
ance of the pathogen, leading to better survival rates
compared with mice inoculated with wild type (Mirbod-
Donovan et al., 2006). Urease production is therefore
required for the pathogenesis of C. posadasii parasitic
cells.
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Cryptococcus neoformans
Cryptococcosis is the leading invasive fungal infection in
the world today, responsible for c. 1 million cases of
cryptococcal meningitis per year. Over the past century,
this opportunistic basidiomycete has risen from the status
of medical curiosity to a common but life-threatening
central nervous system pathogen of the immunocompro-
mised population, particularly patients with AIDS (Casa-
devall & Perfect, 1998). The primary ecological niche of
the ubiquitous C. neoformans is pigeon guano, and the
majority of the nitrogen is present in the form of uric
acid, with the remainder consisting primarily of xanthine,
urea and creatinine (Staib et al., 1978). Normally isolated
as a budding yeast, C. neoformans can also undergo a
dimorphic transition to filamentous growth form via
mating or monokaryotic fruiting that leads to the pro-
duction of potentially infectious airborne basidiospores
(Morrow & Fraser, 2009).
Progression through these sexual cycles is regulated by
a specialised region of the genome that confers cell-type
identity known as the mating-type locus, and environ-
mental cues such as darkness, desiccation and nitrogen
starvation (Fraser et al., 2004). During ammonium limi-
tation, the high-affinity ammonium permease Amt2 is
required for the induction of mating (Rutherford et al.,
2008). Although both mating in C. neoformans and
ammonium-dependent filamentous growth in S. cerevisiae
and C. albicans appear superficially similar, the morpho-
logical changes associated with mating are distinct as it
involves the formation of hyphae, basidia and spores
(Morrow & Fraser, 2009). Like the S. cerevisiae ammo-
nium permease Mep2, C. neoformans Amt2 is not
required for virulence (Kingsbury et al., 2006; Rutherford
et al., 2008). However, initiation of invasive growth in
response to nitrogen limitation is dependent on Amt2
(Rutherford et al., 2008).
One particular nitrogen-scavenging enzyme in
C. neoformans that has evoked as much interest as it has
in C. posadasii is urease. Apart from converting the abun-
dant urea to a usable nitrogen source, urease promotes
yeast sequestration within the microcapillary beds of the
brain during haematogenous dissemination, facilitating
C. neoformans crossing of the blood-brain barrier
(Olszewski et al., 2004). Both murine intravenous and
inhalation models of cryptococcosis revealed that mice
infected with ure1D mutants lacking urease survived
significantly longer than mice infected with wild type
(Cox et al., 2000; Olszewski et al., 2004). However, direct
co-inoculation of wild-type and ure1D mutants into the
cerebrospinal fluid of corticosteroid-treated rabbits or into
the brain of mice revealed no significant differences in
Table 1. Roles of a selected panel of fungal nitrogen regulatory proteins on virulence-associated phenotypes
Gene Protein
Mutant
phenotype
in mice Other phenotypes in vitro References
S.c. MEP2 Ammonium permease Wild type Pseudohyphal growth defect Lorenz & Heitman (1998) and Kingsbury
et al. (2006)
C.a. MEP2 Ammonium permease Unknown Pseudohyphal growth defect Biswas & Morschhauser (2005)
C.n. AMT2 Ammonium permease Wild type Inability to initiate invasive growth form Rutherford et al. (2008)
S.c. DUR1,2 Urea amidolyase Wild type Inability to utilise urea as a nitrogen source Kingsbury et al. (2006)
C.a. DUR1,2 Urea amidolyase Unknown Inability to utilise urea as a nitrogen source.
Germ tube formation defect
Ghosh et al. (2009) and Vylkova et al.
(2011)
C.p. URE Urease Attenuated Inability to utilise urea as a nitrogen source Mirbod et al. (2002) and Mirbod-Donovan
et al. (2006)
C.n. URE1 Urease Attenuated Inability to utilise urea as a nitrogen source Cox et al. (2000) and Olszewski et
al. (2004)
S.c. GLN3 GATA factor Attenuated Inability to utilise a wide array of nitrogen
sources. Pseudohyphal growth defect
Lorenz & Heitman (1998) and Kingsbury
et al. (2006)
C.a. GLN3 GATA factor Attenuated Inability to utilise a wide array of nitrogen
sources. Pseudohyphal growth defect
Dabas & Morschhauser (2007) and
Liao et al. (2008)
C.a. GAT1 GATA factor Avirulent Inability to utilise a wide array of nitrogen
sources
Limjindaporn et al. (2003)
A.f. areA GATA factor Attenuated Inability to utilise a wide array of nitrogen
sources
Hensel et al. (1998)
C.n. GAT1 GATA factor Slight
hypervirulence
Inability to utilise a wide array of nitrogen
sources. Basidiospore production defect.
Overproduction of melanin. Enhanced
growth at febrile temperature
Lee et al. (2011, 2012)
S.c., Saccharomyces cerevisiae; C.a., Candida albicans; A.f., Aspergillus fumigatus; C.p., Coccidioides posadasii; C.n., Cryptococcus neoformans.
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colony counts when strains were recovered (Cox et al.,
2000; Olszewski et al., 2004). Urease is therefore impli-
cated in the dissemination process of pathogenesis, but
the importance of this virulence factor appears infection
site specific as its activity is not required for C. neoformans
proliferation in the host brain or cerebrospinal fluid.
Instead, the enzyme laccase is crucial for C. neoformans
survival in the brain (Nosanchuk et al., 2000). Both urease
and laccase act synergistically to promote invasion of the
host central nervous system. While urease facilitates inva-
sion through brain microcapillaries, laccase enables yeast
growth and proliferation within the brain parenchyma.
Laccase catalyses the oxidation of catecholamines found in
the central nervous system to produce the virulence factor
melanin that protects against toxic free radicals generated
by the host immune system (Nosanchuk et al., 2000).
Interestingly, the nitrogen responsive GATA factor Gat1/
Are1 negatively regulates LAC1-encoded laccase expression
and consequently melanin production (Lee et al., 2011,
2012). Additionally, Gat1/Are1 impacts other virulence
attributes including infectious basidiospore production,
antiphagocytic capsule biosynthesis and febrile body
temperature growth (Lee et al., 2011). These findings are
consistent with classic studies demonstrating that nitrogen
source utilisation affects cryptococcal virulence factor
expression (Chaskes & Tyndall, 1975; Staib et al., 1978).
Conclusions
Pathogenic fungi are an increasing public health problem
due to the growing immunocompromised population, par-
ticularly due to the advent of the AIDS pandemic. These
fungi are found in diverse and often hostile conditions
where they are constantly challenged by nutrient availabil-
ity such as nitrogen limitation. The ability to survive, pro-
liferate and colonise their respective niches is therefore
dependent on well-coordinated regulation of nitrogen
metabolism. While filamentous fungi have the ability to
utilise a wide variety of compounds as nitrogen sources,
yeast-like growing fungi generally assimilate a narrower
range of nitrogen sources. Nonetheless, numerous fungal
species such as S. cerevisiae, C. albicans and C. neoformans
have the ability to undergo a dimorphic transition that
involves the interconversion between multiple growth pat-
terns in response to environmental cues. This morphologi-
cal developmental pathway, at least in part controlled by
ammonium permeases, is likely a scavenging mechanism
that enables nonmotile organisms to procure nutrients and
has long been studied as a model of fungal pathogenesis.
Expression of the ammonium permease genes is regulated
by GATA transcription factors that are master switches
employed to globally control nitrogen metabolism. The
lack of GATA factor most obviously results in an inability
to utilise a wide array of nitrogen sources; not surprisingly,
GATA factor mutants of S. cerevisiae, C. albicans and
A. fumigatus exhibit attenuated virulence. The other major
nitrogen-associated mediator of fungal adaptation and
pathogenesis, whose transcription is also dependent on
GATA factors, is the virulence factor and catabolic enzyme
urease that has been characterised in C. posadasii and
C. neoformans. Activities of the common proteins among
the fungal species described in this article are summarised
in Table 1. The complex interplay between the host envi-
ronment and the fungal pathogen is also a critical determi-
nant; host immune cells generate highly toxic reactive
nitrogen species against microbial invaders, but the nitro-
sative stress response of the pathogen in catabolising and
detoxifying these chemical compounds enable its survival
during infection. Clearly, it is becoming increasingly appar-
ent that nitrogen regulation is a major factor modulating
pathogenesis in fungi. An important area for future
research is to dissect the nature and origin of intracellular
signals that govern the metabolic processes involved in
nitrogen acquisition, in the context of host-pathogen
interactions.
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Table S1. The presence or absence of a selected panel of nitrogen sources in various tissues of a 
healthy individual. Ammonium, asparagine and proline are present in all major tissue locations. 
           N source 
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Adipose tissue + + + + + + + - + 
Adrenal cortex + - - + + + - - - 
Adrenal medulla + - + + - + - - - 
Bladder + - - + + + + - + 
Brain + - - + - + + - - 
Epidermis + - + + + + + - - 
Erythrocyte + - - + - + + - - 
Fibroblasts + + + + + + - - + 
Gonads + - - + + + - - - 
Gut + + - + - + - - - 
Intestine + + + + + + + - - 
Kidney + + + + + + + + + 
Liver + - - + - + + + + 
Muscle + + + + + + + - + 
Myelin + + + + + + - - - 
Nerve cells + - + + + + - - + 
Neuron + + + + + + - - - 
Pancreas + + + + + + - - + 
Placenta + + + + + + + - + 
Platelet + - + + + + + - + 
Prostate + - - + + + - - + 
Skeletal muscle + + + + + + - - + 
Skin + - - + - + - + - 
Spleen + + + + + + + - + 
Stratum corneum + + + + + + - - - 
Testes + + - + + + - - + 
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Thyroid gland + - - + - + - - + 
+ Present; - Absent 
Data obtained from the Human Metabolome Database website (http://www.hmdb.ca/).	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Table S2. The concentration (µM) of a selected panel of nitrogen sources in various biofluids of a 
healthy individual. Urea is present at very high levels in both the human blood and cerebrospinal fluid 
(CSF). 
       N source 
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Blood 29.0 586.0 24.0 41.0 80.0 168.0 256.8 28.5 6500.0 74.1 
CSF 11.9 444.0 1.8 5.4 18.3 4.0 29.3 9.3 4160.0 65.2 
Saliva - >10.0 >10.0 - - >10.0 <1.0 - - >10.0 
Data obtained from the Human Metabolome Database website (http://www.hmdb.ca/). 
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Thesis premise and aim 
From its humble beginning as an isolate obtained from peach juice in 1894 and its 
link to a single case of human disease a year later, the basidiomycetous pathogen 
Cryptococcus neoformans has evolved into a leading cause of life-threatening 
meningitis especially in the immunocompromised population today [1]. More than 30 
million people are living with AIDS/HIV worldwide, a large portion of whom reside 
in sub-Saharan Africa. Recent estimates indicate that there are one million cases of 
cryptococcal infections globally each year in AIDS patients, leading to approximately 
625,000 deaths [2]. Extensive research has been conducted towards understanding C. 
neoformans adaptation to key features within a mammalian host environment 
including carbon, iron and copper limitation, pH, as well as hypoxia [3,4,5,6,7,8].  
However, there is generally little known about regulation of nitrogen 
metabolism by C. neoformans in the literature. As one would anticipate, nitrogen 
concentrations in the human lungs, brain and other anatomical sites are significantly 
lower compared to C. neoformans ecological niche of pigeon guano and decaying tree 
barks. Hence, in order to establish infection in a host, C. neoformans needs to sense 
and adapt to nitrogen limitation. The mechanisms involved in nitrogen sensing and 
adaptation to low nitrogen conditions have been extensively studied in the model 
ascomyctes Saccharomyces cerevisiae, Aspergillus nidulans and Neurospora crassa 
[9,10,11]. However, this important aspect towards understanding the pathobiology of 
C. neoformans remains elusive.  
In view of this lack of knowledge, the broad aim of my research as a whole 
focuses on investigating the interplay between nitrogen catabolism and virulence in 
the hope of identifying novel genes and cellular processes important for C. 
neoformans pathogenesis. The main objective is to gain a deeper understanding of the 
nitrogen requirements of C. neoformans and its consequent metabolic gene regulation 
in response to nitrogen availability, that may contribute to new strategies for pathogen 
control via identification of potential therapeutic targets from key components of the 
nitrogen regulatory pathway. Unless otherwise stated, studies were almost exclusively 
carried out on C. neoformans H99, the type strain for variety grubii (most clinically 
prevalent form responsible for >90% of cryptococcal infections worldwide) that was 
disseminated to the research community [12].  
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Thesis outline 
This thesis is presented in a slightly unconventional format, as a collection of mini-
review and research papers accepted in peer-reviewed journals. Accordingly, the 
introduction chapter consisted of an abstract, literature review and conclusion; each 
results chapter is a complete body of work comprising of an abstract, introduction, 
materials and methods, results, and discussion. Because the specific aim of most 
results chapters ensued from the findings of the previous, I have taken the liberty of 
writing a preface before the start of each results chapter to guide you through this 
comprehensive nitrogen story in a progressive fashion. Briefly, Chapters 3 and 4 
explore C. neoformans global nitrogen regulation (GATA factor and Nmr proteins), 
while Chapters 5 and 6 dissect key nitrogen catabolic pathways of interest (proline 
and uric acid degradation). Finally, Chapter 7 summarises the research outcomes of 
the thesis and the new insights it yields to the field, and proffers some future 
directions.    
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3.1 Preface 
The fungal pathogen Cryptococcus neoformans infects humans via inhalation of 
basidiospores or desiccated yeast cells from the environment. When effective immune 
containment is compromised, the initial pulmonary infection has a unique 
predisposition to disseminate to the central nervous system resulting in meningitis. 
This insidious fungus must therefore make the transition from its ecological niche of 
pigeon feces and eucalyptus trees to the different mammalian niche of intracellular 
locale of phagocytic cells and extracellular sites in the lungs, bloodstream and central 
nervous system. Well-characterised mechanisms of adaptation during this transition 
include the expression of virulence factors such as capsule, melanin and urease. The 
remodeling of central nitrogen metabolism and the expression of specific nitrogen 
acquisition systems however, remains poorly defined; these concepts are particularly 
relevant as specific macro- and micronutrient availability is scarce in a human host 
relative to bird droppings. This chapter investigates the global regulation of nitrogen 
catabolism and its impact on C. neoformans virulence.  
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ABSTRACT
Proper regulation of metabolism is essential to maximizing fitness of organisms in their chosen
environmental niche. Nitrogen metabolite repression is an example of a regulatory mechanism in fungi
that enables preferential utilization of easily assimilated nitrogen sources, such as ammonium, to conserve
resources. Here we provide genetic, transcriptional, and phenotypic evidence of nitrogen metabolite
repression in the human pathogen Cryptococcus neoformans. In addition to loss of transcriptional activation of
catabolic enzyme-encoding genes of the uric acid and proline assimilation pathways in the presence of
ammonium, nitrogen metabolite repression also regulates the production of the virulence determinants
capsule and melanin. Since GATA transcription factors are known to play a key role in nitrogen metabolite
repression, bioinformatic analyses of the C. neoformans genome were undertaken and seven predicted
GATA-type genes were identified. A screen of these deletion mutants revealed GAT1, encoding the only
global transcription factor essential for utilization of a wide range of nitrogen sources, including uric acid,
urea, and creatinine—three predominant nitrogen constituents found in the C. neoformans ecological
niche. In addition to its evolutionarily conserved role in mediating nitrogen metabolite repression and
controlling the expression of catabolic enzyme and permease-encoding genes, Gat1 also negatively regu-
lates virulence traits, including infectious basidiospore production, melanin formation, and growth at high
body temperature (39!–40!). Conversely, Gat1 positively regulates capsule production. A murine inhalation
model of cryptococcosis revealed that the gat1D mutant is slightly more virulent than wild type, indicating
that Gat1 plays a complex regulatory role during infection.
NITROGEN is a major component of macromole-cules ranging from proteins to nucleic acids that
are essential to all living organisms (Carroll and Salt
2004). Yet while almost 80% of the earth’s atmosphere
is made up of diatomic nitrogen gas, very few species
are able to break the strong triple bond that exists be-
tween the two atoms to reduce gaseous nitrogen into
a state that is biologically available (Postgate 1998). In
organisms unable to utilize nitrogen directly from the
atmosphere, the ability to scavenge reduced forms of
nitrogen from alternative sources is crucial and elabo-
rate control mechanisms are needed to ensure its con-
stant supply.
As major decomposers of organic material in the
biosphere, fungi are well known for their ability to
utilize numerous compounds as nitrogen sources by
expressing catabolic enzymes and permeases in a range
of pathways. Readily assimilated compounds such as
ammonium and glutamine are usually the preferred
nitrogen sources of fungi, although in the absence of
these sources, less easily assimilated nitrogen sources
such as amines, amides, purines, and pyrimidines may
also be utilized (Marzluf 1997). In members of the
phylum Ascomycota, the selective utilization of these
secondary nitrogen sources is typically tightly controlled
by transcriptionally regulating the synthesis of the en-
zymes and permeases required for their scavenging and
degradation (Mitchell and Magasanik 1984; Marzluf
1997; Fraser et al. 2001; Magasanik and Kaiser 2002).
Achieved through a global regulatory circuit known
as either nitrogen metabolite repression or nitrogen
catabolite repression, this process ensures secondary
nitrogen source degrading pathways are not expressed
when more easily assimilated nitrogen sources are avail-
able, thereby maximizing the fitness of the organism in
its ever-changing local environment (Wiame et al. 1985;
Marzluf 1997; Fraser et al. 2001). By combining nitro-
gen metabolite repression with pathway-specific induc-
tion mediated by an array of dedicated transcription
factors, resources are even more tightly conserved until
preferred nitrogen sources are depleted (Davis et al.
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cgi/content/full/genetics.111.128538/DC1.
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1993; Feng and Marzluf 1998; Berger et al. 2006,
2008). In this way, the fungus activates the transcription
of catabolic genes only when their substrates are imme-
diately available.
In ascomycete species where it has been observed,
nitrogen metabolite repression is mediated by tran-
scription factors belonging to the GATA family. These
proteins are distinguished by their highly conserved
DNA-binding domain consisting of a Cys2/Cys2-type
zinc finger motif followed by an adjacent basic region
and are named after the DNA sequence 59-GATA-39 that
they recognize (Ko and Engel 1993; Merika and Orkin
1993; Ravagnani et al. 1997). GATA transcription factors
are widely found in eukaryotes, including metazoans and
plants, and have diverse biological functions. For exam-
ple, in the nematode worm Caenorhabditis elegans, the
GATA factor ELT-2 is required for immunity to bacterial
and fungal pathogens such as Salmonella enterica and C.
neoformans (Kerry et al. 2006). In the plant Arabidopsis
thaliana, the GATA factor HAN regulates the develop-
ment of flower and shoot apical meristems (Zhao et al.
2004).
The first GATA factor mutant, however, was identified
in Neurospora crassa on the basis of its central role in ni-
trate metabolism (Fincham 1950). Subsequent analyses
showed that these positively acting nitrogen regulatory
GATA factors often act synergistically with pathway-
specific transcription factors to activate the expression
of catabolic enzyme and permease-encoding genes re-
quired to assimilate secondary nitrogen sources when
preferred sources are lacking (Davis et al. 1993; Feng
andMarzluf 1998; Berger et al. 2006, 2008). As a conse-
quence, loss of such global trans-acting GATA regulatory
genes including areA in Aspergillus nidulans and nit-2 in
N. crassa render these species incapable of utilizing ni-
trogen sources other than ammonium or glutamine
(Arst and Cove 1973; Stewart and Vollmer 1986; Fu
and Marzluf 1987; Kudla et al. 1990; Caddick 1992;
Marzluf 1997). These GATA factors have also been
shown to affect virulence in a number of pathogenic
fungi. Aspergillus fumigatus areA∆, clinical Saccharomyces cer-
evisiae gln3D, and Candida albicans gat1D or gln3Dmutants
all exhibit reduced virulence compared to wild type in mu-
rine virulence assays (Hensel et al. 1998; Limjindaporn
et al. 2003; Kingsbury et al. 2006; Liao et al. 2008).
The importance of nitrogen metabolism in the study
of C. neoformans, an opportunistic pathogen of the phy-
lum Basidiomycota that causes life-threatening menin-
goencephalitis predominantly in immunocompromised
individuals, is also evident (Casadevall and Perfect
1998). The primary ecological niche of C. neoformans is
nutrient-rich pigeon guano; 70% of the nitrogen pres-
ent is in the form of uric acid with the rest consisting
primarily of xanthine, urea, and creatinine (Staib et al.
1976; Staib et al. 1978; Casadevall and Perfect
1998). In contrast, nitrogen availability becomes scarce
upon infection of humans. Beyond these obvious differ-
ences in nitrogen availability that C. neoformans often
encounters as part of its infection cycle, there are more
subtle indications that nitrogen metabolism may also
play a role in the regulation of virulence. The antipha-
gocytic polysaccharide capsule is a well-known virulence
factor that is highly induced in the presence of uric acid
(Staib et al. 1976, 1978). Assimilation of uric acid as
a nitrogen source requires a number of catabolic en-
zymes including the virulence factor urease, a nitrogen-
scavenging enzyme shown to play a role in central
nervous system invasion (Cox et al. 2000; Olszewski
et al. 2004; Shi et al. 2010). While evidence that nitrogen
availability may play a role in pathogenicity of C. neofor-
mans is mounting, little is known about this process.
In this study we provide the first proof of canonical
ascomycete-like nitrogen metabolite repression in the
basidiomycete C. neoformans. We also reveal that beyond
the traditional role in nitrogen scavenging, this regula-
tory mechanism controls the coordinated production of
the virulence factors capsule and melanin. Study of de-
letion mutants of every predicted GATA-type gene in
the C. neoformans genome revealed the existence of only
one positively acting nitrogen regulatory GATA factor:
Gat1. Gat1 mediates nitrogen metabolite repression
and is required for utilization of most nitrogen sources
including the preferred ammonium; this represents an
anomaly from archetypical nitrogen metabolite repres-
sion. Gat1 also functions to negatively regulate mating,
melanin production at human body temperature (37!),
and growth at high body temperature (39!–40!) and is
required for capsule synthesis. Importantly, this com-
plex series of changes in the regulation of C. neoformans
virulence composite combines to create an unexpected
phenotype during murine infection: the gat1D mutant is
slightly more virulent than wild type. Together, these
studies indicate that in addition to controlling the regu-
lon of genes for nitrogen acquisition, Gat1 is a key co-
ordinator of multiple virulence-associated phenotypes.
MATERIALS AND METHODS
Strains and media: Cryptococcus strains (supporting infor-
mation, Table S1) were grown in YPD (1% yeast extract, 2%
Bacto-peptone, 2% glucose) or YNB (0.45% yeast nitrogen base
w/o amino acids and ammonium sulfate, 2% glucose, 10 mm
nitrogen source) unless specified otherwise. Biolistic transform-
ants were selected on YPDmedium supplemented with 100 µl/ml
G418 (Sigma) and/or nourseothricin (Werner BioAgents).
Pigeon guano medium was prepared as described previously
while the derivative pigeon guano (unfiltered) medium was
prepared with the exclusion of the filtration step to ensure
that insoluble nitrogen sources such as uric acid would not be
removed (Nielsen et al. 2007). l-3,4-Dihydroxyphenylalanine
(l-DOPA) medium was prepared as described previously with
the original nitrogen source (asparagine) replaced with 10 mm
of the specified nitrogen source (D’souza et al. 2001). V8 (5%
V8 juice, 3 mm KH2PO4, 0.1% myo-inositol, 4% Bacto-agar) and
Murashige & Skoog (MS) mating media (PhytoTechnology Lab-
oratories) at pH 5.0 were prepared as described previously
310 I. Russel Lee et al.
(Kwon-Chung et al. 1982; Xue et al. 2007). Christensen’s urea
agar was prepared as described previously (Cox et al. 2000).
Nematode growth medium (NGM) was prepared as described
previously (Brenner 1974). Escherichia coli Mach-1 cells served
as the host strain for transformation and propagation of all
plasmids, which were carried out according to methods of
Sambrook et al. (1989). C. elegans strain N2 was maintained at
15! and propagated on its normal laboratory food source E. coli
OP50 cells as described previously (Brenner 1974; Honda et al.
1993; Garsin et al. 2001).
Bioinformatic analyses: The genome sequence of C. neoformans
var. grubii reference strain, H99 (http://www.broadinstitute.org/
annotation/genome/cryptococcus_neoformans/MultiHome.html),
was used in our study to gain insights into the regulation of
nitrogen metabolism and virulence in C. neoformans. Sequence
analyses were performed using BLAST and MacVector 9.5
(MacVector Inc, Cary, NC) (Altschul et al. 1990). Sequence
alignments were created using ClustalW v. 1.4 within MacVec-
tor (Thompson et al. 1994). Sequence traces generated at the
Australian Genome Research Facility (Brisbane, Queensland,
Australia) were analyzed using Sequencher 4.7 (Gene Codes
Corporation, Ann Arbor, MI).
Construction and complementation of mutant strains:
GATA-type gene deletion mutants were created using overlap
PCR and biolistic transformation as described previously
(Davidson et al. 2000, 2002). All primers used for the gen-
eration of deletion mutants are listed in Table S2. For exam-
ple, to construct the gat1∆ mutant, the 4239-bp GAT1
(CNAG00193.2) coding sequence was replaced with the neo-
mycin phosphotransferase II-encoding selectable marker NEO
using a construct created by overlap PCR combining an !1-kb
fragment upstream from the GAT1 start codon, the NEO
marker, and an !1-kb fragment downstream from the GAT1
stop codon. Strain H99 genomic DNA and the plasmid pJAF1
were used as PCR templates (Fraser et al. 2003). The con-
struct was transformed into the wild-type strain H99 via par-
ticle bombardment. Transformants were selected on YPD
plates supplemented with 100 µl/ml G418. Deletion of
GAT1 was confirmed by Southern blot, creating strain RL1
(Southern 2006). To complement the gat1∆ mutant, the
wild-type GAT1 gene was amplified from genomic DNA via
PCR, the product cloned into pCR2.1-TOPO (Invitrogen) to
give pIRL1, and sequenced. The 5.95-kb AscI/SacI GAT1 frag-
ment of pIRL1 was subcloned into the AscI/SacI sites of the
Cryptococcus nourseothricin resistance vector pPZP-NATcc,
creating the complementation construct pIRL3 (Walton
et al. 2005). pIRL3 was subsequently linearized with AscI and
XmaI, then biolistically transformed into the gat1∆ mutant.
Stable transformants were selected on YPD plates supple-
mented with 100 µl/ml nourseothricin and transformants
containing a single copy of the wild-type GAT1 gene were
identified by Southern blot.
Quantitative real-time PCR: Strains were grown in YNB
supplemented with 10 mm of the specified nitrogen source or
YPD and shaken at 30! for 16 hr. Overnight cultures were
harvested, cell pellets frozen and lyophilised, total RNA iso-
lated using TRIzol reagent (Invitrogen), and cDNA generated
using the SuperscriptIII first-strand synthesis system (Invi-
trogen). Primers for genes URO1 (CNAG04305.2), DAL1
(CNAG00934.2), URE1 (CNAG05540.2), GDH1 (CNAG01577.2),
GLN1 (CNAG00457.2), GLT1 (CNAG04862.2), GDH2
(CNAG00879.2), AMT1 (CNAG00235.2), AMT2 (CNAG04758.2),
PUT1 (CNAG02049.2), PUT5 (CNAG02048.2), and PUT2
(CNAG05602.2) (Table S2) were designed to span exon–exon
boundaries and tested to verify that they bind specifically to
their respective cDNA genes but not H99 genomic DNA (data
not shown). Quantitative real-time PCR (qRT-PCR) was per-
formed using SYBR green supermix (Applied Biosystems) and
an Applied Biosystems 7900HT fast real time PCR System with
the following cycling conditions: denaturation at 95! for
10 min, followed by amplification and quantification in 45
cycles at 95! for 15 sec and 60! for 1 min, with melting curve
profiling at 95! for 2 min, 60! for 15 sec, and 95! for 15 sec.
Dissociation analysis confirmed the amplification of a single
PCR product for each primer pair and an absence of primer
dimer formation. Relative gene expression was quantified using
SDS software 1.3.1 (Applied Biosystems) on the basis of the
2-∆∆CT method (Livak and Schmittgen 2001). Several house-
keeping genes including GPD1 (glyceraldehyde-3-phosphate
dehydrogenase), HHT1 (histone H3), and TUB2 (b-tubulin)
were tested, but the ACT1 (actin) gene was eventually used as
a control for normalization since its gene expression demon-
strated the highest consistency across all growth conditions
tested. Statistical analysis of variance (one-way analysis of vari-
ance) was performed using the unpaired, two-tailed t-test in
GraphPad Prism Version 5.0c. P values ,0.05 were considered
statistically significant.
Capsule assays: Strains were inoculated onto YNB plates
supplemented with 10 mm specified nitrogen source or into
RPMI/DMEM supplemented with 10% fetal calf serum
(Gibco), and incubated at 37! for 2 days. To visualize capsule,
cells were stained with India ink (Becton Dickinson) and ob-
served using a ZEISS Axioplan 2 epifluorescent/light micro-
scope. Pictures were taken with an Axiocam grayscale digital
camera using the AxioVision AC imaging software. Quantita-
tive analysis of capsule diameter was performed as described
previously (Zaragoza et al. 2003).
Growth, melanization, and urease assays: Starter cultures
were prepared by growth in YPD at 30! overnight with shak-
ing, diluted to OD595 nm ¼ 0.05 in water, and then further
diluted 10-fold in series. For nitrogen utilization, melaniza-
tion, and urease assays as well as growth test on pigeon guano
and at human body temperature, each diluted cell suspension
was spotted onto YNB or l-DOPA supplemented with 10 mm
specified nitrogen source, Christensen’s urea agar, 25% (wt/vol)
pigeon guano medium, or YPD medium, respectively. Results
were imaged after 2 days’ incubation at 30! (nitrogen utiliza-
tion, growth test on pigeon guano, and urease assays), 30! and
37! (melanisation assays), or 37!–40! (growth test at human
body temperature).
Mating assays: Mating assays were conducted as described
previously (Nielsen et al. 2003). Briefly, strains were pregrown
on YPD plates for 2 days, after which a small amount of cells
was removed using a flat-end toothpick and patched onto V8
and MS mating media (pH 5.0) either alone or mixed in equal
proportions with a strain of the opposite mating-type (MAT)
(Kwon-Chung et al. 1982; Xue et al. 2007). Plates were then
incubated at room temperature in the dark for 1 week and
assessed by light microscopy for formation of filaments and
basidia.
C. elegans killing assays: Starter cultures of C. neoformans
strains were prepared by growth in YPD at 30! overnight with
shaking. Overnight cultures, 10 µl, were spread onto both
brain–heart infusion (BHI) (Becton Dickinson) and 2.5% pi-
geon guano agar plates (35 mm), and incubated at 25! over-
night. Approximately 50 young adult C. elegans worms were
then transferred from a lawn of E. coli OP50 on NGM to the
lawn of BHI and pigeon guano media-grown C. neoformans
(Mylonakis et al. 2002). Plates were incubated at 25! and
worms examined for viability at 24-hr intervals using a dissect-
ing microscope, with worms that did not respond to a touch
with a platinum wire pick considered dead. Each experimen-
tal condition was performed in triplicate. Survival was plotted
against time, and P values were calculated by plotting a Kaplan–
Meier survival curve and performing a log-rank (Mantel–Cox)
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test using Graphpad Prism v. 5.0c. P values ,0.05 were
considered statistically significant.
Murine virulence assays: For murine killing assays, C. neofor-
mans strains were used to infect 7-week-old female BALB/c
mice by nasal inhalation (Cox et al. 2000). Ten mice were
inoculated each with a 50-µl drop containing 1 · 105 cells of
each strain. Mice were weighed before infection and daily
thereafter; animals were sacrificed by cervical dislocation once
their body weight had decreased by 20% of the preinfection
body weight. Survival was plotted against time, and P values
were calculated by plotting a Kaplan–Meier survival curve and
performing a log-rank (Mantel–Cox) test using Graphpad
Prism v. 5.0c. P values ,0.05 were considered statistically
significant.
Ethics statement: This study was carried out in strict
accordance with the recommendations in the Australian Code
of Practice for the Care and Use of Animals for Scientific
Purposes by the National Health and Medical Research Council.
The protocol was approved by the Molecular Biosciences
Animal Ethics Committee of The University of Queensland
(AEC approval no. SCMB/473/09/UQ/NHMRC). Infection
and sacrifice were performed under methoxyflurane anesthesia,
and all efforts were made to minimize suffering through
adherence to the Guidelines to Promote the Wellbeing of
Animals Used for Scientific Purposes as put forward by the
National Health and Medical Research Council.
RESULTS
Cryptococcus assimilates a limited subset of
nitrogen sources: Work on Cryptococcus has demon-
strated the ability of this organism to assimilate a number
of different nitrogen sources (Chaskes and Tyndall
1975; Staib et al. 1976; Polacheck and Kwon-Chung
1980; Fiskin et al. 1990; Kmetzsch et al. 2010). However,
these studies have not taken into consideration the sig-
nificant advances that have been made in understanding
the population structure of the species: the former vari-
ety Cryptococcus gattii has now been classified as a sepa-
rate species, and eight distinct Cryptococcus haploid
molecular types have been identified, each of which dis-
plays distinct physiological properties and virulence fea-
tures (Kwon-Chung and Varma 2006; Litvintseva et al.
2006). To begin to better understand nitrogen metab-
olism in this pathogen, we sought to extensively iden-
tify the panel of usable nitrogen sources in the context
of this complex population structure.
We assessed the ability of an array of 16 strains that
represent all eight molecular types of the Crypto-
coccus species complex to assimilate a diverse range
of 42 different compounds as sole nitrogen sources on
YNB defined medium, including the common l-amino
acids as well as a range of purines, pyrimidines, amides,
and amines (Table S3). As commercial formulations of
agar have been shown to contain substantial concentra-
tions of nitrogen as impurities (up to 4 mm when 20 g/
liter is present), we performed all nitrogen assimilation
assays using agarose (SeaKem LE) as the gelling agent
(Scholten and Pierik 1998). Unlike other well-known
fungal genera such as Aspergillus and Neurospora,
which can assimilate a remarkably large collection of
nitrogen sources, the nitrogen assimilation profile of
Cryptococcus more closely resembled that of Saccharo-
myces; both species are largely restricted to utilization
of ammonium and more complex macromolecules
such as amino acids and purines (Kinsky 1961; Hynes
1970). Only a subset of strains was able to utilize xan-
thine, lysine, and nicotinamide as the sole nitrogen
source. None of the strains were able to utilize cadaver-
ine, nitrite, or nitrate as sole nitrogen sources. Impor-
tantly, while interstrain growth variability on different
nitrogen sources was observed, this did not correlate
with molecular type.
The explanation for some of these significant differ-
ences between Cryptococcus and Aspergillus or Neu-
rospora is evident at the genomic level. As previously
reported, analysis of the C. neoformans genome con-
firmed an absence of genes required for molybdenum
cofactor biosynthesis, an essential component in all pre-
viously characterized fungal nitrate metabolism path-
ways (Heck et al. 2002; Cultrone et al. 2005). Genes
encoding homologs of key catabolic enzymes for cadav-
erine, nitrate, and nitrite utilization were also not found
in the genome of VNI strain H99 via BLASTp analysis,
explaining the lack of growth on these nitrogen sour-
ces. We are therefore unable to explain the Cryptococ-
cus growth phenotype associated with nitrate utilization
that was observed by Jiang et al.; consistent with our
bioinformatic analyses, none of the 16 Cryptococcus
strains tested were able to utilize nitrate or nitrite as
the sole nitrogen source ( Jiang et al. 2009).
Nitrogen metabolite repression of transcription ex-
ists in C. neoformans: In many members of the phylum
Ascomycota, nitrogen metabolite repression ensures
that of the options available, favored nitrogen sources
such as ammonium are assimilated before all others. To
address if the same regulatory mechanism exists in the
most clinically prevalent form of C. neoformans (VNI),
we bioinformatically identified several predicted cata-
bolic genes belonging to the uric acid degradation path-
way in the unpublished H99 genome and employed
qRT-PCR to analyze their transcriptional regulation:
URO1 (encoding urate oxidase), DAL1 (encoding allan-
toinase), and URE1 (encoding the virulence factor
urease) (Figure 1A). When compared to an ammonium-
grown control, the level of expression of URO1 and
DAL1 was significantly upregulated (.10-fold) during
growth in uric acid as the sole nitrogen source, while
that of URE1 was only slightly upregulated (!3-fold)
(Figure 1B). When both uric acid and ammonium were
present, this upregulation was abolished, the hallmark
of traditional nitrogen metabolite repression (URO1,
P ¼ 0.0224; DAL1, P ¼ 0.0058; URE1, P ¼ 0.1448) (Fig-
ure 1B). It is worth noting that nitrogen metabolite reg-
ulation of URE1 was not statistically significant, indicating
that nitrogen metabolite repression may not affect every
nitrogen catabolism-associated gene in C. neoformans.
However, it is possible that differential expression of
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URE1 may be observed under other untested nitrogen
conditions such as nitrogen starvation.
Nitrogen metabolite repression regulates well-
established virulence factors: Expanding our analysis,
we sought to determine whether nitrogen metabolite
repression plays a role in regulating the expression of
other key virulence factors. Early studies have shown
that the virulence factors capsule and melanin are
expressed differently during growth on different nitro-
gen sources (Chaskes and Tyndall 1975; Staib et al.
1976, 1978). To expand on these classic analyses, we
grew C. neoformans on a wider selection of easily assim-
ilated (e.g., ammonium) and less easily assimilated (e.g.,
uric acid) nitrogen sources and found that varying cap-
sule size was indeed observed in the presence of differ-
ent nitrogen-yielding substrates (Figure 2A and Figure
S1). The size of capsule was uniformly small when C.
neoformans was grown on ammonium, glutamine, pro-
line, or alanine as the sole nitrogen source. In contrast,
capsule production was much more prolific when cells
were grown on asparagine, compounds from the uric
acid degradation pathway (urea, uric acid), or creati-
nine. Significantly, simultaneous addition of ammo-
nium to each of these nitrogen sources repressed
capsule production to a level equivalent to that seen
on ammonium alone, providing the first evidence that
nitrogen metabolite repression directly influences the
formation of the virulence determinant capsule (Figure
2A and Figure S1).
We next investigated C. neoformans formation of the
dark antioxidant pigment melanin on l-DOPA medium
supplemented with the same panel of nitrogen sources.
Again, varying virulence factor production was observed
in response to the available nitrogen source (Figure
2B). Creatinine, uric acid, and alanine-grown cells syn-
thesized the least melanin, proline synthesized an in-
termediate amount, and glutamine, asparagine, urea,
and ammonium were the most prolific producers of
melanin. It was interesting to note that the effect of
creatinine and uric acid on capsule production was in-
versely proportional to melanin production: while uric
acid and creatinine induce capsule formation to the
largest extent, melanization on these nitrogen sources
was the poorest. Similarly, while ammonium induces
melanization to the largest extent, capsule formation
was extremely poor on this nitrogen source. Consistent
with conservation of the nitrogen metabolite repression
regulatory paradigm, simultaneous addition of ammo-
nium restored melanin production to the same level as
that of the ammonium control (Figure 2B). The only
unusual exception occurred with proline-grown cells,
which melanized to the same extent with or without
ammonium, suggesting that proline catabolism in C.
neoformans may be insensitive to the repressing effects
of ammonium. This observation was not seen with the
capsule assays previously, as both proline and ammo-
nium were equally poor inducers of capsule synthesis.
Overall, we observed that the general effect of nitrogen
metabolite repression on melanin was opposite to that
observed for capsule—rather than blocking virulence
factor production, the presence of ammonium induces
the highest level of melanin formation.
Figure 1.—The predicted catabolic enzyme-
encoding genes of uric acid, URO1 and DAL1,
are sensitive to nitrogen metabolite repression.
(A) Scheme representing the predicted (partial)
uric acid degradation pathway of C. neoformans.
(B) cDNA from wild-type H99 grown in YNB sup-
plemented with ammonium, uric acid, or uric
acid plus ammonium (10 mm each nitrogen
source) were amplified via qRT-PCR using pri-
mers against URO1 (urate oxidase), DAL1 (allan-
toinase), URE1 (urease), and the control gene
ACT1 (actin). In the presence of uric acid as
the sole nitrogen source, the expression of
URO1 and DAL1 was significantly increased while
that of URE1 was slightly increased, but this upre-
gulation was abolished when ammonium was also
present. This nitrogen metabolite repression sen-
sitivity of URO1 (* denotes P , 0.05) and DAL1
(** denotes P , 0.01) was statistically significant.
Error bars represent standard errors across three
biological replicates.
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The C. neoformans genome encodes up to seven
GATA factors: Our phenotypic analyses showed that
beyond controlling nitrogen catabolism, nitrogen me-
tabolite repression plays a role in regulating at least two
important virulence factors in C. neoformans: capsule
and melanin. The production of these factors varied
on different nitrogen sources, with the addition of am-
monium dominating over other nitrogen signals (apart
from proline) to either abolish (capsule) or highly ac-
tivate (melanin) virulence factor production. In the
phylum Ascomycota, this dominance of ammonium in
controlling a physiological response is mediated by tran-
scription factors belonging to the GATA zinc finger
family. We therefore chose to pursue potential GATA
factors of C. neoformans as likely candidates for the un-
derlying mechanism controlling these responses to ni-
trogen availability.
GATA transcription factors are distinguished by their
highly conserved DNA-binding domain consisting of
a Cys2/Cys2-type zinc finger motif followed by an adja-
cent basic region (Fu and Marzluf 1990; Marzluf
1997). Within the consensus “Cys–X2–Cys–Xvariable–Cys–
X2–Cys,” there are always two residues separating cysteines
1 and 2, and always two residues separating cysteines 3
and 4 of the zinc finger motif. In contrast, the number
of residues comprising the central loop separating cys-
teines 2 and 3 can vary. For example, the zinc finger
motif of the A. nidulans nitrogen regulatory protein
AreA contains a 17-amino-acid central loop while that
of N. crassa blue light response factor WC1 contains 18
residues (Kudla et al. 1990; Ballario et al. 1996). We
sought to establish a more precise description of this
consensus domain in fungi to assist in accurately pre-
dicting all of the bona fide GATA factor-encoding genes
in the genome of C. neoformans strain H99.
To more accurately define the sequence constraints
associated with fungal GATA factors, we aligned the
DNA-binding motif sequences of all 38 known charac-
terized GATA factors, originating from 17 fungal spe-
cies (Figure S2). By comparing the number of amino
acid residues at the central loop of the zinc finger motif
and the distribution of basic residues within 25 amino
acids adjacent to the zinc finger motif, we were able to
define a more stringent GATA motif consensus for
fungi: all reported examples matched the motif “Cys–
X2–Cys–X17–20–Cys–X2–Cys 1 5–12 basic residues within the
25 beyond the most C-terminal cysteine.”
Parallel searches were subsequently taken to identify
potential GATA factors in the C. neoformans genome. In
the first approach, the protein sequences of all 38 known
characterized fungal GATA factors were searched against
the Broad Institute genome sequence database of strain
H99 for potential homologs using BLASTp, leading to
the identification of five potential GATA factor-encoding
genes (Table S4). However, this approach was heavily
biased in requiring the GATA factors detectable in the
C. neoformans genome to have first been identified in
other fungi. In the second approach, we searched the
C. neoformans genome for the consensus “Cys–X2–Cys–
X17–20–Cys–X2–Cys” using a Perl script-based approach,
and hits analyzed for a match with the “5–12 basic residues
within the 25 beyond the most C-terminal cysteine” consensus.
This broader analysis identified the same five GATA
factor-encoding genes as the BLASTp analysis, plus
two additional candidates. In the third approach, we
BLASTed all seven hits back against the H99 genome,
finding no additional homologs. Through these com-
bined bioinformatic analyses, we therefore identified
a total of seven possible GATA factor-encoding genes.
Of the seven predicted GATA ORFs identified, all four
previously characterized C. neoformans members of this
family were present: Bwc2, Cir1, Gat201, and Gat1—thus
validating the combination approach taken (Idnurm
and Heitman 2005; Jung et al. 2006; Liu et al. 2008;
Figure 2.—Nitrogen metabolite repression influences cap-
sule and melanin formation. (A) India ink cell staining under
light microscopy showed that wild-type H99 produces capsules
that vary in size when grown on YNB supplemented with dif-
ferent nitrogen sources (10 mm each). Capsule size increased
in the following order: (ammonium, glutamine, proline, ala-
nine), asparagine, urea, uric acid, and creatinine. Upon cocul-
ture of each of these nitrogen sources with ammonium, capsule
size was restored to that of the ammonium control. Scale bar,
10 µm. (B) Wild-type H99 produces varying amounts of mela-
nin when grown on l-DOPA supplemented with different ni-
trogen sources (10 mm each). Melanization increased in the
following order: (creatinine, uric acid), alanine, proline and
(glutamine, asparagine, urea, ammonium). Upon coculture
of each of these nitrogen sources with ammonium, melanin
production was restored to that of the ammonium control, with
the exception of the proline-grown cells, which melanized to
the same extent with or without ammonium.
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Kmetzsch et al. 2010). Furthermore, sequence searches
of these candidates in Pfam confirmed the presence of
a predicted GATA zinc finger, supporting the hypothesis
that all seven are bona fide GATA factors. Consistent
with the observation of Wong et al., all C. neoformans
GATA factors lack putative leucine zippers that are pres-
ent in negatively acting nitrogen regulatory GATA fac-
tors such as Dal80 and AreB of S. cerevisiae and A.
nidulans, respectively (Wong et al. 2008).
Only one positively acting GATA factor controls global
nitrogen source utilization in C. neoformans: Despite the
fact that four GATA factors have been previously
characterized in C. neoformans, to our knowledge any
potential role in nitrogen metabolite repression has
not been explored in these transcription factors. It is
possible that a GATA factor may play a regulatory role
in more than one global response or that more than one
GATA transcriptional activator may play a role in nitro-
gen regulation as in systems of S. cerevisiae and C. albicans
(Stanbrough et al. 1995; Limjindaporn et al. 2003; Liao
et al. 2008). All seven ORFs containing our strict consen-
sus for a fungal GATA DNA-binding domain were
therefore deleted via homologous recombination.
The seven GATA mutants were viable and had similar
growth rate as the wild-type strain on YPD medium at
30! (Figure 3). However, all but one of the C. neoformans
GATA mutant strains exhibited growth equivalent to
wild-type H99 on YNB defined medium supplemented
with a wide panel of 38 usable nitrogen sources (Figure
3 and Table S5). Consistent with previous studies con-
ducted by Kmetzsch et al. (2010), deletion of ORF
CNAG00193.2 (GAT1) rendered C. neoformans incapa-
ble of utilizing a wide repertoire of nitrogen sources.
The gat1D mutant, however, could still utilize a limited
selection of amino acids, notably proline, strengthening
our hypothesis that proline utilization is largely indepen-
dent of nitrogen metabolite repression. Importantly, we
found that the gat1D mutant was also unable to utilize
uric acid and creatinine, two predominant nitrogen con-
stituents found in the ecological niche (pigeon guano)
of C. neoformans (Staib et al. 1976, 1978; Casadevall
and Perfect 1998).
Gat1 mediates nitrogen metabolite repression: The
fact that the gat1∆ mutant does not grow on a wide
variety of nitrogen sources does not ipso facto prove that
Gat1 mediates nitrogen metabolite repression. To in-
vestigate the regulatory mechanism of Gat1, we per-
formed qRT-PCR to analyze how the deletion of GAT1
affects transcriptional regulation of genes associated
with nitrogen metabolism. The unusual observation
that loss of GAT1 merely reduces growth on the less
easily assimilated nitrogen source proline rather than
completely abolish it provided an ideal condition under
which to study the transcriptional effects of the loss of
this regulatory gene. Growth in proline enabled the
isolation of RNA from defined medium without con-
cern for starvation-related artifacts of the gat1∆ mutant
associated with growth in nonutilizable nitrogen sour-
ces such as uric acid. Hence, by choosing proline as the
sole source of nitrogen for culturing of both the wild-
type and mutant strains, we were able to isolate RNA
from a steady-state, actively growing culture with a de-
fined nitrogen source.
Bioinformatic analyses of the H99 genome identified
several genes predicted to encode enzymes required for
degradation of proline: PUT1 and PUT5, two paralogs
that each encode proline oxidase, and PUT2, which
encodes pyrroline-5-carboxylate dehydrogenase (Figure
4A). qRT-PCR using RNA isolated from wild-type cells
revealed that only one of these three proline catabolic
genes was regulated by nitrogen metabolite repression,
with higher levels of transcription (.15-fold) on pro-
line than when both proline and ammonium were pres-
ent (PUT1, P , 0.0001) (Figure 4B). In the gat1∆
mutant, transcription of PUT1 was not highly activated
but instead showed the same level of transcription irre-
spective of the presence of ammonium, confirming the
role of Gat1 as the mediator of nitrogen metabolite re-
pression (Figure 4B). Unlike PUT1, both PUT5 and
PUT2 were unaffected by nitrogen metabolite repres-
sion, explaining why the gat1∆ mutant can utilize pro-
line as the sole nitrogen source, albeit less effectively
than wild type. Although the expression of PUT1 was
drastically reduced in the gat1∆ mutant, PUT5 was still
expressed at wild-type levels sufficient to produce proline
oxidase, as was PUT2 (encoding pyrroline-5-carboxylate
dehydrogenase), enabling Gat1-independent growth on
proline as the sole nitrogen source.
Figure 3.—The gat1∆
mutant is unable to utilize
a wide variety of nitrogen
sources. Tenfold spot dilu-
tion assays of wild-type H99
and GATA-type deletion
mutants for nitrogen utiliza-
tion showed that the gat1∆
mutant is unable to grow
on YNB supplemented with
10 mm ammonium, uric acid,
urea, or creatinine but exhibits only a slight growth defect compared to wild type on 10 mm proline. Complementation of the gat1∆
mutant with the GAT1 gene restored wild-type nitrogen utilization phenotype (Figure S3).
Nitrogen Metabolite Repression 315
Gat1 positively regulates the expression of key
ammonium assimilation and permease genes: While
certain phenotypic similarities to ascomycete nitrogen
regulatory GATA factor mutants were clear, this basid-
iomycete ortholog mutant exhibited an ammonium
phenotype much more extreme than that seen in
previously described GATA factor mutants. The gat1D
mutant is unable to utilize the most easily assimilated
nitrogen source in both ammonium replete and suf-
ficient conditions (1–100 mm) (data not shown), para-
doxically suggesting that the nitrogen metabolite
repression mechanism that occurs in the presence of
ammonium blocks the ability to utilize ammonium
itself. While a slight reduction in growth on ammonium
has been observed for other fungal nitrogen regulatory
GATA mutants, the complete loss of growth is unprec-
edented and counterintuitive (Christensen et al. 1998;
Hensel et al. 1998; Liao et al. 2008). To investigate this
difference in phenotype, we bioinformatically identified
the predicted central nitrogen metabolism genes in the
H99 genome: GDH2 [encoding NAD1-dependent glu-
tamate dehydrogenase (NAD-GDH)] as well as the am-
monium assimilation enzyme-encoding genes GDH1
[encoding NADP1-dependent glutamate dehydroge-
nase (NADPH-GDH)], GLN1 [encoding glutamine syn-
thetase (GS)], and GLT1 [encoding NAD1-dependent
glutamate synthase (GOGAT)] (Figure 5A).
qRT-PCR was again employed, this time to analyze
the transcriptional regulation of these central nitrogen
metabolism genes as well as the two known ammonium
permease-encoding genes AMT1 and AMT2 in both
the wild-type and gat1D mutant strains (Figure 5B)
(Rutherford et al. 2008). When grown in rich unde-
fined YPD medium that contains a wide array of nitrogen
sources including the generally preferred ammonium,
glutamine, and glutamate, the level of expression of
the major ammonium assimilation enzyme-encoding
gene GDH1 as well as the permease-encoding genes
AMT1 and AMT2 was significantly lower (!10–20-fold)
in the gat1D mutant compared to wild type (GDH1, P ,
0.0001; AMT1, P ¼ 0.0086; AMT2, P ¼ 0.0308). The level
of expression of the other central nitrogen metabolism
genes was also consistently lower (!1.5-fold) in the
gat1D mutant than in wild type, although these differ-
ences for the remaining two ammonium assimilation
enzyme-encoding genes GLN1 and GLT1 were not
quite statistically significant (GLN1, P ¼ 0.0666;
GLT1, P ¼ 0.0523; GDH2, P ¼ 0.1308). This result
indicates that Gat1 controls the expression of the am-
monium assimilation enzyme-encoding gene GDH1
and permease-encoding genes AMT1 and AMT2 in
C. neoformans.
Gat1 is not required for the growth of C. neoformans
on pigeon guano: The gat1∆ mutant is unable to utilize
uric acid, urea, or creatinine, the most abundant nitro-
gen sources found in the natural habitat of C. neofor-
mans. This raises the question of whether the GAT1
gene is essential for optimum growth on pigeon guano,
a growth medium previously validated for both C. neo-
formans and C. gattii (Nielsen et al. 2007). We therefore
Figure 4.—Gat1 regulates nitrogen me-
tabolite repression. (A) Scheme represent-
ing the predicted proline degradation
pathway of C. neoformans. (B) cDNA from
wild-type H99 and gat1∆ mutant grown in
YNB supplemented with proline or proline
plus ammonium (10 mm each nitrogen
source) were amplified via qRT-PCR using
primers against PUT1 (proline oxidase),
PUT5 (proline oxidase), PUT2 (pyrroline-
5-carboxylate dehydrogenase), and the con-
trol gene ACT1 (actin). One of the pre-
dicted catabolic enzyme-encoding genes of
proline, PUT1, was sensitive to nitrogen me-
tabolite repression in wild type (***
denotes P , 0.0001) but not in the gat1∆
mutant. The remaining two catabolic
genes, PUT5 and PUT2, were nitrogen me-
tabolite repression insensitive in both
strains. Error bars represent standard
errors across three biological replicates.
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investigated whether the loss of GAT1 affected growth
on this substrate that mimics the environmental niche.
Our growth assays indicate that the wild-type and gat1∆
mutant strains displayed equivalent growth on both fil-
tered and unfiltered 25% pigeon guano agar media,
revealing that pigeon guano contains at least one nitro-
gen source that supports robust growth and whose uti-
lization is Gat1 independent (Figure S4).
Gat1 negatively regulates mating in both mating-type
a and a strains: During nitrogen limiting or starvation
conditions, C. neoformans can undergo sexual reproduc-
tion that leads to the production of potentially infec-
tious air-borne basidiospores (Kwon-Chung 1976;
Lengeler et al. 2000; Giles et al. 2009). To address
whether Gat1 plays a role in this sexual development,
we created a gat1D derivative of MATa C. neoformans
strain KN99a (VNI) by replacing the GAT1 ORF with
the nourseothricin acetyl-transferase (NAT ) selectable
marker, to serve as a mating partner for our existing
gat1::NEO of MATa strain H99. Wild type (wild type ·
wild type), unilateral (gat1 · wild type), and bilateral
(gat1 · gat1) crosses were then performed by mixing
strains of opposite mating type on V8 and MS media.
The ability to mate was examined by microscopically
inspecting the production of filaments and basidia at
the edges of the mating patches. Unexpectedly, fila-
mentation and production of basidia were enhanced
in both unilateral and bilateral gat1D crosses in compar-
ison to wild-type crosses (Figure 6). Furthermore, de-
letion of GAT1 in both the MATa and MATa strains led
to the most robust filament formation and production
of basidia, indicating that the effect of this gene dele-
tion is additive. This result indicates that Gat1 plays
a critical role in regulating morphological differentia-
tion in both mating types of C. neoformans.
Gat1 positively regulates capsule synthesis, but neg-
atively regulates melanin formation and growth at high
body temperature: Given that nitrogen metabolite
repression plays a role in regulation of capsule synthe-
sis, we next chose to examine capsule production by the
gat1D mutant. Strains were cultured in amino-acid-rich
RPMI and DMEM media supplemented with 10% fetal
calf serum; both media supported growth of all strains
including the gat1∆ mutant (Zaragoza et al. 2003). In-
dia ink staining revealed that while the wild-type strain
produced characteristic halos around its cells represent-
ing enlarged capsule, the gat1D mutant produced re-
duced amounts of capsule under these serum-induced
conditions (Figure 7A and Figure S5). This result indi-
cates that Gat1 plays a positive role in the regulation of
capsule synthesis.
Like capsule, melanin synthesis is also under the
influence of nitrogen metabolite repression control.
The role of Gat1 was therefore evaluated for melanin
production at both 30! and 37! on l-DOPA medium
supplemented with proline as the sole nitrogen source,
since proline supports the most robust growth in the
gat1∆ mutant on defined medium. Interestingly, the
gat1∆ mutant melanized to the same extent as wild type
at 30! but produced more melanin than wild type at 37!
(Figure 7B). This result indicates that Gat1 plays a neg-
ative role in regulating melanin production at human
body temperature.
We also evaluated the role of Gat1 in regulating the
activity of the nitrogen-scavenging enzyme urease on
Christensen’s urea agar. Although both the gat1∆ and
negative control ure1∆ mutants are unable to utilize urea
as the sole nitrogen source, the mutants could still grow
on Christensen’s medium as impurities found in agar
likely provide alternative sources of consumable nitrogen.
Figure 5.—Gat1 regulates the expression of the ammonium assimilation enzyme and permease-encoding genes. (A) Scheme
representing the predicted pathway of central nitrogen metabolism in C. neoformans. (B) cDNA from wild-type H99 and gat1∆
mutant grown in YPD were amplified via qRT-PCR using primers against GDH1 (NADPH-GDH), GLN1 (GS), GLT1 (GOGAT),
GDH2 (NAD-GDH), AMT1 (ammonium transporter 1), AMT2 (ammonium transporter 2), and the control gene ACT1 (actin).
The expression of GDH1, AMT1, and AMT2 was significantly lower in the gat1∆ mutant compared to wild type, while that of
GLN1, GLT1, and GDH2 was slightly lower. This difference in level of expression for GDH1 (*** denotes P , 0.0001), AMT1 (**
denotes P , 0.01), and AMT2 (* denotes P , 0.05) was statistically significant. Error bars represent standard errors across three
biological replicates.
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In support of our previous qRT-PCR data indicating that
urease is not significantly regulated by nitrogen metabo-
lite repression, the gat1D mutant still produces urease
even though the mutant is unable to utilize the ammonia
resulting from urea catabolism (Figure 7C).
To complete a thorough phenotypic analysis of the
gat1D mutant, we evaluated the role of Gat1 for its abil-
ity to grow at high temperature (37!–40!), a common
stress that C. neoformans encounters both in a mamma-
lian host and in its ecological niche. While growth up to
38! was equivalent in the wild-type and gat1∆ mutant
strains, the mutant exhibited better growth in compar-
ison to wild type at 39!, the febrile temperature com-
monly experienced by most patients upon the onset of
cryptococcal meningoencephalitis (Figure 7D). Fur-
thermore, at 40!, growth of the wild-type strain was
completely abolished while the gat1∆ mutant was still
able to proliferate, albeit at a slow rate. This unantici-
pated finding indicates that Gat1 plays a negative role in
regulating growth at high temperature.
Gat1 is not required for the killing of C. elegans but
modestly represses virulence in a murine inhalation
model of cryptococcosis: Our ultimate interest in C.
neoformans lies in better understanding its pathogenic-
ity. In this context our data thus far were confusing, as
Gat1 arguably contributes to production of some viru-
lence attributes but repression of others. For example,
the gat1D mutant’s reduction in capsule synthesis and
abated ability to utilize a variety of nitrogen sources
suggest that this strain should exhibit a decrease in
virulence, just like that seen in equivalent ascomycete
GATA factor mutants. In contrast, the increase in mel-
anin production and enhanced growth at high tem-
perature would support an increase in virulence. To
determine the effect of Gat1 on virulence, we per-
formed C. elegans killing assays and a murine inhalation
model of cryptococcosis.
C. neoformans presumably interacts with C. elegans in
the environment and killing of C. elegans by C. neofor-
mans in vitro has previously been validated as a model
for studying pathogenesis (Mylonakis et al. 2002). We
performed C. elegans virulence assays using two different
media: the standard BHI medium for nematode killing
experiments, as well as 2.5% pigeon guano medium to
Figure 6.—Gat1 inhibits filament formation during mating.
Filamentation assays on V8 and MS mating media (pH 5.0)
showed that filament formation was enhanced in unilateral
gat1D crosses in comparison to the wild-type crosses. Filamen-
tation was enhanced even further in a bilateral gat1D cross.
Complementation of the H99a gat1D and KN99a gat1D
mutants with the GAT1 gene restored wild-type mating in all
tested crosses (data not shown).
Figure 7.—Gat1 is required for capsule synthe-
sis, but negatively regulates melanization and
growth at 39! or 40!. (A) India ink cell staining
under light microscopy revealed that the wild-type
H99 and gat1D 1 GAT1 strains produce enlarged
capsules while the gat1∆ mutant produces resid-
ual amount of capsule when strains were cultured
under serum-induced growth conditions. Scale
bar, 10 µm. (B) The gat1∆ mutant produces more
melanin compared to both the wild-type and
gat1∆ 1 GAT1 strains when grown on l-DOPA
medium supplemented with 10 mm proline at
37!. In contrast, all three strains melanized to
the same extent when grown at 30!. (C) Unlike
the negative control ure1∆ mutant, the wild-type,
gat1∆ mutant and gat1∆ 1 GAT1 strains all had
the ability to produce urease when grown on
Christensen’s urea agar as reflected by the bright
pink clearing surrounding the aliquot of spotted
cells. (D) Tenfold spot dilution assays on YPD
medium at human body temperature showed that
the gat1∆ mutant exhibits enhanced growth com-
pared to both the wild-type and gat1∆ 1 GAT1
strains at 39! and 40!.
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mimic C. neoformans ecological niche. Under both
growth conditions, killing of C. elegans by the gat1D mu-
tant [LT50 (time for half of the worms to die) ¼ 6 days
for both BHI and pigeon guano media] was not signif-
icantly different to that observed for wild type (LT50 ¼ 6
days and 7 days, for BHI and pigeon guano media, re-
spectively) (Figure 8A). Gat1 is therefore not required
for C. neoformans-mediated killing of the invertebrate
C. elegans.
On the other hand, the murine inhalation model of
cryptococcosis more closely mimics human infection by
C. neoformans—inhaled cryptococcal cells first infect the
lungs before disseminating to the brain to cause menin-
goencephalitis. Interestingly, mice infected with the
gat1Dmutant succumbed to infection slightly faster (be-
tween 14 and 21 days postinfection, median survival of
19 days) than mice infected with the wild-type strain
(between 17 and 28 days postinfection, median survival
of 23 days) (wild type vs. gat1D, P ¼ 0.0151) (Figure 8B).
This result suggests that the gat1D mutant is modestly
more virulent than wild type during murine infection.
Thus, in addition to regulating nitrogen metabolism
and virulence factor expression in vitro, Gat1 also re-
presses virulence in a vertebrate host.
DISCUSSION
The ability to acquire and catabolize nutrients from
the environment is imperative for survival of an
organism. While fungi are well known for their ability
to utilize a broad range of nitrogen sources, the study of
molecular mechanisms controlling nitrogen acquisition
and catabolism in model fungi have until now been
primarily limited to members of the phylum Ascomy-
cota (Wong et al. 2008). Our studies of transcriptional
regulation and phenotypic responses to the presence of
ammonium have shown that utilization of nitrogen
sources by C. neoformans is controlled in a similar fash-
ion. The results we report here represent the first de-
finitive characterization of the regulatory phenomenon
of nitrogen metabolite repression in a second phylum
of the kingdom fungi, the Basidiomycota. In addition to
functional conservation between these two phyla, the
repertoire of physiological responses controlled by ni-
trogen metabolite repression in C. neoformans has ex-
panded to encompass regulation of virulence factor
expression. We have also shown that the GATA factor
Gat1 is responsible for mediating nitrogen metabolite
repression in C. neoformans.
Bioinformatically, the predicted GATA factor of C.
neoformans Gat1 shows little similarity to nitrogen regu-
latory GATA factors of the Ascomycota for the majority
of the protein, except within the GATA motif itself
(Table S6). With 19% overall protein identity, it showed
poor but still highest similarity to the various nitrogen
regulatory GATA factors of the Ascomycota. This
Figure 8.—The gat1D mutant kills C. elegans as efficiently as
wild-type H99, but exhibits modestly enhanced virulence in
a murine host. (A) C. elegans infection: !50 nematode worms
were transferred to a lawn of wild-type, gat1D, or gat1D 1
GAT1 cells as the sole food source on both BHI and 2.5%
pigeon guano media, and survival was monitored at 24-hr
intervals. There was no observable difference in C. elegans
killing by all three strains on both BHI (wild type vs. gat1D,
P ¼ 0.1066; gat1D vs. gat1D 1 GAT1, P ¼ 0.9230) and pigeon
guano media (wild type vs. gat1D, P ¼ 0.0250; gat1D vs.
gat1D 1 GAT1, P ¼ 0.3614). (B) Mus musculus infection: 10
mice were infected intranasally with either 1 · 105 cells of wild
type, gat1D, or gat1D 1 GAT1 strains, and survival was moni-
tored daily. Mice infected with the wild-type and gat1D 1
GAT1 strains progress to morbidity at the same rate (wild type
vs. gat1D1 GAT1, P ¼ 0.6691), whereas mice infected with the
gat1D strain progress to morbidity more rapidly (wild type vs.
gat1D, P ¼ 0.0151).
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similarity, however, was largely restricted to the pre-
dicted GATA zinc finger where identity to A. nidulans
AreA and N. crassa Nit2 was 88 and 90%, respectively.
The dependence of C. neoformans nitrogen metabo-
lism on a single GATA factor is in stark contrast to S.
cerevisiae or C. albicans, where multiple nitrogen regula-
tory GATA factors are required (Stanbrough et al.
1995; Limjindaporn et al. 2003; Liao et al. 2008). It
is important to note that the existence of the two
positively acting GATA factors, Gln3 and Gat1, in the
hemiascomycete S. cerevisiae is not the result of the
whole-genome duplication event that occurred around
100 million years ago, since these two orthologs are
also present in C. albicans, a species that did not un-
dergo this event (Wong et al. 2008; Gordon et al.
2009). C. neoformans global nitrogen regulatory circuit
instead more closely resembles the single positively act-
ing GATA factor systems in A. nidulans and N. crassa
(Stewart and Vollmer 1986; Kudla et al. 1990).
Given that N. crassa nit-2 was named after the mutant’s
inability to utilize nitrate, which C. neoformans is unable
to do, and the apparent existence of only one GATA
factor responsible for nitrogen utilization, we therefore
recommend an alternative and more informative name
to this gene: ARE1.
The similarities in the global nitrogen regulatory
circuit between C. neoformans and A. nidulans or N.
crassa continue when NmrA and Nmr1 are considered.
The Nmr proteins are inhibitors of the functions of
A. nidulans AreA and N. crassa Nit2, and a potential
homolog of this protein named Tar1 has recently been
characterized in C. neoformans, suggesting that the reg-
ulation of GATA factor activity may operate in a similar
fashion to these filamentous ascomycetes (Pan et al.
1997; Andrianopoulos et al. 1998; Jiang et al. 2009).
However, this model is confounded by conflicting
observations between the studies of Jiang et al. and
our own. Most notably, we have bioinformatics and phe-
notypic evidence indicating that C. neoformans is unable
to utilize nitrate as a nitrogen source. Confusingly,
Jiang et al. observed growth changes on this same nitro-
gen source as evidence that Tar1 plays a role in nitro-
gen metabolism, an observation that we are unable to
explain. Furthermore, C. neoformans Gat1/Are1 lacks
the highly conserved C-terminus sequence of AreA
and Nit2, which is involved in Nmr recognition (Platt
et al. 1996; Pan et al. 1997; Andrianopoulos et al.
1998). Nevertheless, Nmr proteins also interact with
the DNA-binding domain of AreA and Nit2, and further
study will be required to determine if Tar1 is a true
functional ortholog of NmrA/Nmr1.
Unlike regulation of AreA and Nit2 by Nmr, the S.
cerevisiae GATA transcriptional activators Gln3 and Gat1
are negatively regulated by the structurally unrelated
prion-forming glutathione-S-transferase Ure2, pre-
dicted to have been horizontally transferred from the
bacterial species Burkholderia vietnamiensis (Masison
and Wickner 1995; Xu et al. 1995; Hall and Dietrich
2007; Wong et al. 2008). Our analyses did not identify
a Ure2-like candidate encoded in the C. neoformans ge-
nome. Together, these data support the model that
C. neoformans and the filamentous ascomycetes share
a nitrogen regulatory mechanism that more closely
resembles the ancestral nitrogen metabolism regulatory
pathway than that seen in S. cerevisiae. We therefore
propose that the last common ancestor of the Ascomy-
cota and Basidiomycota likely had one positively acting
GATA factor (the AreA/Nit2/Gat1/Are1 ortholog) and
corepressor protein Nmr; after the phyla separated,
a second GATA factor (Gln3) and Ure2 coevolved in
S. cerevisiae, and the nmr gene was lost.
While the effect of the loss of GAT1/ARE1 on nitro-
gen metabolism largely met our predicted phenotype,
a key aspect of it did not. One of the most confusing,
and seemingly contradictory, phenotypes of the gat1/
are1∆ mutant is its inability to grow on ammonium as
the sole nitrogen source. We subsequently gained
insights into this paradox by proving that along with
its established role as an activator of secondary catabolic
gene expression in the absence of ammonium, Gat1/
Are1 is also functional in the presence of ammonium.
Like A. nidulans AreA, C. neoformans Gat1/Are1 also
regulates the expression of the major ammonium as-
similation enzyme-encoding gene GDH1 as well as the
permease-encoding genes AMT1 and AMT2
(Christensen et al. 1998; Monahan et al. 2002, 2006;
Rutherford et al. 2008). Since the alternative pathway
of ammonium assimilation (via GLN1 and GLT1) is not
significantly impaired in the gat1/are1D mutant, we
speculate that the basal levels of transcription of
AMT1 and AMT2 may be insufficient for ammonium
uptake. It is worth noting that our nitrogen metabolite
repression study followed the traditional use of ammo-
nium as the “repressing” nitrogen source. In reality, it
is likely that the true signal affecting Gat1/Are1 activity
may be intracellular concentrations of glutamine and/
or glutamate since these metabolites reflect the nitro-
gen status of the cell in other species. Further work
using glutamine, glutamate, and perhaps even nitro-
gen starvation will be required to dissect this aspect of
the nitrogen-sensing mechanism.
The opposing regulatory effect of Gat1/Are1 on
melanin and capsule production has been observed in
previously characterized GATA factors of C. neoformans:
Cir1 and Gat201 ( Jung et al. 2006; Liu et al. 2008).
Notably, although LAC1 is the major contributor to
melanin biosynthesis, we were unable to find putative
Gat1/Are1 HGATAR binding sites within a 1-kb region
upstream from the start codon of LAC1 (Pukkila-
Worley et al. 2005). In contrast, numerous HGATAR
sites were found in the promoter regions of CAP60 and
CAP64, two key genes that are regulated to control cap-
sule biosynthesis (Chang et al. 1996; Chang and Kwon-
Chung 1998). Together, these data suggest that Gat1/
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Are1 may activate the transcription of capsule biosyn-
thesis genes directly, but indirectly regulate melanin
production, perhaps by regulating the expression of
a repressor of LAC1 transcription.
To gain insights into the role of Gat1/Are1 in the
environment we employed a novel approach, combin-
ing an established virulence model based on a known
predator (C. elegans) with a medium designed to emu-
late the environmental niche (pigeon guano). This
study enabled us to make an important observation:
Gat1/Are1 does not appear to have a significant effect
on virulence in the environmental niche; instead it may
play a role in nitrogen scavenging. However, in a murine
host, this gene has likely been co-opted into regulating
various aspects of the virulence composite.
It is nevertheless worth noting that the C. elegans kill-
ing assays were conducted at 25! instead of mammalian
body temperature. Whereas the enhanced growth and
melanization abilities of the gat1/are1D mutant may be
exhibited during the infection process in mice, these
virulence attributes could not be displayed in C. elegans.
While the slightly quicker progression to morbidity in
mice infected with the gat1/are1D mutant would not be
considered great enough to classify this strain as “hyper-
virulent,” it certainly highlights the complexity of the
role of Gat1/Are1 in gene regulation of C. neoformans
during infection. We note that Kmetzsch et al. (2010)
recently reported that the gat1/are1D mutant exhibited
equivalent virulence to wild type when high doses (1 ·
107 cells per strain) were used, which resulted in mice
succumbing to infection as early as the third day post-
infection. In contrast, we employed the more tradi-
tional inoculum of 1 · 105 cells to ensure the gradual
progression of disease. We believe this increased sensi-
tivity helped identify the subtle difference in virulence
between the wild-type and gat1/are1D mutant strains
that had previously been missed.
Notably, all other known GATA factors of C. neofor-
mans (Bwc2, Cir1, and Gat201) play a role in virulence
factor expression in vitro and affect virulence during
murine infection (Idnurm and Heitman 2005; Jung
et al. 2006; Liu et al. 2008). Bwc2, Cir1, Gat201, and
Gat1/Are1 together with the three other uncharac-
terized GATA factors (CNAG03401.2, CNAG04263.2,
CNAG06762.2) we have identified are predicted to bind
to 59-GATA-39 sites in the genome (Ko and Engel 1993;
Merika and Orkin 1993; Ravagnani et al. 1997).
Whether these GATA factors antagonize and compete
for the same 59-GATA-39 binding sites in the promoter
regions of genes, act in synergy to activate transcription
of genes, or act interchangably remains to be deter-
mined. Notwithstanding, it is becoming increasingly
apparent that Bwc2, Cir1, Gat201, and Gat1/Are1 can
act in parallel to regulate multiple virulence pathways in
C. neoformans.
In summary, Gat1/Are1 not only regulates nitrogen
metabolite repression and the expression of catabolic
enzyme and permease-encoding genes required for
nitrogen assimilation, it is also a key regulator of es-
sential virulence traits in this important human patho-
gen. While the significance of Gat1/Are1 is now clearly
demonstrated, full appreciation of its role awaits fur-
ther analysis of the gene targets and processes regu-
lated by this global transcription factor as well as its
potential interactions with other GATA factors. Cer-
tainly, a more complete understanding of the complex
regulatory circuit governing nitrogen metabolism and
virulence mechanisms in C. neoformans will require fur-
ther study.
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FIGURE S1.–Quantitative measurements of relative capsule diameters of wild-type H99 cells grown on YNB 
supplemented with various nitrogen sources (10 mM). A total of 60 cells (20 cells from three independent experiments) were 
measured for each nitrogen condition. Error bars represent standard errors. 
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FIGURE S2.–ClustalW multiple sequence alignment of GATA DNA-binding domains from various fungi retrieved either 
from GenBank or Broad Institute H99 database. Residues highlighted in yellow represent the universally conserved cysteines 
involved in zinc ion chelation. Amino acids at the central loop separating the second and third cysteines are in the range of 
17-20 residues in length. Residues highlighted in blue indicate basic amino acids within 25 residues beyond the most C-
terminal cysteine. Accession numbers or Broad annotations of protein sequences: Saccharomyces cerevisiae (Sc) Gln3 P18494.2, 
Candida albicans (Ca) Gln3p XP_721981.1, Cryptococcus neoformans (Cn) Gat1 CNAG00193.2, Neurospora crassa (Nc) Nit2 
P19212.2, Gibberella fujikuroi (Gf) AreA P78688.1, Aspergillus parasiticus (Ap) AreA AAD37409.1, Aspergillus nidulans (An) AreA 
XP_681936.1, Aspergillus niger (As) AreA O13412.1, Aspergillus oryzae (Ao) AreA XP_001816951.1, Magnaporthe grisea (Mg) Nut1 
XP_366679.1, Penicillium chrysogenum (Pc) Nre Q01582.1, Ca Gat1p AAP50501.1, Sc Nil/Gat1 NP_116632.1, Sc Dal80 
CAA42757.1, Sc Gfz3 NP_012425.1, Debaryomyces hansenii (Dh) Gfz3 CAJ78410.1, Nc Asd4 Q9HEV5.1, An AreB 
XP_663825.1, Pc NreB XP_002557977.1, An SreA XP_657780.1, Pc SreP XP_002567610.1, Ustilago maydis (Um) Urbs1 
XP_757197.1, Histoplasma capsulatum (Hc) Sre1 ABY66603.1, Cn Cir1 CNAG04864.2, Nc Sre XP_961978.1, Aspergillus 
fumigatus (Af) SreA XP_753523.1, Bipolaris oryzae (Bo) Blr2 BAF47401.1, Nc WC2 P78714.1, Cn Bwc2 CNAG02435.2, 
Schizosaccharomyces pombe (Sp) Gaf2 AAB38022.1, Sp Ams2 NP_588400.2, An NsdD XP_660756.1, Cn Gat201 
CNAG01551.2, Sc Ash1 NP_012736.1, Ca Ash1p CAC48044.1, Nc WC1 Q01371.2, Sc Srd2 NP_015304.1 and Sc Srd1 
NP_009944.2.
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FIGURE S3.–Complementation of nitrogen utilisation phenotype to wild-type levels upon the re-introduction of GAT1 
into the gat1 mutant. 10-fold spot dilution assays for nitrogen utilisation showed that the gat1 + GAT1 strain exhibited 
wild-type growth on 10 mM ammonium, uric acid, urea, creatinine and proline. 
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FIGURE S4.–Gat1 is dispensable for growth on pigeon guano. 10-fold spot dilution assays on 25% (wt/vol) pigeon guano 
media showed that both the gat1 and gat1 + GAT1 strains exhibited similar growth rates to wild-type H99. 
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FIGURE S5.–Quantitative measurements of relative capsule diameters of wild-type H99, gat1 and gat1 + GAT1 cells 
grown in RPMI and DMEM (10% fetal calf serum). A total of 60 cells (20 cells from three independent experiments) of each 
strain were measured. Error bars represent standard errors. 
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TABLE S1 
Cryptococcus strains used in this study 
Strain Strain details 
Molecular 
type 
Country of 
origin 
Source 
H99 Laboratory strain VNI USA J. Perfect 
RL1 H99 gat1 VNI N/A This study 
CM127 H99 gat1+GAT1 VNI N/A This study 
RL2 H99 gat201 VNI N/A This study 
RL3 H99 bwc2 VNI N/A This study 
RL4 H99 CNAG04263.2 VNI N/A This study 
RL5 H99 CNAG06762.2 VNI N/A This study 
RL6 H99 CNAG03401.2 VNI N/A This study 
H9CIR4 H99 cir1 VNI N/A J. Kronstad 
RL8 KN99a gat1 VNI N/A This study 
YL5 H99 ure1 VNI N/A This study 
125.91 Clinical isolate VNI Tanzania J. Heitman 
8-1 Clinical isolate VNII USA J. Heitman 
I57 Clinical isolate VNII India B. Fries 
JEC21 Laboratory strain VNIV USA J. Kwon-Chung 
NIH430 Clinical isolate VNIV Denmark Kavanaugh 
Bt33 Clinical isolate VNB Botswana A. Litvintseva 
Bt63 Clinical isolate VNB Botswana A. Litvintseva 
WM276 Environmental isolate VGI Australia W. Meyer 
E566 Environmental isolate VGI Australia J. Fraser 
R265 Environmental isolate VGII Canada J. Fraser 
CBS 1930 Veterinary isolate VGII Aruba W. Meyer 
NIH312 Clinical isolate VGIII USA J. Kwon-Chung 
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B4546 Environmental isolate VGIII Australia J. Fraser 
MMRL2651 Clinical isolate VGIV India W. Schell 
Bt201 Clinical isolate VGIV Botswana A. Litvintseva 
C. neoformans consists of variety grubii and variety neoformans, comprising four molecular types, VNI, VNII, VNB 
and VNIV (variety neoformans). C. gattii comprises molecular types VGI, VGII, VGIII and VGIV (variety gattii). 
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TABLE S2 
Primers used in this study 
Primer name Purpose Sequence (5’-3’) 
UQ613   URO1 qRT-PCR TGAGTACACCCTCCGAGTCCTT 
UQ733   URO1 qRT-PCR TTTACAGTGTCGGTAGCAACGAC 
UQ609   DAL1 qRT-PCR CTTATCGACACCCACGTCCA 
UQ736   DAL1 qRT-PCR GCATGTCGATCAGGGTGGT 
UQ739   URE1 qRT-PCR TAAGATCAAACTCGCTGACATGG 
UQ740   URE1 qRT-PCR CTCGAATGACCTTACCTCCACC 
UQ1070   PUT1 qRT-PCR AAAAGCTAAAGAGAACGACGTTGC 
UQ1071   PUT1 qRT-PCR TCTCACTCTTTGACTTTGGAGGTTT 
UQ1072   PUT5 qRT-PCR AGAAGGCTAAGGAGAACAACATCATT 
UQ1073   PUT5 qRT-PCR GTCCAGATCTCCTCCTTGGAAG 
UQ1074   PUT2 qRT-PCR TCATTAACGGTGAGGAGGTCAAG 
UQ1075   PUT2 qRT-PCR GCAAGAGCACCGTCAATGG 
UQ1586 GDH1 qRT-PCR 
GCTTCCCAGAATGAGCTTAACG 
UQ1587 GDH1 qRT-PCR 
CGTCAAGTGTACAGCCCATGTT 
UQ1588 GDH2 qRT-PCR 
CTTATGCTTATGTCGGATGGATCTT 
UQ1589 GDH2 qRT-PCR 
TGGACTCATCCAGAGCATCCT 
UQ1590 GLN1 qRT-PCR 
TCGAATCCCCAGGCATGT 
UQ1591 GLN1 qRT-PCR 
CGACGAGGATGGCTGTGACT 
UQ1592 GLT1 qRT-PCR 
CCGTTGGATCAGAGAAATTCTACC 
UQ1593 GLT1 qRT-PCR 
CTGCTGAGGACCGAGGAAAC 
UQ1630 AMT1 qRT-PCR 
TTATGTTTTGCTGGACTACCTTGGT 
UQ1631 AMT1 qRT-PCR 
CGCCACCTGCATAGTCCAAT 
UQ1632 AMT2 qRT-PCR 
TGAGGTTAAGGGCTAGCGAAGA 
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UQ1633 AMT2 qRT-PCR 
CGGGATCTGTGCCAACATAGT 
UQ482   ACT1 qRT-PCR CCTACAACTCTATCATGAAGTGTGATCTC 
UQ728   ACT1 qRT-PCR TCTGCATACGGTCGGCAATAC 
UQ856   GAT1 deletion GTTGCGGGATGCTGGTGAAAT 
UQ857   GAT1 deletion AGCTCACATCCTCGCAGCCCTAGCCGCCGCTAGCTG 
UQ858   GAT1 deletion GTGTTAATACAGATAAACCGCGAATGAATGGAAGCA 
UQ859   GAT1 deletion GCCCAGCAACTACCATCGTGT 
UQ946 GAT1 deletion CAGCTAGCGGCGGCTAGGGCTGCGAGGATGTGAGCT 
UQ947  GAT1 deletion TTGCTTCCATTCATTCGCGGTTTATCTGTATTAACA 
UQ864  GAT201 deletion CCGCTAAGGAAGGAAGTGGTG 
UQ865 GAT201 deletion AGCTCACATCCTCGCAGCTGTGCTGGCAAGTAGGGA 
UQ866 GAT201 deletion GTGTTAATACAGATAAACCTGAGAATAGGAAAGAAC 
UQ867 GAT201 deletion CAGGGTAAAGGCCGTTAGATA 
UQ963 GAT201 deletion TCCCTACTTGCCAGCACAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ964 GAT201 deletion GCTGTTCTTTCCTATTCTCAGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ872 BWC2 deletion TACTCCAGTATCGCTGTCTCC 
UQ873 BWC2 deletion AGCTCACATCCTCGCAGCTGGCCGTGCTATAGGTGA 
UQ874 BWC2 deletion GTGTTAATACAGATAAACCGAGTAGTACTTTGGACT 
UQ875 BWC2 deletion TCAGCCTCGCACATAATCTAA 
UQ966 BWC2 deletion TCACCTATAGCACGGCCAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ967 BWC2 deletion CAGTCCAAAGTACTACTCGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ876 CNAG04263.2 deletion CTTGAAGCTGCGTTAGAACAT 
UQ877 CNAG04263.2 deletion CTCACATCCTCGCAGCTGTGGTTTTTGTAGGC 
UQ878 CNAG04263.2 deletion GTTAATACAGATAAACCGGAGTGATTAAGAGG 
UQ879 CNAG04263.2 deletion TTAGCTTCTGGCGTCTGATGA 
UQ968 CNAG04263.2 deletion CCGCCTACAAAAACCACAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ969 CNAG04263.2 deletion CCACCTCTTAATCACTCCGGTTTATCTGTATTAACACGGAAGAGATGTAG 
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UQ888 CNAG06762.2 deletion GGGAAGATTAGCGCACCAAAC 
UQ889 CNAG06762.2 deletion AGCTCACATCCTCGCAGCTGTTGGGGAAAAAGGAAA 
UQ890 CNAG06762.2 deletion GTGTTAATACAGATAAACCGTGTTGTAACGAGTCGA 
UQ891 CNAG06762.2 deletion CGCTGCTCTTATCATGTCCAT 
UQ974 CNAG06762.2 deletion TTTCCTTTTTCCCCAACAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ975 CNAG06762.2 deletion ATCGACTCGTTACAACACGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ852 CNAG03401.2 deletion CTTGAAGGTTAATCGTGACGG 
UQ853 CNAG03401.2 deletion AGCTCACATCCTCGCAGCCCTATAATTCTCTTTTAT 
UQ854 CNAG03401.2 deletion TGTTAATACAGATAAACCAATGCCAGGGAGAGAATT 
UQ855 CNAG03401.2 deletion ATCCGCCAACAACAGTACCAC 
UQ960 CNAG03401.2 deletion ATAAAAGAGAATTATAGGGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ961 CNAG03401.2 deletion AATTCTCTCCCTGGCATTGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ1234 GAT1 complementation GTGGCGCGCCGCTGGTGAAAT 
UQ1235 GAT1 complementation GCCCAGGAGCTCCCATCGTGT 
M13F General sequencing  GTAAAACGACGGCCAG 
M13R General sequencing CAGGAAACAGCTATGAC 
UQ1027 GAT1 sequencing GAAAGGCGAATAAAGGCTGTT 
UQ1028 GAT1 sequencing TCTGCCGCGTCTTCCCGGCCC 
UQ1029 GAT1 sequencing CCAAAAGCTGCTAGGGGCACC 
UQ1030 GAT1 sequencing TTGCCAAACGGTTTGTCTCTT 
UQ1031 GAT1 sequencing GCAGCCGCAGCAACGGCTGCG 
UQ1032 GAT1 sequencing AAAAAAAAGCATAAATAAAAA 
UQ1033 GAT1 sequencing TGACCGCACAGACGTATTTTT 
UQ1034 GAT1 sequencing AGCTTTCGGTAATGGCCGGAT 
UQ1035 GAT1 sequencing GTGGTCGAAGGATGTCTTCCG 
qRT-PCR primers were designed using Primer Express software 2.0 (Applied Biosystems). All remaining primers were designed 
using Oligo 6.8 (Molecular Biology Insights, West Cascade CO). 
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TABLE S3 
Nitrogen utilisation profile of various Cryptococcus strains 
Molecular 
type 
VNI VNII VNIV VNB VGI VGII VGIII VGIV 
     
          Strains 
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Prolinea +++ +++ ++ +++ ++ +++ + +++ +++ +++ +++ +++ ++ ++ +++ +++ 
Glutaminea +++ +++ ++ ++ +++ +++ + +++ +++ +++ +++ +++ ++ + +++ +++ 
Asparaginea +++ +++ ++ +++ +++ +++ + ++ ++ +++ +++ +++ +++ + +++ +++ 
Glutamatea +++ +++ ++ +++ +++ +++ + +++ +++ +++ +++ +++ ++ + ++ ++ 
GABAa +++ +++ + +++ +++ +++ +/- +++ +++ +++ +++ +++ ++ + +++ +++ 
Creatininea +++ + ++ ++ +++ +++ + + +++ +++ +++ +++ +++ + +++ +++ 
Glycinea +++ +++ + ++ ++ +++ + ++ +++ +++ +++ +++ ++ + +++ +++ 
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Ammoniuma +++ +++ + ++ +++ +++ + +++ +++ ++ +++ +++ + +/- +++ ++ 
Argininea ++ ++ + ++ + ++ ++ ++ +++ +++ +++ +++ ++ + +++ ++ 
Aspartic acidb ++ ++ + + + +/- + +++ +++ +++ +++ +++ + /- +++ +++ 
Ureab ++ ++ ++ ++ + + ++ ++ ++ ++ ++ ++ + +/- ++ ++ 
Alanineb ++ + + ++ ++ ++ +/- + ++ ++ ++ ++ + +/- ++ ++ 
Tyrosineb ++ ++ + ++ + ++ + ++ ++ ++ + ++ +/- /- ++ ++ 
Guanineb ++ ++ + + ++ + +/- + + ++ ++ ++ + +/- ++ ++ 
Serineb + + +/- + ++ ++ +/- + + ++ ++ ++ ++ + ++ + 
Uric acidb ++ ++ + + /- /- + ++ ++ ++ ++ ++ + ++ ++ ++ 
Kynurenineb + + + + + + +/- + ++ ++ ++ ++ + +/- ++ + 
Citrullineb ++ ++ +/- + + + ++ ++ + + + + +/- +/- + + 
Histidineb + + + + + + + + ++ + + + + +/- + + 
Tryptophanc ++ +/- + + +/- + +/- ++ + + + + +/- +/- + + 
Threoninec + + + + + + +/- + + + + + +/- +/- + + 
Leucinec + +/- + + + + +/- + ++ + + + +/- /- + + 
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Ornithinec + + +/- +/- +/- +/- ++ + + + + + +/- +/- ++ + 
Allantoinc + + + + +/- +/- + +/- + + + + +/- +/- + + 
Lysinec ++ ++ + + +/- +/- +/- ++ + + + + - - + + 
Isoleucinec + + + +/- + + +/- +/- + + +/- + +/- +/- +/- + 
Methioninec + +/- +/- +/- +/- + +/- +/- + + + + +/- +/- + + 
Valinec +/- +/- +/- +/- +/- +/- +/- +/- ++ + + + + +/- + + 
Guanosinec /- /- + + + + + + + + +/- +/- +/- +/- + + 
Phenylalaninec + + +/- +/- +/- +/- +/- + + +/- +/- + /- /- + +/- 
Adeninec +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- 
Adenosinec +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- 
Glucosamined +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- /- /- +/- +/- 
Acetamided +/- +/- +/- +/- +/- +/- /- +/- +/- +/- +/- +/- +/- /- +/- +/- 
Formamided +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- +/- /- /- /- +/- 
Nicotinamided +/- +/- /- +/- +/- +/- /- +/- - +/- +/- +/- /- /- +/- +/- 
Uracild +/- +/- +/- +/- /- /- /- +/- +/- +/- +/- +/- /- /- +/- +/- 
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Niacinamided +/- +/- /- +/- +/- /- /- +/- /- /- /- +/- /- /- +/- +/- 
Xanthined - - /- /- - - /- /- - /- /- /- /- /- - - 
Cadaverinee - - - - - - - - - - - - - - - - 
Nitritee - - - - - - - - - - - - - - - - 
Nitratee - - - - - - - - - - - - - - - - 
aGood nitrogen source; bAverage nitrogen source; cPoor nitrogen source; dVery poor nitrogen source; eNot a nitrogen source 
+++ denotes excellent growth; ++ denotes good growth;  + denotes moderate growth;  +/- denotes poor growth;  /- denotes very poor growth; - denotes no growth 
 
10-fold spot dilution assays revealed that the strains exhibited varying growth rates on different nitrogen sources (10 mM) that were mainly limited to ammonium, purines and amino acids.
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TABLE S4 
Reciprocal BLASTp analyses of characterised fungal GATA factors against the C. neoformans 
genome 
Species Protein Function Reference Best hit in C. 
f
E value 
N. crassa Nit2 Nitrogen metabolism 
(Positively – acting) 
Stewart 1986 CNAG00193.2 
(Gat1) 
1.12689E-21 
G. fujikuroi AreA  Mihlan 2003  1.28176E-19 
A. parasiticus AreA  Chang 2000  1.16799E-24 
A. nidulans AreA  Kudla 1990  9.05971E-25 
A. niger AreA  MacCabe 1998  2.24874E-23 
A. oryzae AreA  Christensen 1998  1.16799E-24 
A. fumigatus AreA  Hensel 1998  1.23235E-21 
M. grisea Nut1  Froeliger 1996  1.81053E-34 
P. chrysogenum Nre  Haas 1995  3.09042E-23 
C. albicans Gat1p  Limjindaporn 2003  1.14722E-20 
S. cerevisiae Gln3  Minehart 1991  5.14654E-18 
C. albicans Gln3p  Liao 2008  1.29509E-15 
S. cerevisiae Gat1  Stanbrough 1995  2.77123E-20 
C. neoformans Gat1  Kmetzsch 2010  0.0 
D. hansenii DhGzf3 Nitrogen metabolism 
(Negatively – acting) 
Garcia-Salcedo 2006  9.62535E-19 
S. cerevisiae Gzf3  Soussi-Boudekou 1997  5.37613E-17 
A. nidulans AreB  Conlon 2001  9.70406E-20 
P. chrysogenum NreB  Haas 1997  1.3125E-18 
S. cerevisiae Dal80  Cunningham 1992  6.18739E-16 
H. capsulatum Sre1 Iron uptake Chao 2008  8.20534E-17 
A. fumigatus SreA  Schrettl 2008  2.02048E-16 
N. crassa Asd4 Sexual development Feng 2000  3.01803E-17 
U. maydis Urbs1 Iron uptake Voisard 1993 CNAG04864.2 
(Cir1) 
4.96038E-20 
A. nidulans SreA  Haas 1999  1.23395E-13 
P. chrysogenum SreP  Haas 1997  1.35569E-17 
N. crassa Sre  Zhou 1998  3.6177E-19 
S. pombe Gaf2  Hoe 1996  1.00542E-26 
C. neoformans Cir1  Jung 2006  0.0 
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N. crassa WC1 Blue light signal Ballario 1996 CNAG05181.2 
(Bwc1) * 
0.0 
N. crassa WC2  Linden 1997 CNAG02435.2 
(Bwc2) 
2.91186E-12 
B. oryzae Blr2  Moriwaki 2008  2.86005E-13 
C. neoformans Bwc2  Idnurm 2005  0.0 
S. cerevisiae Ash1 Pseudohyphal growth Chandarlapaty 1998  0.00163479 
A. nidulans NsdD Sexual development Han 2001 CNAG01551.2 
(Gat201) 
6.06295E-11 
S. cerevisiae Srd1 Pre-rRNA processing Hess 1994  4.0921E-5 
S. cerevisiae Srd2 Pseudohyphal growth Canizares 2002  2.55412E-7 
C. neoformans Gat201 Anti-phagocytosis Liu 2008  0.0 
S. pombe Ams2 Cell cycle Chen 2003 CNAG03401.2 4.1389E-9 
C. albicans Ash1p Pseudohyphal growth Munchow 2002  0.00266078 
* C. neoformans Bwc1 is not strictly a GATA factor due an absence of the zinc finger DNA-binding domain in this 
ortholog 
Protein sequences of fungal GATA factors retrieved from GenBank were queried against the C. neoformans strain H99 
genome sequence available at the Broad Institute. 
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TABLE S5 
Growth responses of wild-type H99 and GATA-type deletion mutants on various utilisable 
nitrogen sources 
Strains 
Nitrogen source 
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 
Proline +++ ++ +++ +++ +++ +++ +++ +++ 
Glutamine +++ +/- +++ +++ +++ +++ +++ +++ 
Asparagine +++ +/- +++ +++ +++ +++ +++ +++ 
Creatinine +++ - +++ +++ +++ +++ +++ +++ 
Glutamate +++ +/- +++ +++ +++ +++ +++ +++ 
GABA +++ +/- +++ +++ +++ +++ +++ +++ 
Glycine +++ - +++ +++ +++ +++ +++ +++ 
Ammonium +++ - +++ +++ +++ +++ +++ +++ 
Arginine ++ + ++ ++ ++ ++ ++ ++ 
Uric acid ++ - ++ ++ ++ ++ ++ ++ 
Urea ++ - ++ ++ ++ ++ ++ ++ 
Aspartic acid ++ +/- ++ ++ ++ ++ ++ ++ 
Alanine ++ +/- ++ ++ ++ ++ ++ ++ 
Tyrosine ++ - ++ ++ ++ ++ ++ ++ 
Guanine ++ - ++ ++ ++ ++ ++ ++ 
Citrulline ++ - ++ ++ ++ ++ ++ ++ 
Tryptophan ++ - ++ ++ ++ ++ ++ ++ 
Lysine ++ +/- ++ ++ ++ ++ ++ ++ 
Serine + - + + + + + + 
Kynurenine + - + + + + + + 
Histidine + - + + + + + + 
Threonine + - + + + + + + 
Leucine + - + + + + + + 
Ornithine + +/- + + + + + + 
Isoleucine + - + + + + + + 
Allantoin + - + + + + + + 
Methionine + - + + + + + + 
Phenylalanine + - + + + + + + 
Valine +/- - +/- +/- +/- +/- +/- +/- 
Adenine +/- - +/- +/- +/- +/- +/- +/- 
Adenosine +/- - +/- +/- +/- +/- +/- +/- 
Guanosine +/- - +/- +/- +/- +/- +/- +/- 
Glucosamine +/- - +/- +/- +/- +/- +/- +/- 
Formamide +/- - +/- +/- +/- +/- +/- +/- 
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Nicotinamide +/- - +/- +/- +/- +/- +/- +/- 
Uracil +/- - +/- +/- +/- +/- +/- +/- 
Acetamide +/- - +/- +/- +/- +/- +/- +/- 
Niacinamide +/- - +/- +/- +/- +/- +/- +/- 
- denotes no growth; +/- denotes poor growth; + denotes moderate growth; ++ denotes good growth; +++ 
denotes excellent growth 
Media was supplemented with 10 mM of each nitrogen source. Summarised results of the nitrogen utilisation 
assays. 
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TABLE S6 
Sequence identity of characterised fungal GATA factors in comparison to predicted C. neoformans members 
 % DNA-binding domain (Protein) identity to C. neoformans GATA factor candidates 
Species Protein Function 
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N. crassa Nit2 Nitrogen metabolism (Postively-acting) 90 (19) 31 (14) 32 (13) 40 (18) 36 (17) 64 (20) 28 (15) 
G. fujikuroi AreA  88 (19) 31 (17) 32 (15) 40 (18) 36 (18) 66 (19) 26 (18) 
A. parasiticus AreA  88 (19) 31 (18) 32 (15) 34 (18) 36 (19) 66 (21) 26 (17) 
A. nidulans AreA  88 (18) 31 (17) 32 (16) 40 (17) 36 (20) 66 (21) 26 (17) 
A. niger AreA  88 (18) 31 (19) 32 (15) 40 (18) 36 (19) 66 (20) 26 (19) 
A. oryzae AreA  88 (18) 31 (18) 32 (15) 34 (17) 36 (17) 66 (20) 26 (17) 
M. grisea Nut1  88 (18) 31 (16) 32 (15) 34 (18) 36 (18) 66 (21) 26 (16) 
P. chrysogenum Nre  88 (17) 31 (17) 32 (18) 34 (18) 36 (19) 66 (19) 26 (17) 
C. albicans Gat1p  86 (15) 39 (15) 34 (14) 44 (18) 36 (17) 66 (18) 38 (16) 
S. cerevisiae Gat1  78 (13) 29 (16) 38 (17) 40 (15) 38 (16) 64 (13) 28 (19) 
C. albicans Gln3p  76 (17) 39 (17) 34 (16) 32 (17) 36 (16) 60 (19) 26 (19) 
S. cerevisiae Gln3  72 (18) 39 (17) 34 (16) 32 (17) 36 (17) 58 (18) 16 (17) 
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D. hansenii DhGzf3 Nitrogen metabolism (Negatively-acting) 74 (17) 31 (21) 34 (20) 36 (20) 38 (18) 66 (16) 22 (17) 
S. cerevisiae Gzf3  74 (16) 29 (18) 32 (19) 32 (17) 38 (18) 68 (18) 26 (17) 
A. nidulans AreB  74 (10) 21 (20) 38 (19) 34 (15) 40 (7) 68 (12) 28 (17) 
P. chrysogenum NreB  74 (8) 37 (19) 38 (20) 34 (16) 40 (16) 70 (12) 28 (18) 
S. cerevisiae Dal80  72 (4) 29 (11) 32 (3) 36 (8) 38 (5) 62 (4) 24 (10) 
U. maydis Urbs1 Iron uptake 68 (22) 35 (10) 34 (15) 36 (19) 42 (19) 76 (19) 22 (16) 
A. nidulans SreA  64 (16) 35 (18) 32 (19) 38 (20) 36 (20) 76 (17) 24 (22) 
H. capsulatum Sre1  64 (17) 35 (20) 30 (18) 38 (22) 40 (17) 74 (17) 22 (19) 
P. chrysogenum SreP  74 (17) 35 (21) 30 (17) 36 (18) 36 (18) 74 (17) 26 (20) 
A. fumigatus SreA  44 (16) 39 (18) 36 (18) 42 (19) 32 (20) 46 (16) 28 (19) 
N. crassa Sre  44 (16) 37 (18) 38 (19) 34 (18) 34 (17) 44 (16) 28 (18) 
S. pombe Gaf2  46 (17) 33 (20) 38 (18) 28 (19) 38 (18) 40 (17) 30 (22) 
C. neoformans Cir1  64 (16) 39 (11) 32 (8) 36 (14) 36 (13) 100 (100) 24 (10) 
B. oryzae Blr2 Blue light signal transduction 32 (12) 47 (23) 63 (21) 50 (19) 32 (18) 28 (17) 36 (18) 
N. crassa WC2  36 (16) 47 (21) 58 (22) 46 (20) 28 (18) 28 (16) 34 (19) 
C. neoformans Bwc2  34 (9) 45 (19) 100 (100) 50 (15) 34 (12) 32 (8) 32 (15) 
N. crassa WC1  44 (17) 39 (14) 40 (11) 38 (17) 34 (17) 38 (17) 30 (14) 
N. crassa Asd4 Sexual development 74 (13) 37 (16) 33 (21) 35 (18) 37 (17) 66 (12) 25 (18) 
A. nidulans NsdD  41 (15) 54 (27) 41 (19) 37 (20) 35 (19) 31 (17) 43 (18) 
S. cerevisiae Srd1 Pre-rRNA processing 34 (6) 41 (16) 36 (19) 26 (14) 28 (9) 24 (7) 32 (15) 
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C. neoformans Gat201 Anti-phagocytosis 33 (12) 100 (100) 45 (19) 43 (16) 33 (15) 39 (10) 41 (17) 
S. pombe Ams2 Cell cycle 29 (18) 25 (18) 27 (17) 31 (18) 31 (18) 31 (17) 25 (21) 
S. cerevisiae Ash1 Pseudohyphal growth 38 (17) 29 (19) 38 (21) 38 (19) 22 (18) 36 (18) 32 (19) 
S. cerevisiae Srd2  34 (4) 35 (15) 34 (18) 26 (12) 32 (8) 22 (4) 40 (13) 
C. albicans Ash1p  36 (12) 29 (19) 36 (17) 38 (20) 22 (18) 32 (16) 26 (21) 
Protein sequences of fungal GATA factors retrieved from GenBank were individually aligned with each C. neoformans strain H99 GATA factor candidate using ClustalW to obtain the 
percentage (%) DNA-binding domain/protein identity. Values highlighted in bold represent the highest % identity with DNA-binding domain identity given priority over protein identity, due to 
the established fact of high conservation at each function-specific GATA DNA-binding domain. 
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 4.1 Preface 
The ability of Cryptococcus neoformans to sense nitrogen availability and respond 
with appropriate metabolic remodeling is crucial for adaptation, proliferation and 
colonisation in an infected host. As the previous chapter has concluded, Gat1/Are1 
represents a nitrogen-responsive transcription factor that integrates metabolic 
functions (nitrogen acquisition) with elaboration of virulence factors (capsule, 
melanin and high temperature growth). This chapter extends the investigation from 
Chapter 3 to dissect the molecular mechanisms by which Gat1/Are1 activity is 
regulated in response to changes in nitrogen availability, as would occur when C. 
neoformans leaves its purine-rich ecological niche of pigeon guano to infect a 
mammalian host, which in comparison is nutrient limiting. 
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Abstract
Nitrogen source utilization plays a critical role in fungal development, secondary metabolite production and pathogenesis.
In both the Ascomycota and Basidiomycota, GATA transcription factors globally activate the expression of catabolic enzyme-
encoding genes required to degrade complex nitrogenous compounds. However, in the presence of preferred nitrogen
sources such as ammonium, GATA factor activity is inhibited in some species through interaction with co-repressor Nmr
proteins. This regulatory phenomenon, nitrogen metabolite repression, enables preferential utilization of readily assimilated
nitrogen sources. In the basidiomycete pathogen Cryptococcus neoformans, the GATA factor Gat1/Are1 has been co-opted
into regulating multiple key virulence traits in addition to nitrogen catabolism. Here, we further characterize Gat1/Are1
function and investigate the regulatory role of the predicted Nmr homolog Tar1. While GAT1/ARE1 expression is induced
during nitrogen limitation, TAR1 transcription is unaffected by nitrogen availability. Deletion of TAR1 leads to inappropriate
derepression of non-preferred nitrogen catabolic pathways in the simultaneous presence of favoured sources. In addition to
exhibiting its evolutionary conserved role of inhibiting GATA factor activity under repressing conditions, Tar1 also positively
regulates GAT1/ARE1 transcription under non-repressing conditions. The molecular mechanism by which Tar1 modulates
nitrogen metabolite repression, however, remains open to speculation. Interaction between Tar1 and Gat1/Are1 was
undetectable in a yeast two-hybrid assay, consistent with Tar1 and Gat1/Are1 each lacking the conserved C-terminus
regions present in ascomycete Nmr proteins and GATA factors that are known to interact with each other. Importantly, both
Tar1 and Gat1/Are1 are suppressors of C. neoformans virulence, reiterating and highlighting the paradigm of nitrogen
regulation of pathogenesis.
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Introduction
With over 1,500,000 species estimated to be present in the
Earth’s biosphere, the kingdom Fungi consists of a spectacularly
large group of eukaryotes [1]. To successfully thrive in their broad
range of niches, many fungal species have evolved mechanisms
that enable them to utilize a wide variety of nitrogen sources. The
expression of permease and catabolic enzyme-encoding genes
needed for the scavenging of most nitrogenous compounds
requires activation by global transcription factors belonging to
the GATA family. These nitrogen regulatory GATA factors are
conserved throughout the phyla Ascomycota and Basidiomycota. In the
model ascomycetes, two positively acting GATA factors GLN3 and
GAT1 are encoded in the genome of the yeast Saccharomyces cerevisiae
while single positively acting factors nit-2 and areA are encoded in
the genomes of the moulds Neurospora crassa and Aspergillus nidulans,
respectively [2,3,4,5,6,7,8]. Loss-of-function mutations in these
ascomycete GATA genes result in an inability to utilize a diverse
array of nitrogen sources apart from the readily assimilated and
hence generally preferred ammonium or glutamine [9]. Thus,
both ammonium and glutamine are metabolites that likely trigger
nitrogen metabolite/catabolite repression, resulting in the gener-
ation of signals that antagonize activation of secondary (non-
preferred) nitrogen gene expression by GATA factors [10,11,12].
Although GATA factors are employed to globally control
nitrogen metabolism in S. cerevisiae, N. crassa and A. nidulans, there
are compelling differences in key aspects of the molecular circuitry
that underlies the regulation of these transcription factors in
different fungal species. Studies thus far have shown that GATA
factor activity is regulated in response to nitrogen availability in
the surroundings and/or the nitrogen status of the cell. In S.
cerevisiae, transcriptional activation of GAT1 is cross-regulated by
both the positively acting factor Gln3 and negatively acting Dal80
[13]. The functions of Gln3 and Gat1 are also regulated
posttranscriptionally via protein subcellular localization, through
phosphorylation and interaction with the prion-forming glutathi-
one S-transferase Ure2 [14,15,16,17].
In N. crassa, the function of Nit2 is instead regulated via
interaction with a co-repressor protein known as Nmr1 (Nitrogen
metabolic regulation 1) [18]. Loss-of-function mutations in nmr-1
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result in derepression of a range of secondary nitrogen catabolic
genes under normally repressing conditions (nitrogen sufficient
conditions, e.g. in the presence of ammonium and/or glutamine)
[19]. Unlike S. cerevisiae Ure2, there is no evidence suggesting that
the structurally unrelated N. crassa Nmr1 affects Nit2 subcellular
localization. Rather, Nmr1 likely exerts its effect by modulating
the trans-activation function of Nit2 by interfering with its DNA
binding activity [20]. Like N. crassa Nit2, the function of A. nidulans
AreA is also regulated by an Nmr ortholog, NmrA [12,21,22,23].
In addition, AreA activity is further controlled by autogenous
regulation and control of transcript stability mediated through an
element in the 39 untranslated region of the areA mRNA
[23,24,25]. These pioneering studies of nitrogen metabolism in
S. cerevisiae, N. crassa and A. nidulans have played a crucial role in
our current understanding of gene regulation in eukaryotes.
Over the past decade, interest in nitrogen regulation has
expanded to encompass a number of important human fungal
pathogens, implicating gene regulation by nitrogen availability in
virulence. For example, during nitrogen limitation, Candida albicans
dimorphic transition from the budding yeast to filamentous growth
form that facilitates tissue invasion is dependent on the Mep2
ammonium permease, whose expression is regulated by the GATA
factors Gln3 and Gat1 [26,27]. Both gln3D and gat1D mutants
exhibit reduced virulence in a murine model of disseminated
candidiasis [28,29]. Likewise, the GATA factor AreA enables
nutritional versatility that is a key attribute influencing the ability
of Aspergillus fumigatus to cause disease [30]. Consistent with this
notion, the AreA ortholog in Penicillium marneffei has recently been
proposed to contribute to pathogenicity by regulating the
production of extracellular proteases that are potential virulence
factors [31]. Impact of nitrogen regulation on virulence is not
merely limited to members of the Ascomycota but is also observed in
the basidiomycete Cryptococcus neoformans, a species that causes life-
threatening meningoencephalitis predominantly in immunocom-
promised individuals [32]. For instance, apart from nitrogen
catabolism, the GATA factor Gat1/Are1 regulates multiple
virulence attributes including infectious basidiospore production,
capsule biosynthesis, high temperature growth and melanin
pigment formation [33,34].
Gaining insights into the molecular mechanism governing the
regulation of GATA factor activity is therefore important for the
understanding of how these pathogenic fungi establish disease in a
mammalian host. In C. albicans, Gln3 is proposed to be regulated
by an Ure2-like mechanism, similar to other closely related yeasts
[35,36]. In contrast, AreA of both A. fumigatus and P. marneffei are
likely to be regulated in an Nmr-like fashion, similar to the related
moulds [31,37]. A recent study by Jiang et al. suggests that the
yeast C. neoformans may follow this previously mould-specific
paradigm [38]. The potential Nmr homolog Tar1 (Temperature
associated repressor 1) was first identified in C. neoformans through
the overproduction of melanin at 37uC in a clone from a random
insertional mutagenesis library [38]. The expression of TAR1 was
induced at high temperature (37uC), and Tar1 was found to
negatively regulate LAC1-encoded laccase that catalyses the
formation of melanin in C. neoformans [38]. Like N. crassa Nmr1
and A. nidulans NmrA, Tar1 harbours a predicted canonical
Rossmann fold motif that is also found in other co-repressors such
as S. cerevisiae Gal80 and mammalian CtBP [21,38,39,40,41,
42,43].
As part of an ongoing effort to elucidate the global nitrogen
regulatory circuit in the most clinically prevalent form of C.
neoformans (var. grubii strain H99), we have investigated the genetic
and physical interactions between Tar1 and the GATA factor
Gat1/Are1. In addition, we have examined the role of Tar1 in
virulence factor expression and pathogenesis. Overall, our study
provides evidence of divergence between different fungal species in
the evolution of Nmr-associated proteins, and demonstrates the
importance of Tar1 in modulating C. neoformans virulence.
Materials and Methods
Strains and media
All fungal strains used in this study are listed in Table S1, and
were grown in YPD (1% yeast extract, 2% Bacto-peptone, 2%
glucose) or YNB (0.45% yeast nitrogen base w/o amino acids and
ammonium sulfate, 2% glucose, 10 mM nitrogen source) unless
specified otherwise. C. neoformans biolistic transformants were
selected on YPD medium supplemented with 200 mg/mL G418
(Sigma) or 100 mg/mL nourseothricin (Werner BioAgents).
Melanin-inducing media using L-3,4-dihydroxyphenylalanine (L-
DOPA), norepinephrine or caffeic acid as the laccase substrate
supplemented with 10 mM of the specific nitrogen source were
prepared as described previously [32,38,44,45,46]. Unfiltered 1%
pigeon guano medium was also prepared as described previously
[34,47]. Escherichia coli Mach-1 cells served as the host strain for
transformation and propagation of all plasmids using lysogeny
broth supplemented with either 100 mg/mL ampicillin (Sigma) or
50 mg/mL kanamycin (Sigma) [48]. Caenorhabditis elegans strain N2
was maintained at 15uC and propagated on its normal laboratory
food source E. coli OP50 cells [49,50,51]. Nematode growth
medium (NGM) was prepared as described previously [49].
Bioinformatic analyses
C. neoformans genes were identified using annotation from the
H99 genome sequence from the Broad Institute (http://www.
broadinstitute.org/annotation/genome/cryptococcus_neoformans/
MultiHome.html). Gene annotations from the Broad are designated
by their nomenclature ‘‘CNAG#####.#’’. Sequence analyses
were performed using BLAST and MacVector 9.5 (MacVector Inc,
Cary NC) [52]. Sequence alignments were created using ClustalW
v1.4 within MacVector [53]. Sequence traces generated at the
Australian Genome Research Facility (Brisbane, Queensland) were
analysed using Sequencher 4.7 (Gene Codes Corporation, Ann
Arbor MI).
Construction and complementation of C. neoformans
mutant strains
All primers and plasmids used in this study are listed in Table
S2 and S3, respectively. Gene deletion mutants were created using
overlap PCR and biolistic transformation as described previously
[54]. Briefly, to construct the tar1D mutant strain in the H99
background, the 1,067 bp TAR1 (CNAG04934.2) coding sequence
was replaced with the neomycin phosphotransferase II-encoding
selectable marker NEO using a construct created by overlap PCR
combining a ,1 kb fragment upstream the TAR1 start codon, the
NEO marker and a ,1 kb fragment downstream the TAR1 stop
codon. Strain H99 genomic DNA and plasmid pJAF1 were used
as PCR templates [55]. The construct was transformed into C.
neoformans cells via particle bombardment and transformants
selected on YPD plates supplemented with G418. A similar
approach was adopted to delete TAR1 in the H99 gat1/are1::NEO
and wild-type KN99a strains using the NAT selectable marker
from pCH233, with transformants selected on YPD supplemented
with nourseothricin. Deletion of TAR1 was confirmed by
diagnostic PCR and Southern blot [56]. To complement the
H99 tar1D mutant, the TAR1 gene including ,1 kb promoter and
terminator was amplified from genomic DNA using high fidelity
PCR, cloned into pCR2.1-TOPO (Invitrogen) to give pIRL25,
Nitrogen Metabolite Repression in Cryptococcus
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and sequenced. The TAR1 fragment of pIRL25 was then
subcloned into pCH233, creating the complementation construct
pIRL26. pIRL26 was subsequently linearised and biolistically
transformed into the tar1D mutant. Stable transformants were
selected on YPD supplemented with nourseothricin and comple-
mented strains containing a single copy of the wild-type TAR1
gene were identified by Southern blot.
Quantitative real-time PCR
C. neoformans strains were grown in YNB or L-DOPA
suppflemented with 10 mM of the specified nitrogen source
and shaken at 30 or 37uC for 16 hr. For nitrogen starvation
cultures, ammonium-grown cells were gently centrifuged at
1,000 rpm for 3 min, the loose pellets washed with YNB, and
cells transferred to fresh YNB medium lacking a nitrogen source
for an additional 4 hr. Overnight cultures were harvested, cell
pellets frozen and lyophilized, total RNA isolated using TRIzol
reagent (Invitrogen) and cDNA generated using the SuperscriptIII
First-Strand Synthesis System (Invitrogen). Primers for genes
PUT1 (CNAG02049.2), GAT1/ARE1 (CNAG00193.2), TAR1
(CNAG04934.2), LAC1 (CNAG03465.2) and LAC2 (CNAG03464.2)
were designed to span exon-exon boundaries and tested to verify
that they bind specifically to cDNA but not genomic DNA.
Quantitative real-time PCR (qRT-PCR) was performed using
SYBR Green Supermix (Applied Biosystems) and an Applied
Biosystems 7900HT Fast Real Time PCR System with the
following cycling conditions: denaturation at 95uC for 10 min,
followed by amplification and quantification in 45 cycles at 95uC
for 15 sec and 60uC for 1 min, with melting curve profiling at
95uC for 2 min, 60uC for 15 sec and 95uC for 15 sec. Dissociation
analysis confirmed the amplification of a single PCR product for
each primer pair and an absence of primer dimer formation.
Relative gene expression was quantified using SDS software 1.3.1
(Applied Biosystems) based on the 22DDCT method [57]. The
housekeeping actin-encoding gene ACT1 was used as a control for
normalization. One-way analysis of variance was performed using
the unpaired, two-tailed t test in GraphPad Prism Version 5.0c.
P values of ,0.05 were considered statistically significant.
Nitrogen utilization, toxic analog sensitivity,
melanization, high temperature growth and capsule
assays
Starter C. neoformans cultures were prepared by growth in YPD
at 30uC overnight with shaking, diluted to OD595 nm= 0.05 in
water, then further diluted tenfold in series. Each diluted cell
suspension was then spotted onto YPD or YNB, L-DOPA,
norepinephrine and caffeic acid medium supplemented with the
specified nitrogen source or toxic analog. Results were imaged
after 2–3 days incubation at 30uC (nitrogen utilization and toxic
analog sensitivity assays), or both 30 and 37uC (melanization and
high temperature growth assays). For capsule assays, cells were
scrapped off the YNB plates, stained with India ink (Becton
Dickinson), and visualized under a ZEISS Axioplan 2 epifluor-
escent/light microscope.
Yeast two-hybrid assay
Yeast two-hybrid experiments were conducted as described
previously [20,58]. Briefly, full-length GAT1/ARE1 and TAR1
ORFs were amplified from H99 cDNA template using high fidelity
PCR, and cloned into pCR2.1-TOPO to generate pIRL27 and
pIRL21, respectively. The inserted products were sequenced to
verify the absence of errors. cDNAs of first-third (nucleotides 1–
1,284), second-third (nucleotides 1,285–2,562) and final-third
(nucleotides 2,563–3,834) GAT1/ARE1 fragments, as well as full-
length GAT1/ARE1 (3,834 nucleotides) and TAR1 (867 nucleo-
tides), were amplified from either pIRL27 or pIRL21 using
restriction site-incorporating primers, subcloned into both
pGBKT7 and pGADT7 to give pIRL28-37, and again sequenced
to ensure correct reading frames obtained. The generated prey
and bait constructs with different inserts, as well as the relevant
positive (pGBKT7-53, pGADT7-T) and negative (pGBKT7,
pGADT7) controls, were subsequently co-transformed into the S.
cerevisiae reporter strain AH109 using the lithium acetate/heat
shock method [59]. Transformants were selected on YNB medium
lacking leucine and tryptophan. Interaction was assessed by
growth in the absence of adenine and histidine (+5 mM 3-Amino-
1,2,4-triazole), and b-galactosidase activity [60].
C. elegans killing assays
Starter cultures of C. neoformans strains were prepared by growth
in YPD at 30uC overnight with shaking. 10 mL overnight cultures
were spread onto both brain-heart infusion (BHI) (Becton
Dickinson) and pigeon guano agar plates (35 mm), and incubated
at 25uC overnight. ,50 young adult C. elegans worms were then
transferred from a lawn of E. coli OP50 on NGM to BHI and
pigeon guano medium-grown C. neoformans [34,61]. Plates were
incubated at 25uC and worms examined for viability at 24 hr
intervals using a dissecting microscope, with worms that did not
respond to a touch with a platinum wire pick considered dead.
Each experimental condition was performed in triplicate. Survival
was plotted against time, and P values were calculated by plotting
a Kaplan-Meier survival curve and performing a log-rank (Mantel-
Cox) test using Graphpad Prism Version 5.0c. P values of ,0.05
were considered statistically significant.
Murine inhalation model of cryptococcosis
For murine virulence assays, C. neoformans were used to infect 6
weeks old female BALB/c mice by nasal inhalation [62]. For every
tested strain, ten mice were each inoculated with a 50 mL drop
containing 56105 cells. Mice were weighed before infection and
daily thereafter; animals were sacrificed using CO2 inhalation once
their body weight had decreased to 80% of the pre-infection weight.
Survival was plotted against time, and P values were calculated by
plotting a Kaplan-Meier survival curve and performing a log-rank
(Mantel-Cox) test using Graphpad Prism Version 5.0c. P values of
,0.05 were considered statistically significant.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes by the National Health
and Medical Research Council. The protocol was approved by the
Molecular Biosciences Animal Ethics Committee of The Univer-
sity of Queensland (AEC approval number: SCMB/008/11/UQ/
NHMRC). Infection was performed under methoxyflurane
anaesthesia, and all efforts were made to minimize suffering
through adherence to the Guidelines to Promote the Wellbeing of
Animals Used for Scientific Purposes as put forward by the
National Health and Medical Research Council.
Results
Tar1 is not required for nitrogen source utilization
Although the genome of VNI strain H99 of C. neoformans contains
multiple open reading frames encoding putative GATA factors,
only Gat1/Are1 regulates nitrogen catabolism [34]. An equivalent
nitrogen regulatory system that is dependent on a single positively
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acting GATA factor also occurs in A. nidulans and N. crassa where
AreA and Nit2, respectively, have been extensively characterized
[2,3,8]. Like the ascomycete moulds, a predicted Nmr homolog
Tar1 has been identified in C. neoformans but curiously, Jiang et al.
have suggested that Tar1 plays a negative role in nitrogen
metabolism as indicated by the tar1D mutants faster growth on
potassium nitrate as compared to wild-type [38]. This observation is
counterintuitive as the inability of C. neoformans to utilize nitrate is a
classic trait that has long been used as a diagnostic tool to identify
this fungus; our recent bioinformatic and phenotypic analyses also
supported this lack of nitrate utilization [34,63,64].
A set of deletion mutants lacking TAR1, GAT1/ARE1 or both
was therefore created via homologous recombination in strain
H99 to investigate if Tar1 plays a regulatory role in nitrogen
utilization (Figure 1). All three generated mutants were viable and
had a growth rate indistinguishable from wild-type on rich
undefined YPD medium. However, on YNB defined medium
supplemented with a panel of different sole nitrogen sources
including ammonium, amino acids, purines, nitrate or nitrite, both
the gat1/are1D and double gat1/are1D tar1D mutants only had the
ability to proliferate on proline. This result is consistent with
previous studies indicating that the gat1/are1D mutant is unable to
utilize ammonium or glutamine but is able to consume proline, a
marked difference in phenotype compared to well-characterized
ascomycete GATA factor mutants [33,34]. On the other hand, the
tar1D mutant displayed wild-type growth on all tested nitrogenous
compounds except nitrate and nitrite, which all strains were
unable to grow on. Together, our results indicate that unlike
Gat1/Are1, Tar1 is not required for nitrogen source utilization.
Additionally, the similar nitrogen utilization phenotypes displayed
by the gat1/are1D and double gat1/are1D tar1D mutants suggest
that if Tar1 does indeed play a regulatory role in these nitrogen
catabolic pathways, Gat1/Are1 functions downstream of Tar1.
Tar1 modulation of nitrogen metabolite repression at the
phenotypic level
Gat1/Are1 has been shown to play a role in nitrogen metabolite
repression, a regulatory mechanism that enables preferential
utilization of readily assimilated nitrogen sources such as ammonium
and glutamine [34]. We sought to determine if Tar1 is also
functionally associated with this metabolic response. We note that
Jiang et al. have previously assessed the existence of inappropriate
derepression of secondary nitrogen catabolism in the tar1Dmutant by
growing the strain solely on potassium chlorate (a toxic analog of
potassium nitrate) in the absence of a preferred nitrogen source [38].
However, such sensitivity assays used to determine constitutive
expression of non-preferred nitrogen structural genes that are
subjected to nitrogen metabolite repression could only be interpreted
if a repressing nitrogen source is simultaneously present [21,23].
We therefore tested the tar1D mutants sensitivity to thiourea (a
toxic analog of urea) in the presence of ammonium or glutamine
(Figure 2A). Like ascomycete nmrD mutants that exhibit partially
derepressed phenotypes due to derepression of the urea permease, the
tar1D mutant displayed a slight increase in sensitivity relative to wild-
type while the negative control gat1/are1D and double gat1/are1D
tar1D mutants were unable to proliferate due to their inability to
utilize these nitrogen sources [65]. This result suggests that the tar1D
mutant is metabolizing thiourea to a greater extent than wild-type,
despite the simultaneous presence of preferred nitrogen sources.
Complementation of the tar1D mutant subsequently restored the
wild-type phenotype (Figure S1). Together, these results indicate that
Tar1 plays a negative role in the regulation of genes involved in
utilization of more complex nitrogen sources. We also tested
sensitivity to potassium chlorate in the presence of ammonium or
glutamine and found that the tar1Dmutant grew to the same extent as
wild-type, consistent with C. neoformans lacking nitrate reductase
needed to catabolize potassium chlorate (Figure 2A) [9].
The S. cerevisiae Dal80 and Gzf3, and A. nidulans AreB proteins are
negatively acting GATA factors involved in nitrogen regulation
[66,67]. In C. neoformans, six additional GATA factors have been
identified: Gat201 and Gat204 work in concert to prevent
phagocytosis by macrophages, Bwc2 regulates cell fusion and hyphal
development in response to blue light, Cir1 controls iron acquisition,
while CNAG04263.2 and CNAG03401.2 have unknown functions
[34,68,69,70,71]. To determine if any of these GATA factors play a
negative role in nitrogen catabolism, we tested the gat201D, gat204D,
bwc2D, cir1D, CNAG04263.2D and CNAG03401.2D mutants sensitiv-
ity to thiourea in the presence of ammonium or glutamine (not
shown). The six GATA deletion mutants exhibited wild-type
sensitivity, suggesting that negatively acting nitrogen regulatory
GATA factors are likely to be a unique evolutionary feature of the
ascomycetes. Consistent with this notion, all seven C. neoformans
GATA factors including Gat1/Are1, lack putative leucine zippers
that are present in the negative acting S. cerevisiae Dal80 and Gzf3, or
A. nidulansAreB. Overall, our analysis thus far revealed that only Tar1
plays a negative role in secondary nitrogen catabolism.
Tar1 modulation of nitrogen metabolite repression at the
transcriptional level
We sought to provide support for our sensitivity assays and prove
that Tar1 is implicated for the response to nitrogen metabolite
repression in a range of metabolic pathways. We therefore analysed
the transcriptional regulation of the proline oxidase-encoding gene
PUT1 using qRT-PCR on RNA extracted from the wild-type, tar1D,
gat1/are1D and double gat1/are1D tar1Dmutant strains grown in YNB
supplemented with proline or proline plus ammonium (Figure 2B).
The proline catabolic pathway was chosen to be examined as this
traditionally non-preferred nitrogen source supports the most robust
growth in the gat1/are1D and double gat1/are1D tar1D mutants, thus
enabling the isolation of RNA from a defined medium. Furthermore,
PUT1 has previously been shown to be sensitive to nitrogenmetabolite
repression, providing an ideal condition to test how Tar1 and Gat1/
Are1 are affiliated to this regulatory control mechanism [34].
As expected, high levels of PUT1 expression were observed
when the wild-type strain was cultured in proline as the sole
nitrogen source, and this upregulation was largely abolished (,30-
fold difference) with the simultaneous presence of ammonium. In
the tar1D mutant, intermediate levels of PUT1 mRNA were
observed in the presence of proline, and this upregulation was only
partially reduced (,5-fold difference) when ammonium was
simultaneously present. While the 2–3-fold more PUT1 transcript
produced by the tar1D mutant relative to wild-type when grown in
proline plus ammonium was anticipated, the 2–3-fold less PUT1
expression of the tar1D mutant compared to wild-type in the sole
presence of proline was surprising (WT nitrogen metabolite
repression sensitivity vs tar1D nitrogen metabolite repression
sensitivity, P=0.0195). The former indicates that PUT1 transcrip-
tion in the tar1D mutant was not completely repressed in the
presence of a preferred nitrogen source, and reiterates the fact that
Tar1 prevents the expression of secondary nitrogen structural
genes under repressing conditions. The latter, intriguingly,
suggests that Tar1 also plays a positive role in the activation of
secondary nitrogen structural genes under non-repressing condi-
tions, despite the fact that the tar1D mutant exhibited indistin-
guishable phenotypic growth rate relative to wild-type on various
nitrogen sources (Figure 1). Tar1 therefore contributes to the
expression of nitrogen catabolism associated genes, however, it
does not overcome the requirement for Gat1/Are1.
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The expression of GAT1/ARE1, but not TAR1, is regulated
in response to nitrogen availability
In A. nidulans, NmrA modulation of AreA activity is finely tuned;
this well-coordinated control mechanism begins at the transcrip-
tional level as expression of areA and nmrA are inversely regulated
in response to the quality of the nitrogen source available [37]. To
determine if a similar phenomenon occurs in C. neoformans, we
analysed the transcriptional regulation of both GAT1/ARE1 and
TAR1 using qRT-PCR on RNA extracted from wild-type H99
grown in YNB supplemented with different nitrogen sources
(Figure 3). During growth in ammonium, a low level of GAT1/
ARE1 mRNA was observed, while an elevated level (,7-fold) of
GAT1/ARE1 transcript was present when grown in proline (Pro vs
NH4, P=0.0003). A marked increase (.10-fold) in GAT1/ARE1
transcript level was seen when cells were starved for nitrogen (N
free vs NH4, P=0.003). In stark contrast to the expression profile
of GAT1/ARE1, the level of TAR1 transcript was relatively
unaltered when cultured under these different nitrogen conditions.
Overall, our qRT-PCR data indicates that GAT1/ARE1 expres-
sion is transcriptionally induced in response to nitrogen limitation,
whereas TAR1 transcription is unaffected by nitrogen availability.
Tar1 plays a dual function in positive and negative
regulation of GAT1/ARE1 expression according to the
nitrogen source present
Given that Gat1/Are1 is involved in the utilization of most
nitrogen sources, we sought to determine if Tar1 regulates GAT1/
ARE1 expression, and vice versa. We first analysed the transcrip-
tional regulation of both GAT1/ARE1 and TAR1 using qRT-PCR
on RNA extracted from the wild-type, tar1D and gat1/are1D
mutant strains grown in YNB supplemented with proline
(Figure 4A). As expected, no GAT1/ARE1 or TAR1 transcripts
were detected in the gat1/are1D and tar1D mutants, respectively,
validating our diagnostic PCR and Southern blot analyses for
confirmation of gene deletion. Consistent with nitrogen indepen-
dence of TAR1 expression, the gat1/are1D mutant produced wild-
type levels of the TAR1 transcript. On the other hand, the tar1D
mutant expressed ,3-fold less GAT1/ARE1 mRNA compared to
wild-type (WT vs tar1D, P=0.0008). This result provides a
plausible explanation for why the tar1D mutant transcribed less
PUT1 mRNA relative to wild-type in the sole presence of proline
(Figure 2B), and indicates that Tar1 positively regulates GAT1/
ARE1 expression under non-repressing conditions.
To provide support for the model that Tar1 plays a dual function
in positive and negative regulation of nitrogen catabolism, we
analysed the transcriptional regulation of GAT1/ARE1 using qRT-
PCR on RNA extracted from the wild-type and tar1D mutant
strains grown in YNB supplemented with ammonium (Figure 4B).
As expected, the wild-type strain produced low levels of GAT1/
ARE1 transcripts under such nitrogen sufficient conditions, while
the tar1D mutant transcribed ,3-fold more GAT1/ARE1 mRNA
relative to wild-type (WT vs tar1D, P=0.0481). This result indicates
that Tar1 negatively regulates GAT1/ARE1 expression under
repressing conditions. Collectively, Tar1 can function to elicit both
activation and repression of GAT1/ARE1 autoregulation according
to the quality of the nitrogen source present.
Gat1/Are1 lacks the highly conserved extreme
C-terminus domain of A. nidulans AreA and N. crassa
Nit2 known to be involved in Nmr recognition
Our phenotypic and transcriptional data suggest that the
molecular mechanism of action of Tar1 may operate in a fashion
similar to ascomycete Nmr homologs. In A. nidulans and N. crassa,
certain mutations of the GATA DNA-binding domain or extreme
Figure 1. Tar1 is not required for nitrogen source utilization. Tenfold spot dilution assays for nitrogen utilization showed that the tar1D
mutant exhibited wild-type growth on YNB supplemented with ammonium, glutamine, glutamate, asparagine, proline, glycine, phenylalanine,
leucine, uric acid, urea and creatinine (10 mM each nitrogen source). In contrast, both the gat1/are1D and double gat1/are1D tar1D mutants were
only able to proliferate on proline as the sole nitrogen source. All tested strains were unable to grow on 7% potassium nitrate or sodium nitrite.
doi:10.1371/journal.pone.0032585.g001
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Figure 2. Tar1 plays a role in modulating nitrogen metabolite repression. (A) Tenfold spot dilution assays for nitrogen utilization showed
that the tar1Dmutant exhibited slight sensitivity to 5 mM thiourea when compared to wild-type in the simultaneous presence of 10 mM ammonium
or glutamine. (B) cDNA from wild-type H99 and the mutant strains grown in YNB supplemented with proline or proline plus ammonium (10 mM each
nitrogen source) were amplified via qRT-PCR using primers against the proline oxidase-encoding gene PUT1 and the control gene ACT1. In the wild-
type strain, PUT1 expression was significantly increased in the presence of proline but upregulation was largely abolished when ammonium was also
present. In the tar1D mutant, PUT1 transcription was intermediate in the presence of proline and upregulation was only partially reduced when
ammonium was simultaneously present. Nitrogen metabolite repression sensitivity of PUT1 in the wild-type strain statistically differs from that in the
tar1D mutant (* denotes P,0.05). In the gat1/are1D and double gat1/are1D tar1D mutants, PUT1 expression was low under both tested growth
conditions. Error bars represent standard errors across three biological replicates.
doi:10.1371/journal.pone.0032585.g002
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C-terminus of AreA and Nit2 lead to partially derepressed
phenotypes under nitrogen sufficient conditions similar to that
observed for nmrD mutants, suggesting that these regions are
critical for interaction with Nmr proteins and modulation of
GATA factor transcriptional activity [18,23].
However, global alignment of C. neoformans Gat1/Are1 showed
little overall sequence conservation to AreA or Nit2 (15 and 16%
identity, respectively) (Figure S2). Importantly, the extreme C-
terminus of AreA and Nit2 known to be critical for modulating
activities by the co-repressors NmrA and Nmr1, respectively, is
absent in Gat1/Are1 (Figure 5A and E) [18,21,23]. In fact, the last
nine and 12 C-terminus residues of A. nidulans AreA are identical
to N. crassa Nit2 and Penicillium chrysogenum GATA factor Nre,
respectively (Figure 5E and not shown) [2,23,72]. Nonetheless,
three notable blocks of conservation do exist between Gat1/Are1
and AreA or Nit2: two regions of unknown function (in AreA and
Nit2, these two regions lie near the N-terminus while in Gat1/
Are1, they lie further towards the middle or C-terminus region of
the protein) (Figure 5A, B and C), and the GATA DNA-binding
domain consisting of a zinc finger motif followed by an adjacent
basic region (Figure 5A and D). The zinc finger domain has been
shown to play a role in the DNA-binding activity of both AreA and
Nit2, and the same scenario is likely occurring in C. neoformans
given the high level of conservation seen among the zinc fingers of
Gat1/Are1, AreA and Nit2 [2,3]. In summary, one of the two
regions of ascomycete GATA factors known to be important for
interaction with Nmr proteins is absent in Gat1/Are1: the
Cryptococcus GATA DNA-binding domain is conserved but the
extreme C-terminus has diverged.
Tar1 lacks the conserved C-terminus domain of A.
nidulans NmrA known to be important for interaction
with AreA
We next analysed the sequences of the Nmr homologs of A.
nidulans, N. crassa and C. neoformans. In A. nidulans, the conserved a-
helix at the C-terminus of NmrA is also known to be critical for
interaction with AreA [40,41]. Given that the sequence of N. crassa
Nmr1 is highly conserved with A. nidulansNmrA, it is likely that both
these proteins share similar structural features [21,43]. In contrast,
global alignment of C. neoformans Tar1 revealed only moderate
overall sequence conservation to both NmrA and Nmr1 (19 and
16% identity, respectively) (Figure S3). Tar1 harbours the residues
GlyXXGlyXXGly that are predicted to form a Rossmann fold in
the N-terminus, while NmrA and Nmr1 contain a slightly diverged
canonical Rossmann motif AsnXXGlyXXAla [38,41,73]. Howev-
er, Tar1 lacks the long C-terminus region of NmrA and Nmr1 that
is predicted to play a role in interaction with GATA factors. Based
on bioinformatics conducted on these GATA factors and Nmr
proteins, it was not apparent whether Tar1 is likely to physically
interact with and inhibit the function of Gat1/Are1.
Interaction between Tar1 and Gat1/Are1 was not
detectable in vivo
The direct interaction of N. crassa Nit2 and Nmr1 was originally
shown via yeast two-hybrid experiments. The DNA-binding
domain or extreme C-terminus of Nit2 fused to the Gal4
activation domain (AD) interacted with an Nmr1-Gal4 DNA-
binding domain (BD) fusion protein, with stronger interaction
detected when both the DNA-binding domain and C-terminus
regions of Nit2 were present [20]. To investigate if a similar
situation occurs in C. neoformans, we also performed a yeast two-
hybrid assay to test if protein-protein interaction occurs between
Gat1/Are1 and Tar1 (Table S4). We fused the first-third
(nucleotides 1–1,284), second-third (nucleotides 1,285–2,562;
contains the first conserved motif of unknown function) and
final-third (nucleotides 2,563–3,834; contains the second con-
served motif of unknown function, GATA DNA-binding domain
and C-terminus) GAT1/ARE1 fragments, as well as full-length
GAT1/ARE1 and TAR1 cDNA, to both the GAL4 AD and BD.
Every possible combination of the clones were then expressed in S.
cerevisiae AH109 in which the GAL promoter regulates ADE2, HIS3
and lacZ reporter genes. If any protein-protein interaction did
exist, it would likely be the final-third Gat1/Are1 fragment and/or
full-length Gat1/Are1 (both contains the conserved GATA DNA-
binding domain) that may interact with Tar1.
In AH109 strains expressing the first-third fragment or full-
length Gat1/Are1-Gal4 BD fusion protein, auto-activation of the
bait occurred indicating that an activation domain is present
within the nucleotides 1–1,284 of GAT1/ARE1. However, in
AH109 strains expressing any of the three individual fragments or
full-length Gat1/Are1-Gal4 AD fusion protein and Tar1-Gal4 BD
fusion protein, cells failed to grow in the absence of adenine and
histidine, and did not produce b-galactosidase activity. Our
bioinformatics coupled with yeast two-hybrid data therefore
suggest that no protein-protein interaction is likely occurring
between Gat1/Are1 and Tar1 when expressed in the nucleus of
the hemiascomycete S. cerevisiae. Additionally, our two-hybrid
Figure 3. The expression of GAT1/ARE1, but not TAR1, is
regulated in response to nitrogen availability. cDNA from wild-
type H99 grown in YNB supplemented with ammonium, proline
(10 mM each nitrogen source) or no nitrogen source were amplified via
qRT-PCR using primers against GAT1/ARE1, TAR1 and the control gene
ACT1. In the presence of a preferred nitrogen source (ammonium), the
expression of GAT1/ARE1 was low but in the presence of a traditionally
non-preferred nitrogen source (proline), or under nitrogen starvation
conditions, GAT1/ARE1 transcription was significantly upregulated
(** denotes P,0.01, *** denotes P,0.001). In contrast, TAR1 expression
was relatively unaltered under these different nitrogen growth
conditions. Error bars represent standard errors across three biological
replicates.
doi:10.1371/journal.pone.0032585.g003
Nitrogen Metabolite Repression in Cryptococcus
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e32585
analysis provides no indication of Gat1/Are1 or Tar1 homo-
dimerization.
Gat1/Are1 negatively regulates laccase-encoding LAC1
expression at 37uC
Jiang et al. originally identified Tar1 through its negative role in
antioxidant melanin production at 37uC on norepinephrine-
containing asparagine medium, which eventually led to their
finding that Tar1 regulates laccase-encoding LAC1 expression [38].
The two paralogs LAC1 and LAC2 encode laccases that catalyse the
formation of melanin in C. neoformans, with Lac1 being the main
enzyme responsible [45,74,75]. Interestingly, our group has also
observed that Gat1/Are1 negatively regulates melanin production
at 37uC on L-DOPA-containing proline medium [34]. We therefore
investigated the genetic epistasis between TAR1 and GAT1/ARE1-
regulated production of melanin and expression of laccases.
Given that the gat1/are1D and double gat1/are1D tar1D mutants
are unable to utilize asparagine as a nitrogen source, we analysed
melanin production of the deletion mutants on L-DOPA (proline)
agar grown at both 30 and 37uC (Figure 6A). All strains melanized
robustly when cultivated at 30uC. However, at 37uC, the gat1/
are1D and double gat1/are1D tar1D mutants produced more
melanin than the wild-type and tar1D mutant strains, reiterating
the observation that the gat1/are1 mutation is dominant over the
tar1 mutation but disagreeing with those seen by Jiang et al. [38].
We then analysed the transcriptional regulation of LAC1 and LAC2
using qRT-PCR on RNA extracted from the wild-type and
mutant strains grown in L-DOPA (proline) at both 30 and 37uC
(Figure 6B). As previously reported, transcription of LAC1 was
severely decreased (50–100-fold) at 37uC compared to 30uC [76].
Consistent with our melanin phenotypic plate assays, both the
gat1/are1D and double gat1/are1D tar1D mutants transcribed more
(,2-fold) LAC1 mRNA as compared to the wild-type or tar1D
mutant strains at 37uC (WT vs gat1/are1D, P=0.0003; WT vs
double gat1/are1D tar1D, P=0.0131). No significant difference in
the expression of LAC1 at 30uC or LAC2 at 30 and 37uC was
observed among the tested strains. Altogether, our data indicates
that Gat1/Are1, but not Tar1, represses melanin production and
LAC1 expression at human body temperature when L-DOPA is
used as the laccase substrate.
The different substrate used for melanin production may have
resulted in conflicting observations made by Jiang et al. and our
group [38]. We therefore tested melanin production of wild-type
H99 and three independent H99 tar1D mutants, as well as the
isogenic wild-type MATa strain KN99a and six independent
KN99a tar1D mutants, at both 30 and 37uC on additional laccase
substrates: norepinephrine and caffeic acid, supplemented with
asparagine as the nitrogen source (Figure S4). Under all tested
growth conditions, no visual difference in melanin production was
observed between the wild-type and tar1D mutant strains.
Therefore, in our hands, we are unable to reproduce the increased
melanin production and LAC1 expression phenotypes of the tar1D
mutant as described by Jiang et al. [38]. We speculate that the
passage of H99 during subculture between laboratories may have
possibly caused the phenotypic variation. In support of this notion,
Figure 4. Tar1 plays both positive and negative roles in
regulating GAT1/ARE1 transcription according to the nitrogen
source available. (A) cDNA from wild-type H99, gat1/are1D and tar1D
mutant strains grown in YNB supplemented with 10 mM proline were
amplified via qRT-PCR using primers against GAT1/ARE1, TAR1 and the
control gene ACT1. The expression of GAT1/ARE1 was significantly lower
in the tar1Dmutant compared to wild-type (*** denotes P,0.001). Error
bars represent standard errors across three biological replicates. (B)
cDNA from wild-type H99 and tar1D mutant strains grown in YNB
supplemented with 10 mM ammonium were amplified via qRT-PCR
using primers against GAT1/ARE1 and ACT1. The expression of GAT1/
ARE1 was significantly higher in the tar1D mutant compared to wild-
type (* denotes P,0.05). Error bars represent standard errors across
three biological replicates.
doi:10.1371/journal.pone.0032585.g004
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Morrow et al. have recently reported that various H99 subcultures
have differing melanization abilities [77]. Additionally, the
indistinguishable growth rate of the tar1D mutants in comparison
to their wild-type H99 or KN99a counterparts on YPD medium at
37uC suggests that Tar1 does not play a role in high temperature
growth.
Expanding our analysis on virulence factor expression, we
examined the polysaccharide capsule that has an antiphagocytic
function [78]. We grew the wild-type and tar1D mutant strains on
YNB supplemented with creatinine, uric acid or urea that are
known inducers of capsule formation, and found that both the
wild-type and tar1D cells possess equally large capsule on each of
these individual medium (not shown) [34]. Given that nitrogen
metabolite repression plays a role in the regulation of capsule
production, we also examined the capsule of both strains when
grown on the same capsule-inducing media but with the
simultaneous presence of ammonium (not shown) [34]. Under
these growth conditions, the wild-type cells should possess
completely repressed (small) capsule since ammonium is a poor
inducer of capsule formation, while we were predicting that the
tar1D cells would possess partially repressed (intermediate) capsule
due to inappropriate depression of secondary nitrogen (creatinine,
uric acid, urea) catabolism [34]. Unexpectedly, the capsule size
was equally small and indistinguishable between the wild-type and
tar1D mutant strains under such nitrogen metabolite repression
conditions. The subtle role of Tar1 in modulating nitrogen
metabolite repression may explain why the tar1D mutants capsule
was not detectably derepressed, as can be seen in the toxic
thiourea assays where the tar1D mutant only exhibited slight
sensitivity relative to wild-type (Figure 2A). Taken together, Tar1
does not appear to affect well-established virulence factors
including, but not limited to, melanin production, growth at
human body temperature and capsule biosynthesis.
Tar1 is not required for killing of C. elegans but modestly
represses virulence in a murine inhalation model of
cryptococcosis
Our overarching interest in C. neoformans lies in better
understanding its pathogenicity in an animal host. We therefore
investigated the role of Tar1 in pathogenesis by performing both in
vitro and in vivo virulence assays. First, we conducted C. elegans
killing assays using two different media: the standard BHI medium
for nematode killing experiments, as well as pigeon guano medium
to mimic the C. neoformans ecological niche (Figure 7A). Under both
growth conditions, killing of C. elegans by the tar1D [LT50 (time for
half of the worms to die) = 5 and 3 days, for BHI and pigeon guano
medium, respectively] and double gat1/are1D tar1D mutants
(LT50 = 5 and 4 days, for BHI and pigeon guano medium,
respectively) was not significantly different to that observed for
wild-type (LT50 = 6 and 3 days, for BHI and pigeon guano
medium, respectively). The undiminished pathogenicity of the
double gat1/are1D tar1D mutant is consistent with our previous
work showing that Gat1/Are1 does not affect killing of C. elegans
[34].
Since the C. elegans virulence assays were conducted at 25uC, we
questioned if Tar1 is required for infection of a host at mammalian
body temperature given that the TAR1 promoter contains putative
heat shock sequence elements [38]. To test this hypothesis, we
performed a murine inhalation model of cryptococcosis (Figure 7B).
Mice infected with the tar1Dmutant succumbed to infection slightly
faster (between 16 and 19 days post infection, median survival of 18
days) than mice infected with the wild-type strain (between 18 and
24 days post infection, median survival of 21.5 days) (WT vs tar1D,
P=0.0021). It should be noted that mice infected with the
complemented tar1D+TAR1 strain did not progress to morbidity
at the same rate as wild-type (between 17 and 21 days post infection,
median survival of 18 days). However, the difficulty associated with
the restoration of wild-type phenotype of the tar1Dmutant in certain
physiological aspect has previously been reported [38]. Alternative-
ly, the role of Tar1 in virulence may be dependent on its expression
levels, which could have been adversely affected by integration of
TAR1 into a non-native locus. Mice infected with the double gat1/
are1D tar1D mutant also succumbed to infection slightly faster than
mice infected with the wild-type strain, consistent with our previous
work demonstrating that Gat1/Are1 modestly represses virulence
during murine infection (between 15 and 22 days post infection,
median survival of 19 days) (WT vs gat1/are1D tar1D, P=0.0342)
[34]. Together, these results suggest that both the tar1D and double
gat1/are1D tar1D mutants are slightly more virulent than wild-type
Figure 5. Representative domain architecture and domain sequences of A. nidulans AreA, N. crassa Nit2 and C. neoformans Gat1/Are1.
(A) The two conserved regions of unknown function are represented by red ovals and orange diamonds, while the GATA DNA-binding domain is
represented by blue squares. The extreme C-terminus domain of AreA and Nit2 (dark green rectangles) is highly conserved but that of Gat1/Are1 has
diverged (light green rectangle). Amino acid sequences of all four domains are shown in (B, C, D and E). In addition, the Gat1/Are1 domain
architecture is marked with dotted lines to indicate the boundary of the Gat1/Are1 fragments that were tested for protein-protein interaction with
Tar1 (see yeast two-hybrid assay section). The universally conserved cysteines involved in zinc ion chelation of the zinc finger are highlighted in
yellow.
doi:10.1371/journal.pone.0032585.g005
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during in vivo infection. Hence, in addition to fine-tuning regulation
of nitrogen catabolism, Tar1 also modulates pathogenesis in a
mammalian host.
Discussion
Nitrogen starvation stimulates the initiation of the infection
cycle of the ubiquitous C. neoformans, whereby sexual reproduction
occurs, leading to the production of potentially infectious
basidiospores [69,79,80]. This mating process is controlled by
multiple signalling cascades including the high affinity ammonium
permease Amt2, which is in turn regulated by the GATA factor
Gat1/Are1 [34,81]. In addition to regulating nitrogen catabolism,
Gat1/Are1 also impacts multiple virulence attributes such as
melanin production, high temperature growth and capsule
biosynthesis [33,34]. Therefore, the underlying mechanism
regulating Gat1/Are1 activity in response to nitrogen availability
is important for the understanding of the C. neoformans life cycle in
the environment and successful proliferation during infection of a
host.
In the model hemiascomycete S. cerevisiae, the function of the
GATA factors Gln3 and Gat1 are negatively regulated by
interaction with the prion-forming glutathione S-transferase
Ure2 [14,15,16,17]. As in the system of the filamentous
ascomycete A. nidulans, there is no genetic or molecular evidence
for the existence of an Ure2 homolog in C. neoformans [82,83].
Although we have identified a putative protein sequence
(CNAG04110.2) in the H99 genome which contains a glutathione
S-transferase domain that shows weak overall sequence similarity
to Ure2, CNAG04110.2 lacks several features unique to Ure2
including an N-terminus extension and loop region [84,85].
In A. nidulans and N. crassa, the function of the GATA factors
AreA and Nit2 are negatively regulated by interaction with Nmr
proteins that are unrelated to glutathione S-transferases
[12,18,20,21,22,23,82,83]. Recently, the group of Jiang et al.
identified the C. neoformans potential Nmr homolog Tar1 during
their search for gene disruption mutants that hypermelanize at
37uC [38]. In this study, we further characterized Tar1 function
from a different perspective based on our interest in regulation of
nitrogen metabolism. Our findings indicate that Tar1 possesses
several unique regulatory and functional features in comparison to
A. nidulans NmrA and N. crassa Nmr1.
In A. nidulans, nmrA expression is low during nitrogen limitation
but increases during nitrogen sufficiency [37]. The bZIP
Figure 6. Gat1/Are1 negatively regulates melanin production and LAC1 expression at 376C. (A) Tenfold spot dilution assays for
melanization showed that the gat1/are1D and double gat1/are1D tar1D mutants produce more melanin than the wild-type and tar1D mutant strains
on L-DOPA medium supplemented with 10 mM proline at 37uC. (B) cDNA from wild-type H99 and the mutant strains grown in L-DOPA (10 mM
proline) at 30 and 37uC were amplified via qRT-PCR using primers against the laccase-encoding genes LAC1 and LAC2, and the control gene ACT1.
LAC1 expression was significantly higher in the gat1/are1D and double gat1/are1D tar1D mutants compared to wild-type or the tar1D mutant when
strains were grown at 37uC (* denotes P,0.05, *** denotes P,0.001). Error bars represent standard errors across three biological replicates.
doi:10.1371/journal.pone.0032585.g006
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Figure 7. The tar1Dmutant kills C. elegans as efficiently as wild-type, but exhibits modestly enhanced virulence in a murine host. (A)
C. elegans infection: ,50 nematode worms were transferred to a lawn of wild-type H99, tar1D, tar1D+TAR1 or double gat1/are1D tar1D cells as the
sole food source on both BHI and 1% pigeon guano medium, and survival was monitored at 24 hr intervals. There was no observable difference in C.
elegans killing by all four strains on both media. (B) Mus musculus infection: 10 mice were each intranasally infected with either 56105 cells of wild-
type H99, tar1D, tar1D+TAR1 or double gat1/are1D tar1D strains, and survival was monitored daily. Mice infected with the tar1D, tar1D+TAR1 and
double gat1/are1D tar1D strains progress to morbidity slightly more rapidly than mice infected with the wild-type strain.
doi:10.1371/journal.pone.0032585.g007
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transcription factor MeaB activates the expression of nmrA, and
MeaB homologs are found in all the available filamentous
ascomycetes genome databases [37]. In contrast, TAR1 transcrip-
tion is unaffected by nitrogen availability and our bioinformatic
analyses indicate that the C. neoformans H99 genome does not
encode an obvious homolog of MeaB. In addition, the promoter
region of TAR1 lacks the conserved element, TTGCACCAT; in
vitro studies have shown that A. nidulans MeaB binds to
TTGCACCAT and this binding site is also present in the
promoters of NmrA homologs in other filamentous ascomycetes
[37]. Instead, Jiang et al. have reported that TAR1 expression is
upregulated at high temperature (37uC), consistent with the fact
that its promoter contains three TTC/GAA repeats that are
putative binding sites for the heat shock factor [38].
However, Tar1 does contain the characteristic NAD/NADH
dinucleotide binding motif, GlyXXGlyXXGly, found in members of
the short-chain dehydrogenase/reductase family such as the
negatively acting Gal80 of S. cerevisiae, which acts to block the
activation domain of Gal4 required for transcription of galactose-
inducible genes [42,86,87,88]. Like the negative transcription
regulators A. nidulans NmrA and N. crassa Nmr1, Tar1 retains the
evolutionary conserved function of Nmr proteins of preventing
activation of secondary nitrogen catabolism when preferred nitrog-
enous compounds are present. However, the role of Tar1 in this
regulatory aspect is quite subtle, indicative that additional factors are
likely operating to modulate nitrogen metabolite repression or to
repress Gat1/Are1 activity in C. neoformans. For example, in A.
nidulans, the activity of AreA is also controlled through autogenous
regulation and differential transcript stability [23,24,25].
Intriguingly, we also discovered a novel role of Tar1 in
positively regulating the expression of the proline oxidase-
encoding gene PUT1 under non-repressing conditions. The dual
function of Tar1 in fine-tuning nitrogen catabolism appears to be
mediated through modulation of GAT1/ARE1 transcription in
response to the quality of the nitrogen source available (Figure S5).
Given that Tar1 is not required for nitrogen source utilization, we
speculate that only basal-to-intermediate levels of GAT1/ARE1
transcripts are needed to efficiently activate secondary nitrogen
catabolism under non-repressing conditions. The exact mecha-
nism by which Tar1 regulates Gat1/Are1 activity remains unclear
as no physical interaction could be detected amongst these two
proteins. Since Tar1 does not appear to have a DNA-binding
domain, this protein may possibly control the activity of an
unknown co-factor(s)/accessory transcription apparatus that in
turn influences GAT1/ARE1 autoregulation in response to
nitrogen availability. Further work will be required to dissect the
nature and origin of intracellular signals that govern the activity of
Gat1/Are1.
Notwithstanding, although a plethora of information about
nitrogen metabolism is known in A. nidulans and N. crassa, studies
into the regulation of GATA factor and Nmr protein activity have
had their fair share of controversies. For example, while Lamb et
al. have previously suggested that the N-terminus is required for
modulating derepression activity of A. nidulans AreA, Caddick and
Arst later disagreed with this theory [89,90]. In more recent times,
Lamb et al. demonstrated that the extreme nine C-terminus
residues of AreA that are highly conserved across a range of
filamentous ascomycete homologs does not affect the affinity for
NmrA binding, contradicting the findings of Pan et al. and Xiao et
al. [18,20,40]. Most recently, Wagner et al. asserted that nmrA
expression in A. nidulans is not dependent on MeaB, an observation
that contrasts those of Wong et al. [37,91]. Hence, the mechanism
of action governing the activity of GATA factors and Nmr proteins
in model ascomycetes, too, remain elusive.
Such research into nitrogen regulation is of immense interest as
nitrogen source utilization influences key aspects of fungal biology
including development, secondary metabolite production and
pathogenesis. In the context of virulence, nitrogen regulated
pathogenesis has been documented in clinically prevalent human
pathogens such as C. albicans and A. fumigatus [28,29,30]. Our
analysis of TAR1 and GAT1/ARE1 reiterated this dogma; both
genes are suppressors of C. neoformans virulence. A parsimonious
explanation as to why no opposing regulatory effects on
pathogenesis were observed between the tar1D and gat1/are1D or
double gat1/are1D tar1D mutants may relate to the scarce nutrient
availability during in vivo infection, a condition in which Tar1 is
predicted to positively regulate GAT1/ARE1 activity [34].
Nonetheless, we cannot rule out the possibility that Tar1 is not
exclusively involved in regulation of nitrogen catabolism but may
also control targets involved in a broader spectrum of metabolic
processes. The fact that the TAR1 promoter contains putative heat
shock elements supports this notion [38]. Using whole transcrip-
tome sequencing, we are currently attempting to identify novel
virulence and stress adaptation associated genes that are regulated
by both Tar1 and Gat1/Are1 during infection of a mammalian
host. Indeed, Kronstad et al. have recently highlighted transcrip-
tional profiling and genetic studies as invaluable research tools,
with the means to provide insights into C. neoformans adaptation to
key features within a mammalian host environment including
nitrogen availability [92].
In summary, there is a pressing need to combat infection from
the killer fungus C. neoformans that is responsible for .625,000
deaths annually in predominantly AIDS patients [93]. Our study
has provided deeper insights into the molecular mechanisms that
wire the Cryptococcus global nitrogen regulatory circuit. Specifically,
we provide an indication of how Tar1 controls Gat1/Are1 activity
in response to changes in nitrogen availability, as would occur
when C. neoformans leaves its purine rich ecological niche of pigeon
guano to infect a human host which in comparison is nutrient
limiting [94]. Understanding the intricate details of how Gat1/
Are1 function is pivotal, as candidate genes in several nitrogen
catabolic pathways represent potential drug targets for therapeutic
intervention in this important pathogen of humans.
Supporting Information
Figure S1 Complementation of toxic analog sensitivity
phenotype to wild-type levels upon the re-introduction of
TAR1 into the tar1D mutant. Tenfold spot dilution assays for
nitrogen utilization showed that the tar1D+TAR1 strain exhibited
wild-type growth on 5 mM thiourea plus 10 mM ammonium.
(DOC)
Figure S2 ClustalW multiple sequence alignment of A.
nidulans AreA (XP_681936.1), N. crassa Nit2 (P19212.2)
and C. neoformans Gat1/Are1 (CNAG00193.2). Identical
amino acid residues are shaded dark grey while similar residues
are shaded light grey. Gat1/Are1 shows little overall sequence
conservation to AreA and Nit2 at the entire protein level.
However, three notable blocks of conversation do exist between
Gat1/Are1 and AreA or Nit2: two regions of unknown function
(boxed in red and orange) and the GATA DNA-binding domain
(boxed in blue). The second conserved motif of unknown function
(boxed in orange) was identified through Pustell dot plot protein
matrix. The extreme C-terminus domain of AreA and Nit2 (boxed
in green) is highly conserved but that of Gat1/Are1 has diverged.
Enlarged versions of all four domains are shown in Figure 5B, C,
D and E.
(DOC)
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Figure S3 ClustalW multiple sequence alignment of A.
nidulans NmrA (AAC39442.1), N. crassa Nmr1
(P23762.2) and C. neoformans Tar1 (CNAG04934.2).
Identical amino acid residues are shaded dark grey while similar
residues are shaded light grey. Tar1 shows moderate overall
sequence conservation to NmrA and Nmr1. The predicted
Rossmann fold motif at the N-terminus is boxed in red. The long
C-terminus region of NmrA and Nmr1 is absent in Tar1.
(DOC)
Figure S4 Multiple independently generated tar1D mu-
tants all produced equal amount of pigment melanin in
comparison to their wild-type H99 or KN99a counter-
parts. The tenfold spot dilution assays for melanization on L-
DOPA, norepinephrine and caffeic acid agar (supplemented with
10 mM asparagine as the nitrogen source) were conducted at both
30 and 37uC.
(DOC)
Figure S5 Scheme representing the dual roles of Tar1 in
modulating GAT1/ARE1 transcription that in turn
influences PUT1 expression according to the nitrogen
source available. In the presence of the traditionally non-
preferred proline, the Nmr homolog Tar1 positively regulates the
transcription of the GATA factor-encoding gene GAT1/ARE1 that
is required for induction of the proline oxidase-encoding gene
PUT1. In the presence of the preferred ammonium, Tar1
negatively regulates GAT1/ARE1 transcription leading to reduce
levels of PUT1 expression.
(DOC)
Table S1 Fungal strains used in this study.
(DOC)
Table S2 Primers used in this study.
(DOC)
Table S3 Plasmids used in this study.
(DOC)
Table S4 Interaction between Tar1 and Gat1/Are1
could not be detected in a yeast two-hybrid assay. S.
cerevisiae AH109 was co-transformed with both the bait and prey
constructs, and selected for growth on double dropout medium
(-Leu -Trp). Interaction (denoted by + symbol) was assessed by
growth on quadruple dropout medium (-Leu -Trp -His -Ade), and
b-galactosidase activity. 2 symbol denotes no protein-protein
interaction. A.A. denotes auto-activation. N.T. denotes not tested.
(DOC)
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Figure S1. Complementation of toxic analog sensitivity phenotype to wild-type levels upon the re-
introduction of TAR1 into the tar1Δ  mutant. Tenfold spot dilution assays for nitrogen utilization 
showed that the tar1Δ + TAR1 strain exhibited wild-type growth on 5 mM thiourea plus 10 mM 
ammonium. 
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Figure S2. ClustalW multiple sequence alignment of A. nidulans AreA (XP_681936.1), N. crassa 
Nit2 (P19212.2) and C. neoformans Gat1/Are1 (CNAG00193.2). Identical amino acid residues are 
shaded dark grey while similar residues are shaded light grey. Gat1/Are1 shows little overall sequence 
conservation to AreA and Nit2 at the entire protein level. However, three notable blocks of 
conversation do exist between Gat1/Are1 and AreA or Nit2: two regions of unknown function (boxed 
in red and orange) and the GATA DNA-binding domain (boxed in blue). The second conserved motif 
of unknown function (boxed in orange) was identified through Pustell dot plot protein matrix. The 
	   4	  SI	  
extreme C-terminus domain of AreA and Nit2 (boxed in green) is highly conserved but that of 
Gat1/Are1 has diverged. Enlarged versions of all four domains are shown in Figure 5B, C, D and E.	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Figure S3. ClustalW multiple sequence alignment of A. nidulans NmrA (AAC39442.1), N. crassa 
Nmr1 (P23762.2) and C. neoformans Tar1 (CNAG04934.2). Identical amino acid residues are 
shaded dark grey while similar residues are shaded light grey. Tar1 shows moderate overall sequence 
conservation to NmrA and Nmr1. The predicted Rossmann fold motif at the N-terminus is boxed in 
red. The long C-terminus region of NmrA and Nmr1 is absent in Tar1.	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Figure S4. Multiple independently generated tar1Δ  mutants all produced equal amount of 
pigment melanin in comparison to their wild-type H99 or KN99a counterparts. The tenfold spot 
dilution assays for melanization on L-DOPA, norepinephrine and caffeic acid agar (supplemented with 
10 mM asparagine as the nitrogen source) were conducted at both 30 and 37°C. 
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Figure S5. Scheme representing the dual roles of Tar1 in modulating GAT1/ARE1 transcription 
that in turn influences PUT1 expression according to the nitrogen source available.  In the 
presence of the traditionally non-preferred proline, the Nmr homolog Tar1 positively regulates the 
transcription of the GATA factor-encoding gene GAT1/ARE1 that is required for induction of the 
proline oxidase-encoding gene PUT1. In the presence of the preferred ammonium, Tar1 negatively 
regulates the transcription of GAT1/ARE1 leading to reduce levels of PUT1 expression.  
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Table S1. Fungal strains used in this study. 
Strain Genotype Original source/reference 
H99 Cryptococcus neoformans laboratory strain John Perfect 
RL1 Cryptococcus neoformans H99 gat1/are1::NEO Lee et al. 2011 
RL10 Cryptococcus neoformans H99 tar1::NEO  This study 
RL9 Cryptococcus neoformans H99 gat1/are1::NEO, tar1::NAT This study 
RL14 Cryptococcus neoformans H99 tar1::NEO + TAR1 This study 
RL2 Cryptococcus neoformans H99 gat201::NEO Lee et al. 2011 
RL3 Cryptococcus neoformans H99 bwc2::NEO Lee et al. 2011 
RL4 Cryptococcus neoformans H99 CNAG04263.2::NEO Lee et al. 2011 
RL5 Cryptococcus neoformans H99 gat204::NEO Lee et al. 2011 
RL6 Cryptococcus neoformans H99 CNAG03401.2::NEO Lee et al. 2011 
H9CIR4 Cryptococcus neoformans H99 cir1::NAT Won Hee Jung 
KN99a Cryptococcus neoformans congenic strain Kirsten Nielsen 
RL11 Cryptococcus neoformans KN99a tar1::NAT  This study 
AH109 Saccharomyces cerevisiae matchmaker two-hybrid strain Clontech  
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Table S2. Primers used in this study. 
Primer Purpose Sequence (5’-3’) 
UQ1070 PUT1 qRT-PCR AAAAGCTAAAGAGAACGACGTTGC 
UQ1071 PUT1 qRT-PCR TCTCACTCTTTGACTTTGGAGGTTT 
UQ1634 GAT1/ARE1 qRT-PCR CAATGCGTGTGGACTTTTCTATAAA 
UQ1635 GAT1/ARE1 qRT-PCR GACCCGCTCGGTTTCTTTTC 
UQ2067 TAR1 qRT-PCR CAGTGTATCTGCTGCGGACTTG 
UQ2068   TAR1 qRT-PCR GACATTCCAGAGGCCTGAAGAC 
UQ1521 LAC1 qRT-PCR TCAATGGACGTGGCCAAAC 
UQ1522 LAC1 qRT-PCR GCAATTGACTGGCACGTGAA 
UQ1523 LAC2 qRT-PCR CCTAGTGTATTCGTTCTTTCAAATGACT 
UQ1524 LAC2 qRT-PCR TGGCCAAAGCCTCAGTAAGG 
UQ856   GAT1/ARE1 deletion / genomic DNA generation GTTGCGGGATGCTGGTGAAAT 
UQ857   GAT1/ARE1 deletion AGCTCACATCCTCGCAGCCCTAGCCGCCGCTAGCTG 
UQ858   GAT1/ARE1 deletion GTGTTAATACAGATAAACCGCGAATGAATGGAAGCA 
UQ859   GAT1/ARE1 deletion / genomic DNA generation GCCCAGCAACTACCATCGTGT 
UQ946 GAT1/ARE1 deletion CAGCTAGCGGCGGCTAGGGCTGCGAGGATGTGAGCT 
UQ947  GAT1/ARE1 deletion TTGCTTCCATTCATTCGCGGTTTATCTGTATTAACA 
UQ1418 TAR1 deletion / genomic DNA generation TAAAGGTCTGGGCACAGGAAG 
UQ1419 TAR1 deletion  AGCTCACATCCTCGCAGCATTGAATTGAAGAATGTA 
UQ1420 TAR1 deletion ACTACATTCTTCAATTCAATGCTGCGAGGATGTGAG 
UQ1421 TAR1 deletion TCTCCCCGGAAGTCTTTTGGTTTATCTGTATTAACA 
UQ1422 TAR1 deletion TGTTAATACAGATAAACCAAAAGACTTCCGGGGAGA 
UQ1423 TAR1 deletion / genomic DNA generation CGGCCAGAGAAAGAGTAGCTG 
UQ18 Sequencing (M13F pCR2.1-TOPO) GTAAAACGACGGCCAG 
UQ19 Sequencing (M13R pCR2.1-TOPO) CAGGAAACAGCTATGAC 
UQ1983 Sequencing (pGBKT7/pGADT7) TAATACGACTCACTATAGGGC 
UQ1984 Sequencing (pGBKT7) TTTTCGTTTTAAAACCTAAGAGTC 
UQ1985 Sequencing (pGADT7) AGATGGTGCACGATGCACAG 
UQ1027 GAT1/ARE1 genomic DNA sequencing GAAAGGCGAATAAAGGCTGTT 
UQ1028 GAT1/ARE1 genomic DNA / cDNA sequencing TCTGCCGCGTCTTCCCGGCCC 
UQ1029 GAT1/ARE1 genomic DNA / cDNA sequencing CCAAAAGCTGCTAGGGGCACC 
UQ1030 GAT1/ARE1 genomic DNA / cDNA sequencing TTGCCAAACGGTTTGTCTCTT 
UQ1031 GAT1/ARE1 genomic DNA / cDNA sequencing GCAGCCGCAGCAACGGCTGCG 
UQ1032 GAT1/ARE1 genomic DNA sequencing AAAAAAAAGCATAAATAAAAA 
UQ1033 GAT1/ARE1 genomic DNA / cDNA sequencing TGACCGCACAGACGTATTTTT 
UQ1034 GAT1/ARE1 genomic DNA / cDNA sequencing AGCTTTCGGTAATGGCCGGAT 
UQ1035 GAT1/ARE1 genomic DNA / cDNA sequencing GTGGTCGAAGGATGTCTTCCG 
UQ1443 TAR1 genomic DNA sequencing CACCAGGCAACACCAGGTTCT 
UQ1444 TAR1 genomic DNA sequencing CATTCTTCAATTCAATATGGC 
UQ1445 TAR1 genomic DNA sequencing ATGCTTGTCACAGACCTCTCA 
UQ1446 TAR1 genomic DNA sequencing GGGGAGAGGGAGGGGGAGACT 
UQ1735 TAR1 genomic DNA sequencing GCTTGAAAGTGAGTCACTGGC 
UQ1765 TAR1 cDNA sequencing GACTTCTGCCTTACGACTTCA 
UQ1766 TAR1 cDNA sequencing CTTGGCGAAGGATGTGCCGCA 
UQ1716 GAT1/ARE1 cDNA generation CGACAATACGCCTCTCCCCGA 
UQ1754 GAT1/ARE1 cDNA generation GTCCACTTCTGCCGAAACCAA 
UQ1755 TAR1 cDNA generation GAAATGTCTTCACATTCGACA 
UQ1767 TAR1 cDNA generation AGTCTCCCCCTCCCTCTCCCC 
UQ1971 Nucleotides 1–1,284 GAT1/ARE1 cDNA (MfeI site) GTTAGCCAATTGACTGCGACCAAACAGCAG 
UQ1973 Nucleotides 1–1,284 GAT1/ARE1 cDNA (BglII site) GGGGCTAGATCTGTCATGAGGAGCTTCAGA 
UQ1974 Nucleotides 1,285–2,562 GAT1/ARE1 cDNA (MfeI site) GAAGCTCAATTGCCTCATGAAGGCCCCATG 
UQ1975 Nucleotides 1,285–2,562 GAT1/ARE1 cDNA (BglII site) GAGTTCAGATCTTGGACCATTGATACCAGG 
UQ1976 Nucleotides 2,563–3,834 GAT1/ARE1 cDNA (MfeI site) GGTCCACAATTGGGCCTCTATACACATAGC 
UQ1972 Nucleotides 2,563–3,834 GAT1/ARE1 cDNA (BglII site) ATTCGCAGATCTTCATTCAACAAGAGCATC 
UQ1969 TAR1 cDNA (EcoRI site) TCGACAGAATTCATGGCGGCCACGACCATC 
UQ1970 TAR1 cDNA (BamHI site) TCTTTTGGATCCCTATAAATCTTGTCGGAA 	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Table S3. Plasmids used in this study. 
Plasmid Detail Original source 
pJAF1 NEO selectable marker in pCR2.1-TOPO  James Fraser 
pCH233 NAT selectable marker in pCR2.1-TOPO  Christina Hull 
pGBKT7 Matchmaker two-hybrid GAL4 BD vector Clontech  
pGADT7 Matchmaker two-hybrid GAL4 AD vector  Clontech  
pGBKT7-53 Murine p53 cDNA in pGBKT7  Clontech  
pGADT7-T SV40 large T antigen cDNA in pGADT7  Clontech  
pIRL25 TAR1 genomic DNA in pCR2.1-TOPO  This study 
pIRL26 TAR1 genomic DNA in pCH233  This study 
pIRL27 Full-length GAT1/ARE1 cDNA in pCR2.1-TOPO  This study 
pIRL21 Full-length TAR1 cDNA in pCR2.1-TOPO  This study 
pIRL30 Nucleotides 1–1,284 GAT1/ARE1 cDNA in pGBKT7  This study 
pIRL31 Nucleotides 1,285–2,562 GAT1/ARE1 cDNA in pGBKT7  This study 
pIRL32 Nucleotides 2,563–3,834 GAT1/ARE1 cDNA in pGBKT7  This study 
pIRL29 Full-length GAT1/ARE1 cDNA in pGBKT7  This study 
pIRL28 Full-length TAR1 cDNA in pGBKT7  This study 
pIRL35 Nucleotides 1–1,284 GAT1/ARE1 cDNA in pGADT7  This study 
pIRL36 Nucleotides 1,285–2,562 GAT1/ARE1 cDNA in pGADT7  This study 
pIRL37 Nucleotides 2,563–3,834 GAT1/ARE1 cDNA in pGADT7  This study 
pIRL34 Full-length GAT1/ARE1 cDNA in pGADT7  This study 
pIRL33 Full-length TAR1 cDNA in pGADT7  This study 
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Table S4. Interaction between Tar1 and Gat1/Are1 could not be detected in a yeast two-hybrid assay. 
 
       GAL4 AD 
 
GAL4 BD 
Full-length 
GAT1/ARE1 
(pIRL34)	  
First-third 
GAT1/ARE1 
(pIRL35)	  
Second-third 
GAT1/ARE1 
(pIRL36)	  
Final-third 
GAT1/ARE1 
(pIRL37)	  
Full-length 
TAR1 
(pIRL33)	  
SV40 large T 
(+ve control, 
pGADT7-T)	  
Empty vector 
(-ve control, 
pGADT7)	  
Full-length 
GAT1/ARE1 
(pIRL29) 
A.A. A.A.	   A.A.	   A.A.	   A.A.	   N.T.	   A.A.	  
First-third 
GAT1/ARE1 
(pIRL30) 
A.A.	   A.A.	   A.A.	   A.A.	   A.A.	   N.T.	   A.A.	  
Second-third 
GAT1/ARE1 
(pIRL31) - -	   -	   -	   -	   N.T.	   -	  
Final-third 
GAT1/ARE1 
(pIRL32) -	   -	   -	   -	   -	   N.T.	   -	  
Full-length 
TAR1 
(pIRL28) -	   -	   -	   -	   -	   N.T.	   -	  
Murine p53 
(+ve control, 
pGBKT7-53) 
N.T.	   N.T.	   N.T.	   N.T.	   N.T.	   + -	  
Empty vector 
(-ve control, 
pGBKT7)	  
-	   -	   -	   -	   -	   -	   -	  
S. cerevisiae AH109 was co-transformed with both the bait and prey constructs, and selected for growth on double dropout 
medium (-Leu -Trp). Interaction (denoted by + symbol) was assessed by growth on quadruple dropout medium (-Leu -Trp -His -
Ade), and β-galactosidase activity. - symbol denotes no protein-protein interaction. A.A. denotes auto-activation. N.T. denotes 
not tested. 	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 5.1 Preface 
As reviewed in Chapters 3 and 4, the Cryptococcus neoformans proline degradation 
pathway has proven to be a fertile area of research for the molecular dissection of the 
regulatory mechanism of nitrogen metabolite repression. While transcriptional 
regulation of the predicted proline catabolic enzyme-encoding genes was investigated, 
the enzymes of this pathway have not been formally characterised. Based on the brief 
examination of the putative catabolic genes of this imino acid, several interesting 
features surfaced that warrant further study. For example, there appears to be two 
paralogs predicted to encode proline oxidase in the H99 genome; gene duplications 
are believed to facilitate evolutionary innovation that often results in an increase in 
the overall fitness of an organism. Also, intriguingly, proline assimilation in the 
basidiomycete C. neoformans is partially independent of a functional GATA 
transcription factor, counterintuitive to the scenario observed in the ascomyctes where 
GATA factors are traditionally required to activate secondary nitrogen source 
utilisation. Further inspection of the literature on proline catabolic enzymes of various 
biological systems support the theory that these homologs in C. neoformans are likely 
to be important for virulence due to their anticipated role in oxidative stress. In this 
chapter, all the C. neoformans genes encoding the proline catabolic enzymes are 
functionally characterised at the molecular level.   
  
 
INVESTIGATION
Reactive Oxygen Species Homeostasis and Virulence
of the Fungal Pathogen Cryptococcus neoformans
Requires an Intact Proline Catabolism Pathway
I. Russel Lee,1 Edmund Y. L. Lui,1 Eve W. L. Chow, Samantha D. M. Arras, Carl A. Morrow,
and James A. Fraser2
Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland,
Brisbane, Queensland 4072, Australia
ABSTRACT Degradation of the multifunctional amino acid proline is associated with mitochondrial oxidative respiration. The two-step
oxidation of proline is catalyzed by proline oxidase and D1-pyrroline-5-carboxylate (P5C) dehydrogenase, which produce P5C and
glutamate, respectively. In animal and plant cells, impairment of P5C dehydrogenase activity results in P5C-proline cycling when
exogenous proline is supplied via the actions of proline oxidase and P5C reductase (the enzyme that converts P5C to proline). This
proline is oxidized by the proline oxidase-FAD complex that delivers electrons to the electron transport chain and to O2, leading to
mitochondrial reactive oxygen species (ROS) overproduction. Coupled activity of proline oxidase and P5C dehydrogenase is therefore
important for maintaining ROS homeostasis. In the genome of the fungal pathogen Cryptococcus neoformans, there are two paralogs
(PUT1 and PUT5) that encode proline oxidases and a single ortholog (PUT2) that encodes P5C dehydrogenase. Transcription of all three
catabolic genes is inducible by the presence of proline. However, through the creation of deletion mutants, only Put5 and Put2 were
found to be required for proline utilization. The put2D mutant also generates excessive mitochondrial superoxide when exposed to
proline. Intracellular accumulation of ROS is a critical feature of cell death; consistent with this fact, the put2D mutant exhibits a slight,
general growth defect. Furthermore, Put2 is required for optimal production of the major cryptococcal virulence factors. During murine
infection, the put2Dmutant was discovered to be avirulent; this is the first report highlighting the importance of P5C dehydrogenase in
enabling pathogenesis of a microorganism.
PROLINE is an important biological proteinogenic aminoacid that is necessary for primary metabolism in organisms
including animals, plants, fungi, and bacteria. This imino acid,
as it is more precisely known, has multiple physiological func-
tions. Apart from being an osmoprotectant, proline can serve as
a transient storage of organic nitrogen, stabilize proteins and
membranes during stressful conditions, prevent protein aggre-
gation during its folding or refolding, and scavenge reactive
oxygen species (ROS) such as superoxide anions (Rudolph and
Crowe 1985; Carpenter and Crowe 1988; Ignatova and
Gierasch 2006; Kaul et al. 2008). However, the exact mechanism
by which proline protects against stresses remains poorly
understood. Intracellular proline must be present at appro-
priate levels to confer stress-protective effects, and an excess
of free proline has been shown to be detrimental to cell growth
or protein functions in numerous organisms (Davis 2000; Morita
et al. 2002; Deuschle et al. 2004; Maxwell and Nomura and
Takagi 2004). The transport, anabolism, and catabolism of pro-
line therefore need to be tightly regulated for proper cellular
defense, adaptation, and growth.
Degradation of proline that takes place in eukaryotic mi-
tochondria or prokaryotic plasma membrane results in high-
energy output and may provide amino nitrogen and reducing
power to post-stress recovering cells (Atkinson 1977; Peng
et al. 1996; Verbruggen et al. 1996; Hare and Cress 1997).
Hence, the process of proline catabolism is also beneficial, in
addition to its intracellular accumulation. The four-electron oxi-
dation steps that convert proline to glutamate, with D1-pyrroline-
5-carboxylate (P5C) as an intermediate, occur in all living
Copyright © 2013 by the Genetics Society of America
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systems (Figure 1A). Oxidation of proline to P5C is first catalyzed
by the O2-dependent proline oxidase (also known as proline
dehydrogenase). The resulting P5C is nonenzymatically
transformed into glutamate-g-semialdehyde (GSA), which acts
as a substrate for P5C dehydrogenase to generate glutamate.
Glutamate is an important precursor molecule for all other
cellular nitrogenous compounds.
Conversely, uncoupled proline oxidase activity can also
be detrimental depending on the behavior of other catabolic
and biosynthesis enzymes of this metabolism. In animals
and plants, when proline oxidase activation is not accom-
panied by P5C dehydrogenase activation, intracellular levels
of the toxic intermediate P5C or GSA (thought to be more
chemically reactive and causative) as well as ROS are in-
creased and redox homeostasis is altered, ultimately leading
to cell death. Excessive ROS is generated from the P5C-
proline cycle that involves the constant interconversion be-
tween P5C and proline, catalyzed by activities of the cytosolic
P5C reductase and the mitochondrial proline oxidase (Phang
et al. 2008; Miller et al. 2009). This seemingly futile cycle con-
trols the cellular accumulation of the proline-derived metabolite
P5C/GSA and provides an excess of electron flow to the
mitochondrial electron transport chain (mtETC) that is partially
diverted to O2, resulting in superoxide anion formation. P5C/
GSA has high reactivity with various cellular compounds and
may act as a signal molecule to elicit deleterious effects in
animal, plant, and yeast cells (Mezl and Knox 1976; Maxwell
and Davis 2000; Deuschle et al. 2001, 2004; Donald et al.
2001; Nomura and Takagi 2004). Incomplete proline oxida-
tion can also enhance the transference of reducing equiva-
lents to the mitochondria altering the NADP+/NADPH ratio
at the cytosol, potentially impacting redox-sensitive pathways
such as the defense-associated oxidative pentose phosphate
pathway (Hare and Cress 1997).
In the model ascomycete Saccharomyces cerevisiae, expres-
sion of PUT1-encoded proline oxidase and PUT2-encoded P5C
dehydrogenase is activated by the pathway-specific transcrip-
tion factor Put3 in the presence of proline and the absence of
easily assimilated nitrogen sources such as ammonium or glu-
tamine (Brandriss and Magasanik 1979; Axelrod et al. 1991;
Huang and Brandriss 2000). Transcriptional regulation of
PUT1 and PUT2 is therefore subjected to nitrogen catabo-
lite/metabolite repression, a regulatory phenomenon that ena-
bles preferential utilization of metabolically favored nitrogen
sources. Proline oxidase and P5C dehydrogenase use FAD and
NAD+ as electron acceptors to generate FADH2 and NADH,
respectively, delivering electrons for mitochondrial respiration.
Transport of proline into yeast cells occurs mainly through the
general amino acid permease Gap1 and high-affinity proline-
specific permease Put4 (Vandenbol et al. 1989; Jauniaux and
Grenson 1990). Activation of the nitrogen catabolite repres-
sion-sensitive GAP1 and PUT4 is induced by the globally acting
GATA transcription factors Gln3 and/or Gat1 (Daugherty et al.
1993; Stanbrough and Magasanik 1996).
Knowledge gained from pioneering studies of gene regulation
in model fungi has steadily laid the foundation for modern-day
research into dissecting the mechanisms of virulence in path-
ogenic fungi. One of the leading fatal fungal infections is
cryptococcal meningoencephalitis. Cryptococcus neoformans
predominantly infects immunocompromised patients, while
its sister species Cryptococcus gattii generally infects immuno-
competent individuals (Heitman 2010). Historically, differential
media were used to distinguish the different basidiomycete
species, capitalizing on their unique ability to metabolize differ-
ent substrates. For example, C. neoformans is unable to utilize
D-proline while C. gattii is among the rare few microorganisms
that can assimilate this dextrorotatory form of proline (Dufait
et al. 1987; Ngamskulrungroj et al. 2012).
In the more clinically prevalent C. neoformans, regulation
of proline (L-proline, unless specified otherwise) utilization
is particularly interesting because a functional GATA factor
(Gat1/Are1) is not required for assimilation of this traditionally
nonpreferred nitrogen source, an observation that is different
from the assimilation seen in the ascomycetes (Kmetzsch et al.
2011; Lee et al. 2011, 2012). Initiation of C. neoformans in-
fection occurs via inhalation of airborne basidiospores or desic-
cated yeast cells, and one of the initial lines of host defense that
this pathogen encounters is reactive oxygen, and nitrogen spe-
cies burst from alveolar phagocytes. In addition, C. neoformans
has to endure various stresses found in different body locations
of the host such as nutrient limitation for successful prolifera-
tion, dissemination, and colonization. Thus, the observation of
Gat1/Are1 independence in proline utilization, coupled with
the supporting literature that proline catabolism is likely a key
regulator of virulence, led us to investigate the role of the
proline catabolic enzymes in C. neoformans pathobiology.
In this study, we examined how the C. neoformans proline
catabolic genes are transcriptionally regulated and both ge-
netically and phenotypically characterized their enzymatic
functions in relation to nitrogen and carbon source utilization,
balance of mitochondrial ROS formation, as well as stress-
adaptation and virulence-associated mechanisms.
Materials and Methods
Strains and media
All fungal strains used in this study are listed in Supporting
Information, Table S1 and were grown in YPD (1% yeast
extract, 2% Bacto-peptone, 2% glucose) or YNB (0.45%
yeast nitrogen base w/o amino acids and ammonium sul-
fate, 2% glucose, 10 mM nitrogen source) unless specified
otherwise. C. neoformans biolistic transformants were se-
lected on YPD medium supplemented with 200 mg/ml
G418 (Sigma) or 100 mg/ml nourseothricin (Werner Bio-
Agents). L-3,4-dihydroxyphenylalanine (L-DOPA) medium
was prepared as described previously (Missall et al. 2005).
Escherichia coli Mach-1 cells served as the host strain for
transformation and propagation of all plasmids using lysog-
eny broth supplemented with either 100 mg/ml ampicillin
(Sigma) or 50 mg/ml kanamycin (Sigma) (Sambrook et al.
1989).
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Bioinformatic analyses
C. neoformans genes were identified using annotation from
the H99 genome sequence from the Broad Institute (http://
www.broadinstitute.org/annotation/genome/cryptococcus_
neoformans/MultiHome.html). Gene annotations from the
Broad Institute are designated by their nomenclature
“CNAG_#####.#.” Sequence analyses were performed us-
ing BLAST and MacVector 9.5 (MacVector Inc., Cary NC)
(Altschul et al. 1990). Sequence alignments were created us-
ing ClustalW v1.4 within MacVector (Thompson et al. 1994).
Sequence traces generated at the Australian Genome Re-
search Facility (Brisbane, QLD, Australia) were analyzed using
Sequencher 4.7 (Gene Codes, Ann Arbor MI). Putative mito-
chondrial localization signals were examined using MitoProt
(http://ihg.gsf.de/ihg/mitoprot.html).
Construction and complementation of C. neoformans
mutant strains
All primers and plasmids used in this study are listed in
Table S2 and Table S3, respectively. Gene deletion mutants
were created using overlap PCR and biolistic transformation
as described previously (Davidson et al. 2002). For example,
to construct the put1Dmutant strain in the H99 background,
the 2035-bp PUT1 (CNAG_02049.2) coding sequence was
replaced with the neomycin phosphotransferase II-encoding
selectable marker NEO using a construct created by overlap
PCR combining an 1-kb fragment upstream from the PUT1
start codon, the NEO marker, and an 1-kb fragment down-
stream from the PUT1 stop codon. Strain H99 genomic DNA
and plasmid pJAF1 were used as PCR templates (Fraser et al.
2003). The construct was transformed into C. neoformans
cells via particle bombardment and transformants selected
on YPD plates supplemented with G418. Deletion of PUT1
was confirmed by diagnostic PCR and Southern blot (Southern
2006). To complement the put1D mutant, the C. neoformans
PUT1 gene, including an 1-kb promoter and terminator, was
amplified from genomic DNA using high-fidelity PCR, cloned
into pCR2.1-TOPO (Invitrogen) to give pELYL1, and sequenced.
The PUT1 fragment of pELYL1 was then subcloned into
pCH233, creating the complementation construct pELYL5.
pELYL5 was subsequently linearized and biolistically transformed
into the put1D mutant. Stable transformants were selected on
YPD supplemented with nourseothricin, and complemented
strains containing a single copy of the wild-type PUT1 gene
were identified by Southern blot.
Cross-species complementation
Full-length C. neoformans PUT1, PUT5, and PUT2 ORFs am-
plified from strain H99 complementary DNA (cDNA) were
fused with 1-kb promoter and terminator sequences of
S. cerevisiae BY4741 PUT1 or PUT2 via high-fidelity overlap
PCR (Brachmann et al. 1998). These fusion genes were cloned
into pCR2.1-TOPO, sequenced, and subcloned into the yeast
shuttle vector YCplac111 (Gietz and Sugino 1988). Likewise,
the control S. cerevisiae PUT1 and PUT2 genes, including their
1-kb promoter and terminator, were amplified from strain
BY4741 genomic DNA, cloned into pCR2.1-TOPO, sequenced,
and subcloned into YCplac111. Plasmids were transformed
into S. cerevisiae put1D or put2D strains obtained from the
BY4741 deletion library using the lithium acetate/heat-shock
method (Gietz and Schiestl 2007). Prior to transformation,
these previously auxotrophic strains had URA3, HIS3, and
MET15 restored, but not LEU2, to remove background in-
terference through supplementation of potential nitrogen
sources (uracil, histidine, methionine). Transformants were
first selected on YNB (2% glucose, 10 mM ammonium sulfate)
lacking leucine; thereafter, LEU2 was restored in the strains.
Likewise, URA3, HIS3, MET15, and LEU2 were restored in the
wild-type and mutant control strains. Functional complemen-
tation of proline oxidase and P5C dehydrogenase activity was
verified through growth on YNB (2% glucose, 10 mM proline)
lacking leucine.
Construction and screening of library for C. neoformans
proline catabolism defective mutants
An Agrobacterium-mediated mutagenesis library of C. neo-
formans H99 was created as described previously (Idnurm
et al. 2004). The majority of transformants harbored a single
copy of randomly integrated T-DNA and were mitotically
stable. To identify genes involved in proline catabolism, rep-
lica spotting of the insertional library consisting of 12,000
clones was carried out on YNB supplemented with proline or
ammonium (10 mM each nitrogen source). Mutants that
grew on ammonium but failed to grow on proline-containing
mediumwere selected for further analysis. The T-DNA insertion
site was mapped using GenomeWalker according to the
manufacturer’s instructions (Clontech). BLAST analysis of
Figure 1 The C. neoformans ge-
nome contains two paralogs that
encode proline oxidases and a
single ortholog that encodes P5C
dehydrogenase. (A) Scheme rep-
resenting the proline degrada-
tion pathway. (B) Exon–intron
structures of PUT1, PUT5, and
PUT2 and their chromosomal
locations.
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these sequences was performed to reveal which loci were
affected.
Quantitative real-time PCR
C. neoformans strains were grown in YNB supplemented
with 10 mM of the specified nitrogen source and shaken
at 30 for 16 hr. Overnight cultures were harvested, cell
pellets were frozen and lyophilized, total RNA was isolated
using TRIzol reagent (Invitrogen), and cDNA was generated
using the SuperscriptIII First-Strand Synthesis System (Invi-
trogen). Primers for PUT1 (CNAG_02049.2), PUT5 (CNAG_
02048.2), and PUT2 (CNAG_05602.2) were designed to
span exon–exon boundaries and tested to verify that they
bind specifically to cDNA but not to genomic DNA. Quanti-
tative real-time PCR (qRT-PCR) was performed using SYBR
Green Supermix (Applied Biosystems) and an Applied Bio-
systems 7900HT Fast Real Time PCR System with the follow-
ing cycling conditions: denaturation at 95 for 10 min,
followed by amplification and quantification in 45 cycles at
95 for 15 sec and 60 for 1 min, with melting-curve profiling
at 95 for 2 min, 60 for 15 sec, and 95 for 15 sec. Dissoci-
ation analysis confirmed the amplification of a single PCR
product for each primer pair and an absence of primer dimer
formation. Relative gene expression was quantified using SDS
software 1.3.1 (Applied Biosystems) based on the 22ΔΔCT
method (Livak and Schmittgen 2001). The housekeeping ac-
tin-encoding gene ACT1 was used as a control for normaliza-
tion. One-way analysis of variance was performed using the
unpaired, two-tailed t-test in GraphPad Prism Version 5.0c.
P-values of ,0.05 were considered statistically significant.
Oxidative and nitrosative stress assays
Starter C. neoformans cultures were prepared by growth in
YPD at 30 overnight with shaking and diluted to a concen-
tration of 1 · 107 cells/ml in water. A 50-ml drop containing
5 · 105 cells was then inoculated into YNB [proline and glu-
tamate (10 mM each nitrogen source)] supplemented with the
stressors menadione (0– 0.003 mM), tert-Butyl hydroperoxide
(0–0.3 mM), sodium nitrite (0–3mM), and S-nitrosoglutathione
(GSNO) (0–9 mM) and shaken at 30 for an additional 16 hr.
Growth density was measured by monitoring the turbidity
with an optical density at a wavelength of 600 nm (OD600nm).
Each experimental condition was repeated in triplicate. One-
way analysis of variance was performed using the unpaired,
two-tailed t-test in GraphPad Prism Version 5.0c. P-values of
,0.05 were considered statistically significant.
Mitochondrial staining, confocal microscopy, and
flow cytometry
C. neoformans strains were grown in YPD and shaken at 30
for 16 hr; thereafter, cells were washed and transferred to
YNB supplemented with 10 mM proline for a further 4 hr.
Cells were then stained with MitoSOX Red (Invitrogen) at a fi-
nal concentration of 5 mM or with MitoTracker Red CMXRos
(Invitrogen) at a final concentration of 25 nM for 15 min at
30. After staining, cells were washed and resuspended in PBS
at a density of 1 · 107 cells/ml. Twenty yeast cells of each
strain were randomly chosen for fluorescence microscopy
analysis. Images were collected on a Zeiss Axioplan 2 imaging
confocal microscope using a 66· oil immersion Plan-Apochromat
objective. Fluorochromes were excited using a 514-nm Argon/2
laser for MitoSOX and a 543-nm HeNe1 laser for MitoTracker.
Differential interference contrast images were collected simul-
taneously with the fluorescence images using the transmitted
light detector. Images were processed using AIM 4.2 LSM
software. MitoSOX fluorescence was also analyzed using a
BD Accuri C6 flow cytometry. The parameters for FACS were
set at excitation of 488 nm, and for emission the data were
collected at FSC, SSC, and 675LP (FL3) channels. Cell debris
represented by distinct low forward and side scatter were
gated out for analysis. All experiments were done in tripli-
cate. One-way analysis of variance was performed using the
unpaired, two-tailed t-test in GraphPad Prism Version 5.0c.
P-values of ,0.05 were considered statistically significant.
Growth and melanization assays
Starter C. neoformans cultures were prepared by growth in
YPD at 30 overnight with shaking, diluted to OD600nm = 0.05
in water, and then further diluted 10-fold in series. Each diluted
cell suspension was spotted onto YPD and YNB supplemented
with the specified nitrogen source or L-DOPA medium. Results
were imaged after 2–3 days incubation at 30 (nitrogen
utilization assay), 30 and 37 (melanization assay), or 37
(high-temperature growth assay).
Capsule assays
C. neoformans strains were inoculated into RPMI supple-
mented with 10% fetal bovine serum (Gibco) and incubated
at 37 for 2 days. To visualize the capsule, cells were stained
with India ink (Becton Dickinson) and observed under
a ZEISS Axioplan 2 epifluorescent/light microscope. Pictures
were taken with an Axiocam grayscale digital camera using
the AxioVision AC imaging software.
Murine inhalation model of cryptococcosis
For murine virulence assays, C. neoformans were used to
infect 6-week-old female BALB/c mice by nasal inhalation
(Cox et al. 2000). For every tested strain, 10 mice were each
inoculated with a 50-ml drop containing 5 · 105 cells. Mice
were weighed before infection and daily thereafter; animals
were killed using CO2 inhalation once their body weight had
decreased to 80% of the pre-infection weight or at 50 days
post infection. In addition, brain, lungs, liver, and spleen
were harvested from killed put2D-infected mice; organs
were weighed, homogenized, and plated onto YPD supple-
mented with 50 mg/ml chloramphenicol (Sigma) for selec-
tive isolation of yeast colony forming units (CFUs). Survival
was plotted against time, and P-values were calculated
by plotting a Kaplan–Meier survival curve and performing
a log-rank (Mantel–Cox) test using Graphpad Prism Ver-
sion 5.0c. P-values of ,0.05 were considered statistically
significant.
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Ethics statement
This study was carried out in strict accordance with the
recommendations in the Australian Code of Practice for
the Care and Use of Animals for Scientific Purposes by the
National Health and Medical Research Council. The protocol
was approved by the Molecular Biosciences Animal Ethics
Committee (AEC) of The University of Queensland (AEC
approval no. SCMB/008/11/UQ/NHMRC). Infection was per-
formed under methoxyflurane anesthesia, and all efforts were
made to minimize suffering through adherence to the Guide-
lines to Promote the Wellbeing of Animals Used for Scientific
Purposes as put forward by the National Health and Medical
Research Council (Australia).
Results
Bioinformatic analyses reveal conserved and duplicated
genes predicted to be involved in proline utilization
in C. neoformans
While transcriptional studies relating to nitrogen metabolite
repression-associated regulation of the C. neoformans pro-
line oxidase and P5C dehydrogenase-encoding genes have
been performed, these putative proline degradation path-
way genes have not been properly characterized at the mo-
lecular level (Kmetzsch et al. 2011; Lee et al. 2011, 2012).
Unlike the genome of the model hemiascomycete S. cerevisiae
that contains a single proline oxidase-encoding gene, chro-
mosome 6 of C. neoformans var. grubii strain H99 contains
two tandemly arrayed genes that are both predicted to en-
code proline oxidases (Figure 1, A and B) (Lee et al. 2011).
These two Cryptococcus paralogs were previously named
PUT1 (CNAG_02049.2) and PUT5 (CNAG_02048.2), for pro-
line utilization 1 and 5 (Kmetzsch et al. 2011; Lee et al.
2011). A similar scenario is observed in the model plant Arab-
idopsis thaliana where two proline dehydrogenase isoforms
have been functionally characterized (Funck et al. 2010). In
contrast to what was seen for proline oxidase, the C. neofor-
mans H99 genome encodes only a single P5C dehydrogenase
on chromosome 14 (Figure 1, A and B). This Cryptococcus
ortholog was previously designated PUT2 (CNAG_05602.2)
for proline utilization 2 (Lee et al. 2011). Thus, unlike the
model filamentous ascomycete Aspergillus nidulans, where
the proline catabolism-associated genes form a cluster within
a single chromosome, the C. neoformans proline oxidase and
P5C dehydrogenase genes are unlinked, like those of S. cerevisiae
(Figure S1) (Arst and MacDonald 1978).
The duplication of the putative proline oxidase gene is an
interesting occurrence into which we sought to gain further
insights. Both genomic DNA and cDNA of these genes were
PCR-amplified and sequenced, verifying the predicted exon–
intron structure. This exercise demonstrated that the posi-
tion of the three introns in PUT1 is precisely conserved in
PUT5, providing evidence that these genes are indeed paral-
ogs (Figure 1B). Using this sequence information, a compar-
ison of Put1 and Put5 revealed 67% identity at the protein
level, suggesting that the duplication event is not recent (Figure
S2). In support of this hypothesis, analysis of the sequenced
genomes of the C. neoformans var. neoformans strain JEC21
(estimated to have diverged from C. neoformans var. grubii
24.5 million years ago) and the C. gattii strain R265 (es-
timated to have diverged from C. neoformans var. grubii 49
million years ago) revealed that the duplication is also present
in these isolates, consistent with the duplication event preceding
the divergence of these species.
Transcription of all the predicted proline catabolic
genes of C. neoformans is regulated by
pathway-specific induction
To provide support for our bioinformatics-based prediction,
we analyzed the transcriptional regulation of the putative
proline catabolic genes using qRT-PCR on RNA extracted from
wild-type H99 grown in minimal YNB medium supplemented
with a range of different sole nitrogen sources (Figure 2).
While only basal levels of expression of PUT1, PUT5, and
PUT2 were observed when cells were cultured in ammonium,
glutamine, glutamate, asparagine, or uric acid, transcription
of these genes was significantly upregulated (.10-fold in-
crease) during growth in proline. This result indicates that
the expression of PUT1, PUT5, and PUT2 is inducible only in
the presence of proline, suggesting that these genes are indeed
proline metabolism-related genes. Nonetheless, the result pro-
vides no indication as to whether PUT1 or PUT5 is likely to be
the true functional proline oxidase ortholog required for proline
assimilation or whether both PUT1 and PUT5 are enzymatically
active.
Cross-species complementation provides evidence that
C. neoformans PUT2 is a true functional ortholog
encoding P5C dehydrogenase, but gives no indication
of the functionality of PUT1 and PUT5
We tested the enzymatic functions of C. neoformans PUT1,
PUT5, and PUT2 by heterologous expression in S. cerevisiae
strains lacking either the proline oxidase or P5C dehydroge-
nase-encoding gene (Figure S3). These well-characterized
S. cerevisiae put1D and put2D mutant strains are unable to
utilize proline as a source of nitrogen for growth (Brandriss
1983; Wang and Brandriss 1986). Transformation of the
S. cerevisiae put2D strain with a plasmid harboring the
full-length cDNA of C. neoformans PUT2 enabled the strain
to catabolize proline, albeit to a poorer extent compared to
a full-length S. cerevisiae PUT2. This result indicates that
C. neoformans PUT2 encodes an enzyme with P5C dehydroge-
nase activity. However, transformation of the S. cerevisiae
put1D strain with plasmids harboring the full-length cDNA of
either C. neoformans PUT1 or PUT5 did not rescue the strains’
proline utilization defect, whereas a full-length S. cerevisiae
PUT1 restored the proline oxidase function. Difficulties associ-
ated with complementing the S. cerevisiae put1D strain with
proline oxidase cDNA of other organisms have previously been
reported (Kiyosue et al. 1996). Hence, the enzymatic functions
of C. neoformans PUT1 and PUT5 remain inconclusive.
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Reverse genetics approach reveals that PUT5-encoded
proline oxidase and PUT2-encoded P5C dehydrogenase
are required for proline utilization in C. neoformans
We therefore adopted another approach to characterize the
functions of the C. neoformans putative proline catabolic
genes. Deletion mutants each lacking PUT1, PUT5, or PUT2
were created via homologous recombination in strain H99. In
addition, a double mutant lacking both PUT1 and PUT5 was
constructed as we reasoned that the single put1D or put5D
mutant might still possess an active proline oxidase isoform.
This is unlike the case for the put2D mutant where degra-
dation of proline to glutamate, a prerequisite for recycling of
nitrogen, is expected to be completely blocked. The gener-
ated proline oxidase deletion mutants (put1D, put5D, dou-
ble put1D put5D) as well as the P5C dehydrogenase deletion
mutant (put2D) were all viable; the proline oxidase deletion
mutants’ growth appears indistinguishable from wild-type
on rich undefined YPD medium, whereas the put2D mutant
exhibited a mild growth defect (see Put2 is required for
optimal production of the major virulence factors).
On YNB-defined medium supplemented with proline as
the sole nitrogen source or sole nitrogen and carbon source
(i.e., with or without the addition of glucose as a source of
carbon), the put1D mutant displayed wild-type growth while
the put5D, double put1D put5D, and put2D mutants were un-
able to proliferate (Figure 3). This result indicates that, unlike
S. cerevisiae that can assimilate only proline as a nitrogen
source, C. neoformans follows the ability of fungi such as
A. nidulans in being able to utilize proline as both a nitrogen
and a carbon source (Brandriss and Magasanik 1979;
Sophianopoulou et al. 1993). Importantly, C. neoformans
Put1 does not play a role in proline utilization under this
specific condition; instead, it is Put5 that appears to be the
major proline oxidase responsible for proline degradation.
Nonetheless, the MitoProt computer-based prediction pro-
gram clearly indicates a characteristic mitochondrial import
signal at the N terminus of Put1 and Put5 with a probability
of 92 and 98%, respectively, suggesting that both these pro-
line oxidases are likely in the correct subcellular localization
to support proline catabolism (Claros and Vincens 1996).
Like Put5, Put2 is also essential for proline assimilation.
Complementation of the put5D, double put1D put5D, and
put2D mutants subsequently restored the wild-type pheno-
type, verifying the proline utilization functions of Put5 and
Put2 (Figure S4).
Forward genetics approach involving
Agrobacterium-mediated insertional mutagenesis did
not reveal any additional proline catabolic enzymes
in C. neoformans
P5C is thought to form a pH-dependent, nonenzymatic
equilibrium with GSA. Recent findings in uric acid catabolism
raise the question of whether this dogma should be accepted
prima facie; in addition to urate oxidase, two new biological
enzymes (HIU hydrolase and OHCU decarboxylase) were
recently discovered to play a role in the conversion of uric
acid to allantoin (Ramazzina et al. 2006). To provide unbi-
ased support for the bioinformatics and phenotypic-based
model of C. neoformans proline catabolism, a T-DNA inser-
tional library of strain H99 was created using Agrobacterium
tumefaciens-mediated transformation. Insertional mutagene-
sis is a powerful tool for identifying novel genes and their
functions, and the frequency of random integration is very
high using this transkingdom DNA delivery approach. In an
attempt to locate as-yet-identified genetic loci involved in
proline utilization, we replica-spotted 12,000 purified individ-
ual transformants onto YNB supplemented with proline or
ammonium (control) as the sole nitrogen source. Only a single
mutant, 65B8, failed to grow on proline but grew on ammo-
nium. We then mapped the T-DNA insertion site of the 65B8
strain and found that its disrupted gene encodes P5C dehy-
drogenase. Hence, our sequence analysis did not reveal any
additional proline catabolic genes beyond what has been bio-
informatically predicted or phenotypically characterized.
Figure 2 Transcription of all the proline catabolic enzyme-encoding genes is regulated by pathway-specific induction. cDNA from wild-type H99 grown
in YNB supplemented with proline, ammonium, glutamine, glutamate, asparagine, or uric acid (10 mM each) was amplified via qRT-PCR using primers
for the proline catabolic genes PUT1, PUT5, and PUT2, normalized against the control gene ACT1. Expression of PUT1, PUT5, and PUT2 was induced in
the presence of proline but not in the presence of the other nitrogen sources (*P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001). Error bars
represent standard errors across three biological replicates.
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C. neoformans put5D and double put1D put5D mutants
display reduce tolerance against certain oxidative and
nitrosative stressors
In S. cerevisiae, metabolically engineered proline-accumulated
cells generated through enhancing the biosynthesis pathway
and/or concomitant silencing of the catabolic pathway are
more tolerant to a wide array of stresses (Takagi et al.
2000, 2005; Morita et al. 2002). For example, S. cerevisiae
put1D mutants display increased resistance against oxidative
damage (Chen et al. 2006). To promote intracellular proline
accumulation in C. neoformans, the proline oxidase deletion
mutants were grown in YNB supplemented with proline and
glutamate as the sole nitrogen sources. Glutamate is the end
product of proline catabolism and the precursor for proline
biosynthesis; in S. cerevisiae, PRO3-encoded P5C reductase
that converts P5C to proline is constitutively expressed (Brandriss
and Falvey 1992). Concurrently, these cultures were subjected
to various oxidative (menadione, tert-Butyl hydroperoxide) and
nitrosative (sodium nitrite, GSNO) stresses; numerous reactive
oxygen/nitrogen species (ROS/RNS)-generating chemicals
were assayed as each compound acts on a different cellular
target.
Spectrophotometric OD600nm readings revealed that toler-
ance against menadione and sodium nitrite is equivalent
between the wild-type strain and proline oxidase deletion
mutants (Figure S5). Interestingly, the put5D and double put1D
put5D mutants exhibit decreased resistance against tert-Butyl
hydroperoxide and GSNO as compared to the wild-type and
put1D strains (Figure 4). This suggests that lack of proline
oxidase activity may potentially impair the C. neoformans
cellular antioxidant system in handling the stresses generated
by ROS/RNS-producing reagents. Therefore, unlike the sce-
nario in S. cerevisiae, proline accumulation in C. neoformans
cells may not necessarily result in enhanced resistance against
oxidative or nitrosative stresses. Instead, the predicted oc-
currence of unregulated proline accumulation is likely to be
slightly inhibitory to general cell growth, as observed by the
put5D and double put1D put5D mutants’ slower growth rate
relative to the wild-type and put1D strains in control cultures
(YNB plus proline and glutamate) devoid of any stressors.
C. neoformans put2D mutant accumulates excessive
mitochondrial ROS in the presence of proline
In S. cerevisiae put2D mutants, exposure to proline has been
shown to result in growth inhibition and an increase in in-
tracellular ROS levels (Deuschle et al. 2001; Nomura and
Takagi 2004). Through external supplementation of proline,
we hypothesized that the predicted P5C-proline cycling
would provide a constant substrate for proline oxidase-linked
FAD reduction in the C. neoformans put2D mutant, resulting
in an increased rate of electron transfer to the mtETC and to
O2 and leading to elevated superoxide production. Genera-
tion and accumulation of ROS is a critical feature of pro-
grammed cell death in animals, plants, and fungi, and this
ROS-induced oxidative stress may be a factor causing the
general growth retardation phenotype in the C. neoformans
put2D mutant (Jabs 1999).
To determine whether the put2D mutant has abnormal
intrinsic ROS levels, C. neoformans strains were first grown
overnight in rich YPD medium after which they were trans-
ferred to YNB supplemented with proline for an additional
4 hr. Strains were then stained with the fluorogenic MitoSOX
Red probe used to selectively detect mitochondrial superoxide
ions (the predominant ROS in mitochondria) of live cells. In
a subset (1/3 of the entire population) of put2D cells, the
extent of ROS formation was by far higher than that generated
in the wild-type or proline oxidase deletion mutant strains as
seen by a more intense red fluorescence caused by oxidation of
the MitoSOX reagent by superoxide (Figure 5A). Because con-
focal microscopic imaging only allows semiquantitative detec-
tion of superoxide generation in relatively few live cells, we
also simultaneously employed flow cytometry that enables
a quantitative measure of a larger population of live cells.
The flow cytometry analysis also revealed two major distinct
populations of put2D cells, with a combined 3.9 6 0.3-fold
increase of mean MitoSOX fluorescence intensity relative to
Figure 3 PUT5-encoded proline oxidase and PUT2-encoded P5C dehy-
drogenase are required for proline assimilation. Tenfold spot dilution
assays for nitrogen or nitrogen and carbon source utilization showed that
the put1Dmutant exhibited wild-type growth on YNB supplemented with
10 mM proline (with or without 2% glucose as a carbon source). In
contrast, the put5D, double put1D put5D, and put2D mutants were un-
able to proliferate on proline as the sole nitrogen or carbon source. The
ammonium-supplemented YNB plates served as a control to demonstrate
that, unlike proline, ammonium can be utilized by C. neoformans only as
a nitrogen source but not as a carbon source.
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the wild-type strain (WT vs. put2D, P = 0.0002) (Figure 5B
and Figure S6). It remains to be determined why a subpop-
ulation of put2D cells displayed wild-type fluorescence in-
tensity while another subpopulation exhibited significantly
enhanced fluorescence. A single population generating wild-
type levels of superoxide production was restored in the
complemented put2D + PUT2 strain, verifying the role of
P5C dehydrogenase in controlling mitochondrial ROS levels
in C. neoformans (Figure S6). Uncoupled coordination of
proline oxidase and P5C dehydrogenase activities therefore
leads to an imbalance in ROS homeostasis.
Given that mitochondria are organelles known to play an
important role in apoptosis, we questioned whether this
anomaly in ROS levels of the put2D mutant impairs mito-
chondrial function. Various aspects of mitochondrial dys-
function can be detected by examining for perturbation in
membrane potential using MitoTracker dyes such as CMXRos.
Confocal microscopy showed that all the proline catabolic
deletion mutants, including the put2D strain, were able to
retain this fluorescence dye, suggesting that mitochondrial
membrane potential is unperturbed and that the respiratory
system is still intact in all these mutants (Figure S7).
Put2 is required for optimal production of the major
virulence factors
The ability of C. neoformans to successfully infect a host is
largely dependent on several well-established virulence fac-
tors, namely, ability to grow at mammalian body tempera-
ture as well as synthesis of the antioxidant pigment melanin
and antiphagocytic polysaccharide capsule. Therefore, we
tested whether the proline catabolic enzymes influence the
expression of these classical virulence traits (Figure 6 and
not shown). No changes in the ability to grow at high tem-
perature or in the production of melanin and capsule were
observed in the put1D, put5D, and double put1D put5D
mutants, indicating that proline oxidase is dispensable for
virulence factor expression. In contrast, the mild growth de-
fect of the put2D mutant that may be caused by general
growth retardation or death of a subset of cells was slightly
exacerbated at 37 on YPD medium. The put2D mutant also
exhibited a subtle but reproducible decrease in melanin pro-
duction at 30 on L-DOPA medium, with this melanization
defect slightly more pronounced at 37. No change in cap-
sule size, however, was observed in the put2D cells when
induced in serum. Virulence factor expression was restored
to wild-type levels in the complemented put2D + PUT2
strain (Figure S8). Collectively, P5C dehydrogenase is crucial
for optimal production of at least two of the well-known
virulence components of C. neoformans.
The put2D mutant is severely compromised for
virulence in a murine inhalation model of cryptococcosis
A recent study in S. cerevisiae has demonstrated that P5C
directly inhibits the mitochondrial respiration, reiterating
our hypothesis that proline catabolism is likely to be important
for C. neoformans virulence (Nishimura et al. 2012). Given
that our overarching interest in C. neoformans lies in better
understanding its pathogenicity in a mammalian host, we
investigated the role of the proline catabolic enzymes during
infection in vivo (Figure 7). Mice intranasally infected with
Figure 4 The put5D and double
put1D put5D mutants are less
tolerant against the oxidative
stressor tert-Butyl hydroperoxide
and nitrosative stressor GSNO.
Wild-type H99 and proline oxi-
dase deletion mutant strains
were grown in YNB [proline and
glutamate (10 mM each)] sup-
plemented with (A) 0–0.3 mM
tert-Butyl hydroperoxide or (B)
0–9 mM GSNO. The put5D and
double put1D put5D mutants
exhibited a significantly lower
growth percentage relative to
the unstressed control when
subjected to these individual
stressors as compared to the
wild-type or put1D strains
(**P , 0.01, ***P , 0.001).
Growth percentage relative to
unstressed control is defined by
dividing each stressed strain’s
growth in OD600 with the same
strain’s growth in OD600 when
unstressed. Error bars represent
standard errors across three bio-
logical replicates.
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the put1D, put5D, and double put1D put5D mutants suc-
cumbed to infection at approximately the same rate as mice
infected with the wild-type strain (killing occurred between
16 and 23 days post infection; median survival of mice =
18.0 days), indicating that proline oxidase is not required
for pathogenesis. In stark contrast, the put2D mutant was
unable to kill any mice even after 50 days, indicating that
P5C dehydrogenase is critical for pathogenesis (WT vs.
put2D, P, 0.0001). Infection of mice with the complemented
put2D + PUT2 strain restored wild-type virulence (killing
occurred between 16 and 23 days post infection; median
survival of mice = 18.5 days), verifying the role of P5C de-
hydrogenase in pathogenesis.
To more precisely characterize the effect of the loss of
P5C dehydrogenase on C. neoformans survival and dissemi-
nation inside the host body, we examined the fungal burden
Figure 5 The put2D mutant generates excessive superoxide ions in the mitochondria when exposed to proline. Wild-type H99 and proline catabolic
deletion mutant strains were briefly subjected to culture in YNB supplemented with 10 mM proline and stained with MitoSOX, and the accumulation of
ROS in the mitochondria was assessed by fluorescence microscopy and flow cytometry. (A) Representative confocal images showing a subpopulation of
put2D cells generate enhanced MitoSOX fluorescence compared to the wild-type or proline oxidase deletion mutant strains. Bar, 10 mm. (B) Repre-
sentative histograms of flow cytometry showing two major distinct populations of put2D cells with one subpopulation exhibiting wild-type MitoSOX
fluorescence and another subpopulation producing enhanced fluorescence. Overall, the put2D mutant generated a significant increase in mean
fluorescence intensity of oxidized MitoSOX relative to the wild-type or complemented put2D + PUT2 strains (Figure S6). Unstained C. neoformans
cells were used as a negative control.
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of various organs at the endpoint of the experiment. Despite
showing no sign of disease at 50 days post infection, the
put2D-infected mice had a low number of CFUs in 9 of 10
tested lung samples and an even lower number of CFUs in 3
of 10 tested brain samples when selected on YPD supple-
mented with chloramphenicol. These CFUs were confirmed
to express resistance to G418 and were unable to utilize
proline as a nitrogen source, consistent with C. neoformans
put2::NEO cells being isolated from the mice. No cells were
detected in the liver or spleen of each of these 10 mice.
Thus, the majority of the killed put2D-inoculated mice did
not clear the cryptococcal infection; dormant-lying put2D
cells were primarily located in the lungs, the initial site of
infection. Nevertheless, compared to the robust proliferation
and widespread dissemination characteristic of a typical
wild-type H99 infection (Ormerod et al. 2013), the put2D
mutant is attenuated in these virulence capacities.
Discussion
C. neoformans has emerged as one of the most medically
important pathogens of the immunocompromised population
(Heitman 2010). To establish infection in a host, C. neoformans
needs to sense and adapt to low-nitrogen and carbon con-
centrations in the human lungs, brain, and other anatomical
sites. The multifunctional amino acid, proline, can act as
a nitrogen or carbon source for C. neoformans and is a poten-
tial source of nutrients during infection. For this to occur,
proline needs to be degraded into the more usable glutamate
that serves as a nitrogen donor for all other cellular nitrogen-
containing compounds (for example, amino acid biosynthesis),
or it can be converted to a-ketoglutarate by NAD-dependent
glutamate dehydrogenase that feeds into the Krebs/TCA cycle
for energy generation (Cooper 1982; Magasanik 1992).
The proline oxidase gene duplication that occurred millions
of years ago has been retained in both C. neoformans and
C. gattii. From an evolutionary perspective, this implies that
the selective pressure that Cryptococcus faces in the environ-
ment or during infection may have resulted in the retention
of both paralogs. Such an advantage usually increases the
overall fitness of an organism and has previously been de-
scribed in the model plant A. thaliana where two functional
proline dehydrogenases with nonredundant but partially
overlapping functions exist; ProDH1 is the main proline uti-
lization enzyme while ProDH2 is believed to play a role in
proline homeostasis under salt stress (Funck et al. 2010). In
C. neoformans, Put5 is the major proline oxidase responsible
for proline assimilation as well as for protection against cer-
tain oxidative and nitrosative stresses. Sensitivity of microor-
ganisms to the toxic activity of oxidants is of particular
importance, as one of the primary mechanisms of host defense
against microbial infection is oxidative burst. Regardless of the
abated nutrient acquisition and stress-sensitive phenotypes of
the put5D mutant in vitro, Put5 is dispensable for virulence
in vivo. This suggests that, in the absence of proline catab-
olism, other nitrogen and carbon sources can still be readily
acquired by C. neoformans within the host and that the activ-
ity of other existing stress response pathways of C. neoformans
is sufficient to confer protection against oxidative and nitro-
sative insults by host immune cells.
The role of the other proline oxidase paralog, PUT1, remains
ambiguous, and our attempted cross-species complementation
experiment failed to provide any insights into its enzymatic
functionality. The failure of both the C. neoformans PUT1
and PUT5 cDNA to complement the S. cerevisiae put1D strain
could be due to multiple factors, including codon usage bias
or divergence of the C. neoformans proline oxidases’ mitochon-
drial targeting signal peptides, resulting in incorrect subcellular
localization of the expressed proteins. While we created fusion
genes to engineer the S. cerevisiae PUT1 promotor and ter-
minator sequences to flank the C. neoformans PUT1 and PUT5
ORFs, the predicted mitochondrial transit peptide of S. cer-
evisiae Put1 was not incorporated into the N terminus of
C. neoformans Put1 or Put5 as the exchange of sequences
within an ORF may potentially interfere with the function-
ality test. Therefore, it remains open to speculation why the
native C. neoformans proline oxidase genes do not enable the
expression of sufficient amounts of active and/or correctly
targeted protein in S. cerevisiae, whereas the C. neoformans
P5C dehydrogenase gene produced a functional protein with
its native mitochondrial transit peptide.
C. neoformans PUT2-encoded P5C dehydrogenase is the
second enzyme of the proline degradation pathway that is
required for proline utilization as well as for control of mi-
tochondrial ROS production. All aerobic organisms generate
Figure 6 P5C dehydrogenase is needed for optimal growth at high tem-
perature and for optimal production of melanin. (A) Tenfold spot dilution
assays on YPD medium demonstrated that the put2D mutant exhibited
a slightly slower growth rate compared to wild type at 30, and this
growth defect was exacerbated at 37. (B) Tenfold spot dilution assays
on L-DOPA medium showed that the put2Dmutant produced slightly less
melanin than wild type at 30 and that this melanization defect was
exacerbated at 37.
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ROS as metabolic by-products primarily through aerobic res-
piration; ROS can damage DNA, proteins, and lipids, caus-
ing cytotoxicity. Multiple lines of evidence suggest that ROS
can also regulate apoptosis, a morphologically distinct form
of programmed cell death. In fact, a growing list of fungi
have been demonstrated to exhibit stress-induced cell death
such as in the model ascomycetes S. cerevisiae and A. nidulans,
as well as in the fungal pathogens Candida albicans, Colleto-
trichum trifolii, and C. neoformans (Madeo et al. 1997; Cheng
et al. 2003; Phillips et al. 2003; Chen and Dickman 2005;
Ikeda and Sawamura 2008; Semighini et al. 2011).
In animals, plants, and probably in the fungus C. neofor-
mans (as we have suggestive evidence here), impairment of
P5C dehydrogenase activity that causes intense P5C-proline
cycling or proline oxidase overexpression leads to ROS ac-
cumulation and induction of apoptosis in cells (Maxwell and
Davis 2000; Donald et al. 2001; Yoon et al. 2004; Phang
et al. 2008; Miller et al. 2009). In fact, the proline oxidase
gene is a target of the pro-apoptotic and tumor suppressor
protein p53 in humans (Polyak et al. 1997). While definitive
proof underlying the mechanism of ROS accumulation is
lacking for most proline oxidases, mounting evidence points
to the ability of the enzyme to load electrons into the mtETC
or directly into O2, causing elevated production of superox-
ide ions. P5C dehydrogenase therefore plays a vital role in
eukaryotes by irreversibly removing P5C from potential P5C-
proline cycling, resulting in an overall reduction of ROS pro-
duction from electron runoff.
Interestingly, certain prokaryotes have evolved strategies
to specifically avoid P5C/GSA accumulation by coupling
proline oxidase and P5C dehydrogenase activities. For exam-
ple, in bacterial species such as Bradyrhizobium japonicum
and Helicobacter pylori, the proline catabolic enzymatic activ-
ities are fused into a unique bifunctional enzyme to channel
the reaction intermediate and thus prevent the release of
P5C/GSA (Krishnan and Becker 2006). In plants lacking
P5C dehydrogenase, the inability to oxidize P5C to glutamate
and, in turn, to a-ketoglutarate may also cause a reduction in
mitochondrial NADPH production, which can affect the re-
generation of reduced glutathione by NADPH-dependent
glutathione reductase and slow down the ascorbate/gluta-
thione cycle, leading to enhanced mitochondrial ROS levels
(Moller 2001). In C. neoformans, P5C dehydrogenase is ad-
ditionally required for proper expression of the major virulence
factors. Accordingly, yeast mutants lacking P5C dehydrogenase
are profoundly attenuated in virulence during a murine inha-
lation model of cryptococcosis. To our knowledge, this is the
first report recognizing P5C dehydrogenase as an important
mediator that enables pathogenesis of a microorganism.
In conclusion, proline oxidases have been shown to
potentiate ROS-mediated cell death in various kingdoms of
life, and this paradigm likely extends to the basidiomycete
pathogen C. neoformans. The role of P5C dehydrogenase in
suppressing proline oxidase–FAD complex activity that, in
turn, controls apoptosis might therefore be an underappreci-
ated ancient function of the enzyme that has been conserved
throughout evolution.
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Figure S1   The proline catabolism-associated genes are located in a cluster on a single chromosome in A. 
nidulans, however in S. cerevisiae and C. neoformans, the genes are unlinked and located on different 
chromosomes. prnA encodes the pathway-specific transcription factor of prn expression, prnD, PUT1 and PUT5 
encode proline oxidase, prnB and PUT4 encode the proline-specific permease, while prnC and PUT2 encode P5C 
dehydrogenase. The multiple candidates of proline permease-encoding genes in C. neoformans are designated 
using the Broad Institute annotations. 
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Figure S2   ClustalW multiple sequence alignment of C. neoformans Put1 and Put5. Identical amino acid residues 
are shaded dark grey while similar residues are shaded light grey. 
4 SI I. M. R. C. Lee et al.  
 
Figure S3   Cross-species complementation using C. neoformans PUT2 partially restored the proline utilization 
ability of the S. cerevisiae put2∆ mutant. Tenfold spot dilution assays for nitrogen source utilization showed that 
C. neoformans PUT2 complemented the S. cerevisiae put2∆ mutant’s proline assimilation defect, albeit to a 
poorer extent than an S. cerevisiae PUT2. On the other hand, neither C. neoformans PUT1 or PUT5 restored the 
proline utilization defect of the S. cerevisiae put1∆ strain. 
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Figure S4   Restoration of proline utilization ability upon the re-introduction of PUT5, PUT1 PUT5 and PUT2 into 
the put5∆, double put1∆ put5∆ and put2∆ mutants, respectively. Tenfold spot dilution assays for nitrogen or 
nitrogen and carbon source utilization showed that the complemented put5∆ + PUT5, put1∆ put5∆ + PUT1 PUT5 
and put2∆ + PUT2 strains exhibited wild-type growth on YNB supplemented with 10 mM proline (with or without 
2% glucose as a carbon source). 
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Figure S5   Tolerance against the oxidative stressor menadione and nitrosative stressor sodium nitrite is 
equivalent between the wild-type and proline oxidase(s) deletion mutant strains. Wild-type H99, put1∆, put5∆ 
and double put1∆ put5∆ strains were grown in YNB [proline and glutamate (10 mM each)] supplemented with 
(A) 0 – 0.003 mM menadione, or (B) 0 – 3 mM sodium nitrite. All strains displayed relatively similar growth 
percentage relative to the unstressed control when subjected to these individual stressors. Growth percentage 
relative to unstressed control is defined by dividing each stressed strain’s growth in OD600 with the same strain’s 
growth in OD600 when unstressed. Error bars represent standard errors across three biological replicates. 
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Figure S6   Restoration of mitochondrial superoxide ions to wild-type levels upon the re-introduction of PUT2 into 
the put2∆ mutant. Wild-type H99, put2∆ and complemented put2∆ + PUT2 strains were briefly subjected to 
culture in YNB supplemented with 10 mM proline, stained with MitoSOX, and the accumulation of ROS in the 
mitochondria was assessed by flow cytometry. Bar chart presented as average ± standard error of triplicate 
experiments showed that the put2∆ mutant had significantly enhanced ∆ mean fluorescence intensity (∆ MFI) of 
oxidized MitoSOX relative to the wild-type or put2∆ + PUT2 strains (*** denotes P < 0.001). ∆ MFI is defined by 
subtracting the background MFI (unstained cells) from the MFI generated from MitoSOX stained cells. 
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Figure S7   None of the proline catabolic deletion mutants display a defect in mitochondrial membrane potential. 
Wild-type H99 and proline catabolic deletion mutant strains were briefly subjected to culture in YNB 
supplemented with 10 mM proline, stained with MitoTracker Red CMXRos, and cells viewed under a confocal 
microscope. The staining profile of the mutants was similar to that of wild-type showing accumulation of the 
fluorescence dye that is dependent on normal mitochondrial membrane permeability. Scale bar, 10 µm. 
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Figure S8   Restoration of virulence factor expression to wild-type levels upon the re-introduction of PUT2 into 
the put2∆ mutant. (A) Tenfold spot dilution assays on YPD medium demonstrated that the complemented put2∆ 
+ PUT2 strain exhibited wild-type growth at both 30 and 37°C. (B) Tenfold spot dilution assays on L-DOPA 
medium showed that the put2∆ + PUT2 strain produced equal amount of melanin as the wild-type strain at both 
30 and 37°C. 
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Table S1   Fungal strains used in this study 
Strain Genotype Original source 
H99 Cryptococcus neoformans MATα John Perfect 
EL13 H99 put1::NEO This study 
EL1 H99 put5::NEO This study 
EL9 H99 put1 put5::NEO  This study 
EL18 H99 put2::NEO This study 
EL22 H99 put1::NEO + PUT1 NAT This study 
EL20 H99 put5::NEO + PUT5 NAT This study 
EL21 H99 put1 put5::NEO + PUT1 PUT5 NAT This study 
EL23 H99 put2::NEO + PUT2 NAT This study 
BY4741 Saccharomyces cerevisiae MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Carrie Brachmann 
4099B7 BY4741 put1::KanMX Thermo Scientific 
1000H4 BY4741 put2::KanMX Thermo Scientific 
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Table S2   Primers used in this study 
Primer Purpose Sequence (5’-3’) 
UQ1070 Cn PUT1 qRT-PCR F AAAAGCTAAAGAGAACGACGTTGC 
UQ1071 Cn PUT1 qRT-PCR R TCTCACTCTTTGACTTTGGAGGTTT 
UQ1072 Cn PUT5 qRT-PCR F AGAAGGCTAAGGAGAACAACATCATT 
UQ1073 Cn PUT5 qRT-PCR R GTCCAGATCTCCTCCTTGGAAG 
UQ1074 Cn PUT2 qRT-PCR F TCATTAACGGTGAGGAGGTCAAG 
UQ1075 Cn PUT2 qRT-PCR R GCAAGAGCACCGTCAATGG 
UQ1300 Cn PUT1 deletion 5’ F / genomic DNA generation F CTGCCATGTACAATCCATAAT 
UQ1301 Cn PUT1 deletion 5’ R CTCTCCAGCTCACATCCTCGCAGCGCGATTTCGTTA 
UQ1302 Cn PUT1 deletion 3’ F TGTTAATACAGATAAACCGTTGGTTCAAGATACTTT 
UQ1303 Cn PUT1 deletion 3’ R / genomic DNA generation R TCTCTACATTACGCAACATGG 
UQ1304 Cn PUT1 deletion NEO F TAACGAAATCGCGCTGCGAGGATGTGAGCTGGAGAG 
UQ1305 Cn PUT1 deletion NEO R AAAGTATCTTGAACCAACGGTTTATCTGTATTAACA 
UQ1306 Cn PUT5 deletion 5’ F / genomic DNA generation F GCACGCCTTCCGAAGTGAAAG 
UQ1307 Cn PUT5 deletion 5’ R AGCTCACATCCTCGCAGCCGTTGTGGATCGTTGGTT 
UQ1308 Cn PUT5 deletion 3’ F TGTTAATACAGATAAACCAACGCTTAAGTGGAGATG 
UQ1309 Cn PUT5 deletion 3’ R / genomic DNA generation R CCTCGTTCGGCTAAAGCTGAC 
UQ1310 Cn PUT5 deletion NEO F CAACCAACGATCCACAACGGCTGCGAGGATGTGAGC 
UQ1311 Cn PUT5 deletion NEO R CATCTCCACTTAAGCGTTGGTTTATCTGTATTAACA 
UQ1312 Cn PUT2 deletion 5’ F / genomic DNA generation F CTCCGGTGTCCATTATTCCTA 
UQ1313 Cn PUT2 deletion 5’ R AGCTCACATCCTCGCAGCTTTTGGTAAGGATGAAGA 
UQ1314 Cn PUT2 deletion 3’ F TGTTAATACAGATAAACCGTCAATGAGAATAGAAAA 
UQ1315 Cn PUT2 deletion 3’ R / genomic DNA generation R TTCTGACGGTGCAGGCGAAGA 
UQ1316 Cn PUT2 deletion NEO F TCTTCATCCTTACCAAAAGCTGCGAGGATGTGAGCT 
UQ1317 Cn PUT2 deletion NEO R TTTTCTATTCTCATTGACGGTTTATCTGTATTAACA 
UQ1036 Universal deletion diagnostic (NEO marker specific) R TGTGGATGCTGGCGGAGGATA 
UQ1410 Cn PUT1 deletion diagnostic F AAACGCTTAAGTGGAGATGAA 
UQ1411 Cn PUT5 deletion diagnostic F AGGCTGAAGATGATGCGAGAA 
UQ1412 Cn PUT2 deletion diagnostic F CGATGACAGCCGATACCTACA 
UQ18 Sequencing (M13F pCR2.1-TOPO)  GTAAAACGACGGCCAG 
UQ19 Sequencing (M13R pCR2.1-TOPO) CAGGAAACAGCTATGAC 
UQ1594 Cn PUT1 genomic DNA sequencing GCTGTTCCGAAAGCTACCAGA 
UQ1595 Cn PUT1 genomic DNA sequencing CCTCCTCGTCCTCTGGTTCT 
UQ1596 Cn PUT1 genomic DNA sequencing TGGCGTTGGAAAAGAGCGGAG 
UQ1597 Cn PUT1 genomic DNA sequencing AAAGAGAACGAGTAGACACAT 
UQ1598 Cn PUT1 genomic DNA sequencing GCGTCATTTTCGGTACTCACA 
UQ1599 Cn PUT1 genomic DNA sequencing AACTTGATTTCATTCGTGCTC 
UQ1600 Cn PUT5 genomic DNA sequencing TCCCCTGCTATTTTTTATCGT 
UQ1601 Cn PUT5 genomic DNA sequencing GACAACTCCTTTTCGACAACC 
UQ1602 Cn PUT5 genomic DNA sequencing TGAAACCGTGGAGGGATGTAT 
UQ1603 Cn PUT5 genomic DNA sequencing GAAGGGCAAGTGGGATGACAT 
UQ1604 Cn PUT5 genomic DNA sequencing CATACAACACGCCGAAGCCAA 
UQ1605 Cn PUT5 genomic DNA sequencing GGCGGCAGAGATGAGGCGAGT 
UQ1606 Cn PUT2 genomic DNA sequencing TGGGTGTTGAAGATTTGGTCG 
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UQ1607 Cn PUT2 genomic DNA sequencing ACCAAAAATGTCTTCCCAACT 
UQ1608 Cn PUT2 genomic DNA sequencing GCCGAAATCGACGCTGCCGCT 
UQ1609 Cn PUT2 genomic DNA sequencing CCCAAAACCTCGACATCTACA 
UQ1610 Cn PUT2 genomic DNA sequencing TACGCTTTTCATTTCCGGCCT 
UQ1611 Cn PUT2 genomic DNA sequencing AGCGATTAGGGTTTACGACAT 
UQ1612 Cn PUT2 genomic DNA sequencing AGAAGAAGAAGTCAGTCAGCA 
UQ270  GenomeWalker adaptor GTAATACGACTCACTATAGGGC 
UQ271 GenomeWalker nested adaptor ACTATAGGGCACGCGTGGT 
UQ272 GenomeWalker 3’ gene specific CTGAATGGCGAATGAGCTTGAGCTTGG 
UQ273 GenomeWalker 3’ nested gene specific ATCAGATTGTCGTTTCCCGCCTTCAG 
UQ274 GenomeWalker 5’ gene specific GAGAGGCGGTTTGCGTATTGGCTAGAG 
UQ275 GenomeWalker 5’ nested gene specific ACGTCCGCAATGTGTTATTAAGTTGTC 
UQ1719 Sc PUT1 genomic DNA / promotor generation F AGACAAAACTGAGCGAGACAG 
UQ1756 Sc PUT1 genomic DNA / terminator generation R GCACCTACACTAACAGCTTCT 
UQ1729 Sc PUT2 genomic DNA / promotor generation F TCACCGCATCGTTCAACTGTC 
UQ1760 Sc PUT2 genomic DNA / terminator generation R TGCAATGCCAAAAGTGTCTGT 
UQ1720 Cn PUT1 cDNA generation F  GGCATCCCATCCATACAACCTCTAGATTTTAGACA 
UQ1761 Cn PUT1 cDNA generation R  GACCAAAGTATCTTGAACCAA 
UQ1725 Cn PUT5 cDNA generation F  CACTAACGCACGCTAGAAATGTCAGCAATCCGACC 
UQ1762 Cn PUT5 cDNA generation R  TTAATCAGAGCCTCCAAAGAA 
UQ1730 Cn PUT2 cDNA generation F  AATTCACAGGAATTGCTTTTCTTTCTTCATCCTTA 
UQ1763 Cn PUT2 cDNA generation R  GATACGAGACATTATGTATGA 
UQ1814 Sc PUT1 promotor generation R for Cn PUT1 GCGGGAGGCACGCATTTCTAGCGTGCGTTAGTGTT 
UQ1758 Sc PUT1 promotor generation R for Cn PUT5 GGTCGGATTGCTGACATTTCTAGCGTGCGTTAGTG 
UQ1815 Sc PUT1 terminator generation F for Cn PUT1 CAAGATACTTTGGTCGAGGACTATAATATATACTC 
UQ1728 Sc PUT1 terminator generation F for Cn PUT5 AGATTCTTTGGAGGCTCTGATTAAGAGGACTATAA 
UQ1759 Sc PUT2 promotor generation R for Cn PUT2 TAAGGATGAAGAAAGAAAAGCAATTCCTGTGAATT 
UQ1816 Sc PUT2 terminator generation F for Cn PUT2 ATGTCTCGTATCAAAAATTTTTGTGGAATAGAACC 
UQ1770 Sc PUT1 genomic DNA sequencing CAGCTATGACCATGATTACGC 
UQ1769 Sc PUT1 genomic DNA sequencing GTCGCTACACACGTACATTGC 
UQ1818 Sc PUT1 genomic DNA sequencing AGTGAAGGTGAAAGCGAGGCA 
UQ1771 Sc PUT1 genomic DNA sequencing CGCCACTCATCAATTGTTTAT 
UQ1772 Sc PUT1 genomic DNA sequencing TCCAAAAGCTCCTTATTAGTT 
UQ1819 Sc PUT1 genomic DNA sequencing ACAACATCCTACTGCCCAATA 
UQ1773 Sc PUT1 genomic DNA sequencing ATGAATATAAGCACCACGAAC 
UQ1774 Sc PUT1 genomic DNA sequencing TCACTTGGTTGTCGCCTCTCA 
UQ1775 Sc PUT1 genomic DNA sequencing AAGATTTCCGTTTGAACTAGC 
UQ1776 Sc PUT2 genomic DNA sequencing ATGACCATGATTACGCCAAGC 
UQ1777 Sc PUT2 genomic DNA sequencing AAGATGGCAAGGGATATGTTT 
UQ1778 Sc PUT2 genomic DNA sequencing CATATCCCTTGCCATCTTCAC 
UQ1820 Sc PUT2 genomic DNA sequencing GACTTTCTCAGTAGGGGTAGA 
UQ1779 Sc PUT2 genomic DNA sequencing AAACCTTCACAAACCGCTGCC 
UQ 1821 Sc PUT2 genomic DNA sequencing CCATGGATATACTTCTGGAGT 
UQ1780 Sc PUT2 genomic DNA sequencing AGCCTTATCGTCGGTACCACT 
UQ1822 Sc PUT2 genomic DNA sequencing GCCACTTTGTATTTTGCCATA 
UQ1781 Sc PUT2 genomic DNA sequencing GGCGAGCAGTCCCTGACAAGA 
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UQ1782 Sc PUT2 genomic DNA sequencing TTCCACATGGCAAAGAATAAA 
UQ1595 Cn PUT1 cDNA sequencing CCTCCTCGTCCTCTGGTTCT 
UQ1596 Cn PUT1 cDNA sequencing TGGCGTTGGAAAAGAGCGGAG 
UQ1598 Cn PUT1 cDNA sequencing GCGTCATTTTCGGTACTCACA 
UQ1601 Cn PUT5 cDNA sequencing GACAACTCCTTTTCGACAACC 
UQ1602 Cn PUT5 cDNA sequencing TGAAACCGTGGAGGGATGTAT 
UQ1603 Cn PUT5 cDNA sequencing GAAGGGCAAGTGGGATGACAT 
UQ1604 Cn PUT5 cDNA sequencing CATACAACACGCCGAAGCCAA 
UQ1605 Cn PUT5 cDNA sequencing GGCGGCAGAGATGAGGCGAGT 
UQ1607 Cn PUT2 cDNA sequencing ACCAAAAATGTCTTCCCAACT 
UQ1608 Cn PUT2 cDNA sequencing GCCGAAATCGACGCTGCCGCT 
UQ1609 Cn PUT2 cDNA sequencing CCCAAAACCTCGACATCTACA 
UQ1611 Cn PUT2 cDNA sequencing AGCGATTAGGGTTTACGACAT 
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Table S3   Plasmids used in this study 
Plasmid  Detail Original source 
pJAF1 NEO selectable marker in pCR2.1-TOPO  James Fraser 
pCH233 NAT selectable marker in pCR2.1-TOPO  Christina Hull 
pELYL1 H99 PUT1 genomic DNA including promotor and terminator in pCR2.1-TOPO  This study 
pELYL2 H99 PUT5 genomic DNA including promotor and terminator in pCR2.1-TOPO  This study 
pELYL4 H99 PUT1 PUT5 genomic DNA including promotor and terminator in pCR2.1-
TOPO  
This study 
pELYL3 H99 PUT2 genomic DNA including promotor and terminator in pCR2.1-TOPO  This study 
pELYL5 H99 PUT1 genomic DNA including promotor and terminator in pCH233  This study 
pELYL6 H99 PUT5 genomic DNA including promotor and terminator in pCH233  This study 
pELYL8 H99 PUT1 PUT5 genomic DNA including promotor and terminator in pCH233  This study 
pELYL7 H99 PUT2 genomic DNA including promotor and terminator in pCH233  This study 
YCplac111 YC-type (centromeric) shuttle vector with LEU2 and ampR markers Daniel Gietz 
pEWC38 H99 PUT1 cDNA in pCR2.1-TOPO This study 
pEWC39 H99 PUT5 cDNA in pCR2.1-TOPO This study 
pEWC37 H99 PUT2 cDNA in pCR2.1-TOPO This study 
pEWC45 H99 PUT1 cDNA flanked by BY4741 PUT1 promotor and terminator in 
pCR2.1-TOPO 
This study 
pEWC46 H99 PUT5 cDNA flanked by BY4741 PUT1 promotor and terminator in 
pCR2.1-TOPO 
This study 
pEWC40 H99 PUT2 cDNA flanked by BY4741 PUT2 promotor and terminator in 
pCR2.1-TOPO 
This study 
pEWC35 BY4741 PUT1 genomic DNA including promotor and terminator in pCR2.1-
TOPO 
This study 
pEWC36 BY4741 PUT2 genomic DNA including promotor and terminator in pCR2.1-
TOPO 
This study 
pEWC48 H99 PUT1 cDNA flanked by BY4741 PUT1 promotor and terminator in 
YCplac111 
This study 
pEWC49 H99 PUT5 cDNA flanked by BY4741 PUT1 promotor and terminator in 
YCplac111 
This study 
pEWC47 H99 PUT2 cDNA flanked by BY4741 PUT2 promotor and terminator in 
YCplac111 
This study 
pEWC50 BY4741 PUT1 genomic DNA including promotor and terminator in 
YCplac111 
This study 
pEWC51 BY4741 PUT2 genomic DNA including promotor and terminator in 
YCplac111 
This study 
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 6.1 Preface 
Uric acid catabolism in Cryptococcus neoformans is largely unexplored but multiple 
lines of evidence, some of which have been discussed in Chapter 3, suggest it plays a 
role in survival in the environment and virulence during infection. C. neoformans is 
commonly isolated from purine-rich pigeon droppings, and the majority of the 
nitrogen content is in the form of uric acid, the particulate white matter seen in the 
excreta. Uric acid induces capsule formation that protects the fungus from engulfment 
by the environmental predator amoebae as well as immune phagocytes. Assimilation 
of uric acid necessitates several enzymes including urease, which is also known to 
promote C. neoformans invasion of the host central nervous system. In humans, uric 
acid is the end product of purine metabolism due to nonsense mutations in the uricase 
gene, and uric acid released from dying cells alerts the immune system to the presence 
of invading microorganisms and promotes inflammation. Degradation of uric acid 
therefore not only serves as a prime candidate for a nitrogen source used during 
infection, but may also represent a method to help the pathogen modulate host 
immune response. This chapter aims to develop an understanding of how uric acid is 
metabolised by C. neoformans, how its utilisation is regulated, and whether the 
enzymes in this catabolic pathway are undiscovered virulence factors themselves. 
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Introduction
Purine catabolism is generally well conserved throughout
organisms ranging from animals and fungi to plants and bacteria.
While the degradation of purines to uric acid1 is common to all
kingdoms of life, the resulting uric acid can either be excreted or
further degraded in the peroxisomes by active uric acid catabolic
enzymes (Figure 1). The various nitrogenous end products in
different organisms are a result of the successive loss-of-function
mutations in urate oxidase (also known as uricase), allantoinase
and allantoicase during evolution. For instance, humans and apes
share the inability to breakdown uric acid with Dalmatian dogs,
birds, reptiles and insects [1,2]. As uric acid is a potent antioxidant
in the human blood plasma and protects cells from damage by
scavenging reactive oxygen species, it has been proposed that the
loss of urate oxidase may have been selected for due to it
promoting longevity [3]. Despite these protective advantages, uric
acid is poorly soluble in the serum and can precipitate to cause
ailments such as gout or urate kidney stones [4].
Until recently, the conversion of uric acid to allantoin had long
been thought to involve a single step catalyzed by urate oxidase
[2]. However, production of allantoin is in fact preceded by two
additional distinct unstable intermediates: 5-hydroxyisourate
(HIU)2 and 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline
(OHCU)3. HIU can spontaneously decompose to OHCU and
subsequently racemic allantoin at a slow, non-enzymatic rate in
vitro [5,6,7]. However, only dextrorotatory allantoin, (S)-allantoin4,
is usually found in living cells [2]. The two additional biological
enzymes, HIU hydrolase and OHCU decarboxylase, are respon-
sible for the quicker in vivo hydrolysis of HIU to OHCU and the
decarboxylation of OHCU to (S)-allantoin, respectively [8,9].
Most mammals, except higher primates, have lost both allantoi-
nase and allantoicase and hence excrete allantoin as the end
product.
Some organisms however, do have the ability to further
catabolize (S)-allantoin to exploit its stored nitrogen, carbon and
energy. Allantoinase catalyzes the hydrolysis of (S)-allantoin to
allantoate5, allantoicase catalyzes the degradation of allantoate to
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urea6 and ureidoglycolate7, while ureidoglycolate hydrolase
degrades ureidoglycolate to glyoxylate8 and another molecule of
urea. In most amphibians and fishes, purine degradation proceeds
to urea and glyoxylate as the end products [10].
Interestingly, in plants and in some bacteria (enterobacteria and
Bacillus spp.), an alternative allantoate metabolic route also exists:
apart from the urea-releasing route, the other results in the
production of ammonia and carbon dioxide
[2,11,12,13,14,15,16,17,18,19]. Allantoate deiminase is responsi-
ble for the catalysis of allantoate for the ammonia-releasing route,
while the urea-releasing route necessitates subsequent urea
hydrolytic activity by urease or urea amidolyase for full catabolism
to ammonia9. Most plants, bacteria and fungi (an exception occurs
in the model yeast Saccharomyces cerevisiae where the pathway does
not begin until the step of allantoin degradation) generally possess
all the necessary nitrogen catabolic enzymes to completely degrade
uric acid to ammonia. Hence, ammonium is the most readily
assimilated nitrogen source that is preferentially utilized by most
bacteria and fungi in order to conserve energy. In the presence of
ammonium, the expression of permease and catabolic enzyme-
encoding genes required to assimilate non-preferred nitrogen
sources is usually repressed, a regulatory mechanism known as
nitrogen catabolite/metabolite repression [20,21,22].
Understanding the uric acid degradation pathway in Cryptococcus
neoformans, a fungal pathogen that commonly causes fatal
meningitis in the immunocompromised population, is clinically
relevant [23]. The C. neoformans primary ecological niche is purine-
rich pigeon droppings, and the majority of the nitrogen present is
Figure 1. The end product of purine metabolism varies from species to species. While degradation of purines to uric acid is generally
conserved among organisms, the end product of uric acid catabolism varies among taxa often due to the loss of functional catabolic enzymes in the
pathway.
doi:10.1371/journal.pone.0064292.g001
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in the form of uric acid, with the rest consisting primarily of
xanthine, urea and creatinine [24]. In addition, the antiphagocytic
polysaccharide capsule is a well-known virulence factor that is
induced in the presence of uric acid as the sole nitrogen source
[25,26]. Assimilation of uric acid necessitates numerous catabolic
enzymes including another well-established virulence factor,
urease, which plays a role in central nervous system invasion
during host infection [27,28,29]. Incidentally, both uric acid and
urea are common metabolites found at high concentration in the
human blood. In fact, necrotic mammalian cells release uric acid
as a danger signal to activate both innate and adaptive immune
effectors including neutrophils, cytotoxic T-cell and antibody
immunity [30].
The association between uric acid availability in the niches
occupied by C. neoformans and how its utilization influences
virulence factor expression and potential modulation of host
immune response, prompted us to characterize the uric acid
catabolic enzymes. Every year, up to a million immunocompro-
mised individuals are infected with C. neoformans, two-thirds of
whom will die [31]. Due to the poor outcomes associated with the
treatment of cryptococcosis, the cost of treatment and the toxicity
of the pharmaceutical agents currently available, it is imperative
that we identify new therapeutic agents to help combat this
disease. Rational drug design was pioneered in the purine
metabolic pathway over half a century ago, and has been the
paradigm for targeted drug discovery since the development of
allopurinol and thioguanine for the treatment of gout and
leukaemia, respectively [32]. Humans have successively lost the
uric acid enzymes during species evolution; should the C.
neoformans uric acid degradation pathway regulate pathogenesis
and provide a viable drug target, there exist over 50 years worth of
literature describing innumerable compounds designed to modu-
late the activity of these enzymes. In this study, we genetically and
phenotypically characterized the functions of all six of the C.
neoformans uric acid catabolic enzyme-encoding genes in relation to
nitrogen source utilization and virulence-associated mechanisms.
Materials and Methods
Strains and media
All fungal strains used in this study are listed in Table S1, and
were grown in YPD (1% yeast extract, 2% Bacto-peptone, 2%
glucose) or YNB (0.45% yeast nitrogen base w/o amino acids and
ammonium sulfate, 2% glucose, 10 mM nitrogen source) unless
specified otherwise. C. neoformans biolistic transformants were
selected on YPD medium supplemented with 200 mg/mL G418
(Sigma) or 100 mg/mL nourseothricin (Werner BioAgents). The
12% (wt/vol) pigeon guano medium was prepared as described
previously, with the exclusion of the filtration step to ensure that
insoluble nitrogen sources such as uric acid would not be removed
[33]. V8 (5% V8 juice, 3 mM KH2PO4, 0.1% myo-Inositol, 4%
Bacto-agar) and Murashige-Skoog (MS) mating media (PhytoTech-
nology Laboratories) at pH 5.0, and L-3,4-dihydroxyphenylala-
nine (L-DOPA) medium at pH 5.6, were prepared as described
previously [34,35,36,37]. Escherichia coli Mach-1 cells served as the
host strain for transformation and propagation of all plasmids
using lysogeny broth supplemented with either 100 mg/mL
ampicillin (Sigma) or 50 mg/mL kanamycin (Sigma) [38].
Caenorhabditis elegans strain N2 was maintained at 15uC and
propagated on its normal laboratory food source E. coli OP50 cells
[39,40,41]. Nematode growth medium (NGM) was prepared as
described previously [39].
Bioinformatic analyses
C. neoformans genes were identified using annotation from the
H99 genome sequence from the Broad Institute (http://www.
broadinstitute.org/annotation/genome/
cryptococcus_neoformans/MultiHome.html). Gene annotations
from the Broad are designated by their nomenclature
‘‘CNAG_#####.#’’. Sequence analyses were performed using
BLAST and MacVector 9.5 (MacVector Inc, Cary NC) [42].
Sequence alignments were created using ClustalW v1.4 within
MacVector [43]. Sequence traces generated at the Australian
Genome Research Facility (Brisbane, Queensland) were analyzed
using Sequencher 4.7 (Gene Codes Corporation, Ann Arbor MI).
Putative peroxisomal localization signals were examined using
Target Signal Predictor Tool (http://www.peroxisomedb.org/
Target_signal.php).
Construction and screening of library for C. neoformans
uric acid catabolism defective mutants
An Agrobacterium-mediated mutagenesis library of C. neoformans
H99 was created as described previously [44]. The majority of
transformants harbored a single copy of randomly integrated T-
DNA and was mitotically stable. To identify genes involved in uric
acid catabolism, replica spotting of the insertional library
consisting of 12,000 clones was carried out on YNB supplemented
with uric acid or ammonium (10 mM each nitrogen source).
Mutants that grew on ammonium but failed to grow on uric acid-
containing medium were selected for further analysis. T-DNA
insertion site was mapped using GenomeWalker according to the
manufacturer’s instructions (Clontech). BLAST analysis of these
sequences was performed to reveal which loci were affected.
Construction and complementation of C. neoformans
mutant strains
All primers and plasmids used in this study are listed in
Table S2 and S3, respectively. Gene deletion mutants were
created using overlap PCR and biolistic transformation as
described previously [45]. For example, to construct the uro1D
mutant strain in the H99 background, the 1,389 bp URO1
(CNAG_04307.2) coding sequence was replaced with the neomy-
cin phosphotransferase II-encoding selectable marker NEO using a
construct created by overlap PCR combining a ,1 kb fragment
upstream the URO1 start codon, the NEO marker and a ,1 kb
fragment downstream the URO1 stop codon. Strain H99 genomic
DNA and plasmid pJAF1 were used as PCR templates [46]. The
construct was transformed into C. neoformans cells via particle
bombardment and transformants were selected on YPD plates
supplemented with G418. Deletion of URO1 was confirmed by
diagnostic PCR and Southern blot [47]. To complement the uro1D
mutant, the URO1 gene including,1 kb promoter and terminator
was amplified from genomic DNA using high fidelity PCR, cloned
into pCR2.1-TOPO (Invitrogen) to give pIRL5, and sequenced.
The URO1 fragment of pIRL5 was then subcloned into pCH233,
creating the complementation construct pIRL13. pIRL13 was
subsequently linearized and biolistically transformed into the uro1D
mutant. Stable transformants were selected on YPD supplemented
with nourseothricin and complemented strains containing a single
copy of the wild-type URO1 gene were identified by Southern blot.
Mating assays
Mating assays were conducted as described previously [33].
Briefly, strains were suspended in PBS either alone or mixed in
equal proportions with a strain of the opposite mating-type (MAT).
Droplets (5 mL) were then spotted onto V8, MS or pigeon guano
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medium [33,35,37]. Plates were incubated at room temperature in
the dark for 1 week and assessed by light microscopy for the
formation of filaments and basidia.
Capsule assays
Strains were inoculated into RPMI supplemented with 10%
fetal calf serum (Gibco) and incubated at 37uC for 2 days. To
visualize capsule, cells were stained with India ink (Becton
Dickinson) and observed under a ZEISS Axioplan 2 epifluor-
escent/light microscope. Pictures were taken with an Axiocam
greyscale digital camera using the AxioVision AC imaging
software.
Growth and melanization assays
Starter C. neoformans cultures were prepared by growth in YPD
at 30uC overnight with shaking, diluted to OD595nm = 0.05 in
water, then further diluted tenfold in series. Each diluted cell
suspension was then spotted onto YPD, YNB supplemented with
the specified nitrogen source or L-DOPA agar. Results were
imaged after 2–3 days incubation at 30uC (nitrogen utilization
assays), 30 and 37uC (melanization assays), or 37–39uC (high
temperature growth assays).
C. elegans killing assays
Starter cultures of C. neoformans strains were prepared by growth
in YPD at 30uC overnight with shaking. Overnight cultures
(10 mL) were spread onto 35 mm brain-heart infusion (BHI)
(Becton Dickinson) agar plates, and incubated at 25uC overnight.
Approximately 50 young adult C. elegans worms were then
transferred from a lawn of E. coli OP50 on NGM to BHI
medium-grown C. neoformans [48]. Plates were incubated at 25uC
and worms examined for viability at 24-hr intervals using a
dissecting microscope, with worms that did not respond to a touch
with a platinum wire pick considered dead. Each experimental
Figure 2. Predicted pathway of uric acid degradation in C. neoformans. While the metabolic pathway of purine degradation is present in
bacteria, fungi, plants and animals, there is hidden complexity between species. In addition to species in which only part of the pathway is present,
these variations include at least three examples of convergent evolution (conversion of xanthine to uric acid, allantoin to allantoate, and urea to
ammonia), offshoots of the pathway that are only present in some species (allantoin racemase, ureidoglycine production and hydrolysis) as well as
points at which spontaneous conversion occur without the need for enzyme activity (dashed arrows). Steps predicted to be absent from C.
neoformans are opaque.
doi:10.1371/journal.pone.0064292.g002
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condition was performed in triplicate. Survival was plotted against
time, and P values were calculated by plotting a Kaplan-Meier
survival curve and performing a log-rank (Mantel-Cox) test using
Graphpad Prism Version 5.0c. P values of ,0.05 were considered
statistically significant.
Murine inhalation model of cryptococcosis
For murine virulence assays, C. neoformans were used to infect 6-
week old female BALB/c mice by nasal inhalation [27]. For every
tested strain, ten mice were each inoculated with a 50 mL drop
containing 56105 cells. Mice were weighed before infection and
daily thereafter; animals were sacrificed using CO2 inhalation
once their body weight had decreased to 80% of the pre-infection
weight. Survival was plotted against time, and P values were
calculated by plotting a Kaplan-Meier survival curve and
performing a log-rank (Mantel-Cox) test using Graphpad Prism
Version 5.0c. P values of ,0.05 were considered statistically
significant.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes by the National Health
and Medical Research Council. The protocol was approved by the
Molecular Biosciences Animal Ethics Committee of The Univer-
sity of Queensland (AEC approval number: SCMB/008/11/UQ/
Figure 3. Nitrogen assimilation phenotypes of the C. neoformans uric acid catabolic deletion mutants. (A) Based on the enzymatic
activity of homologs in other systems, inactivation of each respective catabolic enzyme (in red) is predicted to disrupt the ability of C. neoformans to
utilize one or more pathway intermediates as the sole nitrogen source. (B) Ten-fold spot dilution assays on YNB supplemented with 10 mM uric acid
or its derivatives revealed that the uro1D, uro2D, uro3D, dal1D, dal2,3,3D and ure1D mutants showed a correlation with the anticipated nitrogen
utilization abilities.
doi:10.1371/journal.pone.0064292.g003
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NHMRC). Infection was performed under methoxyflurane
anaesthesia, and all efforts were made to minimize suffering
through adherence to the Guidelines to Promote the Wellbeing of
Animals Used for Scientific Purposes as put forward by the
National Health and Medical Research Council.
Results
Agrobacterium-mediated insertional mutagenesis reveals
several enzymes required for uric acid assimilation in C.
neoformans
Insertional mutagenesis is a powerful tool for identifying novel
genes and their functions, and the frequency of random
integration is very high if Agrobacterium tumefaciens-mediated
transformation is used. A T-DNA insertional library of C.
neoformans strain H99 was therefore created using this transking-
dom DNA delivery approach in an attempt to locate loci involved
in uric acid utilization. We replica spotted 12,000 purified
individual transformants onto minimal YNB medium supplement-
ed with uric acid or ammonium (control) as the sole nitrogen
source, and mapped the T-DNA insertion site of 8 disrupted
mutants that grew on ammonium but exhibited impaired growth
on uric acid (Table S4). Our sequence analysis revealed four
independent ORFs that play a role in uric acid catabolism. Three
of these genes were predicted to encode well-established catabolic
enzymes known in other systems to be necessary for uric acid
degradation (urate oxidase, allantoicase and urease), while one was
predicted to encode the less familiar HIU hydrolase only recently
proposed to be part of this pathway.
Bioinformatic analyses predict the complete uric acid
degradation pathway of C. neoformans
Using the existing knowledge of purine catabolism in model
ascomycetes, bioinformatic analyses were performed to complete
the entire predicted uric acid degradation pathway of the
basidiomycete C. neoformans. Protein sequences of characterized
Aspergillus nidulans or S. cerevisiae uric acid catabolic enzymes were
queried against the H99 genome using reciprocal BLASTp
searches. The candidate C. neoformans uric acid catabolic
enzyme-encoding genes identified were named: URO1
(CNAG_04307.2), URO2 (CNAG_06694.2), URO3
(CNAG_00639.2), DAL1 (CNAG_00934.2), DAL2,3,3
(CNAG_01108.2), and URE1 (CNAG_05540.2). Our previous
work has shown that the expression of at least two of these putative
catabolic genes, URO1 and DAL1, is inducible by the presence of
uric acid (pathway-specific induction) and repressible by the
presence of ammonium (nitrogen metabolite repression) [25].
The URO1 ORF is predicted to encode the urate oxidase
protein of 305 amino acid residues, and comparative analysis of
Uro1 with the A. nidulans homolog UaZ revealed 42% identity and
54% similarity (Figure S1). Importantly, the conserved N-terminus
of eukaryotic uricases that is critical for enzymatic activity is highly
similar between Uro1 and UaZ. The URO2 ORF is predicted to
encode the HIU hydrolase protein of 122 amino acids, and an
alignment with the A. nidulans homolog UaX revealed 32%
identity and 47% similarity (Figure S2). Both Uro2 and UaX
contain the conserved C-terminal tetrapeptide YRGS, a signature
of the thyroid hormone transporter transthyretin which probably
originated from a duplication of an ancestral HIU hydrolase gene
[49,50]. Additionally, both Uro2 and UaX show complete
conservation of all residues involved in the binding of the substrate
in characterized HIU hydrolases [50,51,52]. The URO3 ORF is
predicted to encode the OHCU decarboxylase protein of 204
residues, and an alignment with the A. nidulans homolog UaW
revealed 26% identity and 43% similarity (Figure S3). Notably,
peroxisomal targeting signals were not detected in Uro1, Uro2 and
Uro3 using Target Signal Predictor, providing no indication on
their subcellular localization. Thus, Uro1, Uro2 and Uro3 may
possibly rely on another unidentified peroxisomal targeting
sequence, as previously demonstrated in the A. nidulans glyoxylate
cycle enzyme isocitrate lyase (AcuD) that was shown to be
peroxisomal without any obvious targeting signal peptide [53].
URO1, URO2 and URO3 homologs are absent in S. cerevisiae,
however, the genes encoding proteins required to complete the
remaining steps of this pathway are arrayed in the largest
metabolic cluster known in yeast [54,55]. Allantoin degradation
is best studied in S. cerevisiae and genes in this DAL cluster include
DAL1 (allantoinase), DAL2 (allantoicase), DAL3 (ureidoglycolate
hydrolase), DAL4 (allantoin permease), DCG1 (allantoin racemase)
and DAL7 (malate synthase that reduces the toxicity of allantoin
catabolism via disposal of excess glyoxylate). Analysis of the H99
genome revealed that homologs of all these DAL genes are present
but are not clustered in a single chromosome.
The C. neoformans DAL1 ORF is predicted to encode the
allantoinase protein of 478 amino acids, and an alignment with the
S. cerevisiae homolog Dal1 revealed 43% identity and 59%
similarity (Figure S4). Interestingly, homology to S. cerevisiae
DAL2 and DAL3 in C. neoformans is represented by a single ORF
encoding a fusion allantoicase-ureidoglycolate hydrolase protein of
813 residues. In fact, closer inspection revealed two tandemly
arrayed Dal3 products (Figure S5A). The existence of this
plausible fusion event, presumably encoding a bifunctional
enzyme, was confirmed by the acquisition of cDNA that spanned
the entire ORF, disproving the possibility of gene clustering. This
phenomenon is only present in the phylum Basidiomycota and is not
observed in the Ascomycota or Zygomycota, indicating that the fusion
event occurred 500 million – 1 billion years ago [56]. An
alignment of C. neoformans Dal2 with the S. cerevisiae homolog
Dal2 revealed 36% identity and 52% similarity (Figure S5B). An
alignment of C. neoformans Dal3a (first paralog) with the S. cerevisiae
homolog Dal3 revealed 24% identity and 38% similarity, while C.
neoformans Dal3b (second paralog) showed 23% identity and 40%
similarity (Figure S5C).
Finally, the URE1 ORF that encodes the nickel-containing
urease of 833 amino acids is the only enzyme of the C. neoformans
uric acid degradation pathway that has been characterized, due to
its precedence in fungi and bacteria as an important pathogenic
factor [27,28,29]. An alignment of C. neoformans Ure1 with the A.
nidulans homolog UreB revealed 60% identity and 75% similarity
(Figure S6). In S. cerevisiae, urea utilization occurs via the DUR1,2-
encoded urea amidolyase which is absent in C. neoformans [57].
Altogether, based on random insertional mutagenic screen and
exhaustive bioinformatics, the predicted uric acid degradation
pathway of C. neoformans is deciphered (Figure 2).
Verification of the catabolic functions of the putative C.
neoformans uric acid enzymes using reverse genetics
To verify the functions of URO1, URO2, URO3, DAL1,
DAL2,3,3 and URE1, gene deletion mutants were created via
homologous recombination in strain H99. All the deletion strains
were viable and their growth appeared indistinguishable from
wild-type on rich YPD medium. Growth of the set of deletion
mutants was then tested on YNB medium supplemented with uric
acid and its pathway intermediates as the sole nitrogen source
(Figure 3). However, growth on HIU, OHCU and allantoate were
not tested either due to the compound’s chemical instability (HIU
and OHCU) or discontinued production by biotechnological
companies (allantoate).
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As expected, loss of each respective gene resulted in inability of
the mutant to retain the enzymatic activity required to degrade its
related purine derivative. The uro1D, uro2D and uro3D mutants
exhibited growth defects on uric acid, but displayed wild-type
growth on allantoin, urea and ammonium. While the uro2 and uro3
mutations resulted in impaired growth on uric acid after a two-day
incubation period, growth however catches up on further
incubation, consistent with the fact that spontaneous conversion
of HIU to OHCU and subsequently to allantoin can still occur at a
slow, non-enzymatic rate in the absence of HIU hydrolase or
OHCU decarboxylase (Figure S7). The dal1D and dal2,3,3D
mutants exhibited growth defects on uric acid and allantoin, but
displayed wild-type growth on urea and ammonium. Lastly, the
ure1D mutant exhibited growth defects on uric acid, allantoin and
urea, but displayed wild-type growth on ammonium. Comple-
mentation of all the uric acid catabolic deletion mutants restored
the wild-type nitrogen utilization phenotypes, verifying the
enzymatic functions of Uro1, Uro2, Uro3, Dal1, Dal2,3,3 and
Ure1 (Figure S8).
Figure 4. Uro1, Uro2, Uro3, Dal1, Dal2,3,3 and Ure1 are not required for C. neoformans initiation of mating. Filamentation assays on V8,
MS and pigeon guano (PG) medium showed that filament formation appeared indistinguishable between the crosses of H996KN99a and each of
the uric acid mutants6 KN99a. (A) Periphery of each individual colony. (B) Under higher magnification (6400).
doi:10.1371/journal.pone.0064292.g004
Uric Acid Degradation in Cryptococcus neoformans
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e64292
None of the C. neoformans uric acid catabolic enzymes
play a role in the initiation of mating
Uric acid-rich pigeon guano is a common source for infectious
propagules of C. neoformans and is postulated to play a key part in
transmission from the environment to a human host [23,24].
Quite recently, C. neoformans was shown to undergo robust sexual
reproduction on medium containing sterilized pigeon guano
extracts in the laboratory [33]. To address whether the uric acid
catabolic enzymes play a role in this sexual development, we
unilaterally crossed the wild-type and mutant strains of H99a
background with the opposite mating-type, KN99a, on V8, MS
and pigeon guano medium (Figure 4). Production of filaments and
basidia at the edges of the mating spots were indistinguishable
between the crosses of H996KN99a and each of the uric acid
mutants6KN99a on the various mating medium, suggesting that
the uric acid enzymes are not likely to play a role in the initiation
of morphological differentiation of the C. neoformans life cycle.
Further bilateral mating crosses may be performed to support this
conclusion.
None of the C. neoformans uric acid catabolic enzymes
contribute to the production of capsule or melanin, or
the ability to grow at high temperature
As the influence of uric acid on certain cryptococcal virulence
factor expression has been established, we investigated whether
any of the uric acid catabolic enzymes affect the production of the
antiphagocytic capsule or antioxidant melanin, and the ability to
grow at human body temperature (Figure 5) [25,26]. The uro1D,
uro2D, uro3D, dal1D, dal2,3,3D and ure1D mutants all displayed
these three classical virulence traits that were indistinguishable
from wild-type, suggesting that the uric acid enzymes are
dispensable for virulence factor expression when alternative
nitrogen sources are available to compensate for the lack of uric
acid utilization. This result reiterates the complex regulation of
virulence factor production that is influenced by multiple
physiological conditions.
HIU hydrolase activity is required for C. neoformans killing
of nematode worms
There have been many instances in the Cryptococcus literature
whereby various mutant strains show no reduction in traits
normally associated with virulence in vitro, yet significantly impact
pathogenicity in vivo [58,59]. C. neoformans presumably interacts
with C. elegans in the environment and killing of C. elegans by C.
neoformans has previously been validated as a model for studying
fungal pathogenesis [48]. We performed C. elegans virulence assays
using standard BHI medium to evaluate if any of the uric acid
catabolic enzymes contribute to C. neoformans pathogenesis
(Figure 6). Killing of C. elegans by the uro1D, uro3D, dal1D,
dal2,3,3D and ure1D strains was not significantly different to that
observed for the wild-type strain, indicating that urate oxidase,
OHCU decarboxylase, allantoinase allantoicase-ureidoglycolate
hydrolase and urease are not required for C. neoformans-mediated
killing of invertebrate worms. However, the uro2D mutant killed C.
elegans slightly less efficient than the wild-type strain (WT vs uro2D,
P,0.0001), implicating HIU hydrolase in C. neoformans virulence.
The median survival of the worms infected with wild-type in
comparison to uro2D is 7 and 8 days, respectively.
None of the C. neoformans uric acid catabolic enzymes,
with the exception of urease, is required for
pathogenesis during infection of a mammalian host
We next performed a murine inhalation model of cryptococ-
cosis, widely regarded as the gold standard test for virulence assays
of C. neoformans, to examine the roles of urate oxidase, HIU
hydrolase, OHCU decarboxylase, allantoinase and allantoicase-
ureidoglycolate hydrolase during infection of a mammalian host
(Figure 7). The virulence-associated function of urease has already
Figure 5. Uro1, Uro2, Uro3, Dal1, Dal2,3,3 and Ure1 are not required for expression of the three major virulence attributes. (A) India
ink cell staining under light microscopy revealed that the uric acid catabolic deletion mutants produced characteristic halos around its cells
representing enlarged capsule that were similar to wild-type when cultured under serum-induced growth conditions. Scale bar, 10 mm. (B) Ten-fold
spot dilution assays on L-DOPA medium at both 30 and 37uC showed that the catabolic deletion mutants melanized to the same extent as wild-type.
C. Ten-fold spot dilution assays on YPD medium at human body temperature (37 and 39uC) demonstrated that the deletion mutants exhibited wild-
type growth.
doi:10.1371/journal.pone.0064292.g005
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been thoroughly characterized in several different animal models
of C. neoformans infection and hence it is omitted from this study
[27,28,29]. Surprisingly, mice intranasally infected with the uro1D,
uro2D, uro3D, dal1D and dal2,3,3D mutant strains all succumbed to
infection at approximately the same rate as mice infected with the
wild-type strain (killing occurred between 18 and 31 days post
infection, median survival of mice = 21 days). In order to provide
parsimonious explanations to the conflicting uro2D results in the C.
elegans killing assays and the experimental murine cryptococcosis,
investigating the exact mechanism by which C. neoformans kills C.
elegansmight be beneficial; while accumulation of the fungus within
the gastrointestinal tract of the worm is known to be associated
with killing, the precise nature of the cause of death is unclear [48].
Discussion
Nitrogen scavenging through the uric acid degradation pathway
is complex and it involves multiple enzymatic steps. While this
pathway is conserved in bacteria, fungi, plants and animals, it
nevertheless displays wondrous variation not only between
kingdoms of life, but also from species to species. In the soil
bacterium Bacillus subtilis, eight genes [pucL and pucM (uricases),
pucJ and pucK (uric acid transporters), pucH (allantoinase), pucI
(allantoin permease), pucF (allantoate amidohydrolase), pucR
(transcriptional activator of puc gene expression)] whose products
act in concert to drive uric acid catabolism, are all located in a
cluster with the exception of pucI [14]. In the model hemi-
ascomycete S. cerevisiae, genomic rearrangements have led to the
assembly of six adjacent genes of the DAL cluster that enables
preferential utilization of allantoin as a nitrogen source over
assimilation of uric acid that requires the oxygen-consuming urate
oxidase [55]. Incidentally, baker’s yeast can grow vigorously in
anaerobic conditions.
Such gene clustering for purine metabolism is not observed in
filamentous ascomycetes such as A. nidulans, where the entire uric
acid degradation pathway has recently been dissected [8]. The
Figure 6. HIU hydrolase plays a subtle role in C. neoformans-mediated killing of C. elegans. ,50 nematode worms were transferred to a
lawn of (A) wild-type H99, uro1D, uro1D + URO1, (B) uro2D, uro2D + URO2, (C) uro3D, uro3D + URO3, (D) dal1D, dal1D + DAL1, (E) dal2,3,3D, dal2,3,3D +
DAL2,3,3, (F) ure1D or ure1D + URE1, as the sole food source on BHI medium and survival was monitored at 24-hr intervals. There was no observable
difference in C. elegans killing by the uro1D, uro1D + URO1, uro2D + URO2, uro3D, uro3D + URO3, dal1D, dal1D + DAL1, dal2,3,3D, dal2,3,3D + DAL2,3,3,
ure1D and ure1D + URE1 strains compared to wild-type. In contrast, the uro2D strain killed C. elegans slightly slower than wild-type. All experiments
were repeated three times with similar results.
doi:10.1371/journal.pone.0064292.g006
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discovery of a different form of gene clustering (the gene-fusion
event involving DAL2,3,3) in C. neoformans introduces a new
paradigm to the fungal uric acid degradation pathway. It is not
uncommon for certain protein families in a particular species
comprised of fused domains to correspond to a single, full-length
protein of another species. For instance, the E. coli acetate CoA
transferase a and b subunits has regions of homology to the N- and
C-terminus of human succinyl CoA transferase [60,61]. One of
the most fascinating questions that can be asked of these
biologically related proteins is whether they originated from a
primordial fused protein separated through evolution or vice versa.
An example of the latter, evolved by gene fusion, is the Arom locus
of A. nidulans that encodes a pentafunctional polypepetide. The
AROM complex consists of domains analogous to five bacterial
enzymes (AroA, AroB, AroE, AroK and AroL) responsible for
catalyzing polyaromatic amino acid biosynthesis [61,62]. This
AROM example affirms the fact that fused domains can retain its
specific enzymatic activity; indeed, multiple lines of evidence have
demonstrated that fusion events may even increase the functional
efficiency of the fusion protein [61,63].
Recent metabolic engineering efforts have enabled synthetic
protein scaffolds to be built that spatially recruit successive
pathway enzymes in a designable manner, ultimately improving
the production of the end product while lowering the overall
metabolic load on the chassis organism [64]. The principle behind
such metabolic pipelines is to assemble enzyme complexes that
bring the active sites close together to prevent loss of intermediates
or competition from other pathways. Therefore, while we were
unable to adequately test the enzymatic function of C. neoformans
allantoicase-ureidoglycolate hydrolase, we propose that this fusion
may enable faster and more efficient degradation of allantoate to
urea and glyoxylate, via substrate channeling.
A closer inspection of the literature revealed that the
phenomenon of fusion uric acid catabolic protein is also observed
Figure 7. Uro1, Uro2, Uro3, Dal1 and Dal2,3,3 are not required for infection of a murine host. 10 mice were each intranasally infected
with either 56105 cells of (A) wild-type H99, uro1D, uro1D +URO1, (B) uro2D, uro2D +URO2, (C) uro3D, uro3D + URO3, (D) dal1D, dal1D +DAL1, (E)
dal2,3,3D or dal2,3,3D + DAL2,3,3, and survival was monitored daily. Mice infected with the uro1D, uro1D +URO1, uro2D, uro2D +URO2, uro3D, uro3D +
URO3, dal1D, dal2,3,3D and dal2,3,3D + DAL2,3,3 strains progressed to morbidity as quickly as mice infected with the wild-type strain. Unexpectedly,
the complemented dal1D +DAL1 strain appeared to be significantly less virulent than wild-type; this conundrum is likely caused by integration of
DAL1 into a non-native, virulence-associated (possibly high temperature-associated) locus.
doi:10.1371/journal.pone.0064292.g007
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in plants and legumes, where a fusion OHCU decarboxylase-HIU
hydrolase is present [9,65]. This fusion OHCU decarboxylase-
HIU hydrolase protein contains enzymes that act one after
another, just like allantoicase-ureidoglycolate hydrolase. An
intriguing consideration to come out of these observations is that
these fusions may suggest protein-protein interactions between the
multiple enzymes of this pathway. In support of this notion,
allantoinase and allantoicase have been shown to form a complex
in amphibians [10]. Further studies into the enzyme structures and
protein-protein interactions of members of the uric acid pathway
may provide insights into how C. neoformans has undergone
evolutionary biochemical adaptation for optimized utilization of
this abundant nitrogen source found in pigeon excreta.
In fact, uric acid is also a common metabolite found at
concentrations as high as 2,696 mM in the serum of healthy
individuals [66]. This occurrence is caused by the inactivation of
the urate oxidase gene of hominoids some 15 million years ago in a
primate ancestor [1]. The subsequent inactivation of other
catabolic genes of the pathway is a possible evolutionary scenario;
the human HIU hydrolase gene has several inactivating mutations
while the OHCU decarboxylase gene, although potentially
encoding a complete protein, does not appear to be transcription-
ally expressed [9]. Recently, necrotic mammalian cells have been
shown to release uric acid as a danger signal to enhance immune
response against invading microbes [30]. Such immunomodulat-
ing properties of uric acid are not likely to be exhibited in the
immunocompetent BALB/c mice, commonly used as an animal
model system for testing cryptococcosis, since their biological uric
acid catabolic enzymes are intact. Hence, in order to better mimic
the infection of humans, we are currently in the process of
breeding the C57BL/6J urate oxidase-deficient (hyperuricemia)
mice colonies previously created by Wu et al., to further investigate
the virulence capacities of the C. neoformans uric acid catabolic
mutants [67]. In support of our proposition, studies have shown
that AIDS patients, particularly those undergoing antiretroviral
therapies, have a higher prevalence of hyperuricaemia [68].
Overall, the results we report here represent the first definitive
characterization of the complete uric acid degradation pathway in
a second phylum of the kingdom fungi, the Basidiomycota, and we
have laid the foundation for future research into investigating C.
neoformans virulence via purine metabolism.
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Figure S1. ClustalW sequence alignment of A. nidulans UaZ and C. neoformans Uro1. Identical 
amino acid residues are shaded dark grey while similar residues are shaded light grey. The conserved 
N-terminus sequence needed for enzymatic activity is boxed in red.	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Figure S2. ClustalW sequence alignment of A. nidulans UaX and C. neoformans Uro2. Identical 
amino acid residues are shaded dark grey while similar residues are shaded light grey. The conserved 
C-terminus YRGS motif that distinguishes members of the transthyretin family is boxed in red. The 
residues indicated with an asterisk below the sequence are conserved active site residues, as determined 
in the structures of the enzymes from B. subtilus, Salmonella dublin and Danio rerio.   
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Figure S3. ClustalW sequence alignment of A. nidulans UaW and C. neoformans Uro3. Identical 
amino acid residues are shaded dark grey while similar residues are shaded light grey. 
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Figure S4. ClustalW sequence alignment of S. cerevisiae Dal1 and C. neoformans Dal1. Identical 
amino acid residues are shaded dark grey while similar residues are shaded light grey. 
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Figure S5. The C. neoformans DAL2,3,3 gene encodes a fusion allantoicase-ureidoglycolate 
hydrolase protein. A. Representative protein architecture of S. cerevisiae Dal2 and Dal3, and C. 
neoformans Dal2,3,3. B. ClustalW sequence alignment of S. cerevisiae Dal2 and C. neoformans Dal2. 
C. ClustalW multiple sequence alignment of S. cerevisiae Dal3 and C. neoformans Dal3a and Dal3b. 
Identical amino acid residues are shaded dark grey while similar residues are shaded light grey. 
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Figure S6. ClustalW sequence alignment of A. nidulans UreB and C. neoformans Ure1. Identical 
amino acid residues are shaded dark grey while similar residues are shaded light grey. 
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Figure S7. HIU hydrolase and OHCU decarboxylase activities are not entirely essential, but are 
required for efficient uric acid degradation in C. neoformans. Tenfold spot dilution assays for 
nitrogen source utilization showed that the uro1Δ, uro2Δ and uro3Δ mutants exhibited obvious growth 
defects on YNB supplemented with 10 mM uric acid after a two-day incubation period, however, 
growth of the uro2Δ and uro3Δ strains catches up on further incubation. 
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Figure S8. Restoration of the ability to utilize uric acid and its pathway intermediates upon 
complementation of the uric acid catabolic deletion mutants. Tenfold spot dilution assays for 
nitrogen source utilization showed that the complemented uro1Δ + URO1, uro2Δ + URO2, uro3Δ + 
URO3, dal1Δ + DAL1, dal2,3,3Δ + DAL2,3,3 and ure1Δ + URE1 strains exhibited wild-type growth 
on YNB supplemented with uric acid, allantoin, urea or ammonium (10 mM each). 
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Table S1. Fungal strains used in this study. 
Strain Genotype Source 
H99 Cryptococcus neoformans laboratory strain [1] 
YL1 H99 uro1::NEO  This study 
GS1 H99 uro2::NEO This study 
GS5 H99 uro3::NEO This study 
EL24 H99 dal1::NEO This study 
YL4 H99 dal2,3,3::NEO This study 
YL5 H99 ure1::NEO This study 
RL22 H99 uro1::NEO + URO1 NAT This study 
RL23 H99 uro2::NEO + URO2 NAT This study 
RL15 H99 uro3::NEO + URO3 NAT This study 
RL13 H99 dal1::NEO + DAL1 NAT This study 
RL16 H99 dal2,3,3::NEO + DAL2,3,3 NAT This study 
RL17 H99 ure1::NEO + URE1 NAT This study 	  
 
Reference 
1. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR (1993) Gene transfer 
in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 
175: 1405-1411. 
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Table S2. Primers used in this study. 
Primer Purpose Sequence (5’-3’) 
UQ270  GenomeWalker adaptor GTAATACGACTCACTATAGGGC 
UQ271 GenomeWalker nested adaptor ACTATAGGGCACGCGTGGT 
UQ272 GenomeWalker 3’ gene specific CTGAATGGCGAATGAGCTTGAGCTTGG 
UQ273 GenomeWalker 3’ nested gene 
specific 
ATCAGATTGTCGTTTCCCGCCTTCAG 
UQ274 GenomeWalker 5’ gene specific GAGAGGCGGTTTGCGTATTGGCTAGAG 
UQ275 GenomeWalker 5’ nested gene 
specific 
ACGTCCGCAATGTGTTATTAAGTTGTC 
UQ248 URO1 deletion 5’ F ACATTGTTGGTAAAGCCTTCG 
UQ249 URO1 deletion 5’ R AGCTCACATCCTCGCAGCTATTGCTGATGGGTGTTGTTG 
UQ250 URO1 deletion 3’ F CCGTGTTAATACAGATAAACCTATAGATATGCAGGTGCAAAG 
UQ307 URO1 deletion 3’ R AGTAACAACCGTGGCTGTCAG 
UQ276 URO1 deletion NEO F ACAACACCCATCAGCAATAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ277 URO1 deletion NEO R CTGCATATCTATAGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ670 URO2 deletion 5’ F TTCTGGAGTTTTCGATCCACG 
UQ671 URO2 deletion 5’ R AGCTCACATCCTCGCAGCACTGGAGACGCGATTGAT 
UQ672 URO2 deletion 3’ F TGTTAATACAGATAAACCGATCGATACTGTGTTATA 
UQ673 URO2 deletion 3’ R CCTTTGATGATACCTTTGTGA 
UQ750 URO2 deletion NEO F ATCAATCGCGTCTCCAGTGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ751 URO2 deletion NEO R TATAACACAGTATCGATCGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ674 URO3 deletion 5’ F GCCAAACCTCAAGGTTAGTCT 
UQ675 URO3 deletion 5’ R AGCTCACATCCTCGCAGCGATGAGCGTATGCGTGAT 
UQ676 URO3 deletion 3’ F TGTTAATACAGATAAACCAGCTTTAGATAGATGCTA 
UQ677 URO3 deletion 3’ R GGTTAGAAAACTGATCTGCCA 
UQ752 URO3 deletion NEO F ATCACGCATACGCTCATCGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ753 URO3 deletion NEO R TAGCATCTATCTAAAGCTGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ236 DAL1 deletion 5’ F  ACCAAGCCCAAACAGAGCAGC 
UQ237 DAL1 deletion 5’ R AGCTCACATCCTCGCAGCGAACATAACGGATCAATCTCG 
UQ238 DAL1 deletion 3’ F CCGTGTTAATACAGATAAACCGCTGCACAGGAGACATTACGG 
UQ239 DAL1 deletion 3’ R GTCGGTCTTGGCGGAGAGGTG 
UQ754 DAL1 deletion NEO F TTTTTCTGCATACAAACAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ755 DAL1 deletion NEO R TAATGTCTCCTGTGCAGCGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ240 DAL2,3,3 deletion 5’ F GCCACTGCCCAAGCTATTGAC 
UQ278 DAL2,3,3 deletion 5’ R CGCTCTCCAGCTCACATCCTCGCAGCTGATATAAGCTGTGGGGGACG 
UQ279 DAL2,3,3 deletion 3’ F CATCTCTTCCGTGTTAATACAGATAAACCATAAACGTGTTGAGAAAGCGT 
UQ243 DAL2,3,3 deletion 3’ R CGCCTAATAACACAGCAAATA 
UQ756 DAL2,3,3 deletion NEO F CCCCCACAGCTTATATCAGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ757 DAL2,3,3 deletion NEO R CTTTCTCAACACGTTTATGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ244 URE1 deletion 5’ F ACACCAACTACCGCCATTTCC 
UQ762 URE1 deletion 5’ R AGCTCACATCCTCGCAGCGTATCCGGGCTCGTGTAT 
UQ246 URE1 deletion 3’ F CCGTGTTAATACAGATAAACCGTATCAGTGCATTTCTCCATT 
UQ247 URE1 deletion 3’ R TGTGTTCCACAGCGTTGAGAG 
UQ758 URE1 deletion NEO F ATACACGAGCCCGGATACGCTGCGAGGATGTGAGCTGGAGAGCG 
UQ759 URE1 deletion NEO R GGAGAAATGCACTGATACGGTTTATCTGTATTAACACGGAAGAGATGTAG 
UQ1323 URO1 genomic DNA sequencing TCTTCCGCTTAACGACTGGAC 
	   12	  SI	  
UQ1324 URO1 genomic DNA sequencing CGCACGAGTCGTCCGTGATGG 
UQ1325 URO1 genomic DNA sequencing ACGGCAAGCCTCACAAATGGT 
UQ1326 URO1 genomic DNA sequencing ATTTTGACTTCATGCCCTGCC 
UQ1327 URO2 genomic DNA sequencing TATAAAATCAAATAAAAGGTG 
UQ1328 URO2 genomic DNA sequencing CATCGCAGTGTTAGATTCGTC 
UQ1329 URO2 genomic DNA sequencing GCATTGTAATTTTAAGCAAGA 
UQ1330 URO3 genomic DNA sequencing CTGTTCTTTGCGACGCTTGTT 
UQ1331 URO3 genomic DNA sequencing CCATACTCTGCTTGTTCCATC 
UQ1332 URO3 genomic DNA sequencing CGTTTGGCTGATCGGAAGGGC 
UQ1333 DAL1 genomic DNA sequencing AGATCGTATTTCCAATCCGTC 
UQ1334 DAL1 genomic DNA sequencing GCGTTTTCGTGATTTTGGATT 
UQ1335 DAL1 genomic DNA sequencing GCCAAAGAGGTCGGGGTGAGC 
UQ1336 DAL1 genomic DNA sequencing CCTCTACTGCAATCTGCCTTT 
UQ1337 DAL1 genomic DNA sequencing CTTGTAAGTCGGGCGGTGTCT 
UQ1338 DAL2,3,3 genomic DNA sequencing GGCGTGGTTCTGCTCATTGGA 
UQ1339 DAL2,3,3 genomic DNA sequencing CGTCCCCCACAGCTTATATCA 
UQ1340 DAL2,3,3 genomic DNA sequencing CCTGGAGAGGCTTTCCTGTTA 
UQ1341 DAL2,3,3 genomic DNA sequencing TCTTCTCCCTGGTCGTGGAAT 
UQ1342 DAL2,3,3 genomic DNA sequencing TCCCGCTCTGCCTCTTACCCC 
UQ1343 DAL2,3,3 genomic DNA sequencing GCGGAGTGAGTGCGACACAAG 
UQ1344 DAL2,3,3 genomic DNA sequencing GGCACCCTTATACCAGTCAGA 
UQ1345 DAL2,3,3 genomic DNA sequencing CGAATGATTGAATACTACAGT 
UQ1346 URE1 genomic DNA sequencing ATTCATCTGCATTCTGGATTA 
UQ1347 URE1 genomic DNA sequencing ATTTTTTGCTTTCCCTTTCTT 
UQ1348 URE1 genomic DNA sequencing TTCCCTGCTGCACCCGAGCCA 
UQ1349 URE1 genomic DNA sequencing ACAACTGGCGATAAGATCAAA 
UQ1350 URE1 genomic DNA sequencing TCTCTAGTAGGATGGGGATCA 
UQ1351 URE1 genomic DNA sequencing TCGTTGTCTGTGAATATGAAA 
UQ1352 URE1 genomic DNA sequencing AGATGATCCTCAAGGGCGGTG 
UQ1353 URE1 genomic DNA sequencing AAACCTCTAGTTATCTTCCAA 	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Table S3. Plasmids used in this study. 
Plasmid  Detail Source 
pJAF1 NEO selectable marker in pCR2.1-TOPO  [1] 
pCH233 NAT selectable marker in pCR2.1-TOPO  A gift from Christina 
Hull 
pIRL5 H99 URO1 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL6 H99 URO2 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL7 H99 URO3 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL8 H99 DAL1 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL9 H99 DAL2,3,3 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL10 H99 URE1 genomic DNA including promotor and 
terminator in pCR2.1-TOPO  
This study 
pIRL13 H99 URO1 genomic DNA including promotor and 
terminator in pCH233  
This study 
pIRL14 H99 URO2 genomic DNA including promotor and 
terminator in pCH233  
This study 
pIRL15 H99 URO3 genomic DNA including promotor and 
terminator in pCH233  
This study 
pIRL16 H99 DAL1 genomic DNA including promotor and 
terminator in pCH233  
This study 
pIRL17 H99 DAL2,3,3 genomic DNA including promotor and 
terminator in pCH233  
This study 
pIRL18 H99 URE1 genomic DNA including promotor and 
terminator in pCH233  
This study 
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Table S4. C. neoformans uric acid catabolism defective mutants identified during the Agrobacterium-
mediated insertional mutagenic screen. 
Transformant Gene disrupted Insertion site 
65H07 CNAG_04307.2 (URO1) Promoter 
3H06 CNAG_04307.2 (URO1) CDS 
28E09 CNAG_04307.2 (URO1) CDS 
7H04 CNAG_06694.2 (URO2) Promoter 
7H05 CNAG_06694.2 (URO2) Promoter 
53C07 CNAG_01108.2 (DAL2,3,3) Intron 
88A05 CNAG_05540.2 (URE1) Promoter 
88A06 CNAG_05540.2 (URE1) Promoter 
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7.0 Conclusions  
This thesis has presented work that involves the characterisation of key regulatory 
proteins and catabolic enzymes of nitrogen metabolism in Cryptococcus neoformans. 
The important isolate H99 was used as the foundation for this molecular research 
since it is the most intensively studied type strain that forms the basis for the 
Cryptococcus gene deletion collection and its virulence is well established in 
mammalian models [1,2]. Here, insights were shed into the global as well as pathway-
specific nitrogen regulatory network at the genetic, transcriptional, protein and 
phenotypic levels. First, the mechanisms by which the GATA transcription factor 
Gat1/Are1 and Nmr-like protein Tar1 coordinate to regulate nitrogen metabolite 
repression was dissected using the secondary catabolic pathways of proline and uric 
acid as a reference. Second, the proline and uric acid enzymes were individually 
scrutinised for their catabolic functions. In addition, these regulatory proteins and 
enzymes were examined for their roles in virulence factor expression and 
pathogenesis. Together, an outline of the nutritional (nitrogen) requirements for C. 
neoformans growth during disease development is slowly emerging, along with the 
realisation that certain nitrogen regulatory proteins and catabolic enzymes are co-
opted to control metabolic functions as well as elaboration of virulence attributes.  
7.1 Concluding Remarks 
 7.1.1 Characterisation of the GATA factor Gat1/Are1 
Nitrogen metabolite/catabolite repression was first observed in members of the 
phylum Ascomycota; this regulatory phenomenon serves to enable preferential 
utilisation of readily assimilated nitrogen sources such as ammonium and glutamine 
[3,4,5]. In Chapter 3, this physiological response was shown for the first time to be 
evolutionarily conserved in the basidiomycete C. neoformans. Using qRT-PCR, loss 
of transcriptional activation of a selected panel of catabolic enzyme-encoding genes 
from the uric acid and proline degradation pathways was observed whenever 
ammonium is present. Additionally, ammonium was demonstrated to be dominant 
over other nitrogen signals in regulating the production of the virulence factors 
capsule and melanin.  
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Given that transcription factors belonging to the GATA family control 
nitrogen source utilisation in the Ascomycota, comprehensive bioinformatics ranging 
from reciprocal BLASTp to Perl Script searches of the C. neoformans genome was 
employed to predict potential GATA-type ORFs. GATA factors are distinguished by 
their highly conserved DNA-binding domain consisting of a Cys-X2-Cys-X17-20-Cys-
X2-Cys zinc finger motif followed by an adjacent 5-12 basic residues within the 25 
beyond the most C-terminal cysteine. A total of seven of such putative ORFs were 
identified, all of which were subsequently deleted via homologous recombination, and 
only one (named GAT1/ARE1) was found to play a role in nitrogen regulation. 
Notably, Gat1/Are1 also impacts multiple virulence factor expression and 
consequently pathogenesis. Whether Gat1/Are1 directly or indirectly regulates 
virulence remains open to speculation. Given that it is a global transcription factor, 
there is a possibility that the observed gat1/are1Δ mutant’s virulence-associated 
phenotypes are a pleiotropic effect as a consequence of perturbation of related 
signaling pathways affecting pathogenesis. Virulence factor expression is therefore to 
a certain extent embedded in the regulation of various functions needed for adaptation 
and growth in a mammalian host. 
 7.1.2 Characterisation of the Nmr-related protein Tar1 
Chapter 4 extended the investigation into the molecular mechanisms governing 
nitrogen metabolite repression in C. neoformans that was first begun in Chapter 3. 
Deletion of the NMR homolog (named TAR1) was shown to result in inappropriate 
derepression of secondary nitrogen catabolic pathways in the simultaneous presence 
of preferred nitrogen sources. In comparison to wild-type, 1) the tar1Δ mutant 
displayed increased sensitivity to thiourea, a toxic analog of urea, in the presence of 
ammonium or glutamine, 2) the tar1Δ mutant also expressed more proline oxidase 
transcripts when cultured in proline plus ammonium. Interestingly, in the sole 
presence of proline, the tar1Δ mutant expressed less proline oxidase transcripts. This 
novel dual role of an Nmr protein in both positive and negative regulation of nitrogen 
catabolism according to nitrogen quality/availability was verified through another 
series of qRT-PCR experiments, where the tar1Δ mutant was shown to produce less 
GAT1/ARE1 transcripts in the presence of proline but more GAT1/ARE1 transcripts in 
the presence of ammonium as compared to wild-type.  
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The mechanism by which Tar1 modulates nitrogen metabolite repression is 
atypical to the situation seen in the model filamentous ascomycetes Aspergillus 
nidulans and Neurospora crassa. Protein-protein interaction between Gat1/Are1 and 
Tar1 was undetectable in a yeast two-hybrid assay consistent with bioinformatics-
based prediction. Like gat1/are1Δ, the tar1Δ mutant is modestly hypervirulent during 
murine infection. A parsimonious explanation as to why no opposing regulatory 
effects on pathogenesis was observed between these mutant strains may relate to the 
scarce nutrient availability during in vivo infection, a condition in which Tar1 is 
predicted to positively regulate Gat1/Are1 activity.  
 7.1.3 Characterisation of the proline degradation pathway 
As mentioned in Chapters 3 and 4, transcriptional studies of the proline catabolic 
enzyme-encoding genes have played a crucial role in elucidating how Gat1/Are1 and 
Tar1 coordinate to regulate nitrogen metabolite repression. Chapter 5 expanded the 
investigation into the C. neoformans proline degradation pathway by characterising 
the functions of these catabolic enzymes. Expression of PUT1 and PUT5 [both 
encodes proline oxidase that is known to catalyse the degradation of proline to Δ1-
pyrroline-5-carboxylate (P5C) / glutamate-γ-semialdehyde (GSA)] as well as PUT2 
(encodes P5C dehydrogenase that is known to oxidise P5C/GSA to glutamate) was 
shown via qRT-PCR to be inducible in the presence of proline but not other nitrogen 
sources.  
However, through the creation of gene deletion mutants, only Put5 and Put2 
were found to be required for proline utilisation. In the presence of proline, confocal 
fluorescence microscopy and flow cytometry also revealed that the put2Δ mutant 
produced excessive mitochondrial superoxide ions that are known to induce 
apoptosis. This phenomenon is likely caused by P5C-proline cycling through the 
coupled actions of proline oxidase and P5C reductase (converts P5C to proline), 
allowing proline to be intensively oxidise by the proline oxidase-FAD complex that 
delivers electrons to the mitochondrial electron transport chain and to O2, leading to 
reactive oxygen species overproduction. Additionally, Put2 is required for optimal 
production of major cryptococcal virulence factors such as melanin and high 
temperature growth. The put2Δ mutant is consequently attenuated in its ability to 
cause disease in mice, making this the first report demonstrating the importance of 
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P5C dehydrogenase in enabling virulence of a microorganism. While the functions of 
PUT5 and PUT2 are now apparent, the role of PUT1 remains unclear and open to 
debate whether it is a pseudogene. 
 7.1.4 Characterisation of the uric acid degradation pathway 
In Chapter 3, transcriptional studies of a selected panel of uric acid catabolic enzyme-
encoding genes led to the first definitive characterisation of nitrogen metabolite 
repression in a second phylum of the kingdom Fungi, the Basidiomycota. Chapter 6 
expanded the investigation into C. neoformans uric acid degradation by characterising 
the function of every catabolic enzyme of this pathway. A dual approach of 
Agrobacterium-mediated insertional mutagenesis and bioinformatics led to the 
identification of URO1-encoded urate oxidase, URO2-encoded HIU hydrolase, 
URO3-encoded OHCU decarboxylase, DAL1-encoded allantoinase, DAL2,3,3-
encoded allantoicase-ureidoglycolate hydrolase, and URE1-encoded urease. The 
enzymatic functions of all these candidates were verified through the deletion of each 
individual ORF, and assaying the mutants’ ability to utilise uric acid and its pathway 
intermediates as the sole nitrogen source. The identification of these genes confirms 
the complete absence of clustering of the genes involved in purine utilisation in C. 
neoformans, unlike those seen in many bacterial species. 
 7.1.5 Summary 
Two distinct regulatory aspects of fungal nitrogen catabolism is required for de novo 
synthesis of catabolic enzymes and permeases of specific pathways: first, a global 
signal indicating nitrogen derepression when readily assimilated nitrogen sources are 
unavailable, and second, a pathway-specific signal indicating the presence of the 
substrate or intermediate of a particular pathway. In C. neoformans, the globally 
acting GATA transcription factor Gat1/Are1 is co-opted into regulating nitrogen 
source utilisation as well as virulence-associated phenotypes. In response to nitrogen 
quality/availability, GAT1/ARE1 transcription is tightly controlled by the activity of 
the Nmr-related protein Tar1. Gaining such insights into the process of nitrogen 
sensing is key to elucidating how C. neoformans adapts and survive its transition from 
nutrient-rich ecological niche of pigeon guano to nutrient-poor environment of a 
mammalian host during infection.  
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Potential nitrogen sources available in a human host include proline and uric 
acid. The enzymes PUT5-encoded proline oxidase and PUT2-encoded P5C 
dehydrogenase are required for complete degradation of proline to glutamate. 
Importantly, P5C dehydrogenase is also a critical regulator of mitochondrial redox 
homeostasis and virulence in C. neoformans. Complete uric acid degradation to 
ammonia is more complicated than proline catabolism as it involves numerous 
enzymes: URO1-encoded urate oxidase, URO2-encoded HIU hydrolase, URO3-
encoded OHCU decarboxylase, DAL1-encoded allantoinase, DAL2,3,3-encoded 
allantoicase-ureidoglycolate hydrolase, and URE1-encoded urease. Among these uric 
acid enzymes, urease is the most well characterised nitrogen-scavenging enzyme that 
plays an important role during pathogenesis. Understanding the nitrogen requirements 
for C. neoformans growth and proliferation is pivotal as this may contribute to novel 
strategies for pathogen control.   
7.2 Future Directions 
This thesis has presented investigations into aspects of C. neoformans biology and 
pathogenesis through the context of nitrogen regulation. Due to the broad and 
exploratory nature of this work, exciting avenues of future research present 
themselves and are briefly discussed in accordance to each results chapter. 
Additionally, the significance of examining the arginine catabolic pathway that is 
connected to, and inter-links the uric acid and proline pathways, is discussed. Indeed, 
many of its disease features are still hidden from us; work to understand and control 
cryptococcosis must continue.  
7.2.1 Chromatin immunoprecipitation to determine the DNA-
binding sites of GATA factors in the genome 
To date, five GATA factors (Gat1/Are1, Bwc2, Cir1, Gat201, Gat204) have been 
functionally characterised in C. neoformans, all of which play distinct roles in various 
growth, developmental and survival processes [2,6,7,8,9,10]. Intriguingly, a common 
theme shared by these GATA factors is their reciprocal influence on the production of 
well-recognised virulence factors and their impact on pathogenesis, a finding that 
reinforces the complex regulation of these factors. The coordinated regulation by 
these regulatory proteins of functions for adaptation, nutrient acquisition and 
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elaboration of virulence factors is therefore a fascinating area for future investigation. 
Gat1/Are1, Bwc2, Cir1, Gat201, Gat204 as well as the two other uncharacterised 
GATA factors (Broad Institute annotation: CNAG_03401.2 and CNAG_04263.2) are 
all predicted to bind to the sequence 5’-GATA-3’ [11,12,13]. Whether these GATA 
factors antagonise and compete for the same 5’-GATA-3’ binding sites in the 
promoter regions of genes, or act in synergy to activate transcription of genes, or act 
interchangeably, remains open to investigation. Given the likelihood that Gat1/Are1, 
Bwc2, Cir1, Gat201 and Gat204 are acting in parallel to regulate multiple virulence 
pathways in C. neoformans, investigating the DNA-binding specificities of GATA 
factors in the genome via chromatin immunoprecipitation may provide insights into 
how these factors coordinate to regulate pathogenesis during infection of a 
mammalian host.  
7.2.2 Whole transcriptome sequencing to identify novel 
virulence- and stress adaptation-associated genes that are 
regulated by Tar1 and Gat1/Are1 
The TAR1 promoter contains putative heat shock elements suggesting that Tar1 may 
not be exclusively involved in regulation of nitrogen catabolism but may also control 
targets involved in a broader spectrum of metabolic processes. Transcriptional 
profiling and genetic studies are invaluable research tools with the means to provide 
insights into C. neoformans adaptation to key features within a mammalian host 
environment including nitrogen availability. Using whole transcriptome sequencing, 
novel virulence- and stress adaptation-associated genes that are regulated by Tar1 
(and also Gat1/Are1 given that it is a global transcription factor) can potentially be 
identified. 
7.2.3 Metabolic profiling of the proline catabolic deletion 
mutants using gas chromatography coupled to mass 
spectrometry 
In order to test our hypothesis, certain assumptions were made about the generated C. 
neoformans proline catabolic deletion mutants based on findings from other 
biological systems. For instance, intracellular proline was assumed to accumulate in 
the proline oxidase deletion mutant when subjected to external supply of proline, 
while an anticipated P5C-proline cycling was predicted to occur in the P5C 
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dehydrogenase deletion mutant. To validate these assumptions, gas chromatography 
coupled to mass spectrometry can be performed to metabolically profile the proline 
and P5C contents in the mutant strains [14,15].  
7.2.4 Virulence assays of the uric acid catabolic deletion 
mutants using urate oxidase-deficient mice as an animal 
model system 
In humans, the final end product of purine catabolism is uric acid due to a 
dysfunctional urate oxidase gene caused by deleterious mutations in our hominoid 
ancestors [16,17]. Intriguingly, necrotic mammalian cells have been shown to release 
uric acid as a danger signal to activate both innate and adaptive immune effectors 
including neutrophils, cytotoxic T-cell and antibody immunity [18]. To date, all 
conducted murine virulence assays of Cryptococcus employ mice with an intact urate 
oxidase enzyme. In order to better mimic the actual biological and immunological 
system of humans, urate oxidase-deficient (hyperuricemia) mice can be tested as a 
new animal model for investigating cryptococcosis [19]. This is particularly relevant 
for characterising the function of C. neoformans urate oxidase and its potential role in 
modulating host immune response. 
7.2.5 Investigating the arginine degradation pathway 
In the model yeast Saccharomyces cerevisiae, hydrolysis of arginine occurs via the 
enzymatic activity of CAR1-encoded arginase, producing urea and ornithine [20]. The 
ornithine is transaminated by CAR2-encoded ornithine amino transferase into 
GSA/P5C and glutamate [20]. P5C is then subsequently converted into proline by 
PRO3-encoded proline reductase [21]. Arginine catabolism takes place in the cytosol 
while proline degradation occurs in the mitochondria.  
  Bioinformatic analyses revealed that homologs of CAR1, CAR2 and PRO3 are 
all present in the C. neoformans genome. A scheme representing the predicted 
arginine, uric acid and proline catabolic pathways is depicted in Figure 7-1. Notably, 
two characterised enzymes acting on a byproduct and an intermediate of arginine 
catabolism are essential for C. neoformans virulence. First, urease is a bona fide 
virulence factor that catalyses the hydrolysis of urea and is known to play a role in 
host central nervous system invasion [1,22,23]. Second, P5C dehydrogenase acts on 
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GSA/P5C and is also required for pathogenesis. Therefore, arginine catabolism is 
worth exploring, as it may also be important for C. neoformans virulence.   
 
Figure 7-1. The predicted pathways of uric acid (black arrows), arginine (grey arrows) and 
proline (blue arrows), as well as central nitrogen metabolism (green arrows), in C. neoformans. 
This scheme represents all the nitrogen catabolic enzymes that have been transcriptionally and/or 
genetically analysed, as reviewed in this thesis. Note that deletion studies on the arginase, ornithine 
amino transferase and proline reductase-encoding genes are currently underway.  
In support of this hypothesis, genes for arginine metabolism in the pathogenic 
yeast Candida albicans have been shown to be upregulated following internalisation 
by macrophages [24]. Furthermore, in the presence of urea or arginine, dur1,2Δ 
mutants lacking urea amidolyase are defective in germ tube formation leading to their 
inability to escape from macrophages following phagocytosis [25]. In this regard, 
dimorphic transition from yeast to filamentous hyphal growth form is needed for 
	   151	  
piercing the macrophages’ cell membrane to facilitate escape. Therefore, study of 
arginine catabolism in C. neoformans is likely to provide deeper insights into how this 
fungus employs nitrogen scavenging to modulate host immune response during 
infection. 
7.3 Final Conclusions 
With the growth of immunocompromised patient populations due to the AIDS 
pandemic and increase in immune system-suppressing medical interventions, the 
incidence of secondary infection from pathogenic fungi has risen sharply to become a 
significant cause of morbidity and mortality. Every year, more than a million 
immunocompromised individuals are infected with the basidiomycete fungus C. 
neoformans, two-thirds of whom will eventually succumb to the infection [26]. This 
“sugar-coated” yeast is versatile, complex and ruthless, and it certainly deserves our 
respect and attention. Yet, fungal infections generally do not beget widespread public 
support, allure millionaire philanthropist benefactors or secure supranational 
organisation-coordinated global health campaigns as readily as more promotable 
infectious diseases such as malaria, dengue fever or tuberculosis.  
This thesis is dedicated to researchers of fungal pathogenesis to continually 
strive to elucidate the molecular mechanisms that enable fungal virulence and to be 
innovative with identifying novel targets for therapeutic intervention. Multiple 
features enable successful establishment of disease in a host including the ability to 
metabolise the available nutrients such as nitrogen and carbon sources. A 
comprehensive understanding of the requirements for fungal growth and proliferation 
in vivo may contribute to new strategies for pathogen control. Building upon the solid 
foundation gained from these nitrogen catabolism studies, work on host-pathogen 
interactions should be adopted in the near future to dissect tissue-specific nutritional 
requirements in order to understand and hopefully block the striking neurotropism of 
C. neoformans. 
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Brisbane, Australiab; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USAc; Department of Microbiology, Medical School,
University of Minnesota, Minneapolis, Minnesota, USAd; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina,
USAe; and Centre for Advanced Imaging, University of Queensland, Brisbane, Australiaf
ABSTRACT The accumulation of genomic structural variation between closely related populations over time can lead to reproduc-
tive isolation and speciation. The fungal pathogen Cryptococcus is thought to have recently diversified, forming a species com-
plex containing members with distinct morphologies, distributions, and pathologies of infection. We have investigated struc-
tural changes in genomic architecture such as inversions and translocations that distinguish the most pathogenic variety,
Cryptococcus neoformans var. grubii, from the less clinically prevalent Cryptococcus neoformans var. neoformans and Cryptococ-
cus gattii. Synteny analysis between the genomes of the three Cryptococcus species/varieties (strains H99, JEC21, and R265) re-
veals that C. neoformans var. grubii possesses surprisingly few unique genomic rearrangements. All but one are relatively small
and are shared by all molecular subtypes of C. neoformans var. grubii. In contrast, the large translocation peculiar to the C. neo-
formans var. grubii type strain is found in all tested subcultures frommultiple laboratories, suggesting that it has possessed this
rearrangement since its isolation from a human clinical sample. Furthermore, we find that the translocation directly disrupts
two genes. The first of these encodes a novel protein involved in metabolism of glucose at human body temperature and affects
intracellular levels of trehalose. The second encodes a homeodomain-containing transcription factor that modulates melanin
production. Both mutations would be predicted to increase pathogenicity; however, when recreated in an alternate genetic back-
ground, these mutations do not affect virulence in animal models. The type strain of C. neoformans var. grubii in which the ma-
jority of molecular studies have been performed is therefore atypical for carbonmetabolism and key virulence attributes.
IMPORTANCE The fungal pathogen Cryptococcus is a major cause of mortality among the immunocompromised population, pri-
marily in AIDS patients of sub-Saharan Africa. Most research into the particular variety of Cryptococcus responsible for the vast
majority of infections, Cryptococcus neoformans var. grubii, is performed using the type strain isolated in 1978 from a Hodgkin’s
disease patient fromNorth Carolina. We have determined that this particular isolate contains a chromosomal translocation that
directly interrupts two genes, which all descendants of this strain from various research laboratories appear to possess. Disrup-
tion of these two genes affects multiple virulence factors of Cryptococcus, particularly the ability to grow at human body temper-
ature, which could have wide-ranging implications for molecular genetic studies and virulence assays using this important
strain.
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Increasing numbers of completed genome sequences have madeapparent that large changes in genome structure play a much
greater role in the generation of phenotypic diversity between spe-
cies than previously appreciated. While small mutations such as
single nucleotide polymorphisms have long been associated with
disease states and phenotypic variation in humans, larger struc-
tural alterations have recently been revealed to be at least as im-
portant in generating variation (1). Furthermore, recent theories
propose that the suppression of recombination associated with
large chromosomal rearrangement events allows for accumula-
tion of mutations, reproductive isolation without gene flow in
freely mixing populations, local adaptation, and specialization
(2). Direct association of chromosomal rearrangements with local
adaptation and speciation has since been demonstrated for fungi
(3), plants (4), and insects (5). Both the ubiquity of structural
variants within individual human genomes and contributions to
various disease states have also been demonstrated (6).
Structural variants or gross chromosomal rearrangements can
have profound influences on phenotype and encompass large
changes such as intra- and interchromosomal translocations,
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large duplications and deletions, copy number variations, inver-
sions, and whole-chromosome aneuploidies. Seminal studies
from Drosophila species have shown that inversions can delineate
closely related species (7), while inversions characterize the sex-
determining chromosomes in a variety of species, including hu-
mans (8, 9). Translocations can suppress recombination and se-
quester sets of genes in a manner similar to that of inversions and
can alter gene expression around breakpoints and along their
length through tertiary chromosome positioning (10). Large du-
plications of genes allow for specialization and sub- and neofunc-
tionalization of duplicate copies, with the most famous being the
whole-genomeduplications of the Saccharomycetaceae yeasts and
the teleost fishes (11, 12).
The opportunistic fungal pathogen Cryptococcus neoformans is
a major cause of mortality in the immunocompromised popula-
tion, causing an estimated 625,000 deaths per annum, primarily in
areas where AIDS is endemic (13). The species consists of two
varieties that diverged approximately 24.5million years ago:Cryp-
tococcus neoformans var. grubii, which causes the vast majority of
infections, andCryptococcus neoformans var. neoformans, which is
far less clinically prevalent. The pathogenic Cryptococcus species
complex is further demarcated into molecular subtypes: C. neo-
formans var. grubii comprises subtypes VNI, VNII, andVNBwhile
C. neoformans var. neoformans is subtype VNIV. The sister species
Cryptococcus gattii, which diverged 45 million years ago, com-
prises the subtypes VGI, VGII, VGIII, and VGIV and is generally
considered a primary pathogen of healthy individuals, although
both species have the capacity to infect immunocompetent and
immunodeficient patients (14). The three groupings (C. neofor-
mans var. grubii, C. neoformans var. neoformans, and C. gattii)
display marked differences in distribution, ecology, morphology,
epidemiology, and virulence.
Whether the two C. neoformans varieties represent separate
species is currently under debate, as are proposals to raise the C.
gattii molecular subtypes to the variety or perhaps species level
(15, 16). Recent comparisons of completed Cryptococcus genome
sequences have highlighted rearrangements between C. neofor-
mans var. neoformans and C. neoformans var. grubii (17, 18), be-
tween C. gattii VGI and C. gattii VGII, and between C. gattii
VGI/II and C. neoformans var. neoformans (16). As C. neoformans
var. grubii is far more prevalent than the other two organisms in
cryptococcal infections (!90%) and causes themajority of deaths
worldwide, we were interested in structural variants at the chro-
mosomal level that were unique to C. neoformans var. grubii.
Changes in karyotype arise frequently in Cryptococcus during in-
fection, suggesting that it may be a common mechanism to gen-
erate variation and adapt to the host environment (19, 20). Similar
genomicmicroevolution has been linked with success of infection
in fungal pathogens such as Candida albicans (21, 22). Interrogat-
ing such changes may elucidate modes of speciation in the patho-
genic Cryptococcus species complex or suggest genetic mecha-
nisms for the prevalence and virulence of C. neoformans var.
grubii.
In this study, we compared the sequenced genome of the C.
neoformans var. grubii type strain, H99, with those of the C. neo-
formans var. neoformans strain JEC21 and theC. gattii strain R265
using synteny analysis to identify translocations, duplications, de-
letions, and inversions. We found that C. neoformans var. grubii
possesses very few unique genomic rearrangements; however, the
single large translocation identified appears restricted to the type
strain of C. neoformans var. grubii and is shared by all subcultures
tested. We find that it directly interrupts two genes, one encoding
a protein involved in glucose metabolism during high-
temperature growth and the other encoding a homeodomain-
containing transcription factor that represses melanization. De-
spite the fact that these two genes impact multiple virulence
factors, pathogenicity is unaffected in animal models. As H99 is
themost intensively studied strain ofCryptococcusworldwide, this
could have significant impacts on genetic and virulence studies in
this important human pathogen.
RESULTS
Synteny analysis reveals surprisingly few genome rearrange-
ments unique toC.neoformans var. grubii.Todevelop anunder-
standing of the evolutionary significance and clinical conse-
quences of large-scale genomic rearrangements in C. neoformans
var. grubii, we performed pairwise comparisons using dot plot
analysis on three of the available Cryptococcus pathogenic species
complex genomes: C. neoformans var. grubii (strain H99), C. neo-
formans var. neoformans (strain JEC21), and C. gattii (strain
R265). Thewidely distributed type strainH99was isolated in 1978
from the cerebrospinal fluid of a 27-year-old Caucasian male be-
ing treated for Hodgkin’s disease in North Carolina by John Per-
fect (23). Strain H99 is an important isolate as it is the foundation
of molecular research in Cryptococcus. Pairwise analysis revealed
broad synteny across the 14 chromosomes of the genomes, with
the notable exceptions being the centromeres, the subtelomeric
regions, and MAT. Large genomic rearrangements (greater than
1 kb) specific toC. neoformans var. grubii numbered eight in total.
Six inversions were identified, two on chromosome 1 and one
each on chromosomes 3, 7, 9, and 14; in addition, a small dupli-
cation is associated with the inversion on chromosome 14 and a
large reciprocal translocation is present involving chromosomes 3
and 11 (Fig. 1). The ancestral state of chromosomes 3 and 11 is
likely represented by the chromosomal arrangement in R265;
JEC21 has undergone a pericentric inversion on chromosome 3,
whileH99has undergone a translocation between chromosomes 3
and 11. Rearrangements peculiar to each genome were evident
through our analyses, including previously identified events in C.
neoformans var. neoformans: the introgression of C. neoformans
var. grubii-specific sequence (the identity island) and a duplica-
tion and translocation involving JEC21 chromosomes 8 and 12
(17, 24).
These findings are consistent with those of Sun and Xu (18),
who examined chromosomal rearrangements between C. neofor-
mans var. grubii andC. neoformans var. neoformans and identified
five translocations and 27 rearrangements. Our inclusion of C.
gattii establishes that many of those changes are unique to C. neo-
formans var. neoformans. The five translocations comprise the
telomere-telomere fusion and associated duplication identified by
Fraser et al. (24), the pericentric inversion on JEC21 chromosome
3, and the chromosome 3/11 translocation inH99. There are seven
C. neoformans var. neoformans-specific inversions, two on chro-
mosome 1, two on chromosome 4, and one each on chromosomes
5, 7, and 14. BothC. neoformans var. grubii andC. neoformans var.
neoformans possess separate inversions on chromosome 7 that
share a common breakpoint. The remaining rearrangements
identified in C. neoformans var. neoformans comprise the centro-
meres andMAT.
For the six C. neoformans var. grubii-unique inversions, five
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encompass only two to four genes, while one inversion on chro-
mosome 1 captures 34 genes (Fig. 1). Most of the inversion break-
points are intergenic, and all except the inversion on chromosome
9 are associatedwith a repeated or transposable element. One each
of the breakpoints on chromosomes 1, 7, and 14 is within genes
and creates novel 3= ends for the genes encoding DNA topoisom-
erase II Top2, the replication checkpoint component Tof1, and
elongation factor 1ATif11. The inversion onH99 chromosome 14
also has an associated inverted duplication of 5,567 bp, which
encompasses three genes.
The six inversions identified in H99 appear to be a synapo-
morphy of C. neoformans var. grubii. Genomic inversions can
lead to altered expression of genes surrounding the breakpoints
and contribute to speciation via suppression of homologous re-
combination. To investigate whether the six inversions identified
in the C. neoformans var. grubii genome sequence are unique to
strainH99 (a VNI isolate), we designed PCR assays to test for their
presence or absence. All subcultures and progeny of H99 pos-
sessed the duplication and six inversions (see Fig. S1 in the sup-
plemental material). The seven known amplified fragment length
polymorphism (AFLP) subclades of molecular type VNI also pos-
sessed these seven rearrangements, as do molecular types VNII
and VNB. Both C. neoformans var. neoformansVNIV and C. gattii
VGII lack these features, confirming all seven traits to be charac-
teristic of C. neoformans var. grubii.
Nucleotide dS rates are uniform across the chromosomal in-
versions. Chromosomal inversions lead to local suppression of
recombination in affected chromosomal regions (25). For the C.
neoformans var. neoformans/C. neoformans var. grubii split, we de-
termined the dS (synonymous substitution) values for all genes
contained within the C. neoformans var. grubii-specific inversions
and compared them to those of flanking genes on both sides of the
inversions. All six inversions had average dS values that were com-
parable to that of flanking regions (see Fig. S2 in the supplemental
material). This suggests that the C. neoformans var. grubii com-
mon ancestormay have been geographically isolated and not have
frequently undergone sexual reproductionwith theC. neoformans
var. neoformans ancestor, as there is no evidence of suppressed
recombination across these regions. Furthermore, all inversion-
associated genes had average dN/dS ratios (ratios of nonsynony-
mous to synonymous substitutions) of !1, where values of "1
represent positive selection and values of !1 represent purifying
selection (Fig. S2). Again, these ratios were similar to those of
flanking genes.
TheH99 translocation shows evidence of being produced via
nonhomologous end joining and disrupts two genes. Of all the
changes identified, only the translocation between chromosomes
3 and 11 appeared to be H99 specific. To investigate the origin of
this genomic event, we interrogated an array of 80 diverse isolates
via diagnostic PCR. The translocation was present exclusively in
FIG1 Inversions unique to theC. neoformans var. grubii genome.Green regions are syntenicwith theC. neoformans var. neoformans andC. gattii genomes, while
red regions are inverted and yellow indicates the duplication. Genes are represented by black arrows indicating direction of transcription, while white arrowheads
represent transposable or repeated elements near inversion breakpoints. Images are not to scale. CoA, coenzyme A.
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subcultures of strainH99 and its derivatives (Fig. 2 and results not
shown), suggesting that it was present in the originally isolated
H99 clinical sample. To more precisely characterize the chromo-
some 3/11 H99 translocation, the breakpoint regions were ampli-
fied and sequenced from the VNI isolate 125.91 (Fig. 2). There is a
3-bp microhomology at the breakpoint on both chromosomes,
plus a single-base-pair insertion before the microhomology on
chromosome 11, hallmarks of the translocation arising from non-
homologous end joining (26). BLAST analysis of the breakpoint
suggests that the translocation interrupts two genes such that the
5= ends of both genes converge on chromosome 3while the 3= ends
face away from each other on chromosome 11 (Fig. 2). If tran-
scribed, the 5= fragments of both genes on the H99 chromosome
would form relatively short truncated proteins appended with se-
quence from the antisense strands of the other gene. Careful rean-
notation of these genes with reference to a number of fungal ge-
nomes suggests that both have been misannotated in the existing
Cryptococcus genomes.
One gene disrupted in the H99 translocation, TGR1, is in-
volved in metabolism of glucose at high temperature.Owing to
the translocation, the shorter of the two translocation-associated
genes is annotated as two separate open reading frames (ORFs) in
the unpublished Broad Institute H99 assembly, with the 3= end on
chromosome 11 (CNAG_01857) and the 5= end on chromosome
3 (CNAG_02713). The same gene is located on chromosome 3 in
JEC21 (XM_569672), chromosome 3 inWM276 (CGB_C5260C),
and supercontig 8 of R265 (CNBG_3377). The gene is 1,063 bp,
contains three introns, and yields a predicted protein of 300 amino
acids. BLAST analysis reveals that the gene is widespread in the
Agaricomycotina, appearing in 20 of 27 available genomes, but
appears absent from all other fungal species. There are no charac-
terized homologs and no predicted protein domains or secondary
structure.
A deletion mutant constructed in VNB isolate Bt63 was tested
with a wide variety of media, conditions, and stressors, including
various carbon and nitrogen sources; extremes of pH and ionic
and osmotic stress; oxidative, nitrosative, and sulfhydryl stress;
low-iron and low-phosphate media; metal and metalloid stres-
sors; extremes of temperature; UV resistance; cell wall- and cell
membrane-perturbing agents; and CO2 and O2 stress. All tests
were performed at both 30°C and 37°C to discriminate pheno-
types that may be evident only during infection of a mammalian
host. Over 70 conditionswere tested in total. Themajority of these
tests were uninformative. However, although themutant with the
deletion of this first translocation gene in Bt63 had no phenotype
at 30°C when cultured on minimal medium plus glucose, at 37°C
themutant showed increased growth compared to that of the wild
type. We therefore dubbed the gene TGR1, for temperature-
sensitive glucose-specific growth repressor 1 (Fig. 3). The pheno-
type was specific to the presence of glucose and was abolished
when the mutant was grown on other sole carbon sources includ-
ing mono-, di-, and trisaccharides; acetate; ethanol; glycerol;
amino acids; and fatty acids (Fig. 3 and results not shown). The
phenotype was also apparent when glucose was present and when
FIG 2 Identification and reconstruction of the H99 translocation. (A) Diagnostic PCR assay spanning the translocation boundary designed to produce an
amplicon only when the translocation is present. Extended testing establishes that the translocation is present in all subcultures of H99 tested but absent from all
other strains. (B) Alignment of the translocation breakpoints from H99, JEC21, R265, and VNI isolate 125.91. Note the presence of a microhomology, AGC, at
the breakpoint, along with a single-base-pair insertion,A, before themicrohomology onH99 chromosome 11. In silico reversal of the translocation and removal
of the base pair insertion yields two complete ORFs without frameshift or nonsense mutations.
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other variables were altered, such as culture pHor nitrogen source
(results not shown). Reperforming all other phenotypic tests with
galactose substituted for glucose revealed no additional changes.
In the presence of both glucose and any other carbon source
tested, the glucose effect was dominant and growth was enhanced
in the mutant at 37°C (Fig. 3). Reintroduction of TGR1 into the
Bt63 tgr1# strain yielded a wild-type phenotype under all condi-
tions tested. To ensure that the truncated tgr1#-309 gene present
in H99 was nonfunctional, we cloned the tgr1#-309/yhp2#-588
fusion construct fromH99 and transformed it into the Bt63 tgr1#
strain. The truncated version was unable to complement the phe-
notype of the Bt63 tgr1# strain on glucose at 37°C (results not
shown).
As extremes of temperature can affect cell wall and cell mem-
brane integrity, we tested the mutant on both glucose and galac-
tose at 30°C and 37°C on compounds that perturb these struc-
tures. No common changes were observed on glucose and
galactose when supplemented with caffeine, calcofluor white, or
SDS; however, the tgr1#mutant grew better than did thewild type
in the presence of Congo red irrespective of carbon source or
temperature and displayed poorer growth on diamide (Fig. 3).
Congo red is thought to interfere with "-1,3-glucan assembly in
the fungal cell wall by binding to the assembling "-1,3-glucan
fibrils and preventing their close interactions, resulting in a loss of
rigidity (27). Diamide oxidizes cellular thiol groups, especially
protein cysteine sulfhydryl bonds, and induces pore formation in
the cell wall (28). Consistent with these effects, supplementation
of the medium with the osmotic stabilizer sorbitol, mannitol, or
sucrose ablated high-temperature differences in growth between
the wild type and mutant on glucose and galactose, as well as
growth on Congo red, suggesting that the phenotype is related to
cellular integrity (Fig. 3).
The second genedisrupted,YHP2, encodes a homeodomain-
containing transcription factor.The second and larger of the two
translocation-associated genes is located on chromosome 11 in
JEC21 (XM_567674), chromosome 11 in WM276
(CGB_K2020C), and supercontig 7 of R265 (CNBG_3081). The
gene is annotated as a single ORF at the Broad Institute (3= end
only) on chromosome 11 (CNAG_01858). Reannotation revealed
that the JEC21, WM276, and R265 annotations all excluded a
section containing a putative homeodomain motif. The gene is
2,377 bp long, contains two introns, and yields a protein of 754
residues. Reciprocal best-hit BLAST analysis using the well-
characterized fungal homeodomain proteins Cup9, Pho2, Tos8,
FIG 3 Reverse genetics in strain Bt63 and phenotypic characterization reveal roles for the two genes disrupted by the translocation observed in strain H99. (A)
The two genes disrupted by the translocation, designated YHP2 and TGR1, were deleted via homologous recombination in the VNB isolate Bt63. Tenfold serial
dilutions of each strain were spotted onto YNB plates supplemented with the indicated carbon source, stressor, or osmotic stabilizer. The complemented strain
Bt63 tgr1# TGR1 displayed the wild-type Bt63 phenotype for all assays where it is not shown. (B) Polysaccharide capsule production visualized as a clear halo
around the cell in an India ink stain. Bar$ 10#m. (C)Melanization of strains on L-DOPA-containingmedium.MelanizedCryptococcus cells turn brown-black.
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Yhp1, Yox1,MATalpha2, andHMRa1 from Saccharomyces cerevi-
siae did not reveal any clear orthologs to the predicted protein.
Further BLAST analysis using just the 60-amino-acid homeodo-
main sequence revealed potential homologs in 25 of the 34 avail-
able basidiomycete genomes, although these display limited sim-
ilarity outside the homeodomain itself. We named the second
gene YHP2, for yeast homeodomain protein 2.
Testing a Bt63 yhp2# mutant on the same variety of nutrient
sources, conditions, and stressors as those for the tgr1# strain
yielded no phenotypes under any conditions (Fig. 3 and results
not shown). No differences were observed between 30°C and
37°C.We also did not notice any epistatic effects on a tgr1# yhp2#
double mutant, which was affected in the same fashion as was the
tgr1# mutant on glucose at 37°C but did not show any novel
phenotypes (Fig. 3).
Melanin production is repressed by the YHP2 transcription
factor.We next investigated effects of the single and double gene
deletions on classical Cryptococcus virulence components: mela-
nin, capsule, extracellular protease, urease, and phospholipase B.
While no changes in production of extracellular proteins were
observed for the tgr1#, yhp2#, and tgr1# yhp2#mutants (results
not shown), all three exhibit a slightly reduced capsule size, which
reverts to wild-type levels in the tgr1# TGR1 and yhp2# YHP2
complemented strains (Fig. 3).While the tgr1#mutant was indis-
tinguishable fromwild-type strains in themelanin assays, both the
yhp2# and tgr1# yhp2#mutants showed a subtle but reproducible
increase inmelanin production at both 30°C and 37°C (Fig. 3). No
changes in mating proficiency, filamentation, or antifungal resis-
tance were observed (see Fig. S3 in the supplementalmaterial; also
results not shown).
Melanization and high-temperature growth on glucose are
multigenic traits. Owing to the reciprocal translocation in chro-
mosomes 3 and 11 of H99, at synapsis in meiosis I H99 chromo-
somes will form quadrivalents with the normal chromosomes 3
and 11 of Bt63. Only parental H99-type or Bt63-type chromo-
somes 3 and 11 should therefore be present together in any prog-
eny, as mixed parent chromosome 3/11 segregants will be unbal-
anced and contain large deletions and duplications that should be
fatal. To test this, we analyzed chromosomes of 16 meiotic prog-
eny of H99 % Bt63 crosses using pulsed-field gel electrophoresis
and probed Southern blots using probes toTGR1 andYHP2. Eight
of the progeny displayed bands consistent with a Bt63 karyotype,
while the remaining eight displayed banding consistent with an
H99 genotype (see Fig. S4 in the supplemental material). No hy-
brid combinations were observed, suggesting that the 50% of
progeny bearing a nonparental set of chromosomes 3 and 11 are
inviable. Consistent with this, basidiospore germination frequen-
cies for two separateH99%Bt63 crosses were below 50%,with the
obtained values of 23.0% and 30.2% implying that further lethal
phenotypesmay have been segregating among the progeny.When
tested for melanization, capsule production, and growth at 37°C
in the presence of glucose, the phenotypes did not cosegregate
with their parental karyotype in the 16 progeny, and we instead
observed a gradient of phenotypes for all three conditions
(Fig. S4). We hypothesize that these traits in Cryptococcusmay be
multigenic traits and that other contributing genes may obscure
segregation of the deletion phenotypes.
Transcription of genes involved in melanin production is
unaffected in the yhp2!mutant.Melanization inCryptococcus is
catalyzed by two laccases, Lac1 and Lac2, and is regulated by the
cyclic AMP (cAMP) pathway, although a variety of proteins and
pathways are known to modulate activity (29). We therefore in-
vestigated potential targets of the Yhp2 transcription factor by
examining changes in gene expression of components of the
cAMP andmitogen-activated protein kinase (MAPK)-protein ki-
nase C (PKC) pathway and the laccase genes LAC1 and LAC2. No
significant changes were observed in any of the genes tested (re-
sults not shown). This suggests that Yhp2 does not alter melaniza-
tion through changes in expression of known signaling pathway
components that control melanization, nor through changes in
levels of LAC1 or LAC2 transcript.
Transcription of HXK1 and components of stress response
pathways are affected in the tgr1!mutant.Changes in growthon
glucose, the most easily assimilable carbon source, have been ob-
served previously in Cryptococcus mutants lacking peroxisome
components (30) or trehalose biosynthesis (31, 32). These
changes potentially involve cellular wall and membrane stresses
and a dysregulation of glycolytic flux. Initially, we determined if
TGR1 gene expressionwas regulated in response to increased tem-
perature using quantitative reverse transcription-PCR (qRT-
PCR). Wild-type Bt63 grown on glucose and galactose at 30°C
showed no significant changes in expression, while strains grown
at 37°C showed an ~4-fold increase in TGR1 expression on glu-
cose (Fig. 4A).
To next investigate if Tgr1 modulates transcription of genes
involved in trehalose metabolism or cellular stress responses, we
analyzed transcript levels of both the wild type and mutant at the
growth-inhibiting temperature of 37°C on two carbon sources. In
addition to six trehalose metabolism genes (TPS1, TPS2, NTH1,
andNTH2; a putative trehalose synthase gene, CCG9; and a puta-
tive phosphotrehalase gene, PTH1), we examined hexokinase I
geneHXK1 and hexokinase II geneHXK2, and components of the
calcineurin/calmodulin pathway, the PKC1-MAPK pathway and
the cAMP pathway. Trehalose biosynthetic genes have previously
been shown in C. gattii to regulate components of the cell wall
integrity MAPK pathway (32), and yeast trehalose biosynthesis
mutants acquire glucose-sensitive (tps1# and tps2#) and thermo-
sensitive (tps2#) phenotypes.
Few significant differences in expression were found for genes
involved in trehalose metabolism, and those were primarily re-
lated to induction or repression based on the carbon source pres-
ent (Fig. 4B).However,HXK1 expressionwas approximately dou-
ble wild-type levels in the tgr1# mutant at 37°C on both glucose
and galactose and thus appears to be a general response of Cryp-
tococcus to loss of the Tgr1 protein. Hexokinase I was also 3-fold
upregulated on galactose in both strains. Expression of stress re-
sponse genes from a variety of pathways revealed six genes that
became unresponsive to galactose-based upregulation in the
tgr1# strain (Fig. 4C). The protein kinase C gene PKC1, the cal-
cineurin A gene CNA1, the MAPK gene HOG1, the Ras protein
geneRAS1, the adenylyl cyclase geneCAC1, and the protein kinase
R gene PKR1were all upregulated 1.5- to 3-fold on galactose com-
pared to glucose in the wild-type strain; this expression change is
abolished in the tgr1#mutant.
Deletion of HXK2 ablates the tgr1! mutant phenotype.
Hexokinase is the entry point for nongalactose hexose sugars into
glycolysis and is tightly regulated. To determine if altered growth
on glucose in the tgr1#mutant is effected through hexokinase, we
examined H99 hexokinase I and hexokinase II mutant strains,
H99 (tgr1#-309) hxk1# and H99 (tgr1#-309) hxk2#, which, by
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virtue of being constructed in H99, also lack TGR1. At 37°C, H99
hxk1# displays normal growth on glucose but reduced growth on
galactose, fructose, and mannose, similar to the phenotype of the
C. gattii R265 hxk1# strain, which shows reduced growth on ga-
lactose (see Fig. S5 in the supplemental material; also results not
shown) (32). In contrast, the H99 hxk2# mutant shows reduced
growth on glucose but not galactose, while the R265 hxk2# strain
displays normal growth on both sugars. Reintroduction of TGR1
intoH99 increases the sensitivity of the strain to high temperature
on glucose, confirming the phenotype observed in Bt63. Subse-
quent reintroduction of TGR1 into the H99 hxk2# mutant does
not further increase the sensitivity of the strain, however. Deletion
of hexokinase II therefore suppresses the phenotype of the tgr1#
mutant in the H99 background.
Metabolite profiling using 1D 1HNMRreveals increased tre-
halose levels in the tgr1!mutant. The Bt63 tgr1#mutant strain
displaysmore robust growth on glucose at 37°C than does thewild
type, suggesting a profound change in intracellular metabolism.
To investigate how deletion of TGR1 affects the metabolome of
Cryptococcus, we performed one-dimensional (1D) proton nu-
clearmagnetic resonance (NMR) spectroscopy onmetabolites ex-
tracted from strains Bt63 and Bt63 tgr1# grown at 37°C on
glucose-containing medium. Correlation of spectral peaks with
existing metabolite databases and chemical shift standards re-
vealed that the spectra were dominated primarily by signals from
sugars, in particular, glucose and trehalose, as well as other me-
tabolites such as succinate, acetate, and glycerol (Fig. 5). To iden-
tify sources of variation between the two strains, we performed a
multivariate analysis employing principal component analysis
(PCA). Therewas clear separation between thewild-type Bt63 and
mutant Bt63 tgr1# strains in the scores plot of principal compo-
nents 1 and 2 (Fig. 5); separation along principal component 2
appeared to contain most of the biological variation between the
two groups. In the corresponding bivariate loadings plot, which
correlates specificmetabolites with either the wild type or themu-
tant, variation in the mutant strain was significantly associated
with higher levels of trehalose, fatty acids, and glycerophospho-
choline and lower levels of glucose and glycerol than those of the
wild type (Fig. 5). Deletion ofTGR1 leading to increased trehalose
levels is consistent with our phenotypic observations, as trehalose
is accumulated in fungi exposed to a variety of stresses, particu-
larly heat (32).
Bt63 tgr1! and yhp2!mutants are unaffected for virulence
in the nematode and murine models of cryptococcosis. Strain
H99 is the type strain of C. neoformans var. grubii and was distrib-
uted to the community to ensure consistency and veracity of re-
search into the organism’s biology and pathogenicity and is the
strain used most widely around the world for virulence assays.
Utilization of a strain altered for processes such as high-
temperature growth and melanization as a standard for virulence
models could have ramifications across the Cryptococcus research
field. To assess the impact on virulence of disruption of these
TGR1 and YHP2 genes in strain H99, we first investigated the
deletion strains in the nematode infection model. There were no
significant changes in survival times for Caenorhabditis elegans
cultured on the Bt63 tgr1#, yhp2#, or tgr1# yhp2#mutants from
the wild-type or complemented strains (Fig. 6). As Yhp2 influ-
ences melanization, we repeated the assay in the presence of the
melanizable substrate l-3,4-dihydroxyphenylalanine (L-DOPA);
however, no change in virulence was apparent for the Bt63 yhp2#
strain (results not shown). Neither Tgr1 nor Yhp2 appears critical
for virulence in the nematode model of cryptococcosis.
As the observedmutant phenotypes occur at 37°C, pathogenic-
ity of bothmutants in amammalian systemwas determined using
the murine inhalation model. Surprisingly, neither the single nor
double mutants were significantly altered for virulence, despite
FIG 4 Expression profiling of TGR1 and genes involved in high-temperature
growth and stress responses. Indicated strains were grown on YNB plus glu-
cose or galactose plates for 2 days. (A) Gene expression analysis of TGR1 in
Bt63 at 30°C or 37°C. (B) Expression analysis of trehalose biosynthesis genes
and the two hexokinases at 37°C. (C) Gene expression quantification of se-
lected genes implicated in high-temperature growth or cellular stress re-
sponses at 37°C. Bars represent means & standard errors of gene expression
relative to that of "-actin (ACT1) from three biological replicates and three
technical replicates. *, P! 0.05; **, P! 0.01; ***, P! 0.001; ****, P! 0.0001
(Student’s two-tailed t test, two sample, equal variance).
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TGR1 and YHP2 affecting multiple cryptococcal virulence factors
in vitro (Fig. 6). The mutants also displayed wild-type patterns of
dissemination, with comparable burdens found in the lungs,
brain, liver, spleen, and kidneys (see Fig. S6 in the supplemental
material). If there are changes to virulence from these mutants,
they are not detectable in this genetic background, although dif-
ferencesmay be apparent under certain conditions, such as within
an immunocompromised host or by using a lower initial inocu-
lum. Futuremolecular and pathogenesis studies utilizingH99will
carry an implicit caveat that the strain is atypical for virulence
traits and carbon metabolism.
DISCUSSION
Chromosomal rearrangements can contribute to reproductive
isolation between closely related fungi and the generation of phe-
notypic diversity. Variations in karyotype are observed in both
clinical and environmental isolates of pathogenic fungi and fre-
quently arise during the infection process (33, 34). Genomic mi-
croevolution in Cryptococcus and Candidamay potentially repre-
sent an adaptive mechanism within the host environment (22),
and changes in karyotype are associated with drug resistance, al-
tered virulence components, and pathogenicity in animal models
(35). Such changes are generally tolerated since pathogenic fungi
can reproduce mitotically and sexual reproduction and meiosis
may be infrequent (36).
Elegant studies utilizing comparative genomics and parsimony
analysis have detailed the structural evolution of the genome
among the yeasts of the Saccharomycotina. The Saccharomyces
sensu stricto complex yeasts Saccharomyces paradoxus, Saccharo-
myces mikatae, and Saccharomyces bayanus are separated from
S. cerevisiae by ~5 to 20million years, similar to theC. neoformans
var. grubii and C. neoformans var. neoformans estimated diver-
gence time of ~24.5 million years (15), and are a useful compari-
son. Relative to the S. cerevisiae genome, S. paradoxus possesses
four inversions and three duplications, S. mikatae possesses four
translocations and 13 inversions, and S. bayanus possesses five
translocations and three inversions (12). The 20 inversions (1 to
30 kb in size) were all flanked by tRNA genes, while one of the
duplications (4 to 18 kb in size) and all the translocations were
associated with the presence of transposable elements. Our anal-
ysis revealed thatC. neoformans var. grubii possesses six inversions
(~7 to 81 kb in size) and one duplication (~6 kb in size) that are
unique. These were of a similar size as those observed in the Sac-
charomyces sensu stricto complex yeasts, and all but one were as-
sociated with a repeated element at the breakpoints, suggesting
that the rearrangements are associated with transposon move-
ment and insertion in the genome.
Recently, D’Souza et al. (16) used synteny analysis to compare
the genome of C. gattii VGI strain WM276 with both the C. gattii
VGII strain R265 and C. neoformans var. neoformans VNIV strain
B3501A genomes. While the C. gattii genomes were broadly co-
linear, there were widespread rearrangements between the two C.
gattii genomes and the C. neoformans var. neoformans genome,
including multiple large inversions and translocations associated
with transposable elements. The presence of extensive chromo-
somal rearrangements that differentiate C. gattii from C. neofor-
mans var. neoformans would be expected to significantly impair
recombination and chromosome pairing at meiosis and is consis-
tent with a contribution towards speciation (16). Our investiga-
tion revealed that only a small number of rearrangements



FIG 5 Metabolomics analysis of Bt63 and the tgr1#mutant strain. (A) 1D
proton NMR spectra of wild-type (top, blue) and tgr1# mutant (bottom,
red) strains. Spectra of representative samples for each strain are shown.
(B) Principal component analysis scores plot for the wild-type and tgr1#
mutant strains. The distance between the points is an indicator of
similarity between the samples. (C) Bivariate loadings line plot. The line
plot displays on the loadings coefficient axis the correlation coefficients
that relate individual integral regions of the NMR spectrum to the PC2
axis of the scores plot. Individual peaks correspond to peaks in the 1D
NMR spectra; here, peaks that are positive indicate metabolites that are
increased in the wild-type Bt63 while negative peaks are increased in the
tgr1# mutant. The overlaid heat map relates the correlation of the peak to
the PC2 axis of the scores plot when using Pareto scaling instead of center
scaling.
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uniquely distinguishC. neoformans var. grubii fromC. neoformans
var. neoformans, and the profound differences in virulence char-
acteristics and epidemiology may instead be conferred at the nu-
cleotide level. Accordingly, the overall nucleotide sequence diver-
gence level between C. neoformans var. neoformans and C.
neoformans var. grubii, between 10 and 15%, is substantial and
suggests potential speciation (17).
The widely distributed C. neoformans var. grubii type strain
H99 forms the foundation formolecular and pathogenesis studies
in C. neoformans var. grubii. Unfortunately, it is not possible to
determine when the translocation occurred, though the absence
of additional mutations in both disrupted genes suggests that it
was very recent. While it is tempting to suggest that a chromo-
somal rearrangement that enhanced growth at host body temper-
ature and increased production of two key virulence components
may have arisen during infection, in vivo virulence studies using
nematodes and mice suggest that the gene disruptions did not
increase pathogenicity, though they may confer an advantage un-
der specific host conditions or in a different strain background. If
the translocation occurred during laboratory passage, it was prior
to the distribution of the strain to the wider community as key
subcultures all contain it.
The only phenotypes that we could ascribe to the YHP2 gene
product were slight repression of melanization and capsule pro-
duction.Wewere excited at the prospect of a potential regulator of
melanin production, a key virulence com-
ponent of Cryptococcus. However, no
changes in expression of melanization-
related genes were observed in the Bt63
yhp2#mutant, and since the perturbation
of melanin production is very modest,
this may be a pleiotropic effect or Yhp2
may instead regulate proteins that poten-
tiate melanin production through other
mechanisms, such as uptake of diphenolic
precursors or cell wall deposition. Despite
the fact that certain subcultures of H99
mate poorly and that homeodomain pro-
teins often regulate developmental pro-
cesses or sexual reproduction (37), nei-
ther YHP2 nor TGR1 appears relevant to
mating, as we did not observe any changes
to hyphal growth or proliferation in uni-
lateral and bilateral crosses using one or
both disrupted genes. Future transcrip-
tomic analysis of Bt63 and Bt63 yhp2#
may identify the regulatory targets of the
Yhp2 protein.
Trehalose is protective against heat
stress and various other cellular stresses in
fungi including cell wall stress. Trehalose
biosynthesis mutants grow more poorly
on glucose at elevated temperatures due
to dysregulation of glycolysis and flux
through hexokinase II (38); while os-
motic stabilizers rescue the phenotype,
temperature sensitivity is not restricted to
glucose but is common to other hexose
sugars and some disaccharides. Our tgr1#
phenotype, however, is restricted solely to
glucose and is not observed on any other hexose or disaccharide,
implying that glucose may produce this effect extracellularly.
Metabolomics analysis revealed that, primarily, trehalose levels
increased and glucose levels decreased in the mutant strain, con-
sistent with our observed phenotype. The cAMP-protein kinase A
(PKA) pathway in Saccharomyces responds to extracellular glu-
cose stimulus, and intriguingly, a low level of cAMP or reduced
PKA pathway activity causes increased heat and stress resistance
and accumulation of trehalose (39). As the phenotype is similar,
Tgr1 in Cryptococcus may potentially modulate cAMP levels di-
rectly or indirectly in response to an extracellular glucose signal.
DisruptionofTGR1 andYHP2 as a result of theH99 translocation
will require some caution to be adopted when interpreting genetic,
biochemical, and virulence data for the C. neoformans var. grubii ge-
nome strain, particularly in regards to carbonmetabolism and signal
transduction.As a corollary, thewell-characterized S. cerevisiae strain
S288c possesses a nonsensemutation in FLO8, encoding a transcrip-
tion factor responsible for activation of FLO11 (40). Lack of Flo11
prevents flocculation and pseudohyphal growth in diploids and in-
vasive growth in haploids in S288c, which is not useful for such stud-
iesbut remainsagoodmodel forotherprocesses.Whilevirulencewas
unaffected in C. neoformans var. grubii in two model systems, high-
lighting that many components beyond traditional virulence factors
contribute to successful infectionofahost,undoubtedly there remain
undiscoveredepistatic interactions forbothgenes thatpotentially im-
FIG 6 Virulence of translocation gene mutants in the nematode and murine inhalation models of
cryptococcosis. (A) Survival times of N2 Bristol nematodes cultured on Bt63, tgr1#, tgr1# TGR1,
yhp2#, yhp2# YHP2, and tgr1# yhp2# strains. (B) Virulence of translocation mutant strains tested in
vivo using amousemodel system.Nonematodes ormice infectedwithmutant strains were significantly
different from those infected with wild-type Bt63.
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pact pathogenesis. Crucially, each single-gene-deletion strain created
usingH99, including theC. neoformans var. grubii gene deletion col-
lection, is effectively a triple deletion strain. Strain H99 has a well-
established virulence profile, however, andwill remain an important
model system for cryptococcal pathogenesis.Carbonmetabolismhas
not been extensively characterized in C. neoformans var. grubii to
date, and this perhaps should be conducted in a separate genetic
background from H99. Signaling pathways, however, have been in-
tensively investigated in Cryptococcus, and identification of a defini-
tive role for Tgr1 in signal transduction may require some reevalua-
tion or reinterpretation of established interactions and cellular
responses.
MATERIALS AND METHODS
Strains and media. Cryptococcus strains utilized in this study are listed in
Table S1 in the supplemental material. Strains representing VNI AFLP
clades were selected from the work of Litvintseva et al. (41). For the trans-
location PCRs, six H99 subcultures were assayed: from the Heitman lab,
H99 #1 (the closest subculture to the original Perfect lab isolate), H99
Wimp, H99 Stud, and H99 #4413. A mixed H99 stock including H99 #1
was passaged through a rabbit and became Stud, and H99 #4413 was a
subculture of Stud. From the Lodge lab, we assayed H99 Eunuch, and
from the Madhani lab, we assayed H99 CM018, which was derived from
Eunuch and is the strain in which the Cryptococcus gene deletion collec-
tion is being constructed. Wimp and Eunuch were derived from H99 #1
and display attenuated virulence. H99 #1 melanizes poorly while Wimp,
Eunuch, and CM018 do not melanize at 37°C. Eunuch and CM018 are
sterile while Stud has increased mating proficiency. We also assayed the
congenic mating pair KN99a and KN99$, which were derived from H99
#4413; theVNIMATa isolate 125.91; and theVNIIMAT$ isolate 8-1 (42).
Cloning applications were performed in the Escherichia coli strain
MACH1 (Life Technologies, Carlsbad, CA). All chemicals were obtained
from Sigma (St. Louis, MO), except nourseothricin (clonNAT), which
was fromWerner BioAgents (Jena, Germany).
Bioinformatics.TheunpublishedC. neoformans var. grubii strainH99
genome is available at the Broad Institute (http://www.broadinstitute.org
/annotation/genome/cryptococcus_neoformans/MultiHome.html). Se-
quence manipulation and dot plot analysis were performed using
MacVector 11.0 (MacVector, Cary, NC). Synonymous and nonsynony-
mous substitution rates were determined using PAL2NAL (43). Se-
quences forTGR1 andYHP2 fromBt63 are available fromGenBankunder
nucleotide accession numbers JQ302192 and JQ302193, respectively.
Molecular techniques.Detailsof routinemolecular techniquesaregiven
in Text S1 in the supplemental material. Oligonucleotides utilized in this
study are presented in Table S2. TGR1 and YHP2were amplified from Bt63,
cloned into pCR2.1-TOPO (Life Technologies), and subcloned into pJAF1
(44) and pPZP-NAT (45), respectively. The TGR1/YHP2 fusion gene was
amplified fromH99, cloned into pCR2.1-TOPO, and subcloned into pJAF1.
Phenotypic and virulence factor assays. Extensive details of pheno-
typic assays and virulence factor assays are given in Text S1 in the supple-
mental material.
Nematode and murine virulence assays. Virulence of the deletion
strains was examined using the Cryptococcus nematode model as de-
scribed elsewhere (46) usingCaenorhabditis elegans strainN2Bristol.Mu-
rine infection was performed according to the protocol of Cox et al. (47)
using 7-week-old BALB/cmice (Animal Resources Centre, Canning Vale,
Australia). Tenmice per strain were infected via nasal inhalation with 1%
105 Cryptococcus cells. Mice were monitored for signs of distress or sick-
ness and sacrificed using CO2 once their body weight had decreased by
20%. Organs were harvested from three mice per strain (the second, fifth,
and ninth mice to die), homogenized, and plated to determine fungal
CFU per gram organ weight. Kaplan-Meier survival analysis was per-
formed using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA).
Statistical significancewas determined using a log-rank test, with aP value
of!0.05 being considered significant. Murine virulence assays were con-
ducted in accordancewith the guidelines in theAustralian code of practice
for the care and use of animals for scientific purposes from the National
Health and Medical Research Council and were approved by the Univer-
sity of Queensland Molecular Biosciences Ethics Committee (AEC#
SCMB/008/11/UQ/NHMRC).
Quantitative real-time PCR. Gene expression analysis via qRT-PCR
was performed as described elsewhere (48). Strains were grown on yeast ni-
trogenbase (YNB)plus 2%glucose andYNBplus 2%galactose plates at 37°C
or in liquid melanization medium (with or without L-DOPA) at 30°C and
were harvested after 24 h. cDNA was synthesized using Superscript III (Life
Technologies). Real-time PCR primers are found in Table S2 in the supple-
mental material. Relative gene expression was evaluated using the threshold
cycle (2'##CT) method normalized against "-actin. Statistical significance
was determined using an unpaired Student’s t test inGraphPadPrism,where
P! 0.05 was considered significant.
1D 1HNMR spectroscopy. Bt63 and Bt63 tgr1# strains were cultured
on YNB plus 2% glucose at 37°C, harvested after 48 h, and lyophilized.
Metabolite extraction was performed using the yeast extraction protocol
of Lewis et al. (49). For 1H NMR analysis, extracts were resuspended in
100 mM potassium phosphate buffer (pH 7.4), 10% D2O, 18 #M 2,2-
dimethylsilapentane-5-sulfonic acid (DSS), and 18 #M 1,1-difluoro-1-
trimethylsilanylphosphonic acid in 5-mm NMR tubes. NMR spectros-
copy was performed on a Bruker AV500 500-MHz spectrometer (Bruker
Biospin, Rheinstetten, Germany), equipped with a 5-mm self-shielded
z-gradient triple resonance probe. Spectra were measured manually at
298 K with 200 scans at 32k resolution with a spectral width of 14 ppm,
using the noesy1prd pulse program (Bruker pulse program library). Low-
power continuous wave irradiation was applied during themixing time of
100 ms and relaxation delay of 2.3 s to suppress the water signal.
Metabolite profiling. 1D spectra were processed using Topspin 3.0
(Bruker Biospin). Spectra were reduced to 0.001-ppm integral regions
using AMIX 3.6.6 (Bruker Biospin); regions corresponding to the water
signal were excluded (%$ 4.5 ppm to 5.05 ppm), and data were normal-
ized to the total intensity of the spectrum. Principal component analysis
(PCA) with center scaling was performed in SIMCA-P( 12.0 (Umetrics
AB, Sweden). The refined model comprised 15 samples and contained 2
principal components, with an R2X value of 0.83 and a Q2 value (from
cross-validation) of 0.684. To gauge the contributions fromweaker NMR
signals more accurately, the 1D loading plot of principal component 2 of
the center-scaled model was heat mapped with the corresponding load-
ings coefficients from a Pareto-scaled PCA model (5 principal compo-
nents; R2X $ 0.837, Q2 $ 0.47). Metabolites were identified using Che-
nomx NMR suite 7.1 (Chenomx, Edmonton, Canada) and the public
databases BioMagRes Data Bank (http://www.bmrb.wisc.edu) and Hu-
man Metabolome Data Bank (http://www.hmdb.ca).
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Abstract
We have investigated the potential of the GTP synthesis pathways as chemotherapeutic targets in the human pathogen
Cryptococcus neoformans, a common cause of fatal fungal meningoencephalitis. We find that de novo GTP biosynthesis, but
not the alternate salvage pathway, is critical to cryptococcal dissemination and survival in vivo. Loss of inosine
monophosphate dehydrogenase (IMPDH) in the de novo pathway results in slow growth and virulence factor defects, while
loss of the cognate phosphoribosyltransferase in the salvage pathway yielded no phenotypes. Further, the Cryptococcus
species complex displays variable sensitivity to the IMPDH inhibitor mycophenolic acid, and we uncover a rare drug-
resistant subtype of C. gattii that suggests an adaptive response to microbial IMPDH inhibitors in its environmental niche.
We report the structural and functional characterization of IMPDH from Cryptococcus, revealing insights into the basis for
drug resistance and suggesting strategies for the development of fungal-specific inhibitors. The crystal structure reveals the
position of the IMPDH moveable flap and catalytic arginine in the open conformation for the first time, plus unique,
exploitable differences in the highly conserved active site. Treatment with mycophenolic acid led to significantly increased
survival times in a nematode model, validating de novo GTP biosynthesis as an antifungal target in Cryptococcus.
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Introduction
Fungal infections of humans are highly refractive to pharma-
cological intervention due to the similarities in eukaryotic cell
physiology. The limited array of fungal cell-specific features has
therefore been the focus of antifungal drug research for many
years, with the fungal cell wall and cell membrane being primary
targets. Recent studies exploring potential drug targets in fungal
genomes have found a surprisingly small number of essential
targets with little identity to a human homologue [1–4]. An
alternate approach to targeting fungal-specific components is
therefore to instead target shared proteins that are well charac-
terized in both the host and pathogen, and exploit more subtle
differences between the two. This approach is exemplified by the
novel antifungal sordarin and its derivatives [5,6].
One of the leading life-threatening fungal infections worldwide
is cryptococcal meningitis caused by Cryptococcus neoformans, a
pathogen that infects primarily immunocompromised individuals,
and its sister species Cryptococcus gattii, which generally infects
immunocompetent individuals [7]. The estimated annual global
incidence of cryptococcal meningitis is estimated to be 1.1 million
cases annually, causing ,624,000 deaths per year, mostly in areas
with high HIV rates, such as sub-Saharan Africa. These are
alarming numbers for a pathogen whose treatment regimen has
not altered significantly in over a decade [8–10]. Treatment of
systemic fungal infections predominantly relies on a small group of
antifungals comprising azoles, polyenes, echinocandins and the
antimetabolite flucytosine. Numerous problems exist with these
treatments however, including their notoriously variable efficacy
across the limited spectrum of human fungal pathogens, high cost
and toxicity, a frequent requirement for hospitalization, and
emerging drug resistance [10,11]. The design of new classes of
effective, readily available and affordable antifungals is therefore a
matter of urgency.
Rational drug design was pioneered in the purine metabolic
pathway, a conserved series of processes responsible for providing
the cell with a ready supply of ATP and GTP as both an energy
source and for critical cellular processes including replication,
transcription, translation and signal transduction. This pathway
has continued to serve as a fertile source of therapeutic agent
development for over fifty years [12], and growing evidence
supports it as a potential source of effective antifungal targets.
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Disruption of de novo ATP or GTP biosynthesis genes in Candida
albicans and Aspergillus fumigatus leads to complete avirulence in
mammalian models [13–15]. In Cryptococcus, mutations that
globally affect ATP and GTP biosynthesis lead to attenuated or
complete loss of virulence in vivo, as well as general growth defects
and impaired virulence factor expression [16,17].
Two key enzymes supplying guanine nucleotides to a cell are
inosine monophosphate (IMP) dehydrogenase (IMPDH), the rate-
limiting catalyst and first committed step of de novo GTP
biosynthesis, and hypoxanthine-xanthine-guanine phosphoribosyl-
transferase (HXGPRT), responsible for recycling purine nucleo-
bases into nucleoside monophosphates in the GTP and ATP
salvage pathways. As a key metabolic enzyme, IMPDH is highly
expressed in proliferating cells and has become a major target of
immunosuppressive and antiviral chemotherapy, and has attracted
great interest as an anticancer, antiprotozoal, antibacterial and
antifungal target [18–21]. Four IMPDH inhibitors are currently
approved for treatments: the immunosuppressants mycophenolic
acid (MPA) and mizoribine, the anticancer agent tiazofurin, and
the antiviral ribavirin. There are significant structural and
functional differences between microbial and human IMPDHs,
suggesting that species-specific inhibitors of key metabolic
pathways hold considerable potential as novel therapeutics
[19,21–23]. In this study we have investigated the potential of
the GTP biosynthesis pathway and the enzymes IMPDH and
HXGPRT as candidate antifungal targets using genetic, structural
and functional approaches to validate purine metabolism as a
viable chemotherapeutic target in C. neoformans.
Results
Purine metabolism in Cryptococcus lacks several
canonical pathway elements
Unlike the purine-rich pigeon guano natural environment of C.
neoformans, the human central nervous system inhabited during systemic
infection is purine-poor [24], suggesting that during infection de novo
purine synthesis could be important for cell survival. A bioinformatic
survey of the available C. neoformans and C. gattii genomes to identify
components of the purine biosynthetic pathway identified Cryptococcus
homologs of most genes of the canonical purine pathway (Figure 1A),
with the exception of adenosine deaminase, adenine deaminase, and
GMP reductase. As previously reported [25], xanthine dehydrogenase
is also absent but a potential equivalent, an a-ketoglutarate-dependent
dioxygenase, is present. Each gene identified is present as a single copy,
including those encoding two key components of the GTP biosynthetic
pathway: IMPDH required for de novo GTP synthesis (IMD1) and a
phosphoribosyltransferase (PRTase) required for the GTP salvage
pathway (HPT1).
IMPDH is essential for de novo GTP biosynthesis
IMPDH performs the rate-limiting, first step in de novo GTP
biosynthesis, the NAD+-dependent conversion of inosine mono-
phosphate (IMP) to xanthosine monophosphate (XMP) via a two-
step oxidation and hydrolysis reaction. The reaction mechanism is
complex and involves a large conformational change mid-reaction,
which a number of inhibitors exploit [26–30]. To determine if the
C. neoformans IMD1 gene encodes a bona fide IMPDH, we deleted it
in the well-characterized C. neoformans var. grubii strain H99. The
imd1D strain was a guanine auxotroph and could not grow on
minimal medium (Figure 1B). Supplementation of the medium
with exogenous guanine restored growth, which we later showed
was via a salvage pathway. Introduction of the E. coli IMPDH guaB
into the deletion mutant fully restored growth on minimal
medium, confirming that the IMD1-encoded enzyme performs
the conversion of IMP to XMP (Figure 1B). Finally, the imd1D
phenotype could be mimicked by the addition of the IMPDH
inhibitor MPA to the growth medium; both the wild-type and
IMD1 complemented strains were equally sensitive to MPA at low
concentrations (5 mg/mL). This phenotype is abolished when the
media is supplemented with guanine, as the salvage pathway is
able to bypass the block at IMPDH.
imd1D rescue via purine salvage is mediated by
phosphoribosyltransferase Hpt1
Purines present in both the bird guano ecological niche of
Cryptococcus and within the human host are potential substrates of a
GTP salvage pathway. Purine salvage is mediated by PRTase
enzymes, which catalyze the transfer of a ribose 5-phosphate-
derived phosphoribosylpyrophosphate group to guanine or other
purine nucleobases [31]. Upon deletion of the identifiedHPT1 gene
in strain H99, the mutant exhibited wild-type growth on rich and
minimal media (Figure 1B). MPA-mediated growth inhibition was
abolished by the presence of guanine in all strains but the hpt1D
mutant, demonstrating that Hpt1 mediates salvage of guanine
(Figure 1B). Heterologous expression of the E. coli PRTase gpt in the
hpt1Dmutant restored wild-type growth on guanine, confirming the
role of the C. neoformans gene as a PRTase. Further testing revealed
that Hpt1 could accept hypoxanthine, xanthine and guanine as
substrates, defining the enzyme as a hypoxanthine-xanthine-
guanine phosphoribosyltransferase (HXGPRT) (Figure S1).
Loss of IMPDH delays synthesis of the cryptococcal
polysaccharide capsule and melanin
As GTP biosynthesis is crucial to many cellular processes, we
sought to determine if guanine auxotrophy affected pathogenicity
via effects on virulence factor production. Despite addition of
guanine, the wild-type phenotype was not completely restored in
the imd1D mutant, which exhibited slow growth at 30uC and was
unable to grow on rich media. Accordingly, in a growth curve
assay the imd1D mutant had an extended lag phase of almost
48 hours compared to wild-type and reached a much lower final
cell density (Figure 2A). In capsule-inducing conditions the imd1D
Author Summary
The fungal pathogen Cryptococcus neoformans is respon-
sible for up to a million deaths annually, and the currently
available antifungal medicines used to combat this
infection are limited and patently inadequate. We have
investigated the GTP biosynthesis pathway as a new drug
target, a pathway that has been a chemotherapy target in
humans for many years. We found that inhibiting or
deleting one specific enzyme in this pathway, IMP
dehydrogenase, was extremely effective at weakening
Cryptococcus as a pathogen or killing it outright. Intrigu-
ingly, we isolated an extremely rare Cryptococcus isolate
that was naturally drug resistant, suggesting that microbial
competitors of Cryptococcus may also use this strategy to
out-compete it in the wild. By comparison of the subtype
responsible for the majority of infections worldwide with
this rare drug resistant form, we have characterized the
enzyme’s structure and mechanism, revealing a number of
strategies to develop more potent and specific anti-IMP
dehydrogenase drugs for Cryptococcus. Treating nema-
todes grown on Cryptococcus with the inhibitors led to
longer survival times for the worms, validating our
strategy.
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strain showed a significantly smaller capsule after 24 hours at both
30uC and 37uC (Figure 2B), approximately one-third and one-
quarter smaller, respectively. Capsule size after extended growth
($96 hours) was similar to wild-type (data not shown). On solid
melanization media the imd1D mutant demonstrated reduced
melanin production at both 30uC and human body temperature
of 37uC (Figure 2C), although this defect was not apparent in liquid
L-DOPA medium (Figure S2). Elaboration of hyphae was notably
attenuated in matings involving an imd1D mutant created in an
isogenicMATamating-type background, while the imd1Dmutant in
the MATa mating-type background was unaffected (Figure 2D). In
contrast to the pleiotropism of the imd1D mutation, the hpt1D
mutant showed no apparent defect in growth at human body
temperature, capsule production, or melanization at either 30uC or
37uC, and loss of Hpt1 also appeared to have no effect on hyphal
filamentation during mating (Figure 2B, C, D and data not shown).
The GTP salvage pathway is dispensable for C.
neoformans virulence in two animal models
GTP salvage pathways are known to play an important role in
recycling metabolically expensive guanine nucleobases and main-
taining purine homeostasis. Although the hpt1D salvage deficient
mutant showed no phenotype on rich or minimal media, we
hypothesized that as the infection process might pose a greater
metabolic strain, this enzymatic function may play an important
role. We cultured Caenorhabditis elegans, a natural predator of
Cryptococcus, on the wild-type, hpt1D and hpt1D HPT1 strains. No
significant difference was observed between survival times of the
worms on the three strains on either rich or minimal media
(Figure 3A). The addition of guanine to both the minimal and rich
media again produced no significant difference between the three
strains (data not shown), indicating that Hpt1-dependent salvage
of purines is dispensable in the nematode model. We also tested
the impact of loss of HPT1 on virulence in the murine inhalation
model of cryptococcosis. Again, there was no significant difference
between the three strains (Figure 3B). Despite the extra stresses of
increased temperature and the murine immune system, de novo
purine biosynthesis alone proved sufficient for full virulence of
Cryptococcus in a mammalian host.
Figure 1. Components of the purine metabolic pathway in Cryptococcus. (A) BLASTp analysis using S. cerevisiae orthologs reveals that the
majority of the components of the canonical purine biosynthetic pathway are present in the genome of C. neoformans var. grubii. Enzymes or
activities missing are greyed. (B) 10-fold serial dilutions of indicated strains were spotted onto YNB medium supplemented with specified purines
(1 mM) and/or MPA (5 mg/mL) and incubated for two days at 30uC. The imd1D deletion strain is an auxotroph; MPA mimics the effect of an imd1D
deletion, while E. coli guaB is highly resistant to MPA. A phenotype for the hpt1D strain is only observed in the presence of MPA.
doi:10.1371/journal.ppat.1002957.g001
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De novo GTP biosynthesis is critical to cryptococcal
virulence in vivo
Metabolic enzymes in Cryptococcus have been shown previously
to play ‘moonlighting’ roles in virulence, most famously urease
[32,33], and some are found in extracellular vesicles of virulence
components secreted by Cryptococcus, including IMPDH [34,35]. In
the C. elegans virulence model on standard worm assay rich media
or rich media supplemented with exogenous guanine, the imd1D
strain did not display any significant difference in killing from the
wild-type strain H99 or the complemented strain imd1D IMD1
(Figure 3C and data not shown). On minimal media lacking
guanine however, the imd1D strain was severely compromised for
virulence (p,0.0001) in the worm.
We next assessed the requirement for the GTP de novo pathway
using the murine inhalation model of cryptococcosis. As in the
nematode minimal media model, the imd1D mutant was unable to
kill mice, even after 50 days (p,0.0001; Figure 3D). Certain
functions of IMPDH are therefore critical for successful infection
of a mammalian host by Cryptococcus. To more precisely examine
the effect of loss of IMPDH on Cryptococcus, we determined the
fungal burden for the imd1D strain for various organs at multiple
timepoints during murine infection. Compared to the proliferation
and dissemination that occurs during a wild-type infection, imd1D
cell counts dropped rapidly after initial inoculation and the strain
Figure 2. Contribution of purine biosynthesis genes to the virulence component of Cryptococcus. (A) Strains were grown for five days in
RPMI 1640 media supplemented with 10% serum and monitored spectrophotometrically at 600 nm. (B) C. neoformans capsule biosynthesis was
examined by growth in RPMI 1640 media plus 10% serum for 16 hours at 30uC and visualized using India ink; the halo of clearance denotes the
capsule. Scale bar is 10 mm. Capsular diameter was measured relative to cellular diameter using CellProfiler image analysis software. Bars denote the
average relative diameter from three biological replicates. Standard error bars are shown; p,0.05 *; p,0.01 **; p,0.001 ***; p,0.0001 ****. (C)
Melanin production was determined on Cryptococcus L-DOPA melanization plates incubated for two days. (D) Mating proficiency was assayed by co-
culturing strains on Murashige-Skoog or V8 medium in the dark for two weeks at 25uC. Magnification is 406. All assays involving the imd1D strain
were supplemented with 1 mM guanine.
doi:10.1371/journal.ppat.1002957.g002
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was not found in the lungs after just seven days (Figure 4A). Cells
were found in the brain on day one (CFU=328/g), although after
three days these were no longer present. No dissemination to the
spleen, liver or kidneys was observed (data not shown). It is
unusual for cells to be recovered from the brain at 3 days after
intranasal infection, which typically take at least 7 days to
disseminate to the CNS from the lungs [36]. By comparison, at 14
days post infection when we observed total clearance, the wild-
type strain is expected to have a log CFU/g of,8 in the lungs and
,5 in the brain [37].
IMPDH inhibitors protect C. elegans from infection in the
nematode model of cryptococcosis
To validate IMPDH as an antifungal chemotherapeutic target
in vivo, we utilized the C. elegans model of cryptococcosis to test the
effect of IMPDH inhibitors on survival times. Nematodes were
cultured on Cryptococcus in the presence of three concentrations of
MPA in the media (5, 10 and 20 mg/mL) under typical assay
conditions. As a control we simultaneously cultured nematodes in
the presence of the fungistatic antifungal fluconazole (5 mg/mL).
C. elegans cultured on Cryptococcus plus fluconazole displayed
significantly enhanced survival (p,0.01). The addition of 10 or
20 mg/mL MPA also significantly enhanced survival times of
worms (p,0.01; p,0.01) (Figure 4B). MPA is toxic to C. elegans
with a LD50 of ,90610 mM (28.8 mg/mL) [38], however, the
lower concentrations of MPA utilized appear tolerable and
protective against C. neoformans infection; similar effects have been
demonstrated with fluconazole, which is toxic to the worm at
concentrations of ,100 mg/mL but is protective against C. albicans
infection at up to 32 mg/mL [39]. Control experiments did not
reveal significant changes in mortality in worms cultured on
20 mg/mL MPA plus a food source versus worms on a food source
alone (Figure S3).
With the exception of a rare subtype, Cryptococcus is
sensitive to the IMPDH inhibitor MPA
Based on our virulence studies, Imd1 but not Hpt1 could serve
as a potential antifungal target. To test this hypothesis, the
sensitivity of the entire Cryptococcus species complex to two IMPDH
inhibitors, MPA and mizoribine, was examined. The C. neofor-
mans/C. gattii species complex consists of eight haploid molecular
subtypes, VNI, VNII, VNIII and VNB of C. neoformans and VGI,
VGII, VGIII and VGIV of C. gattii, which vary in their
distribution, ecology and epidemiology [40,41]. While other
fungal pathogens such as C. albicans are sensitive to mizoribine
inhibition at very low concentrations, we did not observe any
impact on Cryptococcus, even when high concentrations were used
(100 mg/mL) in both MIC and serial dilution plate assays (data not
shown) [21]. All subtypes were highly sensitive to low concentra-
tions of MPA (5 mg/mL) in defined minimal medium, with one
exception: the rare C. gattii VGIV molecular type (Figure 5A).
Broth microdilution susceptibility assays supported this finding
(Figure 5B). To confirm this observation, we tested a further 106
isolates and again found that the eight VGIV isolates in this
Figure 3. Virulence of imd1D and hpt1D in invertebrate and mammalian host systems. (A) Survival of Bristol N2 strain nematodes co-
cultured with indicated Cryptococcus strains cultured on rich Brain Heart Infusion medium or minimal YNB medium at 25uC. (B) Survival of female
BALB/c mice infected with 56105 cells via nasal inhalation. (C) Virulence of indicated Cryptococcus strains co-cultured with nematodes on rich and
minimal medium at 25uC. (D) Virulence of the imd1D mutant in BALB/c mice infected with 56105 cells via nasal inhalation. Virulence was determined
using Kaplan-Meier survival analysis with statistical significance determined using a log-rank test. Survival times were not significantly different for the
hpt1D strain in either model. imd1D was significantly attenuated in the nematode model on minimal medium (p,0.0001) and in the murine model
(p,0.0001).
doi:10.1371/journal.ppat.1002957.g003
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Figure 4. IMPDH is essential for pathogenicity in murine and nematode hosts. (A) Fungal burden of imd1D cells recovered from the lungs
and brain of BALB/c mice infected with 56105 cells via nasal inhalation. Bars represent mean colony-forming units (CFU)/g 6 standard error. (B) N2
Bristol young adult nematodes were co-cultured with C. neoformans wild-type strain H99 on minimal medium supplemented with 5, 10 or 20 mg/mL
MPA or 5 mg/mL fluconazole. MPA significantly enhanced nematode survival over eight days, as did fluconazole treatment; p,0.05 *; p,0.01 **.
doi:10.1371/journal.ppat.1002957.g004
Figure 5. The C. gattii VGIV molecular type is resistant to MPA. (A) Resistance to the IMPDH inhibitor MPA was assessed in all haploid
molecular types of the pathogenic C. neoformans/C. gattii species complex using a serial dilution spotting assay on YNB plus 5 mg/mL MPA. (B) Precise
sensitivity to MPA was determined via MIC broth microdilution assay. MIC50 and MIC90 are the concentrations at which growth was inhibited by 50%
or 90%, respectively. Standard error bars are displayed for all strains.
doi:10.1371/journal.ppat.1002957.g005
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collection were easily identified by their MPA resistance, while all
others were sensitive (data not shown). VGIV MPA resistance was
uniform and 100% reproducible, supporting this as an inherent
characteristic of the VGIV molecular type.
We reasoned that resistance to MPA could arise from mutations
in the IMD1 ORF, overexpression of Imd1, increased IMD1 copy
number, or changes in drug uptake or efflux from the cell. To
determine if MPA resistance could result from changes in
expression level of IMPDH in C. gattii VGIV, we assessed the
transcriptional response of C. neoformans (strain H99) and C. gattii
(strain MMRL2651) IMD1 to challenge by guanine and MPA via
qRT-PCR. After treatment with guanine, both C. neoformans and C.
gattii IMD1 were significantly downregulated, consistent with de
novo GTP synthesis not being required when abundant salvageable
guanine is present (Figure S4). Importantly, no real difference was
observed between the two strains’ responses to either substrate or
inhibitor, suggesting that resistance to MPA may in fact be an
intrinsic property of the VGIV IMPDH isoform. To determine if
either copy number or a feature of the C. gattii VGIV IMD1 allele
(CgIMD1) confer MPA resistance, we introduced both the C.
neoformans var. grubii VNI allele (CnIMD1) from the MPA-sensitive
strain H99 and CgIMD1 from the MPA-resistant strain
MMRL2651 into wild-type H99 and the imd1D mutant. In the
wild-type H99 background, introduction of a second copy of
CnIMD1 resulted in only a very modest increase in MPA
resistance, while introduction of the CgIMD1 allele was sufficient
to enable robust growth and VGIV-level resistance to MPA
(Figure 6). In the imd1D deletion background, introduction of
CnIMD1 restores wild-type MPA sensitivity, while single-copy
CgIMD1 successfully confers VGIV-level MPA resistance
(Figure 6).
Spontaneous resistance to MPA does not arise readily in
Cryptococcus
To present an attractive target for antifungal chemotherapy,
spontaneous resistance to a drug should not arise readily through
mechanisms such as single point mutations or rapid amplifications
of target genes. In C. albicans, MPA-resistant strains were selected
by extended incubation on sub-lethal concentrations of the drug
resulting from a point mutation that changed the conformational
equilibrium of IMPDH [21]. We performed equivalent selection
using the VNI strain H99, but despite repeated attempts, we were
unable to isolate colonies that were stably resistant to the drug
after transfer onto media containing the same or increasing
concentrations of MPA (data not shown).
Cryptococcus gattii VGIV IMPDH has multiple unique
polymorphisms
To investigate the nature of the VGIV resistance to MPA, we
compared the IMD1 coding region between all known haploid
molecular types. While there are 22 residue differences between
VNI (MPA-sensitive) and VGIV (MPA-resistant) IMPDH, there
are only six residues unique to the VGIV subtype: three
conservative and three nonconservative substitutions (Figure S5).
To establish the precise mechanism for MPA resistance, we
introduced the six VGIV unique substitutions into the sensitive
VNI enzyme. No single mutation was sufficient to confer VGIV-
level resistance to MPA when introduced into the imd1D or the
wild-type background, however the simultaneous introduction of
all six mutations into the CnIMD1 allele did confer MPA resistance
(Figure 6 and Figure S6). This finding confirms that a combination
of these six residues is sufficient to confer MPA resistance, which
explains our inability to isolate spontaneous MPA-resistant isolates
of VNI. We therefore generated VNI/VGIV IMPDH chimeras
using convenient restriction sites that split the IMPDH gene into
three parts to combine CnIMD1 and CgIMD1 into six possible
Figure 6. C. gattii IMPDH confers resistance to MPA, mediated by two amino acids. Serial dilution spotting assays of selected IMPDH
mutants on YNB plus 5 mg/mL MPA. Robust growth on MPA is observed in the deletion mutant imd1D transformed with either the CgIMD1 allele or
any IMD1 allele uniting the residues K336 and E446. Two copies of the MPA-sensitive CnIMD1 allele (in H99 CnIMD1) result in only a very modest
increase in resistance to MPA and IMPDH heterotetramerization (in H99 CgIMD1) does not appear to produce novel phenotypes. The juxtaposed
image depicts which portions of the IMPDH allele are present, with yellow representing CnIMD1 and blue representing CgIMD1, split into three thirds
with the vertical bars depicting the six unique residues. Two proteins are depicted for the H99 background where the wild-type allele is also present.
doi:10.1371/journal.ppat.1002957.g006
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configurations. Only the construct comprising the first third of
CnIMD1 and the last two-thirds of CgIMD1 (bearing R446E,
G450A and A500V) conferred VGIV-level resistance to MPA
(Figure 6 and Figure S6). Based on this observation we employed
site-directed mutagenesis of the MPA sensitive VNI allele to
introduce the conservative R336K substitution (the only unique
residue in the middle fragment) in turn with each of the three
residues from the last fragment; the combination of K336 and
E446 was sufficient to confer MPA resistance (Figure 6 and Figure
S6). Again, transformation of these constructs into the wild-type
H99 background yielded levels of MPA resistance comparable
with the imd1D deletion strain, suggesting that simple gene
amplification may be insufficient to produce robust resistance,
and the resulting mixed IMPDH heterotetramers in these strains
did not appear to possess novel drug-resistant characteristics.
Steady-state kinetics of CnIMPDH and CgIMPDH
The catalytic mechanism of IMPDH involves a transition from
a dehydrogenase to a hydrolase reaction; initially, the substrate
IMP and cofactor NAD+ bind, IMP is then oxidized and forms a
covalent transition state complex E-XMP* via a catalytic cysteine,
while NAD+ is simultaneously reduced to NADH. The enzyme
then undergoes a conformational change whereby a large mobile
flap folds into the vacant NAD+ site, carrying a catalytic arginine
residue that activates a water molecule to hydrolyze the E-XMP*
covalent complex, releasing XMP [26,42,43]. To investigate if
resistance to MPA is due to functional differences between
CnImd1 and CgImd1, we determined the steady-state kinetic
parameters (Figure S7). Plots of velocity versus IMP concentrations
were best fit by the Michaelis-Menten equation
(Km(IMP) = 84612 mM, Km(NAD) = 634697 mM for CnImd1 and
Km(IMP) = 178615 mM, Km(NAD) = 532665 mM for CgImd1). How-
ever, both enzymes showed strong NAD+ substrate inhibition
above concentrations of 1,500 mM (Kii(NAD) = 4,4006900 mM for
CnImd1 and Kii(NAD) = 4,0006600 mM for CgImd1), which is
common for IMPDH and is attributed to the formation of an E-
XMP*NNAD+ complex but meant that the data had to be fitted to
a modified version of the Michaelis-Menten equation that takes
substrate inhibition into account. The Km values for both enzymes
were significantly different from the values for both human
isoforms of IMPDH (Table 1) while the turnover numbers were
similar (kcat = 1.560.1 s
21 for CnImd1 and kcat = 2.260.2 s
21 for
CgImd1); IMPDH has a generally low turnover and the rate for
Cryptococcus is similar to those determined for IMPDHs from
humans, other fungi and parasites [19,21,28].
Inhibitor kinetics of CnIMPDH and CgIMPDH
MPA is an NAD+ analogue and an uncompetitive inhibitor that
traps the E-XMP* enzyme-substrate covalent complex by
competing with the flap for the vacant NAD+ site [44]. To further
investigate the mechanism behind increased MPA resistance, we
examined the response of both enzymes in the presence of
inhibitor and varying amounts of both substrates. The concentra-
tion of MPA used was similar to the concentration of enzyme in
the assays, which necessitated tight-binding inhibitor treatment, as
found in C. albicans and Aspergillus nidulans IMPDH [45]. MPA
dependent changes in kinetic parameters were studied for both
isoforms and were best described by an uncompetitive, tight
binding inhibition mechanism versus NAD+, indicative of forma-
tion of E-XMP*NMPA complexes, as has been observed for
multiple organisms (Figure S8). The Kii for the MPA-sensitive
CnIMPDH allele (240618 nM) is higher than the Kii observed for
the well-characterized human type I, human type II and C. albicans
IMPDHs, suggesting that the NAD+ site (Table 1), which is also
the drug-binding site, is functionally different in the wild-type
Cryptococcus enzyme. Curiously, the inhibition constant for MPA is
actually lower for the MPA-resistant CgImd1 enzyme
(Kii=9665 nM), although it displays a greater kcat/Km (NAD) ratio
(4,135663 M21 s21) compared to CnImd1 (2,366639 M21 s21),
suggesting greater enzymatic efficiency. We note that fits for
noncompetitive/mixed tight-binding inhibition for the MPA-
resistant CgImd1 enzyme were extremely similar to those obtained
Table 1. Kinetic parameters for IMPDH from characterized species.
IMPDH kcat (s
21) Km(IMP) (mM) Km(NAD) (mM) Kii(NAD) (mM)
Kii(MPA) (nM) vs.
NAD+ Kii(MPA) (nM) vs. IMP
E. coli 13.0 61 2000 2.8 $10000 ND
C. parvum 3.3 29 150 2.9 9300 ND
T. foetus 1.9 1.7 150 6.8 9 ND
H. sapiens type I 1.8 14 42 ND 11 ND
H. sapiens type II 0.4 4 6 0.6 6 ND
A. nidulans 0.7 10 170 1.5 25 (UC) 22 (UC)
P. chrysogenum A 0.8 40 290 2.4 ND ND
P. chrysogenum B 0.0075 600 640 NA ND ND
P. brevicompactum A 0.7 130 340 4.7 500 (UC) 450 (NC/mixed)
P. brevicompactum B 0.4 1400 790 NA 14000 (UC) 20000 (NC/mixed)
C. albicans 6 60 3500 1.5 11 ND
C. neoformans VNI 1.560.1 84612 634697 4.460.9 240618 (UC) 198663 (NC/mixed)
C. gattii VGIV 2.260.2 178615 532665 4.060.6 9665 (UC) 107631 (NC/mixed)
Steady-state and inhibition constants for species with well-characterized IMPDHs. UC, uncompetitive; NC, noncompetitive; ND, no data; NA, not applicable. Values are
from [19,21,28,58].
doi:10.1371/journal.ppat.1002957.t001
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for uncompetitive tight-binding inhibition and yield a much higher
Kii (293676 nM; data not shown), which may indicate some
affinity of the inhibitor for other enzyme forms. Surprisingly, fits of
MPA versus IMP for both enzymes were best described by
noncompetitive/mixed patterns of inhibition (Figure S8), with a
Kii=198663 nM for CnImd1 and a Kii=107631 nM for
CgImd1. This suggests that in Cryptococcus IMPDH, MPA binds
to additional enzyme forms such as free enzyme or E-IMP. Such a
scenario is also found in MPA-resistant Penicillium brevicompactum
IMPDH, where the initial hydride transfer step (as opposed to the
subsequent hydrolysis step) is either partially or completely rate-
limiting, resulting in the predominate enzyme form being E-IMP-
NAD+ instead of E-XMP*, conferring MPA resistance [46].
Crystal structure of CnImd1
To provide a foundation for fungus-specific inhibitor develop-
ment, we determined the crystal structure of the clinically relevant
C. neoformans var. grubii IMPDH in complex with the substrate IMP
and the inhibitor MPA. CnImd1 forms a tetramer and in the final
model each monomer contains 395 of the 544 residues in the
typical eight-stranded a/b barrel structure, plus one molecule each
of IMP and MPA bound in the active site, consistent with our
functional observations suggesting an uncompetitive mechanism of
enzyme inhibition (Figure 7A). The large accessory subdomain
between residues 130–244 and residues 438–449 from the mobile
flap have no interpretable electron density, common to previous
structural studies on this class of enzymes.
Many of the active site residues are invariant, and the purine
ring, the ribose group and the nucleotide phosphate group of IMP
make mostly conserved interactions to those found in the Chinese
hamster IMPDH:IMP:MPA structure [26]. MPA makes far fewer
interactions in the cryptococcal IMPDH:IMP:MPA complex than
observed in the hamster IMPDH structure, perhaps accounting for
some of the differences in Ki between the mammalian and fungal
enzyme. In particular, T347 (Cryptococcus numbering) faces away
from the active site in the Cryptococcus enzyme and does not bind
MPA, while several other residues including N317, D288 and
G340 participate in fewer interactions with the ligands in the
cryptococcal complex. The six unique residues found in CgImd1
map to the amino terminal region near a monomer-monomer
interface (V55M), the accessory cystathionine-b-synthase (CBS)
domain (A153T), adjacent to the active site loop in the NAD+ and
MPA-binding cavity (R336K), close to a catalytic arginine in the
movable flap (R446E and G450A), and near the carboxy terminus
(A500V). R/K336 forms hydrogen bonds with IMP and MPA in
the hamster enzyme, and R/E446 and G/A450 are near the
catalytic arginine (R458) that resides on the mobile flap. Of note,
one of the two residues responsible for MPA resistance in C. gattii
VGIV IMPDH, R336 (K336 in the resistant enzyme), forms direct
contacts with only IMP in the cryptococcal complex, suggesting a
possible mechanistic explanation for the failure of the R336K
single mutant to exhibit any altered sensitivity to MPA.
Substitution of R336 with K336 in silico increases the distance
from the amine nitrogen of R336K to the IMP ribose O3 hydroxyl
from 3.1 A˚ to 3.9 A˚, which would lead to the loss of contacts with
IMP.
Comparison of the hamster and cryptococcal IMPDH active
site loops with IMP and MPA-bound states indicates differences in
conformations, despite considerable similarity at sequence level; in
the human type I IMPDH structure (bound to the IMP analog 6-
chloropurine ribotide) this loop adopts yet another distinct
Figure 7. Structure of C. neoformans IMPDH. (A) Active site residues of C. neoformans IMPDH with IMP and MPA ligands in ball-and-stick
representation, with hydrogen-bonding interactions indicated by dashed lines. Figure displays residues within 4 A˚ of the active site except for T347,
which adopts a strikingly different conformation in the Cryptococcus enzyme. (B) Residues 339–356 of Cryptococcus IMPDH (green) form the active
site loop and are highly conserved. Comparison of the C. neoformans ENIMPNMPA complex active site loop conformation with the hamster E-
XMP*NMPA complex and the human type I IMPDH in complex with the substrate analogue 6-chloropurine ribotide (CPR) are shown. IMP, CPR and the
catalytic cysteine are shown in stick representation, while MPA is omitted. (C) Surface representation of the active site pocket of C. neoformans and
Chinese hamster IMPDH. The white arrow indicates the region around T347, which forms a unique, potentially exploitable cavity in the fungal
enzyme. MPA is omitted for clarity.
doi:10.1371/journal.ppat.1002957.g007
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conformation (Figure 7B). The change in orientation of the loop in
CnImd1 creates a large, Cryptococcus-specific pocket in the active
site (Figure 7C). There is considerable flexibility in the conforma-
tion of the active site loop observed in structures of different
enzyme complexes, which suggests that it can mimic the changes
during the reaction cycle where it may modulate closure of the flap
[47]. While IMP is covalently bound to the catalytic cysteine in the
hamster and human structures, which may be responsible for the
altered orientation, comparison with Tritrichomonas foetus IMPDH
bound to IMP or mizoribine phosphate (where the ligands are not
covalently bound in either structure) suggests the conformation
observed in the cryptococcal complex to be unique, thus offering a
potential avenue for species-specific inhibition. IMPDH crystal
structures have been demonstrated to provide a reliable indication
of the position of the loop at different parts of the reaction cycle,
suggesting the pocket observed in the Cryptococcus structure to be a
legitimate target [47].
The cryptococcal IMPDH structure is unique in having most of
the mobile flap, except for 12 residues that encompass a small
insertion region unique to Cryptococcus, sufficiently ordered to
permit all but three residues corresponding to the flap in human
IMPDH to be observed. The only comparable structural evidence
for the flap is presented for the parasite T. foetus IMPDH
complexed with mizoribine phosphate, in which the flap is in the
closed conformation within the cofactor site [29] and the Bacillus
anthracis apoenzyme structure [48]. The cryptococcal structure
reveals the flap in the ‘open’ conformation, as would be required
for the initial dehydrogenation before the flap folds into the NAD+
site to hydrolyze the covalent enzyme intermediate. The flap is
folded back onto itself, with residues A455–A465 facing the
following V466–V476, with the catalytic R458 positioned more
than 13 A˚ away from the C2 carbon of the IMP purine ring
(Figure 8A). Comparison with both the T. foetus and B. anthracis
enzymes suggests that the flap undergoes significant conforma-
tional rearrangement, swinging completely around and under-
neath itself to bring the catalytic arginine into close juxtaposition
to the substrate (Figure 8B). Despite being uncomplexed with
substrate or inhibitor, the B. anthracis structure also clearly shows
the enzyme in the closed conformation, with the flap folded into
the active site (Figure 8C). Superposition of the bacterial enzyme
onto the fungal enzyme reveals that the mobile portions of the flap
comprise residues H436-A465 (30 residues in Cryptococcus but only
15 residues in human), while the remaining residues of the flap,
Y414-E435 and V466-K479, appear stationary. Comparison of
the open conformation of the C. neoformans enzyme (MPA-sensitive)
with the closed conformation of the T. foetus and B. anthracis
enzymes (both MPA-resistant) readily demonstrates how MPA can
more easily access the cofactor site in enzymes where the
conformational equilibrium favors the open state [44]. Unfortu-
nately the second residue responsible for MPA resistance in C. gattii
VGIV, E446 (R446 in the sensitive enzyme), was not observed in
the electron density, however this is a strong indicator of
considerable flexibility within the immediate structural context of
this residue, indicating it unlikely to be proximal to the well-
ordered active site in the open conformation. However, as the flap
undergoes structural rearrangement, the residue is likely to be
brought into closer proximity to the active site pocket during the
reaction cycle.
Discussion
New drug targets and novel approaches to treatment are
urgently needed as the immunocompromised population grows
and the burden of opportunistic fungal infections increases. We
have examined and characterized two of the key enzymes from the
GTP de novo biosynthetic and salvage pathways, revealing the
potential of this pathway as a target of anticryptococcal therapy.
We discovered that only the rare C. gattii VGIV molecular type is
resistant to a natural product inhibitor of IMPDH, presenting an
opportunity to investigate the evolution of drug resistance in
IMPDH in the Cryptococcus species complex, and whether this poses
a risk to potential therapies.
GTP synthesis appears to be a natural antimicrobial target, as
both MPA and mizoribine are produced as secondary metabolites
by various mould species. The ubiquity of MPA resistance among
C. gattii VGIV isolates suggests that it may be an adaptation,
perhaps to competitors in its environmental niche. Very little is
known on the ecology of VGIV isolates in particular, and while it
has been isolated from clinical samples from a small number of
countries in South America, sub-Saharan Africa and the Indian
subcontinent, reports of environmental isolates are limited to
certain trees (primarily the Indian almond tree Terminalia catappa)
from Colombia and Puerto Rico [49]. The VGIV subtype is
nevertheless extremely rare, while the clinically-relevant VNI type
is widespread and exquisitely sensitive to MPA.
The finding that the purine salvage deficient hpt1D mutant was
fully virulent in both the worm and mouse model was somewhat
surprising, given the intense nutritional and metabolic stresses and
hostile immune system pressures Cryptococcus is under during the
infection process. Similar PRTase mutants in the apicomplexan
parasites Leishmani donovani and Toxoplasma gondii are viable and
virulent however, although many display certain fitness defects or
partial attenuation of infectivity [50,51]. Given that de novo purine
biosynthesis is an energy intensive process, salvage of purines from
a host could serve as an excellent way to conserve energy during
infection; as the hpt1D mutant is not perturbed for virulence, this
may reflect a generally low concentration of salvageable purines
during the infection process. This model is supported by the
avirulence of the imd1D mutant; generating a ready supply of GTP
via the de novo pathway is obviously of critical importance to the
fungus during infection.
These findings are consistent with other studies demonstrating
that IMPDH and de novo GTP biosynthesis mutants from a range
of pathogenic bacteria are attenuated for virulence [52], and in
pathogenic E. coli, Salmonella enterica and B. anthracis, de novo purine
biosynthesis has been proposed to be the single most critical
metabolic function for growth in human serum and blood [53].
Purine de novo biosynthesis may potentially be rate-limiting to
growth of Cryptococcus during infection, and therefore present an
outstanding target for anti-cryptococcal chemotherapy. Further-
more, in contrast to the simple guanine auxotrophy of S. cerevisiae
and E. coli IMPDH mutants [54,55], the imd1D mutant of
Cryptococcus exhibits a range of pleiotropic phenotypic defects even
when supplemented with exogenous guanine, including slow
growth, attenuated virulence factor expression, and impaired
dissemination and avirulence in two animal models of infection.
Intriguingly, recent studies have revealed that both IMP dehy-
drogenase and GMP synthase, the first and second enzymes of de
novo GTP biosynthesis, act as transcriptional repressors in
Drosophila [35,56], while the accessory CBS domain of IMPDH
has been demonstrated to regulate purine homeostasis in E. coli
[54,57]. It would be valuable to investigate the potential regulatory
roles of IMPDH in Cryptococcus and establish any contributions to
pathogenicity.
That IMPDH is absolutely critical for virulence of Cryptococcus,
and the observation that the most clinically prevalent forms of
Cryptococcus are exquisitely sensitive to the IMPDH-inhibiting drug
MPA, is encouraging for the investigation of IMPDH and de novo
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GTP biosynthesis as an antifungal drug target. Kohler et al. [21]
previously established that the C. albicans form of the enzyme
displays an altered kinetic profile relative to human IMPDH,
suggesting that fungus-specific inhibitors could be developed that
target the MPA binding site. Functionally, the two Cryptococcus
enzymes appear quite similar to other fungal IMPDHs, including
the C. albicans and A. nidulans enzymes, and GTP biosynthesis is
critical for virulence of both C. albicans and A. fumigatus (closely
related to A. nidulans). Cryptococcal IMPDH also shows significant
differences from the human enzyme, despite ,56% sequence
identity. The Km for both IMP and the cofactor NAD
+ are
substantially different from the human forms, suggesting that
there are exploitable aspects of the reaction cycle of the
cryptococcal enzyme. It is less clear why VGIV CgImd1 should
have a lower Kii for MPA than the VNI variant. Residues K336
and E446 together appear to play a pivotal role in C. gattii VGIV
resistance, as demonstrated by their introduction into the
sensitive form, perhaps by altering the affinity of the flap for
the cofactor site or other changes in the enzyme mechanism or
conformation. The dynamics of the flap movement are known to
be key to resistance to cofactor mimic drugs in IMPDH, and key
mutations can alter the preferred state from open and MPA-
sensitive (the state observed in our structure, with the flap poised
above the active site and the cofactor site exposed), to closed,
which restricts access of MPA to the cofactor site and confers
resistance [44]. Residues close to the catalytic arginine are
involved in hydrogen bonding interactions when the flap folds
into the NAD+ site in T. foetus and presumably other species [29].
The combination of residues observed in C. gattii VGIV is
reminiscent of the well-characterized MPA-resistant T. foetus
enzyme, which requires K310 (equivalent to Cryptococcus K336)
and E431 (equivalent to Cryptococcus Q470, also on the flap) in
tandem to provide robust resistance [30]. Our data suggests that
while MPA affinity increased, a compensatory increase in enzyme
catalytic efficiency may have occurred through the combination
of K336 and E446. Recent work also demonstrates that if the
Figure 8. The open and closed conformations of the IMPDH mobile flap. (A) The Cryptococcus neoformans IMPDH structure indicates that
the flap adopts an open conformation in the ligand-bound state, with the catalytic R458 folded above the active site. The flap is rainbow colored and
the catalytic arginine and IMP in the active site are depicted in stick representation. (B) The Tritrichomonas foetus IMPDH structure in complex with
mizoribine phosphate (MZP) is in the closed conformation, with the flap extending out over the active site pocket and the catalytic arginine
positioned underneath. (C) The Bacillus anthracis structure shows the unbound apoenzyme also adopts the closed conformation, with the flap closed
over the active site.
doi:10.1371/journal.ppat.1002957.g008
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initial hydride transfer step becomes rate-limiting, this reduces
accumulation of the enzyme-substrate covalent complex and thus
reduces susceptibility to MPA inhibition. Notably, this has
occurred in MPA-resistant Penicillium brevicompactum IMPDH
without significant residue changes around the substrate/cofactor
binding sites [46,58]. Our work demonstrates that MPA binds to
additional cryptococcal IMPDH forms (an uncompetitive inhib-
itor should bind only to the enzyme-substrate covalent complex),
suggesting the enzyme to be fundamentally functionally different
from the human isoforms.
To provide a solid foundation for chemotherapeutic agent
development, we have determined the structure of C. neoformans
var. grubii IMPDH in complex with IMP and MPA. While the
accessory domain is presumably disordered and was not observed,
we were able to successfully model the residues comprising the
mobile flap domain, which to date had only been structurally
characterized in the closed conformation in the T. foetus and the B.
anthracis enzymes [29,48]. While Cryptococcus IMPDH possesses an
insertion within the flap that was mostly disordered and there is
considerable flexibility associated with the flap region, the
structural evidence suggests that the flap undergoes a drastic
conformational change during the reaction cycle, which has been
demonstrated functionally but not structurally in previous studies
[27,59,60]. In the open enzyme conformation, the catalytic
arginine is positioned away from the active site, with the flap
undergoing a 270u swinging rotation to perform the hydrolysis
reaction. The near-complete flap structure in the open orientation
will aid future drug design efforts, as the flap folds into the cofactor
site – a critical target site for inhibitors. The cofactor site, and the
adenosine subsite in particular, also present an opportunity for
fungus-specific inhibitor development, as there are a number of
critical residues that vary in the Cryptococcus enzyme; for example,
the adenine ring of NAD+ likely stacks between R267 and Y296 in
Cryptococcus IMPDH, and these two residues differ from the
corresponding H253 and F282 in the human enzyme. The
eukaryotic parasite T. foetus shares these two substitutions, which
have been suggested as potential species-specific targets [61]. The
adenosine portion of the cofactor site is also a monomer-monomer
interface, and one of the more variable parts of the enzyme
between species. Recent strategies extend inhibitors from the
nicotinamide subsite (where MPA binds) out to the adenosine
subsite to increase specificity [44,62]. The unique pocket in the
active site loop region of Cryptococcus IMPDH will enable the design
of inhibitors with moieties that occupy the cavity, which should be
selective for the fungal enzyme over the human enzymes.
Overall, we have demonstrated that de novo GTP biosynthesis is
crucial for cryptococcal virulence factor expression and patho-
genesis, and multiple exploitable avenues exist in IMPDH to
develop inhibitors that are specific for the fungal enzyme. This
work lays the foundation for purine biosynthesis as a legitimate
antifungal target, and the functional similarity between the
Cryptococcus and Candida enzymes presents an intriguing opportu-
nity to develop novel IMPDH inhibitors that could lead to
effective therapy against a spectrum of fungal pathogens.
Materials and Methods
Ethics statement
The Cryptococcus murine virulence assay protocol was approved
by the Molecular Biosciences Animal Ethics Committee of the
University of Queensland (AEC# SCMB/473/09/UQ/
NHMRC). Assays were conducted in accordance with the
guidelines in the Australian code of practice for the care and use
of animals for scientific purposes by the National Health and
Medical Research Council. Infection and euthanasia were
performed under methoxyfluorane anesthesia, and all efforts were
made to minimize suffering via strict adherence to the Guidelines
to promote the wellbeing of animals used for scientific purposes by
the National Health and Medical Research Council.
Strains and media
C. neoformans and C. gattii strains were cultured in YPD or YNB
(Becton Dickinson, Franklin Lakes NJ) media at 30uC. imd1D
mutants are guanine auxotrophs and were grown on minimal
YNB media supplemented with 1 mM guanine for all manipula-
tions; ade2D and hpt1D ade2D mutants are adenine auxotrophs and
were maintained on rich media. Cloning and plasmid propagation
was performed in E. coli strain Mach1 (Life Technologies,
Carlsbad CA). Genomic DNA for E. coli gene isolation was
prepared from strain K12. C. elegans strain N2 Bristol was
maintained at 20uC on lawns of the E. coli uracil auxotroph strain
OP50 on Nematode Growth Medium using standard procedures
[63]. Recombinant Cryptococcus IMPDH was heterologously
expressed in E. coli strain BL21(DE3)pLysS (Merck, Darmstadt,
Germany). MPA, mizoribine, 5-fluoro-29-deoxyuridine, G418,
NAD+, Tris, Bis-Tris, glycine, NaCl, KCl, DTT, EDTA, DMSO,
uric acid, inosine, hypoxanthine, xanthine, xanthosine, guanine,
guanosine, adenine, adenosine, IMP, AMP, XMP and GMP were
purchased from Sigma (St Louis, MO). Nourseothricin (clonNAT)
was purchased from Werner BioAgents (Jena, Germany). MPA
was dissolved in DMSO and was used at a concentration of 5 mg/
mL. Supplemental purines when required were added to a final
concentration of 1 mM [63].
Molecular techniques
Standard molecular techniques were performed as described by
Sambrook et al. [64]. C. neoformans genomic DNA for Southern blot
analysis was prepared as described [65]. Oligonucleotides used are
given in Table S1. For Southern hybridizations, DNA was
digested with appropriate enzymes, electrophoresed on TAE-
agarose gels and blotted onto Hybond-XL membrane (GE
Healthcare, Little Chalfont, United Kingdom) using standard
procedures. Probes were generated using the Rediprime II
Random Prime Labeling Kit (GE Healthcare) with PCR products
from H99 or MMRL2651 template DNA, and a32P dCTP
(PerkinElmer, Waltham MA). Blots were hybridized overnight at
65uC and membranes were exposed onto Fuji Super RX medical
X-ray film (Fujifilm, Tokyo, Japan). Splice overlap PCR, knockout
transformations and gene complementations were performed as
described [66–69], using particle delivery using a BioRad He-1000
Biolistic Device (Bio-Rad, Hercules CA).
Bioinformatic analysis
The unpublished C. neoformans var. grubii genome is available from
the Broad Institute of MIT and Harvard (http://www.
broadinstitute.org/annotation/genome/cryptococcus_neoformans/
MultiHome.html). To amplify genes from C. gattii strain
MMRL2651, primers were designed from the closely related C.
gattii strains WM276 and R265, which are also available from the
Broad Institute (http://www.broadinstitute.org/annotation/
genome/cryptococcus_neoformans_b/MultiHome.html). Purine
biosynthetic genes were identified using reciprocal best-hit BLAST
analysis and annotated using MacVector 9.5 (MacVector, Cary NC)
[70]. Sequencing was performed at the Australian Genome
Research Facility (Brisbane, Australia) and sequence traces were
analyzed using Sequencher 4.7 (Gene Codes, Ann Arbor MI).
Sequences for Cryptococcus IMPDH from strains 8-1 (VNII), Bt33
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(VNB), NIH312 (VGIII) and MMRL2651 (VGIV) are available
from GenBank under the accession numbers FJ418778–FJ418781.
Phenotypic and virulence factor assays
For growth curve analysis, cells were cultured in RPMI 1640
media (Life Technologies) plus 2% glucose, 10% fetal bovine
serum (Life Technologies) and 1 mM guanine. Cells were freshly
cultured on YNB or YNB plus guanine plates, washed, diluted to
an OD600 of 0.05 and grown in 50 mL cultures with shaking at
180 rpm at 30uC for a total of five days and monitored
spectrophotometrically. Melanization assays were performed on
solid or liquid Cryptococcus melanization media containing L-DOPA
(L-3,4-dihydroxyphenylalanine) and 10 mM asparagine at 30uC
and 37uC [71]. Spectrophotometric analysis was performed on
culture supernatant at OD475 using a NanoDrop spectrophotom-
eter [72]. Capsule growth was induced via overnight growth in
RPMI 1640 media plus 2% glucose and 10% fetal bovine serum,
and stained with India ink (Becton Dickinson) to visualize capsule.
Capsule sizes were determined from phase contrast images using
CellProfiler image analysis software [73]. An algorithm was
developed to identify the cryptococcal capsule and cell wall
boundaries by segmentation. Clumped cells, those outside size
bounds and those touching the border of the image were excluded.
Geometric parameters were measured from the identified capsule
and cell wall boundaries, and the average of the major and minor
axes from an ellipsoid fit used to estimate both capsule size and
cellular diameter. Capsule diameter was expressed as a relative
percentage of cell size. At least 10 independent images were used
from each sample with at least 50 and typically 100–200 cells
measured from each replicate; all measurements were performed
in biological triplicate [74]. Mating tests were performed on
Murashige-Skoog or V8 media plus 100 mg/mL myo-inositol
(pH 5.0) using the MATa H99 isogenic strain KN99a, as
described [75,76].
Nematode virulence assays
Assessment of cryptococcal virulence in the C. elegans model
system was performed as described [77]. Cryptococcus strains were
grown on either rich (Brain-Heart Infusion media, Becton
Dickinson) or minimal (Nematode Growth Medium plus S.
cerevisiae Synthetic Complete Supplement Mixture) media with or
without supplemental guanine. For C. elegans plus antifungal assays,
5, 10 or 20 mg/mL MPA or 5 mg/mL fluconazole were added to
the minimal media plates. For the control drug assays, worms were
cultured on NGM supplemented with 6 mM 5-fluoro-29-deoxyur-
idine to prevent egg laying, plus either OP50 bacteria or heat-
killed OP50 bacteria, with or without 20 mg/mL MPA.
Murine virulence assays and organ burden analysis
Assessment of cryptococcal virulence in the murine model
system was performed as described [78], with slight modification.
Due to the propensity for the imd1D strain to clump in liquid
media, all strains were freshly grown on YNB or YNB plus
guanine plates overnight before washing and counting for
infection. Kaplan-Meier survival curves were plotted using the
software package GraphPad Prism 5.0 (GraphPad Software, San
Diego CA), and statistical significance was assessed using a log-
rank test, with a p value ,0.05 considered significant. For organ
burden analysis, brain, lungs, liver, spleen and kidneys were
harvested from three mice per time point, weighed, homogenized
and plated in serial dilution to determine colony-forming units per
gram organ weight.
Gene expression analysis
Quantitative reverse transcription PCR analysis was performed
as described [79]. Overnight cultures of strains H99 and
MMRL2651 were grown for 16 hours to mid-log phase, before
addition of MPA (5 mg/mL) or guanine (1 mM). Cells were grown
for 15 minutes, 60 minutes or 240 minutes before harvesting and
flash freezing in liquid nitrogen. Total RNA was extracted using
TriZOL reagent (Life Technologies) and cDNA was generated
using Superscript III (Life Technologies).
MIC determination and MPA resistance
MIC susceptibility testing for MPA was performed using the
broth microdilution method according to CLSI (CLSI M27-A2)
modified for Cryptococcus neoformans [80]. Strains tested are found in
Table S2. For analysis of spontaneous MPA resistance, 161010
cells each of H99 overnight cultures were plated onto YNB with
sub-lethal concentrations of MPA (1–5 mg/mL) as described [21].
Plates were incubated at 30uC for two months. Putatively resistant
colonies were subcultured onto fresh YNB plus MPA plates.
Cloning, chimera construction and site-directed
mutagenesis
All primers used in the study are listed in Table S1. IMPDH
genes were amplified from C. neoformans and C. gattii strains, cloned
into pCR2.1-TOPO (Life Technologies) and sequenced. Wild-
type strains utilized are listed in Table S2. IMD1 from C. neoformans
strain H99 and from C. gattii strain were subcloned into
pBluescript SK- (Agilent, Santa Clara CA), then pPZP-NEO
(containing a G418 resistance cassette) and pPZP-NAT (contain-
ing a nourseothricin resistance cassette) to create complementation
constructs [81]. Complementation constructs for C. neoformans
bearing the E. coli xanthine-guanine phosphoribosyltransferase-
encoding gpt and E. coli IMP dehydrogenase-encoding guaB genes
were generated via overlap PCR using the C. neoformans ACT1
promoter and TRP1 terminator, combined with the E. coli strain
K12 gpt or guaB ORF, cloned into pCR2.1-TOPO and sequenced.
Site-directed mutagenesis was used to introduce new residues
into wild-type CnIMD1. All six variants were subcloned into
pBluescript SK- and further subcloned into pPZP-NEO or directly
into pPZP-NAT. Double mutants and the sextuple mutant were
created using successive rounds of mutagenesis. All mutagenesis
products were sequenced to confirm identity and fidelity. IMPDH
gene chimeras were created by dividing the gene into thirds using
two common restriction sites in CnIMD1 and CgIMD1 (XhoI and
NcoI) and reconstructing all six possible combinations. The first
fragment comprises 207 residues and contains the first two unique
residues V/M55 and A/T153, the second fragment comprises 225
residues and contains only the third unique residue R/K336, and
the final third comprises 111 residues and contains the final three
unique residues R/E446, G/A450 and A/V500. Subsequently, all
chimeras were subcloned into pLITMUS28i (New England
Biolabs, Ipswich MA) before further subcloning into both pPZP-
NEO and pPZP-NAT. All strains created are listed in Table S3.
Expression, purification and crystallization of
Cryptococcus IMPDH
In-frame cloning of the cDNA coding for CnImd1 and CgImd1
into expression vectors, heterologous expression in E. coli,
purification of protein and crystallization parameters have been
described previously [82]. For this study, purified protein in
crystallization buffer was mixed with a 10-fold molar excess of the
substrate IMP plus 100 mM of the inhibitor MPA dissolved in
dimethylsulfoxide prior to crystallization. Large crystals were
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obtained in wells containing 1.9 M lithium sulfate and 0.09 M
imidazole/HCl pH 6.5 with either no additive or 3.0–12.0%
pentaerythritol ethoxylate (15/04 EO/OH) for CnImd1.
Steady-state and inhibitor kinetics
All enzymatic assays contained standard IMPDH assay buffer
(50 mM Tris-HCl (pH 8.0), 100 mM KCl, 3 mM EDTA, 1 mM
DTT, 500 mM IMP and 250 mM NAD+) and were performed as
described [21]. Enzymatic assays were performed at 25uC in
triplicate by monitoring the production of NADH at 340 nm
(e=6.22 mM21 cm21) using a Varian Cary 50 spectrophotometer
(Agilent Technologies, Santa Clara CA). For Km determination,
IMP and NAD+ concentrations were varied over a range from
62.5 mM to 5,000 mM, with fixed second substrate concentrations
of 250 mM NAD+ and 500 mM IMP, respectively. Nonlinear
fitting of the data to the Michaelis-Menton equation (Equation 1)
and the uncompetitive substrate inhibition equation (Equation 2)
were performed using SigmaPlot 12.0 (SysStat Software, Chicago
IL). IC50 values for both proteins were determined using fixed
concentrations of IMP (850 mM or 1,800 mM) and NAD+
(1,000 mM) while varying the concentration of MPA (0 nM–
400 nM). The Km and kcat values were then determined in the
presence of concentrations of MPA that produced 0%, 25%, 50%
and 75% inhibition. Velocity data were fitted to the uncompetitive
tight-binding inhibition equation (Equation 3) and the noncom-
petitive/mixed tight-binding inhibition equation (Equation 4) in
SigmaPlot,
v~kcat½E"½S"=(Kmz½S") ð1Þ
v~kcat½E"=(1zKm=½S"z½S"=Kii) ð2Þ
v~(v0=(2½E")):(½E"{½I "{Kappz
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
((½E"{½I "{Kapp)2z4½E"Kapp))
q
Kapp~Kii(1zKm=½S")
ð3Þ
v~(v0=(2½E")):(½E"{½I "{Kappz
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
((½E"{½I "{Kapp)2z4½E"Kapp))
q
Kapp~(½S"zKm)=((KmzKii)z(½S"=aKii))
ð4Þ
where v is the initial velocity; Km is the Michaelis constant; kcat is
the turnover number; [E] is enzyme concentration; [S] is substrate
concentration; [I] is inhibitor concentration; Kii and Kis are the
intercept and slope inhibition constants.
Structure determination
Data were collected on the MX2 beamline of the Australian
Synchrotron, Melbourne, Australia, using the Blu-Ice software
[83]. Diffraction data were processed and reduced using XDS and
SCALA [84,85]. Initial crude molecular replacement phases were
obtained using a search model based on the coordinates of the
human type I IMPDH (PDB ID 1jcn) using the fast Fourier
transform molecular replacement method as implemented in
Phaser [86] as implemented in the PHENIX suite [87,88]. After
extensive manual re-building in Coot [89], combined with
maximum-likelihood-based restrained refinement in BUSTER-
TNT [90], the final model had Rwork/Rfree values of 0.17/0.20
(Table S4). The stereochemistry of the structure was assessed and
validated with MolProbity [91]. Data collection and refinement
statistics are listed in Table S4. Figures were generated with
PyMOL (http://www.pymol.org). Atomic coordinates and struc-
ture factors have been deposited in the Protein Data Bank, www.
pdb.org (PDB ID: 4af0).
Supporting Information
Figure S1 Specificity of Cryptococcus Hpt1. (A) The
nucleobase xanthine and the nucleosides guanosine and xantho-
sine rescued the imd1D mutant, though with less robust growth
than guanine. Neither XMP nor GMP were able to complement
the auxotrophy of the imd1D strain. Hypoxanthine also did not
rescue the mutant, suggesting that the Cryptococcus a-ketoglutarate-
dependent dioxygenase is unable to perform the conversion of
hypoxanthine to xanthine found in the Schizosaccharomyces pombe
homolog. (B) All xanthylic and guanylic nucleotides rescue the
MPA phenotype in the wild-type and complemented strains. Only
nucleoside monophosphates after the IMPDH blockage by MPA
rescue the hpt1D phenotype. (C) The ade2D mutant, defective in de
novo purine metabolism before the pathway branchpoint, can
utilize either adenine or hypoxanthine for purine nucleotide
biosynthesis. Only adenine can rescue the ade2D hpt1D phenotype
on minimal media. As hypoxanthine successfully supplements the
purine auxotrophy of the ade2D mutant, Hpt1 can salvage
hypoxanthine.
(TIF)
Figure S2 Quantification of melanin production. Mela-
nin production was measured in liquid L-DOPA medium from
culture supernatant at OD475. (A) imd1D at 30uC. (B) imd1D at
37uC. (C) hpt1D at 30uC. (D) hpt1D at 37uC. Bars represent mean
OD475 from three replicates with standard error shown. No
significant differences were found between strains.
(TIF)
Figure S3 Effect of 20 mg/mL MPA on nematode
survival. N2 Bristol young adult nematodes were cultivated for
eight days on OP50 or heat-killed OP50 on standard NGM
supplemented with 6 mM 5-fluoro-29-deoxyuridine to prevent egg
laying, plus or minus 20 mg/mL MPA, the highest concentration
of MPA used in the Cryptococcus/MPA nematode virulence assays.
No significant differences were found between treatments.
(TIF)
Figure S4 Quantitative reverse transcription PCR anal-
ysis of IMD1 expression. (A) Strain H99 and strain
MMRL2651 were grown in YNB media at 30uC overnight and
treated with 1 mM guanine before harvesting at three timepoints.
(B) Strains grown overnight and treated with 5 mg/mL MPA
before harvesting at three timepoints. Transcript levels of CnIMD1
and CgIMD1 are expressed as a fold change relative to expression
of the housekeeping gene b-tubulin. Standard error bars are
shown. p,0.05 *; p,0.01 **.
(TIF)
Figure S5 Alignment of IMPDH from all eight molecu-
lar types of Cryptococcus. IMPDH was amplified and
sequenced from the four molecular types for which there was no
existing sequence data (VNII, VNB, VGIII & VGIV) and aligned
with existing sequence data for VNI, VNIV, VGI and VGII.
MPA-resistant C. gattii VGIV IMPDH has 22 substitutions
compared to MPA-sensitive C. neoformans VNI IMPDH, although
only six of these residues are not shared with another molecular
type. Residues unique to VGIV are highlighted in red. The
IMPDH accessory domain is highlighted in green, the active site
loop in blue and the mobile flap in orange.
(TIF)
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Figure S6 Growth of all IMPDH mutants on MPA. Serial
dilution spotting assays of all IMPDH mutants on YNB plus 5 mg/
mL MPA. The juxtaposed images depict which portions of the
IMPDH allele are present, with yellow representing CnIMD1 and
blue representing CgIMD1, split into three thirds with the vertical
bars depicting the six unique residues. Two proteins are depicted
for the H99 background where the wild-type allele is also present.
(A) Transformation of IMPDH variants (point mutants, double
mutants, sextuple mutants, chimeras plus the two wild-type alleles)
into the imd1D deletion background. (B) Transformation of
IMPDH variants (point mutants, double mutants, sextuple mutants,
chimeras plus the two wild-type alleles) into the wild-type H99
background, which possesses one copy of the MPA-sensitive allele.
(TIF)
Figure S7 Steady-state kinetics of Cryptococcus IMPDH.
Plots of velocity versus IMP and velocity versus NAD+ concentration
were generated by fixing one substrate (250 mM IMP and 500 mM
NAD+) and varying the other. For both enzymes, velocity versus IMP
plots were best described by the Michaelis-Menton equation, while
velocity versus NAD+ plots were best fit by the uncompetitive
substrate inhibition equation. (A) CnImd1. (B) CgImd1.
(TIF)
Figure S8 Inhibitor kinetics of Cryptococcus IMPDH.
Inhibition by MPA was investigated at fixed concentration of IMP
(850 mM for CnImd1 and 1,800 mM for CgImd1) and varying
NAD+ (62.5 mM–2,000 mM) and indicated MPA concentrations.
Initial velocity data was best described by the uncompetitive tight-
binding inhibition equation versus NAD+, while initial velocity data
of MPA versus IMP were best fit by a noncompetitive/mixed tight-
binding model. (A) CnImd1. (B) CgImd1.
(TIF)
Table S1 Primers used in this study.
(DOC)
Table S2 Wild-type strains used in this study.
(DOC)
Table S3 Strains created for this study.
(DOC)
Table S4 Crystallographic data collection and refinement
statistics.
(DOC)
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ABSTRACT The opportunistic fungal pathogen Cryptococcus neoformans is a leading cause of mortality
among the human immunodeficiency virus/acquired immunodeficiency syndrome population and is known
for frequently causing life-threatening relapses. To investigate the potential contribution of in-host micro-
evolution to persistence and relapse, we have analyzed two serial isolates obtained from a patient with
acquired immunodeficiency syndrome who suffered an initial and relapse episode of cryptococcal menin-
goencephalitis. Despite being identical by multilocus sequence typing, the isolates differ phenotypically,
exhibiting changes in key virulence factors, nutrient acquisition, metabolic profiles, and the ability to
disseminate in an animal model. Whole-genome sequencing uncovered a clonal relationship, with only
a few unique differences. Of these, two key changes are expected to explain the phenotypic differences
observed in the relapse isolate: loss of a predicted AT-rich interaction domain protein and changes in copy
number of the left and right arms of chromosome 12. Gene deletion of the predicted transcriptional
regulator produced changes in melanin, capsule, carbon source use, and dissemination in the host, con-
sistent with the phenotype of the relapse isolate. In addition, the deletion mutant displayed altered viru-
lence in the murine model. The observed differences suggest the relapse isolate evolved subsequent to
penetration of the central nervous system and may have gained dominance following the administration of
antifungal therapy. These data reveal the first molecular insights into how the Cryptococcus neoformans
genome changes during infection of humans and the manner in which microevolution progresses in this
deadly fungal pathogen.
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Microevolution enables rapid adaptation to selective pressures, permitting
expansion into new niches and persistence in the face of ever-changing
harsh environmental conditions. Pathogenic organisms encounter a wide
array of challenges during infection of the human host, including ox-
idative and nitrosative stresses from immune cells, nutrient limitation,
and high temperature. Accordingly, genomic changes that confer selec-
tive advantages enabling their survival and proliferation have been iden-
tified in diverse species. The gastric pathogen Helicobacter pylori relies
on an elevated mutation rate combined with genetic exchange be-
tween strains during mixed infection to generate genetic diversity
(Kennemann et al. 2011), and chronic Pseudomonas aeruginosa infec-
tion associated with cystic fibrosis involves selection against virulence
factors required for an acute infection (Smith et al. 2006; Hoboth et al.
2009). Such flexibility is not limited to bacterial pathogens but is also
Copyright © 2013 Ormerod et al.
doi: 10.1534/g3.113.005660
Manuscript received January 17, 2013; accepted for publication February 16, 2013
This is an open-access article distributed under the terms of the Creative
Commons Attribution Unported License (http://creativecommons.org/licenses/
by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Supporting information is available online at http://www.g3journal.org/lookup/
suppl/doi:10.1534/g3.113.005660/-/DC1.
Sequence data from this article have been deposited with the NCBI Short Read
Archive under BioProject PRJNA189304.
1Corresponding author: 358 Molecular Biosciences Building, Cooper Road,
The University of Queensland, Brisbane, QLD 4072 Australia. E-mail: jafraser@uq.
edu.au
Volume 3 | April 2013 | 675
evident in eukaryotic parasites such as Leishmania (Ubeda et al. 2008)
and Trypanosoma (Minning et al. 2011). This capacity for rapid geno-
mic change renders pathogens difficult to counter as they can develop
resistance to drug therapies and evade the host immune response.
Pathogenic fungi also undergo microevolution during infection,
most notably in the emergence of drug resistance, which has been
described in the three most common systemically infecting fungal
genera: Candida, Aspergillus, and Cryptococcus (Selmecki et al. 2006;
Sionov et al. 2010; Mortensen et al. 2011). However, beyond antifun-
gal resistance, the adaptive potential of mutation during infection
predicts the emergence of fungal strains that are better suited to the
hostile host environment. With an estimated global burden of 625,000
deaths per annum (Park et al. 2009), Cryptococcus neoformans is one
such fungal pathogen for which this potential is of significant clinical
relevance. A key feature of C. neoformans pathogenesis is the ability to
establish dormant infections, as immunocompetent hosts are thought
to acquire an asymptomatic or subclinical initial infection that remains
latent until immune suppression, at which time the infection can
emerge (Garcia-Hermoso et al. 1999). Patients who appear to have
been successfully treated still frequently relapse, with the majority of
relapses believed to be a consequence of persistence of the original
strain rather than reinfection with a new isolate (Desnos-Ollivier et al.
2010). The molecular mechanisms underlying latency and relapse re-
main unknown and although the patients’ compromised immune sys-
tem is undoubtedly a contributing factor, changes in the fungal genome
may aid the escape from dormancy at the opportune moment.
Previous analyses of serial isolates of C. neoformans have estab-
lished the occurrence of in-host microevolution and attendant phe-
notypic variation, but the precise molecular events occurring in the
genome are poorly understood, although changes in karyotype indi-
cating large-scale genomic rearrangements are frequently observed
(Fries et al. 1996; Fraser et al. 2005). Experimental evolution studies
in Saccharomyces cerevisiae under nutrient-limiting conditions have
demonstrated that large chromosomal mutations occur at a high fre-
quency under such conditions and provide adaptive potential (Dunham
et al. 2002; Gresham et al. 2008). Similarly stressful conditions are likely
to be encountered during a pathogens’ progress through the host, pro-
viding ideal selective pressure for adaptive mutations to proliferate and
spread throughout the population.
Recent studies of C. neoformans var. grubii, the most clinically
prevalent form of this pathogen, have shown that it possesses a re-
markably stable genome, with few rearrangements since its divergence
from the less common var. neoformans an estimated ~20 million years
ago (Morrow et al. 2012). However, there is evidence that the genome
becomes more plastic when placed under the stresses encountered
while infecting a human host, with the appearance of remarkably
different electrophoretic karyotypes not only between patients, but
also between initial and relapse infections of an individual (Fries
et al. 1996). Clinical isolates readily display profound changes in
karyotype (Fries et al. 1996), and isolates placed under antifungal
stress rapidly accumulate characteristic transient aneuploidies that
are lost when the drug pressure is removed (Sionov et al. 2010). A
nascent theme from ongoing molecular analyses of the systemic fungal
pathogens is that although they appear to possess low genetic vari-
ability and are genetically stable, once under the selective pressure of
a host, microevolution and genetic variation rapidly increases. Elegant
studies in the commensal Candida albicans have also demonstrated
that passage through a host or exposure to various stressors increases
the rate of genetic and phenotypic variation (Forche et al. 2009, 2011).
Here we describe the first genome sequencing-based investigation
into microevolution between serial isolates of C. neoformans var.
grubii. Two isolates were obtained from the cerebrospinal fluid of
a woman positive for human immunodeficiency virus suffering from
cryptococcal meningoencephalitis, the first during initial diagnosis and
the second during a relapse episode 77 days later. Using whole-genome
sequencing of both isolates, we describe not only the shared ancestry
but also key differences between the two, ranging from single-nucleotide
variation to chromosomal aneuploidy. A single mutation in an AT-rich
interaction domain (ARID) protein appears responsible for multiple
phenotypic differences observed between the isolated strains, and may
also contribute to a dissemination defect observed in the later isolate
supporting its evolution during infection of the central nervous system
(CNS).
MATERIALS AND METHODS
Strains and phenotypic assays
C. neoformans var. grubii strains used in this study were the type strain
H99 (Perfect et al. 1980) and serial isolates F0 and F2 and G0, G1, and
G2. Fraser Lab H99 is a subculture of the Heitman Lab H99 #4413
(Morrow et al. 2012). F0 and F2 were derived from the cerebrospinal
fluid (77 days apart) of a patient infected with human immunodefi-
ciency virus who presented with cryptococcal meningoencephalitis to
Jacobi Medical Center in the Bronx, New York in 1994. The patient
was initially treated with amphotericin B and had also received at least
7 days of fluconazole prior to obtaining the F0 isolate. The patient was
discharged and presumably further treated with fluconazole (compliance
unclear). She was readmitted 2 months later with relapsed/persistent
cryptococcal meningoencephalitis. Amphotericin B and fluconazole
treatment was reinstituted. The F2 isolate was cultured from the cere-
brospinal fluid 14 days later. Both F0 and F2 have been frozen contin-
uously except during transfer from Albert Einstein College of Medicine.
Details of phenotypic assays are given in the Supporting Information,
File S1.
Multilocus sequence typing (MLST)
and transposon mapping
Strains were grown in yeast peptone dextrose (YPD) at 30 with
shaking for 16 hr. Washed cell pellets were frozen and lyophilized
and DNA extracted via the CTAB extraction method as described
(Pitkin et al. 1996). Sanger sequencing data were analyzed using
Sequencher (4.7, Gene Codes Corp, Ann Arbor, MI) and compared
with the Cryptococcus MLST sequence database (http://cneoformans.
mlst.net). A search for known transposons of C. neoformans with
Basic Local Alignment Search Tool (BLAST) (Altschul et al. 1990)
was performed to identify matches in the var. grubii strain H99 ge-
nome. Primers were designed based on these matches to amplify probes
from H99 genomic DNA for detection of the DNA transposon Cnirt2
and the retrotransposons Tcn1, Tcn2, Tcn4, and Tcn6. Genomic DNA
from each strain was digested, electrophoretically separated, and South-
ern blot (Southern 2006) hybridization patterns for each selected ele-
ment were then compared.
Pulsed-field gel electrophoresis
Preparation of agarose-embedded intact Cryptococcus chromosomal
DNA was performed as described (Lengeler et al. 2000). Chromo-
somes were separated in 1% pulsed-field certified agarose gels using
a CHEF-DRIII pulsed-field gel electrophoresis system (Bio-Rad, Rich-
mond, CA) in 0.5· Tris-borate-ethylenediaminetetraacetic acid run-
ning buffer. Running conditions were as follows: Block 1: ramped
switch time from 75 sec to 150 sec, 120, 4 V/cm, 20 hr; Block 2:
ramped switch time from 200 sec to 400 sec, 120, 4 V/cm, 30 hr. All
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separations were performed at 10214 using a Bio-Rad cooling mod-
ule. Chromosomes were stained and visualized with ethidium bromide.
1D nuclear magnetic resonance (NMR) spectroscopy
Metabolite extraction, 1D 1H NMR spectroscopy, analysis, and me-
tabolite profiling were performed as described (Morrow et al. 2012).
Strains H99, F0, and F2 were cultured in YNB or YPD plus 2% glucose
at 37 for 16 hr for metabolite extraction. The statistical characteristics
of the resulting models are listed in Table S3.
Sequencing and genomic analysis
Using the Illumina Genome Analyzer II, the Australian Genome
Research Facility (Brisbane, Australia) generated 75-bp paired end
reads (~17 million for F0 and F2, ~8 million for H99) with an average
insert size of 200 bp. Reads for H99 were generated to provide a
control against which variation in F0 and F2 could be normalized.
Details of read trimming, mapping, and assembly are given in File S1.
Transposable elements were identified using RepeatMasker (version
open-3.3.0) (Smit et al. 1996-2010). Structural variation was detected
using BreakDancer (Chen et al. 2009), CREST (Wang et al. 2011), and
Dindel (Albers et al. 2011). Details are provided in File S1.
Molecular techniques
Details of molecular techniques are given in File S1 in the supplementary
information. AVC1 was amplified from H99, cloned into pCR2.1-TOPO
(Life Technologies), and subsequently subcloned into the neomycin
resistance marker containing the plasmid pJAF1 (Fraser et al. 2003) and
the nourseothricin resistance marker containing pCH233 (McDade and
Cox 2001). Biolistic transformation was performed as described
(Magditch et al. 2012). Details of primers used in this study are
contained in Table S4.
Nematode and murine survival assays
Survival assay of the nematode Caenorhabditis elegans was performed
according to the protocol of Mylonakis et al. (2002) using strain N2
Bristol with Escherichia coli OP50 as the food source (Brenner 1974).
Assays were performed in triplicate. For murine assays, 7-wk-old fe-
male BALB/c mice were infected via nasal inhalation (Cox et al. 2000).
Ten mice for each strain were inoculated by pipetting a 50-mL drop
containing 2.5 · 106 cells (H99, F0, F2) or 5 · 105 (H99, avc1D, H99 +
AVC1) onto their nares. Mice were killed when their body weight had
reduced by 20% from their preinfection weight. The brain, lungs,
spleen, and liver from killed mice were subsequently removed, homog-
enized, and plated to determine colony-forming units per gram organ
weight. For both survival assays, Kaplan-Meier survival curves were
plotted using GraphPad Prism 6.0 (GraphPad Software, La Jolla CA)
and significance was determined using a log-rank test, whereas organ
burden significance was determined using the Student’s t-test. P values
of , 0.05 were considered significant. Murine virulence assays were
conducted in accordance with the Australian code of practice for the
care and use of animals for scientific purposes by the National Health
and Medical Research Council and were approved by the Molecular
Biosciences Animal Ethics Committee of The University of Queens-
land (AEC approval number: SCMB/008/11/NHMRC).
RESULTS
Serial isolates F0 and F2 share a recent common ancestor
Although relapse of cryptococcal meningoencephalitis is generally
caused by a derivative of the original infecting strain (Spitzer et al.
1993), recent work has shown that approximately 20% of infections
may involve more than one strain, and relapse may sometimes rep-
resent a new infection with a new isolate (Desnos-Ollivier et al. 2010).
We therefore initiated our study of serial isolate strains F0 and F2 by
performing MLST analysis with 12 well-established polymorphic loci
to determine their relationship (Litvintseva et al. 2006). The MLST
profiles of F0 and F2 were identical, consistent with isolate F2 being
derived from the original F0 strain. This genotype (designated M1) is
widespread and in the United States accounted for greater than 25% of
isolates in a study by Litvintseva et al. (2006); it differs from the well-
studied common laboratory strain H99 MLST genotype by only a sin-
gle nucleotide in one (LAC1) of the 12 loci. Although the identical
MLST profiles of F0 and F2 are consistent with a serial relationship,
the ubiquity of this genotype and similarity to H99 highlights the
limited resolution of this technique in a species that is predominantly
clonal.
A more powerful epidemiological tool to discriminate between
highly related isolates is an analysis of their transposon profile.
Approximately 5% of the C. neoformans genome consists of trans-
posons (Loftus et al. 2005), and the distribution of these has been
shown to be highly variable among strains (Jain et al. 2005). We used
a Southern blotting approach that included the use of probes to five
transposons (Cnirt2, Tcn1, Tcn2, Tcn4, and Tcn6) identified by
Goodwin & Poulter (2001) to compare their hybridization profile
against an array of clinical isolates and each other. Of these trans-
posons, Cnirt2, Tcn1, Tcn2, and Tcn4 showed identical profiles be-
tween F0 and F2, profiles that differed from all other isolates tested.
The Tcn6 profile was highly variable in all isolates, indicating that this
element is likely still functional and highly mobile (Figure S1). Com-
bined with the MLST result, these data show F0 and F2 are clonally
related and therefore represent an opportunity to characterize within-
host microevolutionary events that occur during human infection.
F0 and F2 exhibit altered virulence factor expression
but respond similarly to multiple stressors
The theory that C. neoformans undergoes microevolutionary change
in response to selective pressures encountered in the human host
predicts that strains F0 and F2 should exhibit differences in phenotype
such as their virulence factor profile and response to stress. Testing
revealed growth of the relapse strain F2 exceeded F0 and more closely
resembled that of H99, the var. grubii type strain, at all temperatures,
particularly at 37 and 39, potentially indicative of selection for opti-
mized growth at human body temperature (Figure 1). Unexpectedly,
capsule size was reduced in F2, as was melanization at 37. Protease
production appeared greater in F2 and phospholipase B and urease
levels were equivalent between the strains; however, these results are
difficult to interpret due to the growth differential between the strains.
Both strains were largely unaffected when exposed to oxidative,
nitrosative, ultraviolet rays, membrane and osmotic stress, nutrient
limitation, and most cell wall stressors (Figure S2). F0 was severely
impaired at pH 9 and greater and F2 at pH 11 (Figure S2). A slight
increase in resistance to cell wall stress was observed in F2 grown on
caffeine. F2 also displayed increased resistance to fluconazole, with an
MIC90 (i.e., the minimum inhibitory concentration needed to inhibit
the growth of 90% of organisms) of 25 mg/mL, twice that seen for
strain F0 (12.5 mg/mL). The acquisition of increased fluconazole re-
sistance is consistent with the patient having received fluconazole as
part of their treatment regime.
Serial isolates F0 and F2 therefore meet our criteria for strains that
have undergone microevolution: MLST and transposon studies support
a common origin, whereas phenotypic analysis reveals emergent differ-
ences in key phenotypes associated with proliferation and virulence. This
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indicates microevolutionary events not observable through MLST
and transposon profile analysis have occurred during infection,
presenting an ideal opportunity to utilize whole genome sequencing
technologies to uncover their causative mutations.
Substantial genomic variation exists between F0 and F2
and the reference strain H99
Illumina Genome Analyzer II reads for each strain were mapped
against the Broad Institute’s unpublished 19 Mb draft genome of
H99, which comprises 14 chromosomes ranging in size from ~700
kb to ~2.3 Mb. Alignment produced 99.5% coverage of the refer-
ence genome at 59·, 58·, and 30· read depth for F0, F2, and H99,
respectively. In our MLST analysis we had identified one single-
nucleotide variant (SNV) between H99 and our serial clinical iso-
lates F0 and F2; when expanded to the whole genome, 12,119 SNVs
were identified in F0 and F2 in comparison with H99, representing
0.06% of the genome (Figure 2). In addition, 1279 shared inser-
tions and deletions less than 50 bp in length (those affecting genes
with functional annotation are listed in Table S1A) and 33 larger
deletions (Table S1B) were detected in the alignments. Seven ad-
ditional insertions present in F0 and F2 were subsequently detected
using de novo assembly of reads that remained unmapped to the
reference sequence (Table S1B). In short, the strains differ consid-
erably from the control strain H99 despite their almost identical
MLST profile.
Unique differences exist between F0 and F2
Of the 12,000 differences we detected in F0 and F2 in comparison with
the reference strain H99, almost all were common to both isolates. F0
contains just three unique SNVs, one unique indel and a large in-
version affecting the first ~210 kb on the left arm of chromosome 3,
whereas F2 possesses one unique dinucleotide substitution (Table 1).
Of the unique SNVs and indels in F0, the three SNVs are predicted to
be silent mutations, whereas the indel alters the coding sequence of
DNA polymerase g (CNAG_06769). This creates a deletion of serine
817, a residue conserved in Cryptococcus species, but within a large,
200-residue insertion found only in basidiomycete genomes. Polymer-
ase g has been shown to be essential in the maintenance of the
mitochondrial genome in both S. cerevisiae (Foury 1989) and Schizo-
saccharomyces pombe (Chu et al. 2007). As we estimated the number
of mitochondrial genomes per cell to be similar between F0 and F2 (11
and 9, respectively, based on read coverage), there is likely no pheno-
typic effect from this mutation. The unique inversion in F0 affects the
first ~210 kb on the left arm of chromosome 3 and affects two genes:
a small oligopeptide transporter (CNAG_03013) and a short hypo-
thetical protein (CNAG_03012) likely to be an incomplete annotation.
A BLAST search identifies the transporter as part of the OPT oligo-
peptide transporter superfamily. The F2 relapse genome contains one
unique change, a substitution of a TA dinucleotide with a G within an
exon of a hypothetical protein (CNAG_02579) on chromosome 3; the
ensuing frameshift results in a predicted truncation of the protein
from 1543 to 130 residues. The gene appears to be unique to Crypto-
coccus, with high identity to homologs in C. neoformans var. neofor-
mans and C. gattii but no other species. The predicted protein
contains an ARID found in proteins associated with transcriptional
regulation (Kortschak et al. 2000), which is lost after truncation of the
protein. The presence of genetic variations in F0 absent from F2
suggests the relationship between the isolates is not a simple chrono-
logical one and instead likely represents a clonal expansion of an
original infecting isolate to form multiple independent lineages, each
having evolved concurrently during infection.
Both F0 and F2 exhibit aneuploidies of chromosome 12
Careful inspection of the karyotype of strain F2 reveals a minichro-
mosome of approximately 300 kb, only faintly visible in high quality
pulsed-field gels (Figure 3A). Evaluation of read depth revealed a trip-
lication of the left arm of chromosome 12 in F2 (Figure 3B). The size
of the minichromosome suggested it may represent an isochromo-
some comprising both the extra copies of the 140 kb left arm of
chromosome 12 (12L). Subsequent Southern hybridizations using tar-
geted probes confirmed the minichromosome contained 12L, and
digests of intact whole chromosomes on pulsed-field gels yielded
bands that were larger than would be expected if each copy of 12L
were to be maintained individually (results not shown). Sequence read
depth analysis also uncovered an aneuploidy of chromosome 12 in
strain F0, which possesses two complete copies of the chromosome.
Via parsimony, this suggests that the duplicate copy of the right arm
of chromosome 12 was lost during the infection process and the left
arm was then triplicated, potentially indicating a selective advantage
associated with multiple copies of this genomic region.
Chromosome 12 contains 270 predicted genes, 3.9% of the total
genes currently annotated in the H99 genome; 56 of these are con-
tained on the left arm (Table S2). We canvassed the genes on this arm
for those that may be potentially advantageous during infection. There
are four dehydrogenases present, including three aldehyde and aryl-
alcohol dehydrogenases potentially involved in oxidative stress resis-
tance. Interestingly, both genes required for asparagine catabolism are
Figure 1 Strains F0 and F2 differ in their production of several
virulence factors. (A) Growth assays at 30, human body temperature
of 37, and febrile body temperature of 39 on YPD. F2 displays
similar growth to H99 at 30 and 37 but diminished growth at 39.
(B) India ink staining under light microscopy reveals the capsule; F2 is
reduced compared with F0. Scale bar is 10 mM. (C) Melanization was
comparable at 30 on L-DOPA2containing media; however, F2 was
not melanized at 37. (D) F0 produces lower levels of extracellular
protease when grown on bovine serum albumin agar. (E) and (F)
Comparable levels of phospholipase and urease production were
observed when strains were grown on egg yolk and Christensen’s
agar, respectively.
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present, asparaginase (CNAG_06008) and aspartate transaminase
(CNAG_06026). Asparagine is a preferred nitrogen source of Crypto-
coccus and produces robust melanization (Lee et al. 2011). However,
our initial assays revealed F2 was unable to produce significant
amounts of melanin on L-DOPA media containing asparagine as
the nitrogen source at 37. We extended our analysis of melanization
to other nitrogen sources to discern any potential gene dosage effects
from the aneuploidies. Melanin production remained low in F2 at 37
on all nitrogen sources tested (Figure S3), and this defect extended to
30 on most other nitrogen sources, although the extent of inhibition
was not as drastic.
We next examined genes on the right arm of chromosome 12 for
any that could potentially contribute to the phenotypic differences
between the two strains. We first noted the presence of the virulence
factor gene phospholipase B (PLB1, CNAG_06085); however, in-
creased copy number of this gene in F0 did not yield increased levels
of secreted phospholipase B as determined by egg yolk agar assay
(Figure 1E). Also present on this arm is the galactose gene cluster,
consisting of UDP-glucose epimerase 2 (GAL10), galactokinase
(GAL1), and galactose-1-phosphate uridylyltransferase (GAL7). Un-
like the clusters of Saccharomyces, Candida, and Schizosaccharomyces,
the Cryptococcus cluster also includes a putative trehalose permease
(Slot and Rokas 2010). We subsequently assayed growth of F0 and F2
on galactose and trehalose and found F2, which in previous assays
showed stronger growth, was severely impaired on galactose at both
30 and 37, whereas both strains were inhibited on trehalose (Figure
4). This finding raised the possibility that the growth differential seen
between F0 and F2 was sensitive to the carbon source provided.
Growth assays on a range of other sugar and nonsugar carbon sources
revealed F2 was also diminished on lactose and maltose, while the
apparently weaker strain F0 outperformed F2 on most non-sugar
carbon sources tested, except ethanol (Figure S4). Growth on combi-
nations of glucose plus a variety of nonsugar carbon sources resem-
bled that of glucose alone, suggesting the phenotype is dominant (data
not shown).
F0 and F2 exhibit differences in metabolic profiles
The observed differences in nutrient acquisition prompted an in-
vestigation of the metabolic profiles of F0 and F2. We performed 1D
proton NMR spectroscopy on metabolites extracted after growth at
37 in rich or minimal media containing the most easily assimilated
carbon source glucose. Correlation of spectral peaks with existing
Figure 2 Extensive SNVs and indels are observed in
F0 and F2 compared with H99. Circos plot of the 14
Cryptococcus chromosomes (outermost rectangles)
depicting the .12,000 SNVs and 1200 indels
detected in serial isolates F0 and F2 compared with
the reference strain H99. Inner rings represent (from
outermost): SNVs common to F0 and F2, indels com-
mon to F0 and F2, SNVs and indels unique to F0;
and SNVs and indels unique to F2.
n TABLE 1 Unique SNVs and indels in F0 and F2
Strain Chr H99 Change Gene function Effect of mutation
F0 2 CTT — DNA polymerase g Deletion of S817 (of 1,433)
7 C A Conserved hypothetical protein (280 bp upstream)
10 T A Flavin-containing monooxygenase (30 bp downstream)
11 G C Dynamin Synonymous mutation
F2 3 AT G Conserved hypothetical protein Q39R, truncation at 130 (of 1,543)
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metabolite databases and chemical shift standards revealed primarily
sugars and amino acids were present, in particular glucose and treha-
lose, as well as other metabolites such as succinate, acetate, and glyc-
erol. Principal components analysis (PCA) showed systematic
differences between all three strains in both growth media (Figure
5A) with the metabolic fingerprint of F2 being more similar to H99
than F0, in agreement with the growth pattern observed in other
glucose based assays. Pairwise comparisons between F0 and F2
in minimal media revealed clear separation (Figure 5B), with strain
F2 associated with greater levels of trehalose, choline, and lactate and
decreased levels of glucose, glycerol, glutamate, glutamine, formate,
acetate, alanine, and glycerophosphocholine (Figure 5C). These differ-
ences in metabolite profiles were much smaller in rich media than
in minimal media, with isolates not dividing into separate clusters and
the corresponding model having only marginal predictive power, in-
dicating compromised metabolic pathways may be present in F0
which could result in a greater sensitivity to environmental conditions
(Figure S5, A and B, and Table S3). In addition, systematic differences
were observed for each individual isolate when profiles were compared
between rich and minimal media (Figure S5, C-F).
The metabolites observed are in agreement with those identified in
previous C. neoformans metabolomics studies, which have reported
dominance of trehalose and lipids (Bubb et al. 1999; Himmelreich
et al. 2001). Trehalose is also associated with capacity to grow at
37 (Petzold et al. 2006) and increased levels of trehalose have been
associated with heat tolerant mutants of Cryptococcus (Morrow et al.
2012), in agreement with the increased capacity of F2 for growth at
this temperature. The large number of genes affected by the duplica-
tion of chromosome 12 likely contributes to the metabolome differ-
ences observed between the strains; for example the right arm
contains two glycerol-1-phosphatases, amplification of which may
be responsible for increased glycerol levels in F0. However, more than
half the genes on this chromosome have no functional annotation,
leaving many potential contributors unknown.
F0 and F2 are equally virulent in nematode and murine
models but F2 displays compromised dissemination
To determine whether the microevolutionary changes observed
between strains F0 and F2 are associated with a selective advantage
in vivo, we conducted virulence assays in two separate animal model
systems. In the nematode infection model, no significant change in
survival time of Caenorhabditis elegans was observed when cultured
on strains F0 and F2 over 8 d (Figure 6A). In the murine inhalation
model, we initially observed apparently similar virulence between
strains F2 and H99, whereas F0 appeared attenuated (Figure 6B).
However, two mice cleared the infection with strain F2, whereas all
F0-infected mice died. Overall, survival times did not differ signifi-
cantly between F0 and F2. Analysis of fungal burden within multiple
organs, however, revealed significant differences in the progression of
infection between the two strains: F2 cells disseminated from the lungs
poorly, and failed to reach the brain in all but two mice (Figure 6C).
Organ colony-forming unit per gram was significantly reduced for the
Figure 3 Karyotypic analysis reveals
a minichromosome in F2 associated
with aneuploidy observed via read
depth analysis. (A) Pulsed-field gel
electrophoresis of reference strain
H99 and serial isolates F0 and F2
reveals a minichromosome of approx-
imately 300 kb. (B) Read depth analysis
of serial isolates F0 and F2 in compar-
ison with H99 indicates a duplication
of chromosome 12 in F0 and a triplica-
tion of the left arm of chromosome
12 in F2.
Figure 4 Strains F0 and F2 exhibit different growth on alternate
carbon sources. Growth assays on minimal media supplemented with
various carbon sources. F0 displays diminished growth on glucose and
trehalose at 30 and 37. F2 displays poor growth on galactose and
myo-inositol at both temperatures, and acetate at 37.
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brain, liver, and spleen of F2-infected mice, and fungal burden in the
lungs themselves was also reduced. Given it was isolated from the CNS,
this dissemination defect suggests the evolution of F2 after penetration
of the blood brain barrier by the infecting ancestral strain.
Mutation of the ARID protein occurs in multiple,
independent serial isolates
Given no clear association between the genes on chromosome 12 and
the observed phenotypes, we decided to investigate the ARID-
containing gene affected by the single unique mutation identified in
F2. We thus performed sequencing of this gene in our existing
collection of 14 clinical isolate series. To our surprise, despite the
relatively small sample size, we discovered a second series in which
a mutation disrupts this same gene in a relapse isolate, this time in the
third of three isolates denoted G0, G1, and G2. Probing of Southern
blotted G2 DNA revealed that a translocation interrupts exon 3 of the
ARID-containing gene (results not shown), which would result in
a truncated protein of approximately 500 residues (of 1543). The
disruption of this gene in a second, unrelated relapse isolate suggests
a potential role in disease recurrence. Further investigation revealed
G2 exhibited similar growth inhibition on carbon sources as observed
in F2, as well as reduced capsule size. None of the strains in the series
produced significant amounts of melanin at 37. Reintroduction of the
ARID-containing gene into both F2 and G2 mostly abolished the carbon
Figure 5 Strains F0 and F2 exhibit different metabolic profiles. (A) Three-dimensional scores plot of the PCA analysis of F0, F2, and H99 under
two different growth conditions. All six metabolic types can be distinguished. Red: F2 in YNB; orange: F0 in YNB; yellow: H99 in YNB; green: F2 in
YPD; cyan: F0 in YPD; blue: H99 in YPD. Hotelling’s 95% confidence range of the PCA model is indicated by the ellipsoid. (B) PCA scores plot of
principal components 1 and 2 for F0 (orange triangles) and F2 (red squares) in YNB. Distance between the points is an indicator of similarity
between the samples. (C) Corresponding bivariate loadings line plot. The line plot displays on the loadings coefficient axis the (center scaled)
correlation coefficients that relate individual integral regions of the NMR spectrum to the PC1 axis of the scores plot. Individual peaks correspond
to peaks in the 1D NMR spectra; peaks that are positive indicate metabolites significantly increased in F2 whereas negative peaks are increased in
F0. The overlaid heat map relates the relative contribution of the peak to the scores plot when using Pareto scaling instead of center scaling.
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source phenotype in both strains (Figure S6). Virulence factor testing
revealed melanin production was not restored in F2 however capsule size
increased in both complemented strains (Figure S7 and Figure S8).
A deletion mutant was subsequently created in the H99 back-
ground and revealed similar phenotypic characteristics: reduced
growth on a selection of carbon sources, capsule inhibition, and poor
melanization at 37. We were able to rescue all three of these pheno-
types through reintroduction of the gene (Figures 7 and 8). We there-
fore dubbed the gene AVC1 for ARID-containing regulator of
virulence traits and carbon assimilation. The consistency of the carbon
source phenotype between F2 and G2 and avc1Δ indicates the known
glucose-related phenotype of H99 is not distorting these results (Morrow
et al. 2012). We also tested the three strains in the presence of
fluconazole and found slightly increased resistance when AVC1 is
disrupted, which was ablated when the gene was reintroduced into
avc1Δ and F2, but not G2, suggesting the effect is genotype depen-
dent (Figure S9). Significantly, infection with avc1Δ resulted in a re-
duction in fungal burden in a similar manner to that observed in F2,
although not as severe, as more isolates successfully penetrated the
CNS (Figure 9). However, unlike in F2, growth in the lungs was not
inhibited in avc1Δ. We also observed an overall significant reduction
in virulence of avc1Δ which was not seen in F2.
DISCUSSION
One of the challenges regarding the exploration of within-host
microevolution is conclusively demonstrating the relationship be-
tween serial isolates. Traditionally, it was believed that most relapse
was caused by the original infecting isolate and that these reinfections
often corresponded with karyotypic change. More recently it has been
shown that mixed infections occur in up to 20% of cases (Desnos-
Ollivier et al. 2010) and karyotypic change described as microevolu-
tionary may in fact reflect infection with other unrelated strains.
Although MLST analysis has been used to distinguish sequential iso-
lates from co-infection, the resolution of this technique limits the
capacity for differentiation as evidenced by our MLST result compar-
ing F0 and F2 with H99. Sequencing technology now permits com-
plete sequencing of serial isolates, and our preliminary work in
a larger collection of series has shown that strain relationships fall
within two distinct groups: those that differ by thousands of SNVs,
which we propose are coinfections, and those that differ by only a few,
which we propose are cases of microevolution, such as occurs in F0
and F2. Significantly, our results indicate the evolution of multiple
divergent lineages during infection. Although we cannot conclusively
state the timeframe over which these mutations occurred, strain F0
had already accumulated unique changes from the common infecting
ancestor at the time of initial diagnosis. This is in line with the
observed prevalence of rapid and large-scale change in studies of
S. cerevisiae (Dunham et al. 2002; Lynch et al. 2008) as well as other
fungi such as C. glabrata (Polakova et al. 2009) and Mycosphaerella
graminicola (Stukenbrock et al. 2010). The dissemination defect seen
in F2 supports its evolution in-host, once the infection had reached
the CNS. These findings give further credence to the idea that fungal
pathogens may possess dedicated mechanisms for rapidly generating
such large scale changes as a means of adaptation (Selmecki et al.
2010) especially given the stable genome inheritance of var. grubii since
divergence from var. neoformans 20 million years ago.
Aneuploidy of chromosome 12 occurs in both F0 and F2
The development of aneuploidy as an evolutionary process has been
extensively described in multiple yeast species, both in vitro and
in vivo (Kellis et al. 2004; Selmecki et al. 2006; Polakova et al.
2009). The associated gene duplications can have a profound effect
on the proteome (Pavelka et al. 2010) and may also be a substrate for
neofunctionalization (Ohno 1970) through accelerated mutation in
gene copies that are largely free of selection (Kellis et al. 2004). Al-
though we did not observe an increase in mutation rate on chromo-
some 12 using a crude measure of SNV per nucleotide, we do not
know whether this duplication event occurred before or during infec-
tion; if it did occur during infection, the timeframe since its appearance
may be too short to detect an increase in accumulation of mutations.
Tolerance of aneuploidy is contentious; aneuploidy is common
and well tolerated in C. albicans (Selmecki et al. 2009), but demon-
strated to be detrimental or advantageous in S. cerevisiae, presumably
depending on genetic context and growth conditions (Torres et al.
Figure 6 F0 and F2 exhibit significantly different dissemination
patterns despite apparently similar virulence. (A) No significant
difference in survival was seen between each of the strains when
young adult C. elegans worms were cultured on indicated strains. (B) A
murine virulence assay revealed no significant difference in virulence
between F0 and F2; H99 was significantly more virulent than F0 (P =
0.0001). (C) F0 and F2 exhibited significantly different patterns of or-
gan burden: P , 0.05, P , 0.01, P , 0.001, P , 0.0001;
Student’s two-tailed t-test, two sample, equal variance (liver) or un-
equal variance (lungs, brain, spleen).
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2007; Pavelka et al. 2010). Although certain disomic C. neoformans
strains have displayed impaired growth and attenuated virulence in
mice (Sionov et al. 2010), many are afforded increased azole resis-
tance. Simultaneous amplification of multiple chromosomes has been
linked to changes in melanin production in C. neoformans (Hu et al.
2011). Accumulating examples of aneuploidies suggest chromosomal
amplification as an important mechanism of variation in C. neoformans.
Our data support short-term tolerance of aneuploidy in C. neoformans
with minimal phenotypic consequences.
Disruption of transcriptional regulator AVC1 in F2
The ARID is associated with chromatin remodeling, and loss of such
a gene may be pleiotropic and confer broad phenotypic deviation, as
observed in other C. neoformans regulatory gene mutants (Cheon
et al. 2011; Lee et al. 2011). ARID-containing proteins are found in
diverse species, including humans, plants, insects, and fungi, and can
bind DNA in both a sequence-specific and nonsequence-specific man-
ner (Kortschak et al. 2000). Seven subfamilies exist in mammalian and
insect genomes: ARID1 to ARID5 and JARID1 and JARID2. Although
originally named for their interaction with AT-rich sequences, only
two of the subfamilies, ARID3 and ARID5, show AT-rich site prefer-
ence (Patsialou et al. 2005). Orthologs of ARID1, JARID1 and poten-
tially ARID2 and JARID2 have been identified in fungi (Wilsker et al.
2005). Swi1, an ARID1 ortholog in S. cerevisiae, is a component of the
SWI/SNF chromatin remodeling complex that regulates a wide variety
of transcripts, including invertase (SUC2) and galactokinase (GAL1)
(Sudarsanam and Winston 2000). S. cerevisiae has one other anno-
tated ARID-containing protein (Ecm5), whereas Schizosaccharomyces
pombe contains four including Sol1, a SWI/SNF component. AVC1 is
one of three annotated ARID-containing proteins in C. neoformans
var. grubii; CNAG_00240 on chromosome 1 has no known function
while CNAG_07411, within the mating-type locus on chromosome 5,
is the transcription factor Rum1.
Typically, although amino acid identity is high within the ARID
region within a subfamily (70280%), between subfamilies identity
drops to below 30%. Fungal ARID regions drop significantly in iden-
tity, however, with less than 30% identity between Saccharomyces
Swi1 and other members of the ARID1 subfamily, making ortholog
identification difficult. Members of the ARID1 subfamily contain glu-
tamine-rich regions and LXXLL motifs, although the position of these
is not conserved between family members. Avc1 contains both gluta-
mine-rich regions and a single LXXLL motif, as well as proline and
alanine-rich regions. The other uncharacterized ARID-containing
protein in var. grubii, CNAG_00240, also contains glutamine-rich
regions but no LXXLL motifs. BLAST of both ARID regions yields
Swi1 orthologs for Avc1 only. Further work is needed to determine
whether either of these genes is the Cryptococcus homolog of SWI1.
Multiple independent disruptions of AVC1 indicate
a role in relapse
The significance of AVC1 is increased by its being identified in two
relapse isolates, indicative of a role in promoting infection persistence.
However, phenotypic analysis revealed decreased production of two
key virulence traits, capsule and melanin, and an overall decrease in
virulence was observed in avc1D. Clinical isolates of C. neoformans
produce inconsistent virulence profiles, however, and melanin in par-
ticular is frequently variable in these isolates (Clancy et al. 2006;
Pereira et al. 2009). Mutants lacking melanin production due to mu-
tation in the laccase gene LAC1 have been shown to have compro-
mised ability to escape from the lungs, whereas growth in the brain is
unaffected (Noverr et al. 2004). Although both F2 and avc1D
exhibited a degree of dissemination defect, the liver was colonized
in all mice, indicating the infection was not trapped in the lungs.
However, often gene products affecting melanin also affect virulence
and/or dissemination independently (Chun et al. 2007; Waterman
Figure 7 The growth of the deletion mutant avc1D resembles that of
relapse isolate F2 on alternate carbon sources. Growth assays
on minimal media supplemented with various carbon sources. Growth
inhibition of avc1D is abolished after reintroduction of the gene. Figure 8 Capsule and melanin production are inhibited in avc1D. (A)
Growth assays at 30, human body temperature of 37 and febrile
body temperature of 39 on YPD; no change was observed following
deletion of AVC1. (B) India ink staining under light microscopy reveals
the capsule; capsule production is inhibited in avc1D and restored
following reintroduction of the gene. Scale bar is 10 mM. (C) Melani-
zation on L-DOPA containing media is inhibited in avc1D and restored
following reintroduction of the gene. (D2F) Comparable levels of pro-
tease, phospholipase, and urease production were observed in all
strains when grown on bovine serum albumin, egg yolk, and Christen-
sen’s agar, respectively.
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et al. 2007). Changes in carbon source utilization as well as melanin
production at 37 have also been observed in snf1 mutants (Hu et al.
2008). Snf1, a serine/threonine protein kinase, was found to increase
the expression of LAC1 under low glucose conditions and mutants
were unable to persist in the brain, rendering them avirulent. Al-
though the majority of F2 infections failed to reach the brain, the titer
when infection was established was high, indicating F2 was unable to
reach the brain rather than unable to persist. Capsule inhibition has
been shown to produce strains both with limited growth in the lungs
and dissemination to the brain (Wilder et al. 2002). Although F2
showed lower colony-forming unit in the lungs, avc1D did not, in-
dicating this is unlikely to be contributing to the virulence phenotype
of avc1D. Future work consisting of virulence studies utilizing the
intracranial infection model will help to clarify the role of AVC1 in
infection without the confounding variable of CNS penetration.
This work reveals the simultaneous evolution of multiple lineages
derived from a very recent common ancestor during C. neoformans
infection. The observed aneuploidies support via parsimony the pres-
ence of a chromosome 12 duplication in the common ancestor; how-
ever, we cannot determine whether this arose during infection or was
present ex vivo. The CNS dissemination defect in F2 (coupled with its
recovery 77 d after the initial diagnosis) suggests it arose after pene-
tration of the CNS, and the associated increase in fluconazole resis-
tance may have given the isolate a selective advantage after antifungal
therapy. Disruption of a single gene, AVC1, in separate relapse isolates
supports a role for this gene in disease persistence or relapse. These
results illustrate the importance of population diversification in path-
ogenic organisms and the clonal expansion of the fittest member as
selective pressures alter. Studies of more serial isolates may facilitate the
identification of further genomic variation pertinent to clinical relapse
and persistence associated with this important fungal pathogen.
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